data_1g9e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1g9e _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.823 0.344 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.46 122.06 9.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -115.95 158.67 22.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -123.17 170.42 10.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -160.74 133.9 6.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.031 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.31 -32.16 6.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.567 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.29 138.77 27.03 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.948 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.41 -161.8 35.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.289 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.39 143.85 53.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.889 0.376 . . . . 0.0 111.485 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.29 113.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.077 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.01 148.04 36.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.84 145.9 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.391 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.38 -7.34 79.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.678 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.21 118.64 5.91 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.318 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -70.01 135.58 49.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 111.126 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.2 tp -116.81 134.01 55.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.379 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.414 ' NE ' ' HB3' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -107.42 119.66 40.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.505 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 14.4 mt -111.28 139.14 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.36 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.8 p -126.28 98.79 5.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.968 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.447 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 41.4 t -95.19 135.23 37.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.711 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.77 145.66 43.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.273 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.981 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 120.925 0.393 . . . . 0.0 111.094 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.448 ' N ' ' CG ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -153.39 178.49 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.552 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.4 ' O ' HG13 ' A' ' 51' ' ' ILE . 1.6 mtm -140.98 123.05 15.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.287 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.43 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -150.55 150.52 22.54 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.247 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.447 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 79.1 m95 -84.51 152.79 23.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.141 0.496 . . . . 0.0 110.939 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.6 m-85 -132.14 -178.77 5.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.396 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.419 ' CG ' ' CG ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -154.91 161.08 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.976 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -161.6 147.49 13.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.69 163.46 42.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.656 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.19 138.28 36.11 Favored 'Trans proline' 0 CA--C 1.518 -0.318 0 C-N-CA 122.275 1.983 . . . . 0.0 112.372 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.41 -0.73 39.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.752 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.89 -177.45 3.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -100.13 -172.14 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.417 ' HD2' ' CH2' ' A' ' 107' ' ' TRP . 10.2 ptt-85 -102.79 136.06 43.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.365 . . . . 0.0 111.046 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 1.7 pt-20 -131.6 163.65 27.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.331 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.533 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.1 t -104.26 171.08 7.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.267 0.556 . . . . 0.0 111.089 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.9 -67.09 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.491 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.6 136.82 26.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.325 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -141.88 146.33 35.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -114.87 143.29 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.846 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 26.1 t-20 . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 121.177 0.513 . . . . 0.0 110.444 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.935 0.397 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.72 -177.42 3.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.484 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.2 t80 -138.73 92.32 2.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.787 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -93.53 166.27 12.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.013 0.435 . . . . 0.0 111.071 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.24 159.45 19.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.366 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.48 37.19 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 0.0 111.838 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.4 t -116.35 -24.99 7.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.96 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.472 ' HA ' ' NH1' ' A' ' 67' ' ' ARG . 26.9 m -156.82 21.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.046 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 65' ' ' ARG . 16.2 ttp85 -75.26 86.32 2.47 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.884 0.849 . . . . 0.0 110.689 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.84 -17.93 0.85 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.314 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.472 ' NH1' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -115.26 -33.16 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.642 0.258 . . . . 0.0 111.304 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CE2' ' HG2' ' A' ' 83' ' ' MET . 2.6 m-85 -88.88 137.02 32.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.128 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 10.1 m -106.82 153.63 22.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -141.35 136.14 32.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.942 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.501 ' N ' HD12 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -152.66 178.72 9.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.671 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.83 167.59 18.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.019 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -79.4 -37.01 38.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.788 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 m120 62.97 35.5 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.819 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.46 -47.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.18 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.4 tttp -130.07 -64.36 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt 167.66 70.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 64.9 m -135.65 144.78 46.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.006 0.432 . . . . 0.0 111.063 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.8 m -116.54 147.6 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.696 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 2.2 m-85 -136.72 128.65 29.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.906 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -124.7 121.7 35.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.167 0.508 . . . . 0.0 110.808 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -94.59 99.21 11.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.48 ' HG2' ' CE2' ' A' ' 68' ' ' PHE . 1.5 mtp -80.51 87.82 5.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.003 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.65 176.06 7.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.738 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 34.96 48.96 0.37 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.594 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.42 HD13 ' CZ ' ' A' ' 68' ' ' PHE . 1.2 mp -58.2 165.88 1.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.313 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -145.3 167.89 13.35 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.817 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 54.8 Cg_endo -69.71 1.59 4.26 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.553 2.169 . . . . 0.0 113.148 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -98.76 -20.3 16.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.874 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.15 -21.18 46.86 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.083 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 99.9 m -51.79 101.55 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.782 0.325 . . . . 0.0 111.198 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.41 177.66 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.345 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 9.4 p -80.88 101.57 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.197 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.65 101.71 10.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.026 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.482 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 6.3 t -103.23 125.42 49.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.466 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.9 t -81.93 136.5 35.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.171 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.47 176.69 22.14 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.118 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.37 167.81 21.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.355 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -126.52 170.42 18.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.239 -0.982 . . . . 0.0 113.172 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -156.82 132.52 9.45 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.98 13.48 48.26 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.73 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.52 -9.47 45.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.886 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -101.82 179.56 4.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.849 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.452 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 84.3 m95 -136.72 86.23 2.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.576 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.56 19.04 17.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.96 132.42 56.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.417 ' CH2' ' HD2' ' A' ' 45' ' ' ARG . 19.5 m95 -139.24 164.02 30.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.025 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.87 -142.84 10.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.574 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.63 -35.32 15.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.382 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 99.8 150.69 25.38 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.863 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.9 t -145.27 114.67 7.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -76.63 132.36 39.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.971 0.415 . . . . 0.0 111.272 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.43 ' N ' HE21 ' A' ' 112' ' ' GLN . 60.7 t -110.14 124.08 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.901 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.7 m -112.49 117.26 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.62 -168.84 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.083 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.605 0.241 . . . . 0.0 111.262 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.837 0.351 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mp -142.48 -179.57 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -169.13 169.07 9.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.04 163.31 18.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 p -167.74 126.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.62 -31.83 6.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.664 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.39 179.11 0.34 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.766 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.12 -157.79 27.49 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.076 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.45 145.36 52.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.812 0.339 . . . . 0.0 111.262 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.54 132.97 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.171 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.96 129.48 41.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.187 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.61 128.2 22.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.401 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.25 -3.04 82.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.8 -144.56 14.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.444 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.58 140.97 33.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.934 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 83' ' ' MET . 5.8 tp -129.84 141.46 50.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.446 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -122.09 131.38 53.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.489 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 3.9 mt -121.53 145.1 48.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.291 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.445 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 98.5 p -126.11 108.84 11.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.278 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 50.0 t -101.22 135.88 41.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.507 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -122.0 147.85 45.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.939 0.399 . . . . 0.0 111.424 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.822 179.743 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.46 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 43.8 t80 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 121.022 0.439 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -84.47 -176.88 6.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.258 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.9 mtt -141.21 117.78 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.33 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.429 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -141.22 168.16 25.49 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.039 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 77.7 m95 -103.0 158.76 16.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 111.163 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 13.8 m-85 -134.72 178.49 6.97 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -148.58 155.22 40.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.929 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -145.85 110.69 5.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.5 153.24 48.09 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.37 136.46 40.07 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.325 2.016 . . . . 0.0 112.454 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.09 -1.36 33.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.657 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.74 -179.34 3.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.909 0.385 . . . . 0.0 111.048 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.45 -171.58 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.449 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -96.7 154.57 17.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.37 0.605 . . . . 0.0 111.329 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -157.46 139.24 14.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.241 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 1.6 t -67.99 171.98 6.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.478 0.656 . . . . 0.0 111.446 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.414 ' N ' ' OG ' ' A' ' 47' ' ' SER . 2.8 t -130.0 -67.8 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.221 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.14 124.42 13.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.067 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -120.62 147.3 45.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.337 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.31 141.34 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.924 0.392 . . . . 0.0 111.286 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.785 179.906 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.785 0.326 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.424 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -107.63 -179.03 3.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.002 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 50' ' ' ALA . 12.8 t80 -139.04 86.58 2.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.713 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 58' ' ' THR . 9.3 m-85 -86.79 143.57 27.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.38 165.14 24.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.442 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.4 p -82.33 33.66 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 0.0 111.701 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.4 p -118.99 -21.56 7.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.126 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.433 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 17.4 m -148.46 19.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.019 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.5 ttt85 -62.49 79.25 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.63 0.729 . . . . 0.0 110.832 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 134.09 3.16 3.24 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.175 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -119.1 -52.87 2.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.816 0.341 . . . . 0.0 111.069 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 5.2 m-30 -75.5 150.85 38.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.1 m -113.32 157.87 21.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.007 0.432 . . . . 0.0 110.98 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.478 HD11 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -151.58 135.18 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.96 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.478 ' N ' HD11 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -164.8 152.04 11.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.716 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 164.31 11.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.07 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.437 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 54.2 t0 -76.93 -30.33 56.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.989 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.35 25.61 13.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.25 -52.59 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.892 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 2.6 pttt -134.16 -57.53 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 173.42 70.96 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.779 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.454 HG22 ' CE1' ' A' ' 80' ' ' TYR . 25.8 m -134.92 139.42 44.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.114 0.483 . . . . 0.0 111.336 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.92 146.16 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.336 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 1.9 m-85 -135.1 155.16 51.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.72 0.295 . . . . 0.0 111.035 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.427 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -146.31 125.62 13.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.952 0.406 . . . . 0.0 110.941 179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.61 96.5 7.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.536 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.454 ' CE ' ' CE1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -79.38 91.25 5.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.271 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.44 178.53 6.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 t 38.99 40.75 0.48 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.441 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.38 159.49 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.145 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 16.5 mmmt -128.62 163.67 43.36 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.411 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 57.8 Cg_endo -70.99 6.96 1.49 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.37 2.047 . . . . 0.0 113.271 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -109.2 -8.1 15.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.009 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.27 -11.15 58.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.652 0.263 . . . . 0.0 111.308 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 97.6 m -53.18 107.7 0.26 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.057 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.61 -177.65 2.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.525 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.5 t -89.75 105.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.792 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.454 ' CE1' ' CE ' ' A' ' 83' ' ' MET . 11.3 m-85 -87.91 110.2 20.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 7.2 m -111.15 136.08 50.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.718 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.405 ' HB3' ' CE3' ' A' ' 36' ' ' TRP . 15.7 p -98.91 138.66 35.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 111.175 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.73 -169.3 11.69 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.361 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.46 ' CB ' ' CZ ' ' A' ' 32' ' ' TYR . . . -136.92 167.41 21.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 111.193 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.01 -175.8 25.57 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.629 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -173.75 108.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.73 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.09 16.69 49.32 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.764 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.0 -16.51 25.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.558 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -96.49 179.81 4.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.769 0.319 . . . . 0.0 110.475 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.414 ' CH2' ' HB3' ' A' ' 50' ' ' ALA . 79.9 m95 -141.88 92.51 2.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.766 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -117.43 -2.18 11.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.586 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 t -93.28 132.49 37.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -137.28 162.63 33.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.38 -92.49 2.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.403 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -140.36 -69.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 110.845 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.54 151.08 5.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.738 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 t -147.25 106.46 3.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.899 0.38 . . . . 0.0 110.45 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.17 142.22 57.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.203 0.525 . . . . 0.0 111.04 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.416 HG23 ' CD2' ' A' ' 94' ' ' TYR . 41.1 t -117.62 116.43 51.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.182 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.1 m -100.58 108.55 20.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.075 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.31 -158.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.396 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.873 0.368 . . . . 0.0 111.031 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.823 0.344 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 mp -147.82 151.54 36.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -154.32 173.11 16.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.06 164.31 14.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.792 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.92 101.3 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.28 87.17 1.97 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.423 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.62 152.87 16.22 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.447 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.71 -155.25 26.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.41 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.03 134.67 49.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.908 0.385 . . . . 0.0 111.247 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.33 128.96 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.282 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 132.56 46.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.309 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.54 154.26 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.582 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.18 -9.14 73.93 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.792 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.78 -163.14 25.98 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.608 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.48 141.37 41.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tp -128.77 132.27 47.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.612 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -111.57 116.9 31.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.381 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.435 ' CB ' ' CH2' ' A' ' 36' ' ' TRP . 9.9 mt -104.69 133.74 49.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.626 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 p -112.25 134.94 53.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.659 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -134.29 126.12 29.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.92 0.39 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.19 152.75 21.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.971 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 -179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.465 ' CE2' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.996 0.427 . . . . 0.0 111.026 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.419 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 39.1 m-20 -123.45 -176.38 3.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.703 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.9 ttm -145.63 126.43 14.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.192 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.86 162.71 28.97 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.733 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.435 ' CH2' ' CB ' ' A' ' 20' ' ' LEU . 79.7 m95 -91.63 155.12 18.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 111.487 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -137.69 -177.94 5.02 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.785 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -151.49 163.14 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.559 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 39' ' ' GLN . 4.5 tp60 -165.91 128.37 2.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.03 0.443 . . . . 0.0 111.621 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.45 167.94 8.57 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.496 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 137.56 28.64 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.233 1.955 . . . . 0.0 112.476 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.33 2.0 24.22 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.703 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -119.48 152.0 37.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -77.21 156.1 31.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.387 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.9 143.0 52.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.951 0.405 . . . . 0.0 111.245 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.43 143.25 48.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.211 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.542 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.6 t -83.57 172.79 12.0 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 111.183 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.409 ' CG2' ' HG2' ' A' ' 38' ' ' ARG . 2.0 t -129.19 -66.64 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.976 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.09 161.67 40.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.417 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -160.24 144.4 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.995 0.426 . . . . 0.0 111.511 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.4 tt -123.24 143.67 35.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.0 m120 . . . . . 0 N--CA 1.449 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.016 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.86 0.362 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.99 -179.36 3.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.022 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -140.6 142.18 35.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.382 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -128.86 168.32 16.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.84 0.353 . . . . 0.0 111.026 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.0 168.07 13.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 63' ' ' SER . 56.3 m -69.24 153.07 44.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.498 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 t 84.38 -10.23 0.89 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.522 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.6 m -154.2 16.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.462 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ARG . 8.9 tpt180 -82.08 83.15 7.41 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.665 0.745 . . . . 0.0 109.962 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.09 -0.65 7.71 Favored Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.158 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -110.81 -52.63 2.77 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.837 0.351 . . . . 0.0 110.794 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.454 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.3 m-30 -76.86 149.34 36.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 m -111.05 152.37 26.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.879 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.2 tp -137.49 146.19 28.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.761 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.08 172.33 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 111.032 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.85 143.61 50.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.913 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.421 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 7.2 t0 -83.57 -38.07 22.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.09 26.75 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.43 -42.71 2.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.963 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.25 29.09 2.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.876 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt 61.93 53.97 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.418 HG22 ' CE1' ' A' ' 80' ' ' TYR . 97.9 m -118.36 148.72 42.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.026 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.75 141.02 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.843 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 24.9 m-85 -125.96 126.69 44.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.977 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.404 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -120.63 116.81 26.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 0.0 110.51 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -94.76 94.59 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.156 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.454 ' HG2' ' CD2' ' A' ' 68' ' ' PHE . 25.9 mtm -78.02 92.91 4.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.798 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.83 176.44 6.63 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 37.21 43.32 0.34 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.695 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.98 156.65 5.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.02 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -124.24 170.77 8.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.855 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 89.8 Cg_endo -77.96 8.15 3.62 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.515 2.143 . . . . 0.0 112.954 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -116.92 7.52 13.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.257 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -92.4 -10.06 39.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.304 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 97.9 m -53.97 107.79 0.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.256 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.29 177.0 4.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 4.2 p -85.69 106.33 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.027 0.441 . . . . 0.0 110.846 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.96 101.8 13.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.137 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 9.1 m -113.13 136.03 53.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.609 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 25.6 p -100.65 147.12 26.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.029 0.442 . . . . 0.0 111.365 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.83 -171.28 12.45 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.214 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.465 ' CB ' ' CE2' ' A' ' 32' ' ' TYR . . . -138.19 166.73 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 111.269 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.61 176.26 18.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.665 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.49 113.69 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 110.575 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.66 16.97 52.86 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.695 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.87 -14.17 31.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.4 ' CG2' ' H ' ' A' ' 104' ' ' TRP . 4.4 m -96.32 179.31 5.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.548 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' A' ' 33' ' ' ASP . 78.0 m95 -143.76 102.64 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.795 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.11 11.02 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.439 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.87 137.91 42.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.642 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -140.73 164.11 31.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.964 0.412 . . . . 0.0 111.034 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.18 -130.71 6.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.337 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -98.81 -63.23 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 0.0 110.807 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.89 151.07 8.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.665 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.4 t -145.28 109.72 4.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.359 . . . . 0.0 110.428 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.54 141.63 55.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.208 0.528 . . . . 0.0 111.035 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.21 131.82 70.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.254 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 83.9 m -116.85 138.67 51.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.207 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.11 168.17 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.28 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.5 m . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.104 -179.87 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.832 0.348 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.5 mp -140.07 135.32 32.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.17 131.41 44.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.75 164.68 17.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.7 p -158.19 111.73 2.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.03 84.51 1.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.355 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.44 143.81 8.96 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.547 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.83 -156.19 21.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.528 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.08 143.19 54.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.919 0.39 . . . . 0.0 111.362 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.97 126.88 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.135 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.57 139.95 56.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.32 137.06 29.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.323 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.5 -15.73 60.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.703 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.61 -154.65 7.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.42 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.62 139.29 31.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.011 0.434 . . . . 0.0 111.213 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.8 tp -124.45 135.31 53.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.554 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.06 115.31 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 111.557 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.41 ' HB3' ' CH2' ' A' ' 36' ' ' TRP . 12.4 mt -112.61 132.48 55.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.584 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -120.67 113.34 20.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.67 123.14 49.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.791 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.71 165.76 11.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.298 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.912 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.466 ' CE2' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.992 0.425 . . . . 0.0 110.741 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -115.47 -173.65 2.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.86 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.3 mtm -145.87 124.71 12.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.055 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.88 152.93 24.88 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.829 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.41 ' CH2' ' HB3' ' A' ' 20' ' ' LEU . 73.1 m95 -88.46 154.82 20.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.114 0.483 . . . . 0.0 111.427 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.1 m-85 -133.65 -178.69 5.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.266 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.6 ptm180 -152.94 157.86 41.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.752 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -145.46 145.4 31.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.946 0.403 . . . . 0.0 111.336 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.37 151.77 78.11 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.44 139.6 41.75 Favored 'Trans proline' 0 CA--C 1.517 -0.345 0 C-N-CA 122.362 2.041 . . . . 0.0 112.537 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.76 -7.08 43.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.764 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.45 -166.68 1.21 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.798 0.333 . . . . 0.0 110.9 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.86 -171.71 1.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -98.19 133.77 42.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.935 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -131.79 152.28 51.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.423 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 6.6 t -83.41 174.66 10.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.382 0.61 . . . . 0.0 111.079 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.426 ' N ' ' OG ' ' A' ' 47' ' ' SER . 3.8 t -130.12 -62.47 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.071 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.88 129.83 11.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -127.98 145.26 51.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.386 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.0 tt -126.98 142.29 43.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.32 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.74 179.77 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 120.387 0.137 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.85 -179.77 4.54 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.987 0.423 . . . . 0.0 111.19 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 50' ' ' ALA . 65.3 t80 -139.7 91.0 2.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.64 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -76.83 158.06 31.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.2 172.01 7.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.167 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -69.57 150.87 46.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.618 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.0 OUTLIER 84.72 -11.19 0.81 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.623 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.426 HG12 ' CE2' ' A' ' 68' ' ' PHE . 16.4 m -149.21 12.45 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.48 79.2 1.05 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.537 0.684 . . . . 0.0 110.7 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.73 3.11 10.26 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.825 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -108.01 -41.32 4.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.732 0.301 . . . . 0.0 111.09 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.439 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 9.5 m-30 -94.27 146.72 23.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.124 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.7 m -105.12 158.03 16.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.812 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.7 tp -144.79 139.92 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.106 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 m -154.42 137.35 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.679 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.13 152.01 21.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.245 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.472 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 39.4 t0 -84.43 -36.5 22.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.793 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.99 29.98 19.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.95 -46.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.09 31.76 1.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt 62.77 56.14 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 60.6 m -116.04 150.31 37.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.5 131.95 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.928 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.584 ' CD1' ' HB3' ' A' ' 21' ' ' SER . 25.6 m-85 -113.09 120.58 41.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.195 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.09 112.61 23.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.068 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -96.35 96.84 9.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.203 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.439 ' HG2' ' CD2' ' A' ' 68' ' ' PHE . 1.3 mtp -81.94 88.3 6.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.03 177.66 6.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.57 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 t 37.98 40.85 0.32 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.516 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 162.62 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -128.99 170.83 9.84 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.779 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 84.5 Cg_endo -77.67 10.82 2.4 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 113.089 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -122.02 10.98 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.342 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -95.94 -15.46 22.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.608 0.242 . . . . 0.0 111.36 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 82.9 m -49.27 112.86 0.69 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.435 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.34 173.65 5.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.969 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 7.4 p -81.1 105.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.979 0.419 . . . . 0.0 110.925 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.42 ' CD1' HG22 ' A' ' 113' ' ' VAL . 21.9 m-85 -83.95 99.08 10.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.959 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 4.3 m -105.63 128.03 53.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 14.0 p -95.15 143.78 26.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.964 0.411 . . . . 0.0 111.224 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -139.81 -173.06 13.03 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.158 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.466 ' CB ' ' CE2' ' A' ' 32' ' ' TYR . . . -144.69 166.37 25.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.957 0.408 . . . . 0.0 111.264 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.93 171.68 18.21 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.676 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.01 115.5 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.621 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.89 15.8 50.05 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.782 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.77 -14.67 31.98 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.528 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.5 m -99.1 178.79 4.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.789 0.328 . . . . 0.0 110.608 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -138.2 93.06 2.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.655 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -119.2 2.33 11.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.52 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.04 132.72 41.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 110.898 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -140.91 164.93 28.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.71 -154.81 18.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -30.75 20.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.333 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.94 151.0 26.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.883 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.4 t -145.34 109.45 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.262 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -67.61 141.55 56.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.158 0.504 . . . . 0.0 111.052 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.42 HG22 ' CD1' ' A' ' 94' ' ' TYR . 43.5 t -119.87 126.23 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.329 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.8 m -109.99 142.62 41.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.955 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 t -127.52 169.54 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.155 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.813 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.819 0.343 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 mp -149.12 155.1 40.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.66 161.11 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.714 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.81 164.72 12.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.83 0.348 . . . . 0.0 110.978 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -164.76 95.65 0.72 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.59 -28.43 2.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.638 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -50.0 138.43 20.89 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.9 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.0 -172.49 43.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.089 -0.576 . . . . 0.0 112.373 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mp -69.35 150.03 47.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.863 0.363 . . . . 0.0 111.554 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 p -153.39 116.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.941 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.74 139.77 25.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.426 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.17 123.3 7.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.82 0.56 60.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.834 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.31 138.55 14.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.449 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 t -79.68 141.54 36.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 110.966 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.9 tp -132.92 150.44 52.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.309 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -125.45 126.56 45.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.402 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 2.2 mt -114.49 149.72 35.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.799 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.57 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 71.1 m -131.21 118.63 20.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.05 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.0 p -125.37 131.34 52.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.58 169.11 9.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.311 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.035 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.108 0 CA-C-O 120.919 0.39 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 44.2 m-20 -101.6 -172.45 2.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.941 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -143.6 124.1 13.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.733 0.301 . . . . 0.0 111.273 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.52 166.11 29.62 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.939 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' A' ' 20' ' ' LEU . 52.6 m95 -91.9 156.2 17.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.133 0.492 . . . . 0.0 111.307 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 8.1 m-85 -136.45 179.18 6.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.938 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 16.7 ptm180 -152.86 160.56 43.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.723 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -165.5 159.83 17.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.064 0.459 . . . . 0.0 111.459 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.01 162.33 57.32 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.506 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.59 137.39 35.86 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.387 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.54 3.07 38.67 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.722 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 -172.87 2.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.783 0.325 . . . . 0.0 111.058 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.85 -178.84 3.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.739 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.409 ' HD2' ' CH2' ' A' ' 107' ' ' TRP . 18.2 ptt-85 -103.28 139.65 38.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.173 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -140.73 146.74 38.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.236 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.7 t -83.85 175.2 9.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.316 0.579 . . . . 0.0 111.363 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.4 -57.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.786 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.29 157.66 43.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.719 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HA ' ' CA ' ' A' ' 35' ' ' GLY . . . -158.19 140.97 14.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.06 0.457 . . . . 0.0 111.484 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.5 tp -121.21 139.82 47.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.835 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.447 -0.579 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.933 -179.841 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.48 -178.13 3.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.599 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.6 t80 -136.93 142.59 42.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.561 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.424 ' CZ ' ' O ' ' A' ' 68' ' ' PHE . 5.8 m-85 -126.44 165.77 18.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.976 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.6 166.41 11.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.5 152.13 45.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.703 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 83.62 -10.15 0.98 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.571 -178.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.432 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 35.6 m -152.08 15.39 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.237 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.403 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -70.48 78.91 0.56 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.576 0.703 . . . . 0.0 110.752 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.51 3.35 5.63 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.0 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -112.29 -44.04 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.754 0.311 . . . . 0.0 111.016 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.448 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 5.9 m-30 -78.79 140.2 38.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.786 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 28.9 m -105.45 151.06 24.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 111.164 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -145.54 136.8 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.634 -179.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.496 ' N ' HD12 ' A' ' 70' ' ' ILE . 19.3 p -162.41 141.59 9.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.091 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -73.25 165.42 25.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.958 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 37.1 t0 -97.19 -33.5 11.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.826 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 60.34 58.36 2.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.17 -46.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -140.38 29.29 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.72 55.48 2.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.62 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.548 HG21 ' CE1' ' A' ' 80' ' ' TYR . 6.4 m -123.3 158.94 29.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.109 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.19 143.66 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.715 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.57 ' CE1' ' HB3' ' A' ' 21' ' ' SER . 15.2 m-85 -124.5 135.11 52.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.506 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.426 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -127.19 121.04 30.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.084 0.469 . . . . 0.0 110.812 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -99.23 101.15 12.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.838 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.448 ' HG2' ' CD2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -87.75 95.22 10.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.181 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.92 175.36 8.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.833 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 34.4 48.33 0.27 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.794 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.401 ' CD2' HG13 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -54.34 164.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.004 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.43 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -128.68 164.46 38.24 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.813 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 87' ' ' LYS . 63.1 Cg_endo -72.82 6.32 2.5 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.533 2.155 . . . . 0.0 113.155 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -111.89 -0.03 15.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.282 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -84.91 -11.73 54.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.576 0.227 . . . . 0.0 111.237 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 90.8 m -56.02 103.5 0.1 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.67 175.65 4.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.381 . . . . 0.0 111.583 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 7.7 p -80.84 105.37 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.082 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 111' ' ' THR . 9.8 m-85 -84.42 105.04 14.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.656 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.4 m -110.96 127.38 55.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.9 t -81.17 127.4 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.485 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -128.15 -177.41 14.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.471 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -146.13 147.77 31.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.848 0.356 . . . . 0.0 111.213 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.458 ' N ' ' CE3' ' A' ' 104' ' ' TRP . . . -78.77 -170.07 37.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.374 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.28 100.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.67 18.54 45.71 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.761 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.19 -20.28 11.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -97.62 -179.81 4.59 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 110.426 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.458 ' CE3' ' N ' ' A' ' 99' ' ' GLY . 71.8 m95 -145.55 102.54 3.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.945 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -134.96 15.6 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.298 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.37 133.22 51.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.786 0.326 . . . . 0.0 110.66 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.409 ' CH2' ' HD2' ' A' ' 45' ' ' ARG . 9.4 m95 -136.25 162.15 33.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.28 -137.19 9.13 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.494 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -87.07 -51.02 6.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.334 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.39 151.28 12.88 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.661 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 13.9 t -158.56 118.57 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -79.44 142.64 35.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.004 0.43 . . . . 0.0 111.176 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 91' ' ' THR . 52.6 t -116.31 136.48 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.159 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.6 m -109.31 130.0 55.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.011 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.401 HG13 ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -126.18 -158.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.55 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.332 -0.156 0 CA-C-O 120.869 0.366 . . . . 0.0 110.87 -179.829 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.818 0.342 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 mp -160.61 99.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.02 174.01 8.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.012 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.37 163.97 22.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.733 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -169.62 135.94 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.08 -18.36 26.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.729 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.07 -173.83 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.831 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.12 164.36 10.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.509 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mp -69.28 146.51 52.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.85 0.357 . . . . 0.0 111.376 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -165.53 119.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -54.76 154.5 5.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.24 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.64 138.3 14.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.358 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.99 -21.79 44.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.487 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.52 122.98 6.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.305 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 11.4 p -70.0 130.53 42.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 111.131 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.7 tp -109.74 133.74 52.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.494 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -107.29 119.2 38.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 0.0 111.422 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.437 ' HB3' ' CH2' ' A' ' 36' ' ' TRP . 13.9 mt -114.53 136.32 53.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.534 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.5 p -122.34 111.05 16.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.122 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.4 t -107.29 134.52 50.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.514 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.29 152.4 26.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.253 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.055 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' CE2' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.98 0.419 . . . . 0.0 110.854 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -120.26 -171.45 2.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.715 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.67 160.32 40.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.923 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . 179.56 141.62 4.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.0 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.437 ' CH2' ' HB3' ' A' ' 20' ' ' LEU . 81.4 m95 -82.72 154.7 24.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.15 0.5 . . . . 0.0 111.285 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.579 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.5 m-85 -137.89 -178.27 5.18 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.296 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.417 ' CG ' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -148.85 161.04 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.494 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -162.7 137.51 6.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.005 0.431 . . . . 0.0 111.387 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.15 166.77 14.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.49 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.21 135.77 41.42 Favored 'Trans proline' 0 CA--C 1.517 -0.355 0 C-N-CA 122.169 1.913 . . . . 0.0 112.248 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.43 6.35 33.92 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.458 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.51 -177.23 3.18 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.832 0.348 . . . . 0.0 111.022 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -109.7 -171.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.775 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -86.12 134.43 33.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.078 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -131.74 116.45 17.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.412 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 1.5 t -68.09 169.22 10.56 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.599 0.714 . . . . 0.0 111.328 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.417 ' CG2' ' CG ' ' A' ' 38' ' ' ARG . 2.3 t -132.63 -68.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.372 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -140.94 145.99 36.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.71 0.29 . . . . 0.0 111.307 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -140.85 142.18 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.4 tt -125.23 145.75 32.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.249 -179.877 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.958 0.408 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.42 -178.02 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.978 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 52.9 t80 -139.19 96.2 3.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.892 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.37 158.16 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.842 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . -98.13 157.16 16.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 63' ' ' SER . 17.3 p -69.38 151.57 45.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.572 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 86.47 -12.3 0.59 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.556 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.97 7.67 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.497 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 80.23 0.55 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.561 0.696 . . . . 0.0 110.781 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 139.49 1.77 1.86 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.619 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.431 ' HG3' ' CD1' ' A' ' 68' ' ' PHE . 13.4 ptp180 -117.96 -40.03 3.03 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.779 0.289 . . . . 0.0 111.303 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 83' ' ' MET . 14.4 m-30 -90.23 159.0 16.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.115 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.8 m -125.23 157.19 37.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -156.32 134.47 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.997 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.459 ' N ' HD12 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -160.13 140.25 11.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.842 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -78.24 173.3 12.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.95 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 33.3 t0 -98.99 -33.59 10.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.034 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.22 28.7 17.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.54 -59.82 1.51 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.953 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -128.06 28.47 5.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.5 60.02 0.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.149 0.5 . . . . 0.0 110.729 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.421 HG21 ' CE1' ' A' ' 80' ' ' TYR . 95.0 m -122.84 147.93 45.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.047 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.6 m -119.78 139.37 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 41.1 m-85 -124.45 115.88 21.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 0.0 111.197 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -112.24 111.77 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.139 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.42 97.29 9.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.769 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.441 ' CE ' ' CZ ' ' A' ' 94' ' ' TYR . 5.3 mtp -77.18 87.66 3.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.258 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -82.02 176.37 9.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.702 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 37.4 48.55 0.86 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.753 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.98 157.77 29.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.978 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.33 173.83 5.25 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.773 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.38 9.16 3.53 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.613 2.208 . . . . 0.0 113.034 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -113.04 -4.95 13.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.1 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.29 -12.25 58.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.239 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 76.2 m -48.94 104.06 0.06 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.46 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.4 166.62 8.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.365 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.475 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 9.8 p -76.33 105.26 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.038 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.441 ' CZ ' ' CE ' ' A' ' 83' ' ' MET . 5.0 m-85 -82.54 100.26 10.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.4 m -109.11 134.48 51.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 26.7 p -96.49 146.14 25.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.033 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.16 -178.35 16.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.555 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.473 ' CB ' ' CE2' ' A' ' 32' ' ' TYR . . . -131.65 170.18 15.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -118.26 172.56 14.49 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.802 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -159.09 118.08 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.504 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.11 16.03 51.98 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.696 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.31 -12.78 36.73 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.673 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -98.13 180.0 4.57 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.744 0.307 . . . . 0.0 110.672 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.413 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 83.6 m95 -138.45 101.61 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.815 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -123.21 -8.49 8.19 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.474 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.42 140.4 29.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.827 0.346 . . . . 0.0 111.112 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -141.88 165.47 27.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.795 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.27 -149.25 13.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.524 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.03 -55.63 3.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.686 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.91 150.98 9.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.763 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.4 t -146.84 112.21 5.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.375 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -61.95 140.52 58.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.222 0.534 . . . . 0.0 111.012 -179.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.9 t -119.13 97.64 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.037 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.5 m -86.13 135.69 33.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 111.285 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 t -130.87 168.0 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.184 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.674 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.99 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.828 0.347 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mp -145.6 162.87 36.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.42 141.96 27.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -94.52 167.79 11.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -168.85 115.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.869 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.23 -34.77 4.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.555 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.42 138.94 27.33 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.817 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.42 -162.88 31.11 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.44 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.45 152.23 45.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.846 0.355 . . . . 0.0 111.404 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 p -170.12 109.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -57.56 152.29 15.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.338 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.45 153.65 2.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.376 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.08 5.18 75.16 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.722 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.71 119.78 4.37 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.395 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.2 136.82 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 111.032 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 tp -127.34 131.3 50.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.403 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -107.42 133.0 52.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.901 0.381 . . . . 0.0 111.418 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 1.1 mt -120.15 150.78 40.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.072 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.3 p -123.23 140.31 53.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.204 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.4 t -134.1 135.15 43.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.697 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.3 157.09 20.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.051 179.912 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 5.4 t80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.962 0.41 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.92 172.39 13.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.55 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -137.92 117.56 13.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.847 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -145.85 149.65 21.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.849 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.438 ' CE2' HD21 ' A' ' 81' ' ' LEU . 67.4 m95 -88.32 153.62 21.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.13 0.49 . . . . 0.0 111.175 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.3 m-85 -132.32 -178.88 5.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.588 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.406 ' CG ' ' CG ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -151.97 157.21 41.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.157 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.45 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -157.69 141.4 15.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 111.416 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.53 161.63 53.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.535 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.36 137.09 42.21 Favored 'Trans proline' 0 CA--C 1.518 -0.315 0 C-N-CA 122.287 1.991 . . . . 0.0 112.384 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.37 3.74 40.8 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.671 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -112.51 -176.06 2.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.872 0.368 . . . . 0.0 111.056 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -111.53 157.27 20.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.45 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 15.8 ptt-85 -74.47 133.15 42.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.12 0.486 . . . . 0.0 111.732 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 16.4 pt-20 -134.54 165.11 25.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.903 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 12.1 t -101.03 172.64 6.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.194 0.521 . . . . 0.0 111.164 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 t -128.95 -67.51 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.367 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.02 135.42 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.0 111.367 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.414 ' HA ' ' CA ' ' A' ' 35' ' ' GLY . . . -131.65 144.75 51.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.11 143.69 40.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.251 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.1 p30 . . . . . 0 N--CA 1.448 -0.561 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.189 -179.82 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.86 -177.79 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -139.41 92.27 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.805 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -78.7 159.55 27.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.82 161.51 15.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 0.0 111.304 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' SER . 32.8 t -69.28 152.21 45.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.477 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.8 t 88.83 -14.4 0.36 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.515 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.41 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 34.9 m -150.49 16.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.432 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.72 81.3 5.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.523 0.678 . . . . 0.0 111.151 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.89 -11.2 2.36 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.185 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.41 ' CG ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -109.46 -51.37 2.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.777 0.323 . . . . 0.0 111.247 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CE2' ' HG2' ' A' ' 83' ' ' MET . 3.1 m-85 -69.93 140.15 53.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.905 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 m -110.82 146.08 37.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.778 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 71' ' ' SER . 1.1 tp -136.42 140.94 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.88 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -151.13 -174.44 4.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.81 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -130.83 168.06 17.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.005 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.414 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 34.3 t0 -97.32 -37.56 10.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.844 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.41 35.92 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.81 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.32 -67.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.098 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 29.82 7.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.36 44.99 14.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.68 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.43 HG22 ' CE1' ' A' ' 80' ' ' TYR . 46.6 m -112.64 151.5 30.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.173 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.22 158.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.381 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.43 ' CE1' HG22 ' A' ' 78' ' ' THR . 33.9 m-85 -141.71 129.88 22.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.026 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.438 HD21 ' CE2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -125.21 122.15 36.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.094 0.473 . . . . 0.0 110.898 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -95.57 95.96 8.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.438 ' HG2' ' CE2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -77.08 88.43 3.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.855 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.4 176.26 7.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 36.41 40.76 0.13 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.588 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.14 158.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.182 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 6.2 mptt -127.64 162.91 46.24 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.78 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 74.2 Cg_endo -74.91 5.71 3.78 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.457 2.105 . . . . 0.0 112.927 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -109.73 -6.82 15.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.134 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.34 -19.4 46.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.7 m -50.42 106.83 0.13 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.864 0.364 . . . . 0.0 111.25 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.34 -176.2 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.977 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -87.51 103.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.854 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -82.75 108.75 16.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.468 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.2 m -107.5 130.68 54.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.316 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 50.6 t -92.35 138.73 31.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.623 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -146.98 176.36 25.89 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.826 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.484 ' CB ' ' CZ ' ' A' ' 32' ' ' TYR . . . -126.7 172.94 9.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 0.0 111.011 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -124.84 178.21 16.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.185 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -171.38 122.48 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.379 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.66 15.7 54.39 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.642 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.83 -9.4 47.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.826 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.3 m -100.16 178.67 4.71 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 110.775 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.434 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 80.0 m95 -140.89 90.95 2.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -110.26 -6.62 14.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.372 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.85 131.26 36.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.706 0.288 . . . . 0.0 110.782 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -141.3 164.09 31.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.001 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.34 -136.66 8.43 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.46 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -102.96 -35.65 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.928 0.394 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.6 151.1 12.59 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.68 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 t -144.26 104.77 4.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.852 0.358 . . . . 0.0 110.457 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.77 141.12 58.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 111.113 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.79 130.34 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.304 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.1 m -115.72 133.28 56.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.115 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.44 168.01 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.306 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.968 -179.799 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.733 0.301 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mp -156.44 119.26 4.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.133 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -122.9 165.7 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.576 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.44 163.32 15.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.774 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.45 131.23 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.11 -28.36 11.22 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.663 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -53.23 164.23 2.14 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.869 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.64 171.29 25.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.41 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mp -69.07 137.2 53.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.928 0.394 . . . . 0.0 111.398 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.23 128.57 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.991 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -64.2 149.35 48.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.35 144.32 5.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.382 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.98 -14.95 63.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.635 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.29 129.67 9.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.37 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.08 135.54 49.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 111.03 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tp -119.51 132.12 55.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.292 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -114.04 116.53 29.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.828 0.347 . . . . 0.0 111.369 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.429 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 14.5 mt -107.6 138.31 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.403 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 90.9 p -124.96 120.08 30.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.962 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.426 ' HB3' ' CG1' ' A' ' 79' ' ' VAL . 26.8 t -117.89 131.35 56.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.022 0.439 . . . . 0.0 110.595 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.91 149.14 31.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.287 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.022 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.418 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 23.4 m-20 -129.15 -169.13 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.16 120.73 8.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.098 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -144.95 168.87 26.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.861 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.427 ' CH2' ' HB3' ' A' ' 20' ' ' LEU . 74.8 m95 -107.14 159.5 16.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 111.19 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 11.0 m-85 -137.74 178.3 7.21 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.726 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -156.34 154.04 29.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.398 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.406 ' HB3' ' CG1' ' A' ' 93' ' ' VAL . 5.0 tp60 -157.02 119.32 3.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.953 0.406 . . . . 0.0 111.449 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -102.91 169.79 7.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.575 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.73 138.96 32.86 Favored 'Trans proline' 0 CA--C 1.517 -0.328 0 C-N-CA 122.241 1.961 . . . . 0.0 112.447 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.92 3.44 35.84 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.712 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -118.1 158.41 25.08 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.947 0.403 . . . . 0.0 110.984 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.47 157.23 19.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.215 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.441 ' NE ' ' CZ3' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -69.92 144.36 52.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.165 0.507 . . . . 0.0 111.13 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.29 146.91 27.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.407 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 2.6 t -77.01 173.11 12.17 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.456 0.646 . . . . 0.0 111.421 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.423 ' N ' ' OG ' ' A' ' 47' ' ' SER . 15.9 t -127.21 -60.63 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.235 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.99 123.23 7.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.957 0.408 . . . . 0.0 111.197 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -120.34 147.47 44.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.231 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 52' ' ' ASN . 3.1 tp -132.03 141.54 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.027 0.441 . . . . 0.0 111.459 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.418 ' N ' HG13 ' A' ' 51' ' ' ILE . 10.3 m120 . . . . . 0 N--CA 1.448 -0.563 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.815 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.92 -179.3 3.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.777 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 50' ' ' ALA . 9.5 t80 -138.6 85.93 2.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.666 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 58.5 m-85 -72.39 161.74 30.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.06 162.76 15.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 63' ' ' SER . 7.1 m -69.46 151.53 45.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.556 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.3 t 86.33 -12.23 0.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.584 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' HB ' ' CG ' ' A' ' 68' ' ' PHE . 34.2 m -145.33 10.27 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.484 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.2 81.08 6.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.514 0.673 . . . . 0.0 110.971 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 139.51 -3.62 2.68 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.364 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.86 -51.9 1.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.637 0.256 . . . . 0.0 111.297 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 5.4 m-30 -69.93 159.16 34.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.554 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.9 m -124.17 148.35 47.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.375 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.411 HG22 ' CZ ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -138.99 136.31 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.678 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.8 p -153.44 -173.76 4.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 111.076 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.45 160.39 39.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.982 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.425 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 13.6 t0 -90.55 -44.77 9.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 69.72 11.69 7.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.71 -34.96 6.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.891 0.377 . . . . 0.0 110.776 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -142.5 26.89 1.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.633 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.65 52.44 5.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.68 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.9 m -116.06 152.2 34.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.095 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 21' ' ' SER . 8.6 p -117.05 143.47 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.453 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 42.5 m-85 -126.64 110.06 12.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.852 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.429 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -112.82 112.29 23.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.46 . . . . 0.0 110.191 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.74 100.29 12.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.269 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 4.7 mtp -81.66 90.48 6.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.829 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 177.09 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 37.46 47.1 0.71 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.671 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.63 165.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.067 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.486 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 18.6 mmtt -144.99 164.89 24.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.764 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 55.3 Cg_endo -69.47 2.23 3.56 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.418 2.079 . . . . 0.0 113.222 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -104.34 -0.4 28.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.246 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -89.95 -9.95 46.89 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.41 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 87.1 m -50.35 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.724 0.297 . . . . 0.0 111.156 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.22 169.5 7.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.528 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 5.4 p -82.59 107.22 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.291 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.458 ' CD1' ' CG2' ' A' ' 113' ' ' VAL . 13.7 m-85 -85.77 105.74 16.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.602 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 37' ' ' PHE . 21.6 m -109.31 138.62 45.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.156 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.4 p -97.64 142.34 29.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.826 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.17 177.16 21.71 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.294 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . . . -130.29 167.45 18.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.942 0.401 . . . . 0.0 111.098 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.83 175.11 19.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.831 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.86 113.56 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.371 . . . . 0.0 110.735 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.88 16.06 50.83 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.784 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.35 -14.83 33.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.487 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.1 m -97.92 -179.84 4.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.676 0.274 . . . . 0.0 110.426 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.418 ' CH2' ' HB2' ' A' ' 33' ' ' ASP . 77.0 m95 -140.83 98.99 3.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -133.54 10.6 4.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.501 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.38 62.19 0.85 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.308 0.575 . . . . 0.0 110.736 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.441 ' CZ3' ' NE ' ' A' ' 45' ' ' ARG . 29.8 m95 -68.7 165.18 20.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.136 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.77 -121.42 4.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.515 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 -67.79 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 134.41 151.87 6.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.668 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 t -151.84 108.35 3.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.551 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -59.23 141.06 55.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.199 0.524 . . . . 0.0 111.13 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 91' ' ' THR . 37.6 t -121.92 82.85 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.7 m -73.25 141.26 47.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -138.71 177.15 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.321 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.5 p . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.788 0.328 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.92 141.16 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.43 164.35 15.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.794 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.85 163.26 17.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.0 t -163.98 119.1 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.63 -22.81 8.11 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.666 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -47.29 140.62 7.7 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.882 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.39 169.03 37.34 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.375 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.21 145.37 53.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.807 0.337 . . . . 0.0 111.399 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.02 132.78 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.38 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.07 139.98 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.452 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.76 130.36 9.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.588 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.65 -20.84 48.87 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.602 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.24 179.66 53.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.571 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 t -120.5 139.0 53.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.992 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.7 tp -125.6 132.75 52.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.457 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.37 131.17 56.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.0 111.629 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 3.3 mt -121.24 141.29 51.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.311 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' A' ' 80' ' ' TYR . 95.4 p -124.03 113.53 18.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.6 t -108.18 134.56 50.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.636 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.9 145.46 39.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.155 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 120.831 0.348 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -59.61 174.86 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.031 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -143.87 126.59 16.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.17 156.15 26.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.823 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' CYS . 69.9 m95 -87.31 153.74 21.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.144 0.497 . . . . 0.0 111.315 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.7 m-85 -131.63 178.25 6.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.422 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 7.6 ptt180 -152.34 155.24 37.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.815 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -167.03 148.85 6.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.945 0.402 . . . . 0.0 111.273 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.29 167.19 17.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.606 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.15 137.52 48.3 Favored 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 122.228 1.952 . . . . 0.0 112.216 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.92 3.98 45.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.603 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -110.75 -179.61 3.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.819 0.342 . . . . 0.0 110.837 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.01 167.63 9.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.045 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.42 135.19 34.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.098 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HG3' ' CG ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -138.88 166.21 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.657 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 11.4 t -104.47 173.43 6.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.091 0.472 . . . . 0.0 111.078 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.52 -66.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.258 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.62 132.04 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.277 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -132.29 145.3 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.276 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.404 ' CA ' HG21 ' A' ' 58' ' ' THR . 19.1 tt -122.78 142.32 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.459 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.645 179.562 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 120.726 0.298 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.416 ' CG2' HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -97.48 -177.27 3.75 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.967 0.413 . . . . 0.0 110.975 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 50' ' ' ALA . 63.2 t80 -139.41 93.03 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.725 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.424 ' CE1' HG21 ' A' ' 70' ' ' ILE . 89.7 m-85 -80.14 158.0 26.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.39 176.13 5.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.282 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.34 152.03 45.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.578 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 62' ' ' SER . 4.0 t 85.82 -11.64 0.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.522 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.433 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 35.9 m -154.32 17.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.442 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 79.32 0.96 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.557 0.694 . . . . 0.0 110.799 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.46 3.47 9.43 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -111.67 -43.65 3.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.0 m-30 -83.36 151.95 25.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.958 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.3 m -112.25 149.22 32.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.647 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.485 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -163.33 136.84 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.876 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.485 ' N ' HD13 ' A' ' 70' ' ' ILE . 8.0 p -168.35 154.02 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -77.68 139.62 39.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.597 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.5 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 0.4 OUTLIER -79.75 -34.06 40.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.106 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t30 68.21 28.01 6.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.189 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.2 -41.66 4.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.891 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.04 37.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.619 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.5 mttt 61.48 53.12 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.699 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.51 ' CG2' ' CE1' ' A' ' 80' ' ' TYR . 74.6 m -122.96 147.93 46.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.053 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.7 m -111.57 138.68 39.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.413 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.51 ' CE1' ' CG2' ' A' ' 78' ' ' THR . 7.3 m-85 -126.21 125.62 42.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.653 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.453 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -122.29 121.68 37.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.181 0.515 . . . . 0.0 110.926 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -100.47 96.79 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.732 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.444 ' HG2' ' CD2' ' A' ' 68' ' ' PHE . 31.1 mtm -82.21 91.85 6.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.984 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -82.32 176.39 9.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 84' ' ' ASN . 67.1 p 28.99 59.99 0.14 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.754 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.54 162.2 15.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.17 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.516 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.2 OUTLIER -126.62 164.42 34.64 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.545 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 74.3 Cg_endo -75.49 6.05 3.84 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.38 2.053 . . . . 0.0 112.956 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -108.51 -6.15 16.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.847 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.31 -16.05 50.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.287 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.5 m -52.76 106.96 0.18 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.771 0.32 . . . . 0.0 111.19 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.5 -170.72 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.436 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 85.6 t -94.33 106.74 18.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.425 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -86.88 103.38 15.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.199 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.3 m -108.49 127.2 53.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 31.9 p -89.78 146.32 24.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.825 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.92 -173.09 20.61 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.463 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -138.17 149.6 46.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 111.107 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.441 ' N ' ' CE3' ' A' ' 104' ' ' TRP . . . -105.15 148.9 16.65 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.608 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.28 122.71 19.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.826 0.346 . . . . 0.0 110.955 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.59 18.38 51.51 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.79 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.75 -10.69 45.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.695 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.431 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 5.3 m -100.16 -179.96 4.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.441 ' CE3' ' N ' ' A' ' 99' ' ' GLY . 77.2 m95 -145.34 93.92 2.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.884 0.373 . . . . 0.0 110.814 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.4 ' O ' ' CD1' ' A' ' 107' ' ' TRP . 3.8 t70 -112.9 -12.08 13.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.369 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.82 128.76 34.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.768 0.318 . . . . 0.0 110.66 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 105' ' ' ASP . 21.5 m95 -137.87 164.22 29.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.959 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.57 -160.92 19.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -74.23 -38.17 63.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.817 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.52 152.68 26.39 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.647 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.2 t -154.28 122.71 6.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -78.17 143.07 37.54 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.966 0.413 . . . . 0.0 111.131 -179.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 91' ' ' THR . 55.4 t -114.8 132.25 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.159 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.3 m -108.48 132.69 53.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.9 168.23 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.344 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.931 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.817 0.342 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp -148.4 152.17 36.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -164.22 163.42 22.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.801 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.23 162.52 15.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.4 t -158.08 123.04 4.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.81 -30.17 10.51 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.583 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -50.92 139.86 23.26 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.008 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.82 -159.64 24.22 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.379 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mp -69.25 151.1 46.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.473 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.22 109.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.872 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.41 152.2 46.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.118 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.89 129.98 21.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.386 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.35 22.65 50.75 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.57 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.17 116.04 2.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.377 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 92.9 p -69.94 123.67 22.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 111.047 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 tp -126.96 130.78 50.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.525 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -107.61 131.78 54.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.424 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 2.9 mt -116.97 148.28 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.098 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB3' ' CD2' ' A' ' 80' ' ' TYR . 82.7 p -127.85 126.69 42.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -121.38 109.1 14.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.596 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.66 164.46 22.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.381 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.04 179.908 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CE2' ' CB ' ' A' ' 98' ' ' ALA . 9.3 t80 . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.949 0.404 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.404 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 7.5 m-20 -111.89 -176.87 3.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.673 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.09 113.97 7.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.978 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -139.97 158.74 25.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.905 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.422 ' CE2' HD22 ' A' ' 81' ' ' LEU . 63.8 m95 -92.36 154.86 18.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.282 0.563 . . . . 0.0 111.329 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.7 m-85 -135.67 -178.32 5.07 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.455 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.43 ' HG2' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -148.44 156.13 42.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.89 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.414 ' CB ' ' CG1' ' A' ' 93' ' ' VAL . 2.0 mm-40 -153.41 171.07 19.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.9 149.23 14.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.617 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.99 134.72 51.17 Favored 'Trans proline' 0 CA--C 1.517 -0.342 0 C-N-CA 122.273 1.982 . . . . 0.0 112.184 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.53 3.91 35.75 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.479 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.08 178.78 4.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.873 0.368 . . . . 0.0 110.897 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 pm0 -96.22 -176.82 3.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.781 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.82 140.77 39.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.829 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' A' ' 38' ' ' ARG . 12.0 pt-20 -140.46 164.28 30.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.628 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.565 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.9 t -107.25 171.66 7.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.141 0.496 . . . . 0.0 111.085 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.43 ' CG2' ' HG2' ' A' ' 38' ' ' ARG . 2.8 t -129.51 -69.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.677 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -141.05 147.6 38.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 0.0 111.579 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' HA ' ' CA ' ' A' ' 35' ' ' GLY . . . -136.89 141.34 42.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.193 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 tt -117.66 141.59 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.047 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.125 -179.857 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.6 mpp_? . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 120.407 0.146 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.401 ' CG2' HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -116.11 -177.58 3.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.948 0.404 . . . . 0.0 111.096 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 50.9 t80 -135.99 91.33 2.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.853 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.502 ' CZ ' HG21 ' A' ' 70' ' ' ILE . 56.0 m-85 -80.39 152.19 28.99 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.98 163.53 14.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.366 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.81 33.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.017 0.437 . . . . 0.0 111.674 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.9 t -118.54 -20.15 8.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.116 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.0 m -152.41 21.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.969 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.91 80.7 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.72 0.771 . . . . 0.0 110.9 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 131.42 3.55 4.22 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.162 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -111.11 -45.91 3.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.744 0.306 . . . . 0.0 111.056 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 83' ' ' MET . 9.7 m-30 -97.21 161.14 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.128 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.6 m -129.72 94.98 3.86 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.578 0.704 . . . . 0.0 111.371 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.502 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -91.18 137.37 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.614 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.416 ' N ' HG13 ' A' ' 70' ' ' ILE . 1.7 m -162.96 170.81 17.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 110.959 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -116.75 139.87 50.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.764 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.419 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 45.5 t0 -72.71 -31.23 64.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.946 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 58.9 23.34 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.051 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.72 -39.77 3.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.97 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -135.81 25.89 3.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.927 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.67 49.15 10.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.01 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.424 HG22 ' CE1' ' A' ' 80' ' ' TYR . 89.0 m -125.09 145.99 49.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -109.74 146.5 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.661 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' A' ' 21' ' ' SER . 4.2 m-85 -137.61 134.94 36.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.92 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.424 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -128.59 119.16 24.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.068 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -92.51 108.21 19.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.461 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 30.8 mtm -94.39 90.21 6.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.334 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -85.49 175.13 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.67 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 33.16 39.43 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.934 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.51 158.76 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 111.204 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.48 164.25 16.95 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.816 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.74 8.13 4.45 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.66 2.24 . . . . 0.0 112.721 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 10.9 tt0 -119.21 -0.4 11.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.41 -11.04 59.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.658 0.266 . . . . 0.0 111.085 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.9 m -52.14 108.93 0.33 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 111.345 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.71 174.18 5.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.005 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 9.0 p -78.89 104.2 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 111.061 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.447 ' CD1' ' CG2' ' A' ' 113' ' ' VAL . 6.0 m-85 -81.22 98.35 8.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.46 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 37' ' ' PHE . 5.0 m -107.33 129.98 54.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.013 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 28.7 p -99.77 142.57 31.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.682 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -143.05 177.36 22.02 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.318 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.462 ' CB ' ' CE2' ' A' ' 32' ' ' TYR . . . -126.25 164.91 19.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.003 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.18 176.97 22.94 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.724 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.8 117.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.332 . . . . 0.0 110.635 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.34 15.0 50.75 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.759 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.42 -11.67 43.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.644 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.0 m -102.29 179.45 4.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.551 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.404 ' CH2' ' HB2' ' A' ' 33' ' ' ASP . 81.2 m95 -136.75 83.58 2.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.06 -9.58 23.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.496 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -89.66 134.64 34.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.773 0.32 . . . . 0.0 110.81 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -146.0 165.15 29.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.745 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.05 -170.34 21.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.434 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -70.67 -32.12 69.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.95 0.405 . . . . 0.0 110.696 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.72 151.95 25.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 1.5 t -144.39 102.15 3.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 110.407 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -63.26 138.56 58.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 0.0 111.264 -179.426 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.447 ' CG2' ' CD1' ' A' ' 94' ' ' TYR . 52.4 t -112.47 118.25 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.981 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 m -97.65 122.29 40.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.346 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 t -150.99 163.79 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.327 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.845 179.996 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.783 0.325 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mp -156.35 134.99 11.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.969 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 1.5 tt0 -145.39 129.46 17.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.146 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.21 165.09 15.3 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 p -169.66 112.67 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.006 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.67 -26.02 4.93 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.659 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.78 141.09 29.06 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.931 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.18 -178.37 46.82 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.376 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.27 140.19 54.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.897 0.38 . . . . 0.0 111.409 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.44 122.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.078 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -58.86 140.31 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.312 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.61 150.64 6.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.309 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.04 -2.15 82.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.837 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.06 -154.77 26.83 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.439 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -140.94 138.0 33.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.944 0.402 . . . . 0.0 111.214 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.402 HD23 ' CD2' ' A' ' 20' ' ' LEU . 15.2 tp -131.87 148.6 52.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.326 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -124.42 125.72 44.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.377 . . . . 0.0 111.55 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.422 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 4.0 mt -116.3 138.84 50.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.234 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.436 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 24.0 p -123.25 132.57 54.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.034 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 31.6 t -131.53 130.96 42.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.747 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.79 165.9 13.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.197 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.48 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 62.0 t80 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.976 0.417 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -75.43 178.96 5.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.369 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.77 130.54 16.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 111.366 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -153.11 155.52 26.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.621 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.435 ' CE2' HD21 ' A' ' 81' ' ' LEU . 75.5 m95 -86.97 156.22 19.87 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.359 0.599 . . . . 0.0 111.307 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.521 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 6.5 m-85 -140.16 -178.35 5.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.575 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.405 ' CG ' ' CG2' ' A' ' 48' ' ' VAL . 1.6 mtp180 -145.81 158.42 43.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.017 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -161.33 160.56 29.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.952 0.406 . . . . 0.0 111.303 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.6 155.01 22.14 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.606 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.14 137.42 44.01 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.273 1.982 . . . . 0.0 112.297 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.04 1.07 38.48 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.635 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.83 -177.33 3.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.879 0.371 . . . . 0.0 111.155 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -109.54 159.03 17.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.384 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.14 143.28 32.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 111.123 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.86 140.95 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.431 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.521 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.4 t -81.32 172.13 13.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.183 0.516 . . . . 0.0 110.919 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.405 ' CG2' ' CG ' ' A' ' 38' ' ' ARG . 3.1 t -129.99 -68.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.55 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -146.01 126.67 14.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 0.0 111.368 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -126.2 144.73 50.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.422 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.418 HG23 ' NE ' ' A' ' 72' ' ' ARG . 8.0 tt -125.33 148.47 29.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.022 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.89 179.716 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.41 -175.09 3.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.072 0.463 . . . . 0.0 111.028 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.477 ' N ' ' O ' ' A' ' 50' ' ' ALA . 75.1 t80 -139.82 92.48 2.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.542 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -75.0 160.97 29.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.999 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.94 158.69 17.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 63' ' ' SER . 36.5 t -69.35 150.46 47.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.711 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 87.36 -12.94 0.49 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.671 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 m -151.67 14.21 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.566 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.13 81.0 4.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.61 0.719 . . . . 0.0 110.464 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.9 -4.97 2.2 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.427 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.17 -36.67 3.72 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 111.201 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.2 m-30 -82.83 135.87 34.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.83 0.348 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 3.7 m -99.65 145.43 27.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.195 0.521 . . . . 0.0 111.32 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.541 HD11 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -133.53 135.94 55.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.251 -179.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.541 ' N ' HD11 ' A' ' 70' ' ' ILE . 28.7 t -166.29 146.74 6.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.968 0.413 . . . . 0.0 111.302 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.53 ' CZ ' ' HB ' ' A' ' 79' ' ' VAL . 9.2 mpt_? -114.79 144.5 43.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.658 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -64.93 -30.15 71.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.899 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 57.36 24.9 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.977 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.79 -46.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.916 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.99 19.47 16.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp 56.31 46.94 20.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.905 0.383 . . . . 0.0 110.806 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.434 HG22 ' CE1' ' A' ' 80' ' ' TYR . 42.1 m -120.53 143.32 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.315 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.53 ' HB ' ' CZ ' ' A' ' 72' ' ' ARG . 28.9 m -101.99 150.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.481 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 21' ' ' SER . 28.9 m-85 -145.55 124.25 12.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.279 . . . . 0.0 110.866 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.435 HD21 ' CE2' ' A' ' 36' ' ' TRP . 0.4 OUTLIER -124.99 121.37 34.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.074 0.464 . . . . 0.0 110.584 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -99.74 94.96 6.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.792 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.438 ' HG2' ' CD2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -79.72 95.29 5.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 -179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -88.96 176.89 6.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.619 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 t 36.23 41.94 0.16 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.549 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.81 166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.385 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.503 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 3.5 mmtp -126.18 162.26 47.08 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.706 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 64.7 Cg_endo -73.94 8.04 2.19 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.411 2.074 . . . . 0.0 113.104 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -119.42 8.94 11.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.258 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.3 -19.08 30.38 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.592 0.234 . . . . 0.0 111.229 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 63.6 m -49.91 103.66 0.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 111.463 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.02 -174.86 1.87 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.9 t -90.01 105.05 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.654 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.425 ' CG ' HG21 ' A' ' 113' ' ' VAL . 4.1 m-85 -87.03 107.75 18.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.086 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.406 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 4.7 m -106.86 167.21 10.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.3 p -129.91 133.64 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.421 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.01 -177.12 15.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.695 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.48 ' CB ' ' CZ ' ' A' ' 32' ' ' TYR . . . -136.36 167.2 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 111.077 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -108.58 -175.22 21.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.565 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.69 115.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.818 0.342 . . . . 0.0 110.594 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.1 15.66 50.91 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.701 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.83 -12.44 38.32 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.749 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.404 ' CG2' ' H ' ' A' ' 104' ' ' TRP . 4.5 m -100.46 178.93 4.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.694 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.404 ' H ' ' CG2' ' A' ' 103' ' ' THR . 73.9 m95 -140.67 96.62 3.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.684 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -117.9 -5.87 11.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.483 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.63 130.82 37.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.851 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -142.28 164.94 28.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.983 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -101.37 -135.63 8.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.425 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -26.69 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 98.06 148.86 24.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.669 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 t -148.15 119.24 7.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.884 0.373 . . . . 0.0 110.38 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 139.63 57.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.319 0.58 . . . . 0.0 111.351 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 91' ' ' THR . 37.9 t -123.92 86.52 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.1 m -77.71 148.48 34.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.994 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.08 168.58 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.883 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.179 -179.684 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.809 0.338 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp -151.63 107.39 3.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -93.65 168.2 11.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.823 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -120.93 163.35 18.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.822 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.36 124.88 4.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.994 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.23 -29.28 10.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.609 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -50.92 138.61 25.64 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.847 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.54 -159.62 29.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.352 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.38 149.08 48.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.814 0.34 . . . . 0.0 111.375 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.88 126.48 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -70.09 127.05 31.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.012 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.45 125.14 13.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.464 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.03 -1.64 33.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.939 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.84 -153.02 10.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.531 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -139.37 142.51 37.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 tp -124.87 130.12 51.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.283 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.85 128.16 54.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.397 . . . . 0.0 111.562 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.439 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 5.5 mt -116.09 136.67 52.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.244 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.405 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 90.5 p -119.31 115.34 23.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.022 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.95 116.45 29.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.11 148.69 21.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.987 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.875 0.369 . . . . 0.0 110.973 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.415 ' OD1' ' CH2' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -86.67 178.31 7.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.032 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.9 mtm -146.65 132.32 18.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.031 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.34 151.19 23.36 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.658 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -88.29 155.94 19.46 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.206 0.527 . . . . 0.0 111.346 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.546 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -138.99 -179.27 5.74 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.703 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 46' ' ' GLU . 9.9 mtm-85 -143.19 162.09 36.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.922 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -148.45 124.06 10.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.198 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.79 157.61 49.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.733 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.85 137.26 37.73 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.295 1.997 . . . . 0.0 112.383 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 2.26 36.74 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.642 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.97 -175.09 2.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.859 0.361 . . . . 0.0 111.032 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -111.63 -171.73 1.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.636 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -78.2 125.45 29.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -121.53 119.2 31.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.458 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.3 t -71.43 170.69 12.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.269 0.557 . . . . 0.0 110.784 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.94 -69.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.442 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -145.21 128.91 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.035 0.445 . . . . 0.0 111.213 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.411 ' HA ' ' CA ' ' A' ' 35' ' ' GLY . . . -123.55 144.78 49.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.127 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.7 tp -128.96 145.75 35.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.373 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.1 t30 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.717 179.794 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.917 0.389 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.67 -177.9 3.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.902 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 8.2 t80 -137.35 89.67 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.739 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -76.82 156.3 32.36 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.05 167.74 9.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.246 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 63' ' ' SER . 18.7 p -69.33 152.69 44.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.551 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 86.09 -11.99 0.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.486 -178.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.42 HG11 ' CE2' ' A' ' 68' ' ' PHE . 35.4 m -151.05 15.75 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.385 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.02 79.11 0.66 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.514 0.673 . . . . 0.0 110.724 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.47 3.88 8.45 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.896 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -114.3 -40.98 3.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 111.08 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 5.8 m-30 -93.5 117.38 30.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 11.8 m -79.57 152.57 30.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -148.38 136.42 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.012 -178.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.493 ' N ' HD12 ' A' ' 70' ' ' ILE . 4.8 m -161.49 -164.65 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.775 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -139.74 169.65 17.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.968 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.409 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 0.9 OUTLIER -77.75 -12.85 60.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.286 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 44.76 40.24 4.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 111.268 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.9 -49.36 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.064 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 mtmm -115.52 -72.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 167.14 44.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.599 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.2 m -110.33 145.13 38.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.187 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.6 m -108.66 142.0 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.748 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 1.3 m-85 -134.33 128.93 34.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.913 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.439 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 1.3 pt? -127.07 125.82 41.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.064 0.459 . . . . 0.0 110.747 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.81 96.72 8.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.617 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.447 ' HE1' ' CE1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -78.56 88.03 4.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.212 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.62 176.89 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 38.35 48.34 1.17 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.494 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.61 165.72 22.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.327 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.451 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -133.59 178.0 1.98 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.218 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 92.5 Cg_endo -81.31 9.68 3.76 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.316 2.011 . . . . 0.0 112.734 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 7.5 tp10 -109.17 -12.45 14.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.706 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.23 -21.34 58.7 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 110.986 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 98.6 m -50.6 107.73 0.19 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.45 -172.34 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.308 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.5 t -90.28 105.15 15.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.542 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.447 ' CE1' ' HE1' ' A' ' 83' ' ' MET . 13.0 m-85 -88.77 107.66 19.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 83.2 m -113.44 136.54 52.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 11.8 p -100.36 160.4 14.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.818 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -159.2 -170.92 24.34 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.999 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.44 ' HB2' ' CD2' ' A' ' 32' ' ' TYR . . . -143.17 172.49 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.745 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -142.27 -175.69 15.8 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.906 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.456 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 31.1 tt0 -162.33 129.02 3.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.59 15.23 46.22 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.852 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.63 -14.36 32.42 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.68 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.428 ' O ' ' HA3' ' A' ' 99' ' ' GLY . 3.7 m -92.02 176.73 6.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.578 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.45 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 72.2 m95 -147.76 100.21 3.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.768 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -120.71 -3.26 9.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.568 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.89 137.87 34.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.841 0.353 . . . . 0.0 110.86 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -142.89 167.2 22.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.87 -155.8 18.97 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.575 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -87.34 -36.5 17.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 110.853 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.71 153.39 17.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.576 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 t -146.9 107.97 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.653 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.68 141.57 55.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.133 0.492 . . . . 0.0 110.941 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.1 t -121.75 126.6 74.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.387 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.5 m -102.25 133.33 47.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.043 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -149.84 163.03 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.424 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.909 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.41 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.028 0.442 . . . . 0.0 110.48 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.41 ' N ' ' HG3' ' A' ' 3' ' ' GLN . 5.7 mp -142.63 104.27 4.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.83 167.74 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.36 164.98 13.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -162.3 114.3 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.84 -36.3 3.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.656 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -50.03 139.12 19.59 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.913 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.39 -170.69 40.05 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.332 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mp -69.44 155.24 40.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.903 0.382 . . . . 0.0 111.593 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -169.41 120.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.888 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.66 144.32 27.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.69 124.78 11.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.452 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.99 17.76 31.45 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.68 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.72 -166.68 22.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.543 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -129.28 136.63 50.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.956 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 tp -142.66 131.03 22.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.585 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.23 132.91 54.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.185 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 4.1 mt -117.13 135.4 53.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.7 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -120.0 105.77 11.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.769 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.97 116.07 31.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.72 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.87 155.47 17.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.292 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.951 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.457 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 53.5 t80 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.945 0.402 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.422 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 74.6 m-20 -62.75 -175.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.9 124.59 11.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.764 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -147.45 150.8 23.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.986 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.46 ' CZ3' HD13 ' A' ' 20' ' ' LEU . 74.1 m95 -91.44 153.46 19.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.225 0.536 . . . . 0.0 111.371 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.0 m-85 -133.39 -177.15 4.4 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.323 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -156.54 159.93 39.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.743 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -162.37 133.76 5.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.205 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.54 167.63 8.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.613 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.89 138.01 39.55 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.265 1.977 . . . . 0.0 112.328 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.18 4.49 36.4 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.641 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -112.62 -177.12 3.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.868 0.366 . . . . 0.0 111.047 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -102.39 -171.54 1.98 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.581 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.9 ptm85 -100.59 128.89 46.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -131.14 147.92 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.304 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.4 t -82.58 175.68 9.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.263 0.554 . . . . 0.0 111.112 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.435 ' N ' ' OG ' ' A' ' 47' ' ' SER . 3.5 t -132.36 -66.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.143 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.35 123.43 10.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.017 0.437 . . . . 0.0 111.184 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' HA ' ' CA ' ' A' ' 35' ' ' GLY . . . -118.35 148.85 42.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.108 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 tt -133.46 146.54 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.894 0.378 . . . . 0.0 111.534 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.922 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.725 0.298 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.89 178.06 4.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.753 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -140.45 90.81 2.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.668 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 4.6 m-85 -78.8 159.09 28.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.06 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.75 166.53 11.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 63' ' ' SER . 3.7 t -69.48 151.69 45.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.759 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 84.65 -11.0 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.617 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 33.2 m -152.75 16.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.314 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -70.64 79.1 0.59 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.559 0.695 . . . . 0.0 110.88 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.96 2.93 8.46 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.88 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -108.34 -33.47 7.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.76 0.314 . . . . 0.0 111.211 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 9.0 m-30 -96.03 127.77 42.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.151 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 56.9 m -83.54 145.04 29.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.375 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -134.74 136.59 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.216 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.9 p -154.92 -175.88 5.65 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.973 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -138.27 165.9 25.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.084 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.416 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 33.8 t70 -86.6 -31.57 21.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t30 60.74 29.5 19.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.9 -57.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.08 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -102.73 11.32 37.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.277 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.49 52.25 4.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.653 ' OG1' ' CZ ' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -115.54 154.93 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.935 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 21' ' ' SER . 6.1 p -119.81 132.11 70.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.84 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.653 ' CZ ' ' OG1' ' A' ' 78' ' ' THR . 17.6 m-85 -118.11 107.96 14.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.132 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 69' ' ' THR . 0.2 OUTLIER -107.74 114.38 28.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.958 179.44 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.31 95.23 8.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.304 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -80.96 89.85 5.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.981 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -76.95 174.16 10.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.856 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 84' ' ' ASN . 0.6 OUTLIER 22.09 53.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.075 179.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.401 ' CD1' ' HB2' ' A' ' 83' ' ' MET . 0.3 OUTLIER -44.56 162.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.537 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 22.3 mmtt -110.75 161.0 26.65 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.787 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 72.1 Cg_endo -76.84 8.15 3.25 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.441 2.094 . . . . 0.0 112.908 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -121.68 2.91 10.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.236 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.66 -12.42 55.96 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.624 0.25 . . . . 0.0 111.23 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.9 m -55.89 104.82 0.15 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 111.17 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.54 -174.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.268 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.9 t -87.63 103.26 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.725 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.439 ' CD1' ' CG2' ' A' ' 113' ' ' VAL . 8.3 m-85 -82.7 105.79 14.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.914 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 88.5 m -111.64 133.18 54.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 28.0 p -100.45 150.09 23.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.014 0.435 . . . . 0.0 111.155 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -143.22 -175.36 16.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.246 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.457 ' CB ' ' CZ ' ' A' ' 32' ' ' TYR . . . -135.39 164.4 27.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 111.028 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -96.06 -171.67 35.47 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 179.42 111.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.713 0.292 . . . . 0.0 110.743 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.74 16.14 50.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.693 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 -13.99 36.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.522 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.404 ' CG2' ' H ' ' A' ' 104' ' ' TRP . 5.0 m -100.01 179.17 4.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.605 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' A' ' 33' ' ' ASP . 82.2 m95 -135.5 93.82 3.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.736 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -118.0 -4.27 11.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.341 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.22 135.69 33.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.756 0.313 . . . . 0.0 110.786 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -141.58 165.45 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.094 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.2 -148.22 11.86 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.486 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.02 -48.63 6.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 116.1 151.28 9.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.763 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 t -142.49 110.33 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.333 . . . . 0.0 110.454 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 141.11 58.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.21 0.528 . . . . 0.0 111.036 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.439 ' CG2' ' CD1' ' A' ' 94' ' ' TYR . 47.0 t -119.12 125.64 74.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.297 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.3 m -101.41 117.94 35.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 111.03 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.4 HG11 ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -133.49 -158.96 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.524 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.916 0.389 . . . . 0.0 111.077 179.968 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.918 0.39 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 mp -146.78 159.01 44.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.793 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -152.7 175.23 13.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.288 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -128.7 173.22 10.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.988 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.1 t -170.16 143.59 2.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.064 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.67 -33.07 5.95 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.725 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -49.66 140.1 15.85 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.003 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.99 -170.58 43.33 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.396 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mp -69.49 156.01 39.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.782 0.325 . . . . 0.0 111.414 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -170.01 115.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.92 158.82 1.92 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.381 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.95 145.44 3.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.435 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.09 15.87 65.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.603 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.79 112.18 3.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.348 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.93 131.0 43.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -124.21 131.91 53.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.656 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -101.61 128.23 47.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.903 0.382 . . . . 0.0 111.461 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.5 mt -116.06 145.41 43.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.341 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.5 p -125.76 128.51 47.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.899 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.9 t -124.76 136.0 53.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -113.09 144.57 42.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.893 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.321 -179.869 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 121.089 0.471 . . . . 0.0 111.752 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -157.46 -173.9 4.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.031 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.12 158.47 43.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.691 0.281 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 172.35 145.25 4.87 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.045 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -88.55 155.32 19.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.974 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.2 m-85 -132.31 -179.63 5.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.954 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.413 ' CG ' ' CG ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -151.68 161.9 41.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.755 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -149.06 147.24 28.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.183 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.59 158.13 76.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.655 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.25 136.19 31.1 Favored 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 122.341 2.027 . . . . 0.0 112.415 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.77 -1.01 25.19 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.602 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -121.02 150.87 40.48 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 120.871 0.367 . . . . 0.0 110.958 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -69.88 -177.23 1.25 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.458 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -94.14 144.59 25.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 7.3 pt-20 -136.11 167.1 21.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.325 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 7.9 t -102.68 172.84 6.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.157 0.503 . . . . 0.0 110.989 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.69 -68.78 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.203 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -137.08 144.51 43.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.103 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -144.36 142.43 30.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.414 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.1 tt -121.47 143.68 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.983 -179.781 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.004 0.43 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.49 -175.96 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.024 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 86.8 t80 -139.61 125.47 19.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.456 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -113.68 162.52 16.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.31 160.43 14.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.231 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 p -80.78 36.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.864 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 t -118.22 -20.93 8.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.153 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 66' ' ' GLY . 29.7 m -157.05 21.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.045 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.94 80.07 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.651 0.739 . . . . 0.0 111.045 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 135.93 1.16 3.02 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.316 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.65 -35.72 3.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 111.24 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 4.6 m-30 -93.3 159.85 15.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.0 m -129.14 155.07 46.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.6 tp -140.53 144.66 26.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.955 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.16 170.87 21.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.971 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -133.91 141.9 47.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.19 -18.49 42.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.214 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.2 p30 44.48 30.26 0.47 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.415 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.13 -74.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.64 23.41 14.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.05 62.54 0.24 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.462 HG21 ' CE1' ' A' ' 80' ' ' TYR . 91.6 m -131.25 143.67 50.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 111.231 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.3 147.87 19.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.341 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CE1' HG21 ' A' ' 78' ' ' THR . 3.8 m-85 -135.17 128.07 31.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.852 0.358 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.93 118.05 27.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.357 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.51 103.51 15.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.063 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 22.1 mtm -81.53 88.22 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.92 176.45 7.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 36.07 44.9 0.28 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.791 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.72 156.53 10.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.57 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -123.74 171.76 6.54 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.085 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 86.1 Cg_endo -81.77 11.12 3.21 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.433 2.089 . . . . 0.0 112.884 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -118.53 -6.31 10.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.355 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -86.32 -13.19 47.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.499 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 99.4 m -54.53 112.52 1.02 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 111.456 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.2 -170.72 1.01 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.172 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.2 t -94.31 105.36 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -86.87 110.67 20.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.051 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.6 t -109.28 127.34 54.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.981 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 46.9 t -77.42 145.62 37.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.08 166.67 30.53 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.693 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -131.08 150.12 52.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.328 . . . . 0.0 110.978 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . -96.36 165.45 23.79 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.805 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -158.27 113.8 2.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.55 16.26 49.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.98 -16.0 28.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.496 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.409 ' CG2' ' H ' ' A' ' 104' ' ' TRP . 5.2 m -97.72 179.75 4.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.659 0.266 . . . . 0.0 110.393 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.431 ' CH2' ' HB3' ' A' ' 50' ' ' ALA . 81.9 m95 -142.13 91.14 2.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 107' ' ' TRP . 7.4 t70 -106.27 -18.4 14.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.142 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 t -75.16 130.3 38.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.799 0.333 . . . . 0.0 110.786 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.403 ' CD1' ' O ' ' A' ' 105' ' ' ASP . 58.0 m95 -139.19 165.04 28.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.708 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.04 -156.37 15.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.539 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -86.21 -25.44 25.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.95 150.31 24.08 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.4 t -152.31 114.03 4.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.823 0.344 . . . . 0.0 110.166 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.443 HE21 ' N ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -79.29 137.75 37.48 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 120.941 0.401 . . . . 0.0 111.034 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 91' ' ' THR . 56.0 t -116.86 110.76 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.734 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.4 m -97.42 132.63 42.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.863 0.363 . . . . 0.0 111.361 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.42 169.18 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.8 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.932 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.811 0.338 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 mp -160.94 77.27 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -69.85 151.8 45.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.773 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -110.57 165.46 11.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.871 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.9 t -166.05 121.65 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.72 -40.76 2.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.703 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -50.04 139.72 18.6 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.923 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.93 -161.47 27.8 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.431 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mp -69.43 145.84 52.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.869 0.366 . . . . 0.0 111.514 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -170.16 111.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.998 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.23 151.97 45.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.72 146.95 3.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.332 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.21 -13.67 65.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.55 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.88 114.11 3.95 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.371 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -69.95 136.22 50.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 111.128 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 tp -136.04 129.95 32.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.178 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -102.43 145.55 29.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.117 0.484 . . . . 0.0 111.651 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.447 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 6.4 mt -117.64 147.99 42.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.808 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 90.7 p -125.73 114.21 18.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.274 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 3.8 t -117.16 128.8 55.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.597 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.84 141.64 49.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.371 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.043 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 110.952 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -70.67 161.15 31.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.743 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.6 mtm -132.45 128.39 37.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.479 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 50' ' ' ALA . . . -153.29 159.9 28.85 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.113 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.447 ' CZ2' ' HB2' ' A' ' 20' ' ' LEU . 93.1 m95 -86.73 154.11 21.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.12 0.486 . . . . 0.0 110.93 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.3 m-85 -136.89 -176.53 4.4 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.74 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.497 ' HG2' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -146.99 150.75 35.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.837 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -153.81 176.77 11.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.024 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -174.21 152.92 1.89 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.522 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.7 137.15 62.03 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.29 1.993 . . . . 0.0 112.142 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.09 7.36 37.08 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.512 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.81 -169.58 1.48 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 111.02 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -114.91 176.68 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.771 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -97.65 134.91 40.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 0.0 111.175 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -138.96 163.65 31.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.439 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.545 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.5 t -110.61 171.15 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.246 0.546 . . . . 0.0 111.236 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.497 ' CG2' ' HG2' ' A' ' 38' ' ' ARG . 6.0 t -129.51 -69.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.306 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -136.2 133.87 37.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.385 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . . . -128.43 145.2 51.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.017 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 tt -128.01 147.85 32.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.358 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.76 179.941 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 120.767 0.318 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.46 -178.45 3.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 23.3 t80 -138.67 90.31 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.39 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.443 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 8.2 m-85 -80.51 154.9 27.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.18 159.69 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.194 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 63' ' ' SER . 17.9 p -69.09 153.83 43.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.32 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 62' ' ' SER . 2.3 p 87.12 -12.59 0.52 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.462 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -149.11 15.47 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.335 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 65' ' ' ARG . 6.5 tpt180 -77.69 83.5 4.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.779 0.8 . . . . 0.0 110.305 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.61 -7.12 3.31 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.587 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HD2' ' CE1' ' A' ' 68' ' ' PHE . 1.3 ptp180 -116.52 -38.13 3.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.708 0.29 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 3.3 m-30 -90.42 93.82 9.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.49 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 95.5 m -76.53 116.53 17.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.146 0.498 . . . . 0.0 111.313 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.443 HG22 ' CZ ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -109.69 131.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.772 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.36 172.44 18.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.019 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 72' ' ' ARG . 13.5 ttp-105 -105.92 153.92 21.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.419 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 39.7 t0 -91.36 -29.64 16.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.4 26.19 14.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.023 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -114.34 -33.47 5.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.073 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.5 42.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.722 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.11 40.86 14.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.701 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.1 m -97.55 148.56 23.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.062 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.7 m -122.82 132.08 72.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.428 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 25.1 m-85 -113.1 116.07 29.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.988 0.423 . . . . 0.0 110.801 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -113.35 103.29 11.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.445 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -85.9 98.97 11.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.994 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -83.53 88.24 7.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.936 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 176.16 6.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.777 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 34.78 48.19 0.3 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.698 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.439 HD11 ' CE1' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -62.09 165.84 5.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.459 . . . . 0.0 111.197 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.449 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 33.1 mmtt -135.47 163.54 50.04 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.419 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 63.2 Cg_endo -73.23 9.08 1.54 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.365 2.043 . . . . 0.0 113.091 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.92 9.06 13.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.189 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.66 -7.54 37.25 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.533 0.206 . . . . 0.0 111.401 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.7 m -56.33 113.1 1.43 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.767 0.317 . . . . 0.0 111.271 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.56 -172.53 1.24 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.313 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 84.0 t -96.16 102.63 13.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.183 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.416 ' CD1' HG22 ' A' ' 113' ' ' VAL . 24.7 m-85 -84.91 99.52 11.0 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.764 0.316 . . . . 0.0 111.117 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 62.0 m -106.2 129.97 54.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -99.79 147.77 25.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.456 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -159.65 -169.44 22.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.145 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.447 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . . . -134.51 172.68 12.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.875 0.369 . . . . 0.0 110.968 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -147.05 173.35 27.25 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.778 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -160.01 144.92 14.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.58 16.22 49.77 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.58 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.23 -4.92 58.84 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.671 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -107.35 179.17 4.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.796 0.331 . . . . 0.0 110.579 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.404 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 77.5 m95 -139.06 105.33 5.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.514 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -12.32 11.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.49 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.31 133.43 36.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -144.86 165.0 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.0 -165.55 22.26 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.578 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -75.02 -29.11 60.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.16 152.51 28.73 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.603 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 t -148.16 114.31 5.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.41 HE21 ' N ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -80.22 142.46 34.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.018 0.437 . . . . 0.0 111.228 -179.168 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' A' ' 94' ' ' TYR . 54.9 t -114.51 131.83 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.961 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.6 m -110.38 132.48 54.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.867 0.365 . . . . 0.0 111.182 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 t -141.27 168.01 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.156 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 55.2 p . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.178 -179.773 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.771 0.32 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.3 mp -148.05 136.8 21.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.1 169.54 17.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -124.96 164.45 20.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 m -166.24 125.79 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 114.01 -30.6 7.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.602 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -49.86 140.32 16.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.896 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.57 175.84 42.44 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.366 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.15 144.83 53.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.88 0.371 . . . . 0.0 111.468 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.83 126.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -58.97 155.97 12.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.252 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.46 131.7 20.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.388 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.75 3.18 83.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.743 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.63 118.77 6.01 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.471 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.53 140.64 49.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 0.0 111.231 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.413 ' CD2' ' CD2' ' A' ' 20' ' ' LEU . 3.7 tp -136.0 129.1 31.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.703 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.46 119.26 39.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.413 ' CD2' ' CD2' ' A' ' 18' ' ' LEU . 12.7 mt -100.74 138.72 37.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.005 0.431 . . . . 0.0 110.427 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.451 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 7.1 m -117.31 111.11 18.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.213 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.431 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 42.9 t -106.09 133.58 50.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.533 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.26 160.65 21.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.956 179.954 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.461 ' CE2' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.95 0.405 . . . . 0.0 110.827 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -130.11 179.8 5.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.638 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -136.72 124.71 22.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.754 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.9 160.85 28.34 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.906 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.431 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 77.2 m95 -95.61 157.15 16.03 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.069 0.461 . . . . 0.0 111.303 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 11.7 m-85 -135.38 179.65 6.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.342 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.18 151.08 34.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.719 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.59 148.57 36.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.997 0.427 . . . . 0.0 111.222 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.0 158.6 58.66 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.624 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.11 137.4 44.04 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.318 2.012 . . . . 0.0 112.281 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.64 0.44 48.63 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.649 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.25 -173.77 2.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.874 0.369 . . . . 0.0 111.074 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -118.7 -174.97 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.535 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.46 135.7 40.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 111.113 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.27 119.3 15.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.266 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 1.4 t -68.55 170.03 9.91 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 t -130.06 -57.6 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.958 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -152.6 163.24 40.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.949 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -161.08 147.58 14.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.488 HG22 HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.09 143.47 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 111.597 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.455 ' N ' HD11 ' A' ' 51' ' ' ILE . 7.9 t-20 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.267 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.901 0.381 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.41 HG22 ' HB ' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -115.8 178.92 4.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.239 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.1 t80 -141.55 135.33 30.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.524 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.434 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 28.7 m-85 -123.23 163.1 21.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 110.895 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -106.5 155.92 19.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.987 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.18 34.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 111.762 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.0 t -121.65 -15.13 8.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.236 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.424 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 15.7 m -156.76 19.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.232 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -65.98 80.15 0.08 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.563 0.697 . . . . 0.0 110.846 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.98 -2.38 1.16 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.809 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.44 ' HG3' ' CD1' ' A' ' 68' ' ' PHE . 2.6 ptp180 -126.58 -36.16 2.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.833 0.316 . . . . 0.0 111.654 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 7.8 m-30 -94.2 146.98 23.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.196 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 82' ' ' GLN . 5.5 m -112.89 154.42 26.39 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.406 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.503 HD11 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -146.02 134.23 16.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.915 -179.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.503 ' N ' HD11 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -162.49 -172.51 3.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.806 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.53 155.65 50.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.433 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 7.4 t0 -69.05 -27.84 66.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.042 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 66.71 23.34 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.022 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.87 -57.78 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.923 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 4.4 ptpp? -130.21 -54.59 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.713 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 1.8 ttmp? 169.6 74.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.647 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.465 ' CG2' ' CE1' ' A' ' 80' ' ' TYR . 33.4 m -137.7 140.62 40.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.085 0.469 . . . . 0.0 111.243 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.03 135.91 54.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.827 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.465 ' CE1' ' CG2' ' A' ' 78' ' ' THR . 1.5 m-85 -124.79 129.54 50.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.758 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -118.09 118.95 33.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 110.404 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.521 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -93.36 102.83 15.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.031 -179.109 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.466 ' CE ' ' CE1' ' A' ' 94' ' ' TYR . 1.6 mtt -91.59 88.73 6.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.444 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.16 175.89 8.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.666 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 35.35 50.4 0.54 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.881 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.09 161.06 9.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.809 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.404 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 4.2 mttp -134.07 172.82 6.65 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.919 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 87' ' ' LYS . 72.0 Cg_endo -76.28 5.0 4.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.546 2.164 . . . . 0.0 113.076 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.2 tp10 -103.25 -16.95 15.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.739 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -78.48 -17.0 56.91 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.097 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.4 m -51.74 102.78 0.05 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.076 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.48 -171.57 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.923 0.392 . . . . 0.0 111.56 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 91.2 t -93.16 109.87 22.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.82 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.466 ' CE1' ' CE ' ' A' ' 83' ' ' MET . 13.2 m-85 -91.89 109.07 20.4 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.651 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 m -108.72 139.2 43.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.0 111.372 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.7 t -94.86 146.04 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.645 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -148.0 -178.82 23.49 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.74 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.461 ' CB ' ' CE2' ' A' ' 32' ' ' TYR . . . -142.46 165.44 27.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.024 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.58 168.87 14.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.812 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -167.74 120.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.728 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.6 14.76 51.54 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.817 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.46 -12.95 43.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.434 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.3 m -101.89 -179.96 4.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.687 0.28 . . . . 0.0 110.538 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' A' ' 33' ' ' ASP . 73.3 m95 -137.41 81.84 1.89 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.767 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.27 13.7 24.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.463 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.54 130.02 53.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.813 0.339 . . . . 0.0 110.853 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -137.62 164.5 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.045 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.89 -118.29 4.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.6 -44.48 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 110.984 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.97 152.03 13.66 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.762 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 t -154.28 117.23 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.263 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -80.17 143.29 33.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.0 0.429 . . . . 0.0 111.007 -179.334 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.42 ' N ' HE21 ' A' ' 112' ' ' GLN . 48.4 t -116.13 128.46 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.21 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.0 m -104.53 122.19 45.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.155 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 116' ' ' SER . 0.9 OUTLIER -119.67 -151.58 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.393 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 115' ' ' VAL . 75.2 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.769 0.319 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 mp -143.56 122.59 12.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -138.51 163.93 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.09 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.71 163.63 14.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.71 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.06 117.32 3.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.914 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.02 -31.41 6.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -49.51 140.58 14.2 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.878 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.75 -159.2 30.55 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.395 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.45 150.13 47.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.845 0.355 . . . . 0.0 111.427 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -165.53 106.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.975 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -56.26 150.03 15.23 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.308 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.22 141.5 14.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.318 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.16 -4.66 85.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.753 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.4 119.82 6.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.299 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 p -69.87 133.68 47.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 111.229 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.5 tp -118.81 132.09 56.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.425 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.34 121.08 43.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 0.0 111.472 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.429 ' HB3' ' CH2' ' A' ' 36' ' ' TRP . 15.7 mt -109.32 137.88 46.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.409 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -119.99 113.18 20.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.172 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.402 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 17.4 t -111.04 133.91 53.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.361 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.2 147.16 32.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.199 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.075 -179.995 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.0 t80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.0 0.429 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.445 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 5.3 m-20 -58.85 178.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.597 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.87 118.36 10.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 111.025 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -154.54 150.47 22.05 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.811 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.429 ' CH2' ' HB3' ' A' ' 20' ' ' LEU . 76.2 m95 -88.82 152.69 21.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.224 0.535 . . . . 0.0 111.176 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -131.98 -177.31 4.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.727 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -151.23 161.48 42.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.723 179.535 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -163.59 158.72 20.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.995 0.426 . . . . 0.0 111.284 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.27 161.33 34.46 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.681 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.73 137.13 48.53 Favored 'Trans proline' 0 CA--C 1.518 -0.322 0 C-N-CA 122.256 1.971 . . . . 0.0 112.343 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.05 3.05 42.71 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.33 -174.73 2.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.78 0.324 . . . . 0.0 111.035 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -111.17 -171.16 1.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -90.62 131.66 36.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.062 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -133.0 129.62 38.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.599 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.545 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.3 t -85.45 171.28 11.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.285 0.564 . . . . 0.0 110.877 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.432 ' CG2' ' CG ' ' A' ' 38' ' ' ARG . 5.8 t -127.2 -68.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.403 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -142.67 129.21 20.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.237 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -132.67 143.16 49.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.377 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.0 tt -120.51 136.6 57.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.32 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.654 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.378 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.417 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -111.47 -178.46 3.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.809 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 50' ' ' ALA . 50.8 t80 -137.61 96.24 3.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.935 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.417 ' CE1' ' HB ' ' A' ' 58' ' ' THR . 6.0 m-30 -85.9 157.14 20.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 111.033 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.75 162.9 13.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.333 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.0 m -81.76 33.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.015 0.436 . . . . 0.0 111.709 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -118.94 -25.3 6.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.838 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.426 HG13 ' CZ ' ' A' ' 68' ' ' PHE . 30.8 m -148.7 18.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.03 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -71.22 81.21 0.72 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.761 0.791 . . . . 0.0 110.451 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 145.52 -6.69 1.47 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 114.431 -1.259 . . . . 0.0 112.495 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -123.56 -37.53 2.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.681 0.277 . . . . 0.0 111.305 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 4.8 m-30 -84.15 152.23 24.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.078 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.9 m -125.22 154.13 42.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.935 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.52 137.91 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.073 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.0 p -163.06 135.76 5.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.922 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.4 166.94 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.023 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.432 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 11.2 t0 -94.05 -31.0 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.985 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.78 28.62 16.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.33 -52.03 2.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.07 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -132.67 31.6 3.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt 61.74 50.55 4.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.42 HG22 ' CE1' ' A' ' 80' ' ' TYR . 59.3 m -114.0 150.19 34.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.821 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.402 ' CG2' ' HB3' ' A' ' 22' ' ' CYS . 34.7 m -122.53 145.24 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.835 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 27.2 m-85 -130.64 118.79 21.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.972 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.429 HD21 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -114.86 113.98 24.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 110.324 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -92.96 99.26 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.158 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -79.88 86.79 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.88 176.35 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 36.6 47.36 0.52 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.805 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.04 161.84 4.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.492 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -122.9 172.24 5.64 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.139 0.495 . . . . 0.0 111.678 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.69 13.44 2.11 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.567 2.178 . . . . 0.0 112.961 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -131.02 13.73 5.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.504 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -89.08 -7.14 56.4 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.529 0.204 . . . . 0.0 111.192 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.0 m -55.81 107.75 0.38 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.664 0.269 . . . . 0.0 111.373 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.42 170.23 7.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.551 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 5.3 p -82.09 107.07 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.454 ' CE1' ' CE ' ' A' ' 83' ' ' MET . 10.4 m-85 -87.7 103.72 15.86 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.832 0.349 . . . . 0.0 111.256 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.475 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 5.6 t -104.99 130.46 53.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.426 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.7 t -84.96 142.56 29.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.281 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.52 162.46 29.31 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.755 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.41 165.49 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.836 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -96.82 179.34 34.11 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.682 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 177.9 118.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 0.0 110.698 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.7 14.48 50.97 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.811 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.66 -11.99 46.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.577 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.404 ' CG2' ' H ' ' A' ' 104' ' ' TRP . 4.5 m -106.08 -179.26 3.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.642 0.258 . . . . 0.0 110.521 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 33' ' ' ASP . 57.0 m95 -137.22 87.1 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.663 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -118.12 10.23 12.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.608 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.01 61.44 1.51 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.191 0.52 . . . . 0.0 110.768 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -69.97 165.46 21.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.104 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.74 -141.74 8.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.567 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -89.68 -48.25 7.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.331 . . . . 0.0 111.0 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 111.12 151.58 12.24 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.766 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.0 t -153.77 113.27 3.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -74.6 142.05 44.66 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.091 0.472 . . . . 0.0 111.272 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 91' ' ' THR . 55.8 t -114.65 117.79 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.037 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.8 m -96.69 119.35 35.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.094 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -110.68 -167.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.4 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 120.813 0.34 . . . . 0.0 110.883 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.782 0.325 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 mp -153.89 148.94 26.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.32 166.76 29.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.957 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.28 162.79 23.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.782 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.6 p -170.0 118.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.8 -27.67 4.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.596 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -53.69 179.83 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.716 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.12 177.9 25.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.317 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.03 126.05 28.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.074 0.464 . . . . 0.0 111.33 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 29.5 m -126.75 140.33 49.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.606 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -70.13 138.58 52.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.922 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.17 126.09 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.405 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.94 19.38 36.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.681 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -113.31 -156.43 12.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.405 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 t -138.64 137.89 37.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.933 0.397 . . . . 0.0 111.116 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 12.9 tp -135.18 133.29 38.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.589 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -110.68 126.74 54.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.338 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.449 ' CB ' ' CH2' ' A' ' 36' ' ' TRP . 5.7 mt -113.81 139.34 49.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.242 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.8 p -115.98 114.82 25.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.994 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.7 t -106.54 134.69 49.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.617 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -122.89 142.03 51.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.127 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.984 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.442 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.433 -1.298 0 CA-C-O 120.977 0.418 . . . . 0.0 111.622 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -83.95 -176.64 6.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.084 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.1 mtp -144.02 126.61 16.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.33 154.45 25.87 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.928 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.449 ' CH2' ' CB ' ' A' ' 20' ' ' LEU . 73.9 m95 -86.93 153.84 21.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 111.438 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.4 m-85 -135.89 -178.81 5.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.768 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.452 ' CG ' ' CG2' ' A' ' 48' ' ' VAL . 0.9 OUTLIER -147.66 155.05 41.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.976 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -154.34 135.77 14.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.93 147.68 57.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.744 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.65 136.84 51.66 Favored 'Trans proline' 0 CA--C 1.517 -0.351 0 C-N-CA 122.247 1.965 . . . . 0.0 112.273 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.9 3.02 41.43 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.6 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.41 -162.92 0.82 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.692 0.282 . . . . 0.0 110.953 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -118.01 158.2 25.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.789 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.76 149.37 36.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.072 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.29 165.42 34.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.711 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.553 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.8 t -107.04 172.19 6.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.151 0.501 . . . . 0.0 110.865 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.452 ' CG2' ' CG ' ' A' ' 38' ' ' ARG . 2.6 t -128.58 -69.36 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.652 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -147.4 133.5 19.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 0.0 111.356 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -130.96 143.39 50.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.222 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 tp -124.57 141.14 45.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.182 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.57 179.703 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.75 -178.44 4.24 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.022 0.439 . . . . 0.0 110.974 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' N ' ' O ' ' A' ' 50' ' ' ALA . 7.0 t80 -140.18 93.06 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.719 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -76.98 159.42 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.844 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.87 165.97 12.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.133 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 63' ' ' SER . 2.5 p -69.48 150.94 46.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.666 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 86.7 -12.38 0.56 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.618 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.43 HG13 ' CE2' ' A' ' 68' ' ' PHE . 16.9 m -149.15 12.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.525 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -81.39 81.85 7.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.634 0.73 . . . . 0.0 110.513 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.87 -6.81 2.38 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.309 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.412 ' NE ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -119.08 -46.71 2.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.669 0.271 . . . . 0.0 111.257 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.44 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.7 m-30 -69.94 139.85 52.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.702 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.9 m -111.55 153.45 26.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.887 0.375 . . . . 0.0 111.02 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -139.45 140.34 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.834 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.424 ' N ' HG13 ' A' ' 70' ' ' ILE . 9.9 t -154.69 123.65 6.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 162.08 29.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.961 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.441 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 42.6 t0 -91.89 -38.26 12.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 59.7 47.78 10.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.743 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.3 -60.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -126.82 33.1 5.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.21 54.17 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 110.598 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.417 HG23 ' CZ ' ' A' ' 80' ' ' TYR . 92.7 m -119.17 148.83 42.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.073 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.44 144.09 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.673 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 28.5 m-85 -127.45 120.14 27.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.821 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.428 HD23 ' CE2' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -115.28 116.66 28.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.103 0.478 . . . . 0.0 110.644 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -95.9 96.09 8.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.962 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.44 ' HG2' ' CD2' ' A' ' 68' ' ' PHE . 15.6 mtm -80.41 95.42 6.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.95 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.35 176.71 6.62 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.734 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 t 35.9 40.59 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.739 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.34 163.72 1.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.211 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.74 160.96 48.94 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.802 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.1 3.73 5.92 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.49 2.127 . . . . 0.0 112.848 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 12.7 tp10 -107.01 -10.38 15.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.782 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.66 -10.53 59.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.932 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 73.3 m -48.31 106.07 0.09 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.403 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.51 177.92 3.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.328 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 5.0 p -83.95 107.35 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.447 ' CD1' ' CG2' ' A' ' 113' ' ' VAL . 6.1 m-85 -83.99 99.36 10.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.975 0.417 . . . . 0.0 110.679 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 m -103.04 132.05 49.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.282 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.7 t -90.42 135.62 33.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.657 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -136.16 176.0 20.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.402 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 32' ' ' TYR . . . -131.57 148.01 52.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.82 151.1 16.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.606 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -143.8 126.61 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.31 15.8 52.53 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.784 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.19 -9.77 46.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.791 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.7 m -102.22 179.98 4.16 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.598 0.237 . . . . 0.0 110.419 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -145.28 92.29 2.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -115.34 -2.76 12.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.406 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.41 132.39 39.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -136.55 164.67 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.28 -141.65 10.12 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.48 -45.49 8.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 113.11 153.82 11.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.532 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 1.8 t -152.58 106.93 3.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 110.526 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -60.21 141.66 55.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.136 0.493 . . . . 0.0 110.996 -179.565 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.4 t -119.91 88.01 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.181 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.1 m -76.67 132.87 39.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.218 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.79 156.51 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.396 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.917 -179.905 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.798 0.332 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mp -114.83 138.87 50.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 11.2 mt-30 -144.89 134.28 23.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.667 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.13 163.52 13.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.859 0.361 . . . . 0.0 110.897 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.9 t -163.79 118.93 1.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.16 -37.57 3.04 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.715 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -49.12 139.16 14.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.095 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.43 -165.7 34.0 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.413 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.35 148.64 49.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.882 0.372 . . . . 0.0 111.595 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -170.12 106.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -56.68 159.59 3.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.347 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.2 153.71 1.9 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.304 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.48 9.2 68.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.647 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.74 113.62 2.92 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.383 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 m -69.95 135.96 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tp -133.4 131.64 40.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.66 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -108.07 129.58 55.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.162 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HB2' ' CH2' ' A' ' 36' ' ' TRP . 3.7 mt -113.68 144.87 42.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.131 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.473 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 1.9 m -126.97 118.98 25.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.498 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 19.3 p -125.07 121.34 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.999 0.428 . . . . 0.0 110.354 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.26 171.66 9.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.349 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.847 179.958 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.0 t80 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.404 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 12.8 m-20 -48.58 164.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.846 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -145.5 126.28 14.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.821 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -155.82 155.13 26.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.818 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' A' ' 20' ' ' LEU . 78.4 m95 -84.34 153.36 23.53 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.066 0.46 . . . . 0.0 111.022 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 8.9 m-85 -133.2 -176.38 4.11 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.389 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.429 ' CG ' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -146.81 156.67 43.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.668 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -153.94 111.39 3.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.125 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.96 160.74 27.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.685 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.53 136.99 35.04 Favored 'Trans proline' 0 CA--C 1.518 -0.315 0 C-N-CA 122.294 1.996 . . . . 0.0 112.322 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.33 1.89 30.6 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.665 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.56 -174.8 2.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 110.974 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -103.18 -172.76 2.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.598 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -99.26 124.99 44.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -123.18 137.91 54.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.711 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.5 t -75.43 172.19 12.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.517 0.675 . . . . 0.0 111.526 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.429 ' CG2' ' CG ' ' A' ' 38' ' ' ARG . 2.7 t -131.02 -67.7 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.107 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -142.8 128.16 18.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.119 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -136.29 145.99 46.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.743 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.12 140.82 45.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.239 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 . . . . . 0 N--CA 1.448 -0.57 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.029 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.849 0.357 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.87 179.74 4.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.745 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 50' ' ' ALA . 57.4 t80 -140.42 95.59 2.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.574 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 68' ' ' PHE . 78.3 m-85 -78.99 169.84 17.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.45 170.73 7.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.67 150.86 46.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.715 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.0 t 81.96 -8.04 1.33 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.752 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -151.29 11.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.434 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 79.23 0.86 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.534 0.683 . . . . 0.0 110.681 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.9 1.71 5.8 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.07 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.39 -52.92 2.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 4.4 m-30 -74.86 133.65 41.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.668 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 25.0 m -95.68 153.33 17.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.03 0.443 . . . . 0.0 110.975 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.475 HD11 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -152.78 136.12 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.596 -179.194 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.475 ' N ' HD11 ' A' ' 70' ' ' ILE . 10.3 t -156.14 153.39 29.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.958 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.65 141.42 34.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.822 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -74.67 -30.37 61.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.916 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 m120 59.59 27.38 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.94 -54.63 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.018 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -122.76 27.33 7.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp 59.49 51.09 6.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.852 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.44 HG22 ' CE1' ' A' ' 80' ' ' TYR . 69.3 m -122.16 148.67 44.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.125 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.0 142.35 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.699 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.473 ' CE2' ' HB3' ' A' ' 21' ' ' SER . 1.2 m-85 -128.36 138.15 52.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.46 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 1.1 pt? -131.35 124.26 30.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.095 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -96.78 99.74 11.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.165 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -84.69 89.69 7.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.64 174.28 11.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 0.0 111.184 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 32.4 47.08 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.951 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.56 158.95 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 111.125 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.494 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -126.42 174.34 4.23 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.632 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 86.3 Cg_endo -81.18 8.22 4.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.436 2.091 . . . . 0.0 112.855 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -109.69 -8.66 14.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.8 -20.01 43.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.234 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 95.5 m -54.22 101.99 0.05 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 111.305 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.54 -175.61 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.8 t -87.37 102.89 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.623 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.412 ' CD1' HG23 ' A' ' 113' ' ' VAL . 8.1 m-85 -83.65 104.38 13.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.429 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 19.0 m -105.3 132.35 51.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.328 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.0 t -96.16 135.73 37.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.601 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.3 177.3 20.79 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.706 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -131.59 167.56 19.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.357 . . . . 0.0 111.012 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -119.45 -165.63 13.1 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.825 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.62 113.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.798 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.99 52.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.62 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.83 -12.41 34.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.752 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -96.15 177.52 5.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.891 0.377 . . . . 0.0 110.8 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.504 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 76.8 m95 -145.42 107.26 4.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.741 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -133.35 10.67 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.396 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -112.19 134.67 53.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.817 0.341 . . . . 0.0 110.896 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -141.6 165.05 28.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.05 -152.62 16.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -85.54 -31.86 22.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 95.72 156.44 31.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.65 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.8 t -147.99 112.7 5.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.341 . . . . 0.0 110.527 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.02 141.37 56.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 110.992 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.412 HG23 ' CD1' ' A' ' 94' ' ' TYR . 42.4 t -120.02 136.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.445 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 48.1 m -121.18 137.43 54.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.857 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.69 168.37 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.248 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.059 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.811 0.338 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.0 mp -145.72 130.61 18.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -118.06 157.03 27.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.777 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.26 168.3 9.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.072 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.15 131.82 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.969 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.21 -18.59 57.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.749 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.07 138.27 31.29 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.874 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.85 -169.63 39.74 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.435 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.51 154.33 42.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.902 0.382 . . . . 0.0 111.58 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.39 113.92 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.927 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.0 144.18 7.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.384 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.81 121.35 5.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.314 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.8 15.32 58.22 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.599 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.72 133.36 11.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.371 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.12 126.2 28.95 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.099 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.404 ' CD2' ' CD2' ' A' ' 20' ' ' LEU . 5.2 tp -120.52 131.34 54.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.523 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -110.23 122.44 47.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 111.607 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.424 ' HB2' ' CH2' ' A' ' 36' ' ' TRP . 6.8 mt -113.21 138.06 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.193 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.464 ' HB2' ' CD2' ' A' ' 80' ' ' TYR . 12.6 t -121.47 118.62 29.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.967 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 5.9 p -126.66 133.56 50.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.984 0.421 . . . . 0.0 111.174 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -113.87 172.85 6.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.234 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.93 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.479 ' CE2' ' CB ' ' A' ' 98' ' ' ALA . 1.5 t80 . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.905 0.383 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.424 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 46.7 m-20 -110.1 178.76 4.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.775 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 ttm -150.11 129.6 13.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.123 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -150.15 154.47 25.69 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.839 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' A' ' 20' ' ' LEU . 84.8 m95 -83.57 155.61 23.19 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.1 0.476 . . . . 0.0 111.312 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.4 m-85 -137.82 -178.28 5.18 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.473 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.436 ' CG ' ' CG2' ' A' ' 48' ' ' VAL . 2.0 mtm180 -148.41 159.33 44.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.993 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -153.63 109.12 3.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.107 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.66 154.06 38.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.714 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.2 140.43 44.75 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.369 2.046 . . . . 0.0 112.426 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.0 -8.17 39.2 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.728 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -117.87 -179.1 3.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.842 0.353 . . . . 0.0 110.914 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.26 170.63 8.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.552 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.88 130.66 35.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.802 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.14 144.34 51.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.608 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.533 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.0 t -80.76 174.82 11.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.211 0.529 . . . . 0.0 111.054 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.436 ' CG2' ' CG ' ' A' ' 38' ' ' ARG . 2.1 t -131.45 -70.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.358 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -141.26 133.78 28.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -130.33 143.39 50.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.417 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 tp -123.4 142.42 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.045 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.951 179.864 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.634 0.255 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.16 -179.94 4.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.991 0.424 . . . . 0.0 110.95 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 45.2 t80 -137.92 97.8 3.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.783 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -78.65 155.5 29.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.826 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.13 176.1 5.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.225 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -69.57 151.68 45.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.655 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.7 m 81.99 -9.0 1.25 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.571 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.44 HG12 ' CE2' ' A' ' 68' ' ' PHE . 35.4 m -151.56 13.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.352 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.74 80.11 1.12 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.707 0.765 . . . . 0.0 110.387 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.16 6.91 17.78 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.812 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -110.96 -45.31 3.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.814 0.34 . . . . 0.0 111.192 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 83' ' ' MET . 7.8 m-30 -93.02 149.59 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.018 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 14.2 m -107.33 155.5 19.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.487 HD11 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -158.13 136.45 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.116 -179.018 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.487 ' N ' HD11 ' A' ' 70' ' ' ILE . 1.9 p -154.74 170.69 21.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.405 ' NH1' ' HB3' ' A' ' 72' ' ' ARG . 16.9 mtp-105 -113.62 146.19 40.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.926 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.411 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 22.5 t0 -89.9 -11.02 43.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.339 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 43.65 30.97 0.4 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.767 0.317 . . . . 0.0 111.558 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.7 -64.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.32 39.0 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.79 52.18 2.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.828 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.474 ' CG2' ' CE1' ' A' ' 80' ' ' TYR . 79.9 m -115.92 143.92 44.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.116 0.484 . . . . 0.0 111.358 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.98 132.3 71.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.033 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.474 ' CE1' ' CG2' ' A' ' 78' ' ' THR . 2.5 m-85 -115.32 119.43 36.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -115.17 115.47 26.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 0.0 110.48 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.01 92.48 6.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.785 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.441 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -73.09 92.1 1.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.009 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.74 176.02 7.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 35.96 47.22 0.4 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.723 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.404 ' CD1' ' CB ' ' A' ' 83' ' ' MET . 0.2 OUTLIER -64.94 158.49 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.844 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.12 166.52 10.76 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.686 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.92 11.99 2.38 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.616 2.21 . . . . 0.0 112.959 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -131.76 11.42 4.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.495 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -87.08 -5.18 59.12 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.634 0.254 . . . . 0.0 111.195 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 89.5 m -55.39 118.01 4.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 111.028 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.52 -172.26 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.499 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.0 t -92.99 106.26 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.496 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -88.57 103.06 15.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.874 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 37' ' ' PHE . 6.1 t -105.75 142.22 35.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.226 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.57 144.36 25.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.92 175.89 20.07 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.313 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.479 ' CB ' ' CE2' ' A' ' 32' ' ' TYR . . . -143.59 167.65 21.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.902 0.382 . . . . 0.0 111.312 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -121.26 178.39 16.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.848 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -164.52 117.89 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.751 0.31 . . . . 0.0 110.416 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.8 16.41 51.54 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.729 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.66 -12.63 35.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.83 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -97.19 178.71 5.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.762 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.434 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 78.5 m95 -141.56 103.96 4.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -136.66 21.26 3.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.114 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.03 138.16 51.18 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.801 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -137.34 166.87 22.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.003 0.43 . . . . 0.0 111.117 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -111.03 -155.97 14.02 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.443 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -82.32 -41.1 20.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.948 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 104.86 151.37 21.0 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.799 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.0 t -152.62 121.06 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.7 144.38 37.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.957 0.408 . . . . 0.0 111.045 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 91' ' ' THR . 54.1 t -115.03 128.11 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.321 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.7 m -100.93 130.48 46.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.992 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.403 HG12 ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -136.2 -162.0 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.611 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 C--N 1.333 -0.128 0 CA-C-O 120.857 0.36 . . . . 0.0 110.825 -179.816 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.752 0.31 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.76 154.39 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.788 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -148.77 174.14 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.994 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.46 122.06 9.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -115.95 158.67 22.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -123.17 170.42 10.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -160.74 133.9 6.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.031 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.31 -32.16 6.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.567 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.29 138.77 27.03 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.948 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.41 -161.8 35.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.289 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.39 143.85 53.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.889 0.376 . . . . 0.0 111.485 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.29 113.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.077 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.01 148.04 36.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.84 145.9 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.391 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.38 -7.34 79.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.678 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.21 118.64 5.91 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.318 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -70.01 135.58 49.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 111.126 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.2 tp -116.81 134.01 55.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.379 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.414 ' NE ' ' HB3' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -107.42 119.66 40.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.505 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 14.4 mt -111.28 139.14 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.36 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.8 p -126.28 98.79 5.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.968 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.447 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 41.4 t -95.19 135.23 37.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.711 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.77 145.66 43.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.273 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.75 133.24 45.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.97 132.31 15.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.99 -92.73 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.528 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.99 107.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 110.93 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.8 t -170.1 120.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.853 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.76 36.58 0.84 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.98 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.1 t -110.16 -81.51 0.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.759 0.314 . . . . 0.0 110.823 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.2 t -139.68 29.63 2.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.108 0.48 . . . . 0.0 110.496 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -69.71 166.91 18.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.094 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.448 ' N ' ' CG ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -153.39 178.49 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.552 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.4 ' O ' HG13 ' A' ' 51' ' ' ILE . 1.6 mtm -140.98 123.05 15.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.287 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.43 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -150.55 150.52 22.54 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.247 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.447 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 79.1 m95 -84.51 152.79 23.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.141 0.496 . . . . 0.0 110.939 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.6 m-85 -132.14 -178.77 5.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.396 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.419 ' CG ' ' CG ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -154.91 161.08 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.976 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -161.6 147.49 13.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.69 163.46 42.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.656 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.19 138.28 36.11 Favored 'Trans proline' 0 CA--C 1.518 -0.318 0 C-N-CA 122.275 1.983 . . . . 0.0 112.372 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.41 -0.73 39.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.752 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.89 -177.45 3.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -100.13 -172.14 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.417 ' HD2' ' CH2' ' A' ' 107' ' ' TRP . 10.2 ptt-85 -102.79 136.06 43.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.365 . . . . 0.0 111.046 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 1.7 pt-20 -131.6 163.65 27.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.331 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.533 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.1 t -104.26 171.08 7.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.267 0.556 . . . . 0.0 111.089 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.9 -67.09 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.491 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.6 136.82 26.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.325 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -141.88 146.33 35.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -114.87 143.29 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.846 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 26.1 t-20 -86.88 167.82 13.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.177 0.513 . . . . 0.0 110.444 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -117.04 84.04 2.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.131 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.48 -79.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.691 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 169.88 64.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.36 -75.98 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.927 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.39 -164.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.72 -177.42 3.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.484 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.2 t80 -138.73 92.32 2.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.787 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -93.53 166.27 12.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.013 0.435 . . . . 0.0 111.071 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.24 159.45 19.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.366 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.48 37.19 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 0.0 111.838 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.4 t -116.35 -24.99 7.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.96 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.472 ' HA ' ' NH1' ' A' ' 67' ' ' ARG . 26.9 m -156.82 21.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.046 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 65' ' ' ARG . 16.2 ttp85 -75.26 86.32 2.47 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.884 0.849 . . . . 0.0 110.689 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.84 -17.93 0.85 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.314 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' NH1' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -115.26 -33.16 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.642 0.258 . . . . 0.0 111.304 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CE2' ' HG2' ' A' ' 83' ' ' MET . 2.6 m-85 -88.88 137.02 32.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.128 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 10.1 m -106.82 153.63 22.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -141.35 136.14 32.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.942 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.501 ' N ' HD12 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -152.66 178.72 9.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.671 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.83 167.59 18.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.019 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -79.4 -37.01 38.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.788 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 m120 62.97 35.5 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.819 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.46 -47.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.18 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.4 tttp -130.07 -64.36 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt 167.66 70.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 64.9 m -135.65 144.78 46.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.006 0.432 . . . . 0.0 111.063 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.8 m -116.54 147.6 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.696 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 2.2 m-85 -136.72 128.65 29.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.906 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -124.7 121.7 35.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.167 0.508 . . . . 0.0 110.808 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -94.59 99.21 11.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.48 ' HG2' ' CE2' ' A' ' 68' ' ' PHE . 1.5 mtp -80.51 87.82 5.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.003 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.65 176.06 7.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.738 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 34.96 48.96 0.37 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.594 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.42 HD13 ' CZ ' ' A' ' 68' ' ' PHE . 1.2 mp -58.2 165.88 1.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.313 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -145.3 167.89 13.35 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.817 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 54.8 Cg_endo -69.71 1.59 4.26 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.553 2.169 . . . . 0.0 113.148 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -98.76 -20.3 16.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.874 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.15 -21.18 46.86 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.083 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 99.9 m -51.79 101.55 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.782 0.325 . . . . 0.0 111.198 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.41 177.66 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.345 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 9.4 p -80.88 101.57 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.197 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.65 101.71 10.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.026 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.482 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 6.3 t -103.23 125.42 49.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.466 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.9 t -81.93 136.5 35.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.171 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.47 176.69 22.14 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.118 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.37 167.81 21.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.355 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -126.52 170.42 18.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.239 -0.982 . . . . 0.0 113.172 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -156.82 132.52 9.45 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.98 13.48 48.26 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.73 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.52 -9.47 45.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.886 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -101.82 179.56 4.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.849 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.452 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 84.3 m95 -136.72 86.23 2.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.576 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.56 19.04 17.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.96 132.42 56.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.417 ' CH2' ' HD2' ' A' ' 45' ' ' ARG . 19.5 m95 -139.24 164.02 30.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.025 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.87 -142.84 10.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.574 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.63 -35.32 15.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.382 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 99.8 150.69 25.38 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.863 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.9 t -145.27 114.67 7.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -76.63 132.36 39.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.971 0.415 . . . . 0.0 111.272 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.43 ' N ' HE21 ' A' ' 112' ' ' GLN . 60.7 t -110.14 124.08 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.901 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.7 m -112.49 117.26 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.62 -168.84 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.083 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 77.5 p -165.34 -87.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.605 0.241 . . . . 0.0 111.262 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.862 -179.929 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.779 0.324 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.408 HG22 ' CE2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.42 158.87 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -122.79 164.13 18.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.04 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mp -142.48 -179.57 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -169.13 169.07 9.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.04 163.31 18.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 p -167.74 126.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.62 -31.83 6.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.664 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.39 179.11 0.34 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.766 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.12 -157.79 27.49 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.076 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.45 145.36 52.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.812 0.339 . . . . 0.0 111.262 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.54 132.97 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.171 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.96 129.48 41.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.187 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.61 128.2 22.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.401 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.25 -3.04 82.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.8 -144.56 14.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.444 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.58 140.97 33.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.934 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 83' ' ' MET . 5.8 tp -129.84 141.46 50.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.446 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -122.09 131.38 53.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.489 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 3.9 mt -121.53 145.1 48.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.291 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.445 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 98.5 p -126.11 108.84 11.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.278 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 50.0 t -101.22 135.88 41.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.507 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -122.0 147.85 45.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.939 0.399 . . . . 0.0 111.424 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -121.41 163.93 17.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.822 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.07 114.82 10.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.066 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.82 145.39 5.67 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.571 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -79.8 149.66 30.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.0 p -152.94 155.03 36.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.195 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.56 32.23 0.43 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.191 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.93 53.19 1.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.6 23.33 13.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.66 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.46 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 43.8 t80 -69.42 90.35 0.52 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.521 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -84.47 -176.88 6.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.258 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.9 mtt -141.21 117.78 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.33 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.429 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -141.22 168.16 25.49 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.039 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 77.7 m95 -103.0 158.76 16.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 111.163 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 13.8 m-85 -134.72 178.49 6.97 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -148.58 155.22 40.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.929 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -145.85 110.69 5.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.5 153.24 48.09 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.37 136.46 40.07 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.325 2.016 . . . . 0.0 112.454 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.09 -1.36 33.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.657 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.74 -179.34 3.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.909 0.385 . . . . 0.0 111.048 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.45 -171.58 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.449 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -96.7 154.57 17.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.37 0.605 . . . . 0.0 111.329 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -157.46 139.24 14.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.241 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 1.6 t -67.99 171.98 6.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.478 0.656 . . . . 0.0 111.446 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.414 ' N ' ' OG ' ' A' ' 47' ' ' SER . 2.8 t -130.0 -67.8 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.221 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.14 124.42 13.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.067 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -120.62 147.3 45.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.337 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.31 141.34 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.924 0.392 . . . . 0.0 111.286 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -89.32 -164.02 1.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.785 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.437 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -105.86 -167.33 1.3 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.509 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 t0 44.19 26.27 0.15 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.923 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.5 t 41.88 78.5 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 111.452 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.61 -72.87 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.305 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -162.21 167.66 23.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.424 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -107.63 -179.03 3.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.002 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 50' ' ' ALA . 12.8 t80 -139.04 86.58 2.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.713 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 58' ' ' THR . 9.3 m-85 -86.79 143.57 27.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.38 165.14 24.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.442 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.4 p -82.33 33.66 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 0.0 111.701 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.4 p -118.99 -21.56 7.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.126 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.433 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 17.4 m -148.46 19.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.019 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.5 ttt85 -62.49 79.25 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.63 0.729 . . . . 0.0 110.832 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 134.09 3.16 3.24 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.175 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -119.1 -52.87 2.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.816 0.341 . . . . 0.0 111.069 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 5.2 m-30 -75.5 150.85 38.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.1 m -113.32 157.87 21.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.007 0.432 . . . . 0.0 110.98 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.478 HD11 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -151.58 135.18 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.96 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.478 ' N ' HD11 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -164.8 152.04 11.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.716 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 164.31 11.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.07 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.437 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 54.2 t0 -76.93 -30.33 56.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.989 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.35 25.61 13.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.25 -52.59 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.892 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 2.6 pttt -134.16 -57.53 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 173.42 70.96 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.779 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.454 HG22 ' CE1' ' A' ' 80' ' ' TYR . 25.8 m -134.92 139.42 44.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.114 0.483 . . . . 0.0 111.336 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.92 146.16 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.336 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 1.9 m-85 -135.1 155.16 51.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.72 0.295 . . . . 0.0 111.035 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -146.31 125.62 13.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.952 0.406 . . . . 0.0 110.941 179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.61 96.5 7.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.536 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.454 ' CE ' ' CE1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -79.38 91.25 5.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.271 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.44 178.53 6.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 t 38.99 40.75 0.48 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.441 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.38 159.49 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.145 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 16.5 mmmt -128.62 163.67 43.36 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.411 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 57.8 Cg_endo -70.99 6.96 1.49 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.37 2.047 . . . . 0.0 113.271 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -109.2 -8.1 15.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.009 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.27 -11.15 58.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.652 0.263 . . . . 0.0 111.308 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 97.6 m -53.18 107.7 0.26 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.057 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.61 -177.65 2.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.525 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.5 t -89.75 105.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.792 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.454 ' CE1' ' CE ' ' A' ' 83' ' ' MET . 11.3 m-85 -87.91 110.2 20.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 7.2 m -111.15 136.08 50.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.718 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.405 ' HB3' ' CE3' ' A' ' 36' ' ' TRP . 15.7 p -98.91 138.66 35.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 111.175 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.73 -169.3 11.69 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.361 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.46 ' CB ' ' CZ ' ' A' ' 32' ' ' TYR . . . -136.92 167.41 21.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 111.193 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.01 -175.8 25.57 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.629 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -173.75 108.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.73 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.09 16.69 49.32 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.764 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.0 -16.51 25.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.558 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -96.49 179.81 4.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.769 0.319 . . . . 0.0 110.475 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.414 ' CH2' ' HB3' ' A' ' 50' ' ' ALA . 79.9 m95 -141.88 92.51 2.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.766 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -117.43 -2.18 11.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.586 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 t -93.28 132.49 37.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -137.28 162.63 33.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.38 -92.49 2.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.403 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -140.36 -69.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 110.845 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.54 151.08 5.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.738 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 t -147.25 106.46 3.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.899 0.38 . . . . 0.0 110.45 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.17 142.22 57.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.203 0.525 . . . . 0.0 111.04 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.416 HG23 ' CD2' ' A' ' 94' ' ' TYR . 41.1 t -117.62 116.43 51.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.182 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.1 m -100.58 108.55 20.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.075 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.31 -158.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.396 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 78.92 -58.4 0.42 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.873 0.368 . . . . 0.0 111.031 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.934 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.829 0.347 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.2 155.37 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -143.41 150.14 38.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 mp -147.82 151.54 36.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -154.32 173.11 16.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.06 164.31 14.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.792 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.92 101.3 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.28 87.17 1.97 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.423 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.62 152.87 16.22 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.447 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.71 -155.25 26.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.41 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.03 134.67 49.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.908 0.385 . . . . 0.0 111.247 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.33 128.96 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.282 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 132.56 46.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.309 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.54 154.26 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.582 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.18 -9.14 73.93 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.792 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.78 -163.14 25.98 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.608 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.48 141.37 41.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tp -128.77 132.27 47.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.612 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -111.57 116.9 31.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.381 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.435 ' CB ' ' CH2' ' A' ' 36' ' ' TRP . 9.9 mt -104.69 133.74 49.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.626 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 p -112.25 134.94 53.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.659 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -134.29 126.12 29.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.92 0.39 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.19 152.75 21.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.971 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -134.39 112.96 11.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -103.39 157.35 17.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.12 146.21 10.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.515 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -70.15 137.75 51.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.742 0.306 . . . . 0.0 110.856 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.7 t -159.9 127.63 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.023 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.89 35.83 1.56 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.147 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 t -116.09 46.34 1.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 110.972 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.86 32.38 21.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.01 0.433 . . . . 0.0 110.441 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.465 ' CE2' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.8 138.46 54.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.026 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.419 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 39.1 m-20 -123.45 -176.38 3.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.703 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.9 ttm -145.63 126.43 14.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.192 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.86 162.71 28.97 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.733 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.435 ' CH2' ' CB ' ' A' ' 20' ' ' LEU . 79.7 m95 -91.63 155.12 18.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 111.487 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -137.69 -177.94 5.02 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.785 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -151.49 163.14 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.559 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 39' ' ' GLN . 4.5 tp60 -165.91 128.37 2.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.03 0.443 . . . . 0.0 111.621 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.45 167.94 8.57 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.496 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 137.56 28.64 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.233 1.955 . . . . 0.0 112.476 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.33 2.0 24.22 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.703 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -119.48 152.0 37.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -77.21 156.1 31.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.387 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.9 143.0 52.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.951 0.405 . . . . 0.0 111.245 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.43 143.25 48.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.211 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.542 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.6 t -83.57 172.79 12.0 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 111.183 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.409 ' CG2' ' HG2' ' A' ' 38' ' ' ARG . 2.0 t -129.19 -66.64 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.976 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.09 161.67 40.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.417 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -160.24 144.4 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.995 0.426 . . . . 0.0 111.511 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.4 tt -123.24 143.67 35.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -81.47 177.9 8.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.016 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -118.84 -37.38 3.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.087 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.27 -52.68 13.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.365 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.3 t -87.2 -102.34 0.07 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.066 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 177.25 -35.05 0.01 OUTLIER 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.735 0.302 . . . . 0.0 111.339 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.13 148.64 0.41 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.515 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.99 -179.36 3.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.022 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -140.6 142.18 35.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.382 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -128.86 168.32 16.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.84 0.353 . . . . 0.0 111.026 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.0 168.07 13.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 63' ' ' SER . 56.3 m -69.24 153.07 44.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.498 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 t 84.38 -10.23 0.89 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.522 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.6 m -154.2 16.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.462 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ARG . 8.9 tpt180 -82.08 83.15 7.41 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.665 0.745 . . . . 0.0 109.962 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.09 -0.65 7.71 Favored Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.158 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -110.81 -52.63 2.77 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.837 0.351 . . . . 0.0 110.794 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.454 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.3 m-30 -76.86 149.34 36.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 m -111.05 152.37 26.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.879 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.2 tp -137.49 146.19 28.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.761 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.08 172.33 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 111.032 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.85 143.61 50.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.913 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.421 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 7.2 t0 -83.57 -38.07 22.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.09 26.75 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.43 -42.71 2.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.963 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.25 29.09 2.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.876 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt 61.93 53.97 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.418 HG22 ' CE1' ' A' ' 80' ' ' TYR . 97.9 m -118.36 148.72 42.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.026 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.75 141.02 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.843 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 24.9 m-85 -125.96 126.69 44.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.977 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.404 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -120.63 116.81 26.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 0.0 110.51 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -94.76 94.59 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.156 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.454 ' HG2' ' CD2' ' A' ' 68' ' ' PHE . 25.9 mtm -78.02 92.91 4.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.798 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.83 176.44 6.63 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 37.21 43.32 0.34 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.695 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.98 156.65 5.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.02 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -124.24 170.77 8.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.855 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 89.8 Cg_endo -77.96 8.15 3.62 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.515 2.143 . . . . 0.0 112.954 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -116.92 7.52 13.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.257 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -92.4 -10.06 39.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.304 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 97.9 m -53.97 107.79 0.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.256 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.29 177.0 4.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 4.2 p -85.69 106.33 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.027 0.441 . . . . 0.0 110.846 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.96 101.8 13.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.137 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 9.1 m -113.13 136.03 53.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.609 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 25.6 p -100.65 147.12 26.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.029 0.442 . . . . 0.0 111.365 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.83 -171.28 12.45 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.214 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.465 ' CB ' ' CE2' ' A' ' 32' ' ' TYR . . . -138.19 166.73 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 111.269 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.61 176.26 18.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.665 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.49 113.69 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 110.575 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.66 16.97 52.86 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.695 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.87 -14.17 31.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.4 ' CG2' ' H ' ' A' ' 104' ' ' TRP . 4.4 m -96.32 179.31 5.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.548 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' A' ' 33' ' ' ASP . 78.0 m95 -143.76 102.64 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.795 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.11 11.02 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.439 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.87 137.91 42.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.642 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -140.73 164.11 31.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.964 0.412 . . . . 0.0 111.034 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.18 -130.71 6.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.337 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -98.81 -63.23 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 0.0 110.807 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.89 151.07 8.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.665 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.4 t -145.28 109.72 4.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.359 . . . . 0.0 110.428 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.54 141.63 55.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.208 0.528 . . . . 0.0 111.035 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.21 131.82 70.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.254 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 83.9 m -116.85 138.67 51.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.207 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.11 168.17 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.28 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.5 m -150.76 -54.53 0.15 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.104 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.88 -179.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.77 0.319 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.9 m -69.96 152.11 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.236 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -133.77 165.3 25.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.5 mp -140.07 135.32 32.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.17 131.41 44.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.75 164.68 17.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.7 p -158.19 111.73 2.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.03 84.51 1.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.355 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.44 143.81 8.96 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.547 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.83 -156.19 21.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.528 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.08 143.19 54.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.919 0.39 . . . . 0.0 111.362 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.97 126.88 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.135 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.57 139.95 56.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.32 137.06 29.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.323 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.5 -15.73 60.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.703 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.61 -154.65 7.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.42 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.62 139.29 31.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.011 0.434 . . . . 0.0 111.213 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.8 tp -124.45 135.31 53.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.554 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.06 115.31 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 111.557 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.41 ' HB3' ' CH2' ' A' ' 36' ' ' TRP . 12.4 mt -112.61 132.48 55.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.584 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -120.67 113.34 20.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.67 123.14 49.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.791 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.71 165.76 11.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.298 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.96 137.82 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.5 m -122.62 162.74 21.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.986 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.5 152.11 10.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 125.14 25.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.695 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.422 HG23 ' CD2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -149.05 86.41 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.293 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.31 30.95 7.79 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.911 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 t -109.15 33.66 4.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.752 0.31 . . . . 0.0 110.965 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 m 71.69 32.02 2.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.975 0.417 . . . . 0.0 110.424 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.466 ' CE2' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.64 130.27 42.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.741 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -115.47 -173.65 2.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.86 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.3 mtm -145.87 124.71 12.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.055 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.88 152.93 24.88 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.829 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.41 ' CH2' ' HB3' ' A' ' 20' ' ' LEU . 73.1 m95 -88.46 154.82 20.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.114 0.483 . . . . 0.0 111.427 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.1 m-85 -133.65 -178.69 5.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.266 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 1.6 ptm180 -152.94 157.86 41.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.752 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -145.46 145.4 31.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.946 0.403 . . . . 0.0 111.336 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.37 151.77 78.11 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.44 139.6 41.75 Favored 'Trans proline' 0 CA--C 1.517 -0.345 0 C-N-CA 122.362 2.041 . . . . 0.0 112.537 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.76 -7.08 43.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.764 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.45 -166.68 1.21 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.798 0.333 . . . . 0.0 110.9 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.86 -171.71 1.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -98.19 133.77 42.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.935 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -131.79 152.28 51.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.423 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 6.6 t -83.41 174.66 10.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.382 0.61 . . . . 0.0 111.079 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.426 ' N ' ' OG ' ' A' ' 47' ' ' SER . 3.8 t -130.12 -62.47 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.071 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.88 129.83 11.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -127.98 145.26 51.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.386 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.0 tt -126.98 142.29 43.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.32 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -88.05 -163.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.74 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -109.01 -33.64 6.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.702 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -178.83 38.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.65 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 t -93.44 -62.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.062 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.24 -62.87 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.339 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.74 -142.52 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.861 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.85 -179.77 4.54 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.987 0.423 . . . . 0.0 111.19 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 50' ' ' ALA . 65.3 t80 -139.7 91.0 2.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.64 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -76.83 158.06 31.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.2 172.01 7.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.167 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -69.57 150.87 46.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.618 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.0 OUTLIER 84.72 -11.19 0.81 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.623 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.426 HG12 ' CE2' ' A' ' 68' ' ' PHE . 16.4 m -149.21 12.45 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.48 79.2 1.05 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.537 0.684 . . . . 0.0 110.7 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.73 3.11 10.26 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.825 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -108.01 -41.32 4.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.732 0.301 . . . . 0.0 111.09 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.439 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 9.5 m-30 -94.27 146.72 23.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.124 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.7 m -105.12 158.03 16.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.812 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.7 tp -144.79 139.92 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.106 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 m -154.42 137.35 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.679 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.13 152.01 21.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.245 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.472 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 39.4 t0 -84.43 -36.5 22.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.793 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.99 29.98 19.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.95 -46.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.09 31.76 1.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt 62.77 56.14 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 60.6 m -116.04 150.31 37.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.888 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.5 131.95 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.928 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.584 ' CD1' ' HB3' ' A' ' 21' ' ' SER . 25.6 m-85 -113.09 120.58 41.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.195 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.09 112.61 23.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.068 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -96.35 96.84 9.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.203 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.439 ' HG2' ' CD2' ' A' ' 68' ' ' PHE . 1.3 mtp -81.94 88.3 6.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.03 177.66 6.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.57 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 t 37.98 40.85 0.32 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.516 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 162.62 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -128.99 170.83 9.84 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.779 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 84.5 Cg_endo -77.67 10.82 2.4 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 113.089 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -122.02 10.98 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.342 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -95.94 -15.46 22.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.608 0.242 . . . . 0.0 111.36 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 82.9 m -49.27 112.86 0.69 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.435 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.34 173.65 5.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.969 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 7.4 p -81.1 105.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.979 0.419 . . . . 0.0 110.925 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.42 ' CD1' HG22 ' A' ' 113' ' ' VAL . 21.9 m-85 -83.95 99.08 10.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.959 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 4.3 m -105.63 128.03 53.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 14.0 p -95.15 143.78 26.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.964 0.411 . . . . 0.0 111.224 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -139.81 -173.06 13.03 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.158 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.466 ' CB ' ' CE2' ' A' ' 32' ' ' TYR . . . -144.69 166.37 25.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.957 0.408 . . . . 0.0 111.264 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.93 171.68 18.21 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.676 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.01 115.5 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.621 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.89 15.8 50.05 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.782 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.77 -14.67 31.98 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.528 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.5 m -99.1 178.79 4.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.789 0.328 . . . . 0.0 110.608 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -138.2 93.06 2.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.655 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -119.2 2.33 11.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.52 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.04 132.72 41.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 110.898 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -140.91 164.93 28.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.71 -154.81 18.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -30.75 20.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.333 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.94 151.0 26.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.883 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.4 t -145.34 109.45 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.262 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -67.61 141.55 56.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.158 0.504 . . . . 0.0 111.052 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.42 HG22 ' CD1' ' A' ' 94' ' ' TYR . 43.5 t -119.87 126.23 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.329 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.8 m -109.99 142.62 41.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.955 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 t -127.52 169.54 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.155 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.01 -162.9 1.66 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.813 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.881 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.8 162.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.78 150.23 39.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 mp -149.12 155.1 40.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.66 161.11 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.714 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.81 164.72 12.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.83 0.348 . . . . 0.0 110.978 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -164.76 95.65 0.72 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.59 -28.43 2.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.638 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -50.0 138.43 20.89 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.9 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.0 -172.49 43.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.089 -0.576 . . . . 0.0 112.373 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mp -69.35 150.03 47.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.863 0.363 . . . . 0.0 111.554 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 p -153.39 116.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.941 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.74 139.77 25.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.426 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.17 123.3 7.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.82 0.56 60.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.834 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.31 138.55 14.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.449 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 t -79.68 141.54 36.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 110.966 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.9 tp -132.92 150.44 52.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.309 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -125.45 126.56 45.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.402 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 2.2 mt -114.49 149.72 35.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.799 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.57 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 71.1 m -131.21 118.63 20.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.05 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.0 p -125.37 131.34 52.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.58 169.11 9.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.311 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.61 105.29 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.9 p -97.89 103.03 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.52 161.49 13.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -69.94 92.94 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.404 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 12.6 t -154.3 105.35 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.001 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' A' ' 53' ' ' TRP . . . -165.86 34.23 0.24 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.485 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.5 t -121.86 -74.06 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 111.326 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.1 p -114.0 -27.42 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.404 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' CE1' ' HA ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -69.45 130.84 43.63 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.919 0.39 . . . . 0.0 111.275 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 44.2 m-20 -101.6 -172.45 2.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.941 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -143.6 124.1 13.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.733 0.301 . . . . 0.0 111.273 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.52 166.11 29.62 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.939 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' A' ' 20' ' ' LEU . 52.6 m95 -91.9 156.2 17.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.133 0.492 . . . . 0.0 111.307 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 8.1 m-85 -136.45 179.18 6.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.938 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 16.7 ptm180 -152.86 160.56 43.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.723 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -165.5 159.83 17.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.064 0.459 . . . . 0.0 111.459 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.01 162.33 57.32 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.506 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.59 137.39 35.86 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.387 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.54 3.07 38.67 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.722 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 -172.87 2.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.783 0.325 . . . . 0.0 111.058 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.85 -178.84 3.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.739 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.409 ' HD2' ' CH2' ' A' ' 107' ' ' TRP . 18.2 ptt-85 -103.28 139.65 38.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.173 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -140.73 146.74 38.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.236 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.7 t -83.85 175.2 9.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.316 0.579 . . . . 0.0 111.363 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.4 -57.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.786 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.29 157.66 43.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.719 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HA ' ' CA ' ' A' ' 35' ' ' GLY . . . -158.19 140.97 14.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.06 0.457 . . . . 0.0 111.484 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.5 tp -121.21 139.82 47.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.835 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -72.83 157.65 37.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.933 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.435 ' CD1' ' HA2' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -88.65 81.61 7.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.533 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.414 ' O ' ' CB ' ' A' ' 55' ' ' SER . 4.8 p-10 173.75 -27.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.974 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER 80.37 86.38 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.759 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.36 -44.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.139 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.04 149.4 31.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.998 0.428 . . . . 0.0 111.291 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.48 -178.13 3.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.599 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.6 t80 -136.93 142.59 42.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.561 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.424 ' CZ ' ' O ' ' A' ' 68' ' ' PHE . 5.8 m-85 -126.44 165.77 18.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.976 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.6 166.41 11.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.5 152.13 45.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.703 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 83.62 -10.15 0.98 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.571 -178.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.432 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 35.6 m -152.08 15.39 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.237 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.403 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -70.48 78.91 0.56 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.576 0.703 . . . . 0.0 110.752 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.51 3.35 5.63 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.0 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -112.29 -44.04 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.754 0.311 . . . . 0.0 111.016 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.448 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 5.9 m-30 -78.79 140.2 38.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.786 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 28.9 m -105.45 151.06 24.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 111.164 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -145.54 136.8 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.634 -179.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.496 ' N ' HD12 ' A' ' 70' ' ' ILE . 19.3 p -162.41 141.59 9.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.091 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -73.25 165.42 25.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.958 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 37.1 t0 -97.19 -33.5 11.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.826 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 60.34 58.36 2.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.17 -46.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -140.38 29.29 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.72 55.48 2.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.62 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.548 HG21 ' CE1' ' A' ' 80' ' ' TYR . 6.4 m -123.3 158.94 29.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.109 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.19 143.66 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.715 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.57 ' CE1' ' HB3' ' A' ' 21' ' ' SER . 15.2 m-85 -124.5 135.11 52.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.506 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.426 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -127.19 121.04 30.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.084 0.469 . . . . 0.0 110.812 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -99.23 101.15 12.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.838 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.448 ' HG2' ' CD2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -87.75 95.22 10.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.181 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.92 175.36 8.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.833 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 34.4 48.33 0.27 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.794 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.401 ' CD2' HG13 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -54.34 164.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.004 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.43 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -128.68 164.46 38.24 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.813 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 87' ' ' LYS . 63.1 Cg_endo -72.82 6.32 2.5 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.533 2.155 . . . . 0.0 113.155 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -111.89 -0.03 15.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.282 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -84.91 -11.73 54.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.576 0.227 . . . . 0.0 111.237 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 90.8 m -56.02 103.5 0.1 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.67 175.65 4.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.381 . . . . 0.0 111.583 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 7.7 p -80.84 105.37 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.082 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 111' ' ' THR . 9.8 m-85 -84.42 105.04 14.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.656 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.4 m -110.96 127.38 55.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.9 t -81.17 127.4 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.485 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -128.15 -177.41 14.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.471 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -146.13 147.77 31.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.848 0.356 . . . . 0.0 111.213 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.458 ' N ' ' CE3' ' A' ' 104' ' ' TRP . . . -78.77 -170.07 37.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.374 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.28 100.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.67 18.54 45.71 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.761 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.19 -20.28 11.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -97.62 -179.81 4.59 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 110.426 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.458 ' CE3' ' N ' ' A' ' 99' ' ' GLY . 71.8 m95 -145.55 102.54 3.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.945 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -134.96 15.6 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.298 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.37 133.22 51.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.786 0.326 . . . . 0.0 110.66 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.409 ' CH2' ' HD2' ' A' ' 45' ' ' ARG . 9.4 m95 -136.25 162.15 33.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.28 -137.19 9.13 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.494 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -87.07 -51.02 6.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.334 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.39 151.28 12.88 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.661 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 13.9 t -158.56 118.57 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -79.44 142.64 35.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.004 0.43 . . . . 0.0 111.176 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 91' ' ' THR . 52.6 t -116.31 136.48 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.159 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.6 m -109.31 130.0 55.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.011 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.401 HG13 ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -126.18 -158.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.55 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.3 t 65.66 169.96 0.21 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.869 0.366 . . . . 0.0 110.87 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.945 -179.9 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.541 0.21 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.33 151.76 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.634 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -89.62 155.1 19.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.124 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 mp -160.61 99.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.02 174.01 8.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.012 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.37 163.97 22.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.733 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -169.62 135.94 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.08 -18.36 26.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.729 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.07 -173.83 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.831 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.12 164.36 10.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.509 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mp -69.28 146.51 52.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.85 0.357 . . . . 0.0 111.376 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -165.53 119.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -54.76 154.5 5.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.24 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.64 138.3 14.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.358 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.99 -21.79 44.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.487 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.52 122.98 6.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.305 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 11.4 p -70.0 130.53 42.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 111.131 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.7 tp -109.74 133.74 52.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.494 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -107.29 119.2 38.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 0.0 111.422 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.437 ' HB3' ' CH2' ' A' ' 36' ' ' TRP . 13.9 mt -114.53 136.32 53.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.534 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.5 p -122.34 111.05 16.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.122 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.4 t -107.29 134.52 50.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.514 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.29 152.4 26.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.253 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.32 154.0 38.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.2 t -69.93 121.56 17.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.08 56.99 5.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.541 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -125.3 62.14 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.45 HG23 ' CG ' ' A' ' 32' ' ' TYR . 16.5 p -117.9 -161.1 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.706 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.36 -33.84 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.141 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.0 t -69.95 -75.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.4 t -174.36 41.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' CE2' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -69.6 130.72 43.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.854 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -120.26 -171.45 2.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.715 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.67 160.32 40.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.923 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . 179.56 141.62 4.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.0 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.437 ' CH2' ' HB3' ' A' ' 20' ' ' LEU . 81.4 m95 -82.72 154.7 24.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.15 0.5 . . . . 0.0 111.285 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.579 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.5 m-85 -137.89 -178.27 5.18 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.296 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.417 ' CG ' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -148.85 161.04 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.494 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -162.7 137.51 6.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.005 0.431 . . . . 0.0 111.387 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.15 166.77 14.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.49 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.21 135.77 41.42 Favored 'Trans proline' 0 CA--C 1.517 -0.355 0 C-N-CA 122.169 1.913 . . . . 0.0 112.248 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.43 6.35 33.92 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.458 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.51 -177.23 3.18 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.832 0.348 . . . . 0.0 111.022 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -109.7 -171.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.775 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -86.12 134.43 33.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.078 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -131.74 116.45 17.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.412 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 1.5 t -68.09 169.22 10.56 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.599 0.714 . . . . 0.0 111.328 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.417 ' CG2' ' CG ' ' A' ' 38' ' ' ARG . 2.3 t -132.63 -68.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.372 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -140.94 145.99 36.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.71 0.29 . . . . 0.0 111.307 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -140.85 142.18 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.4 tt -125.23 145.75 32.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.56 -167.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.249 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.32 59.49 1.02 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.008 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -177.28 32.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.37 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 m 41.67 33.76 0.34 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.441 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.34 -57.1 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.147 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.81 178.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.06 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.42 -178.02 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.978 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 52.9 t80 -139.19 96.2 3.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.892 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.37 158.16 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.842 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . -98.13 157.16 16.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 63' ' ' SER . 17.3 p -69.38 151.57 45.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.572 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 86.47 -12.3 0.59 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.556 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.97 7.67 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.497 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 80.23 0.55 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.561 0.696 . . . . 0.0 110.781 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 139.49 1.77 1.86 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.619 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.431 ' HG3' ' CD1' ' A' ' 68' ' ' PHE . 13.4 ptp180 -117.96 -40.03 3.03 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.779 0.289 . . . . 0.0 111.303 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 83' ' ' MET . 14.4 m-30 -90.23 159.0 16.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.115 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.8 m -125.23 157.19 37.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -156.32 134.47 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.997 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.459 ' N ' HD12 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -160.13 140.25 11.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.842 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -78.24 173.3 12.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.95 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 33.3 t0 -98.99 -33.59 10.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.034 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.22 28.7 17.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.54 -59.82 1.51 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.953 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -128.06 28.47 5.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.5 60.02 0.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.149 0.5 . . . . 0.0 110.729 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.421 HG21 ' CE1' ' A' ' 80' ' ' TYR . 95.0 m -122.84 147.93 45.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.047 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.6 m -119.78 139.37 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 41.1 m-85 -124.45 115.88 21.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 0.0 111.197 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -112.24 111.77 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.139 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.42 97.29 9.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.769 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.441 ' CE ' ' CZ ' ' A' ' 94' ' ' TYR . 5.3 mtp -77.18 87.66 3.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.258 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -82.02 176.37 9.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.702 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 37.4 48.55 0.86 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.753 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.98 157.77 29.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.978 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.33 173.83 5.25 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.773 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.38 9.16 3.53 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.613 2.208 . . . . 0.0 113.034 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -113.04 -4.95 13.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.1 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.29 -12.25 58.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.239 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 76.2 m -48.94 104.06 0.06 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.46 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.4 166.62 8.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.365 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.475 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 9.8 p -76.33 105.26 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.038 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.441 ' CZ ' ' CE ' ' A' ' 83' ' ' MET . 5.0 m-85 -82.54 100.26 10.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.4 m -109.11 134.48 51.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 26.7 p -96.49 146.14 25.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.033 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.16 -178.35 16.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.555 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.473 ' CB ' ' CE2' ' A' ' 32' ' ' TYR . . . -131.65 170.18 15.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -118.26 172.56 14.49 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.802 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -159.09 118.08 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.504 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.11 16.03 51.98 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.696 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.31 -12.78 36.73 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.673 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -98.13 180.0 4.57 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.744 0.307 . . . . 0.0 110.672 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.413 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 83.6 m95 -138.45 101.61 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.815 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -123.21 -8.49 8.19 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.474 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.42 140.4 29.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.827 0.346 . . . . 0.0 111.112 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -141.88 165.47 27.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.795 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.27 -149.25 13.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.524 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.03 -55.63 3.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.686 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.91 150.98 9.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.763 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.4 t -146.84 112.21 5.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.375 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -61.95 140.52 58.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.222 0.534 . . . . 0.0 111.012 -179.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.9 t -119.13 97.64 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.037 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.5 m -86.13 135.69 33.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 111.285 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 t -130.87 168.0 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.184 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.46 -167.53 2.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.99 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.259 -0.876 . . . . 0.0 110.853 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.814 0.34 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.21 156.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -149.73 173.05 14.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.954 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mp -145.6 162.87 36.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.42 141.96 27.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -94.52 167.79 11.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -168.85 115.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.869 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.23 -34.77 4.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.555 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.42 138.94 27.33 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.817 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.42 -162.88 31.11 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.44 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.45 152.23 45.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.846 0.355 . . . . 0.0 111.404 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 p -170.12 109.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -57.56 152.29 15.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.338 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.45 153.65 2.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.376 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.08 5.18 75.16 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.722 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.71 119.78 4.37 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.395 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.2 136.82 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 111.032 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 tp -127.34 131.3 50.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.403 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -107.42 133.0 52.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.901 0.381 . . . . 0.0 111.418 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 1.1 mt -120.15 150.78 40.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.072 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.3 p -123.23 140.31 53.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.204 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.4 t -134.1 135.15 43.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.697 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.3 157.09 20.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.11 -168.81 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.051 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.21 152.94 25.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.23 23.3 35.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.667 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -94.14 55.96 2.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.924 0.392 . . . . 0.0 110.836 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.2 t -167.19 -166.46 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.6 42.2 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.763 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.0 t -122.92 -70.31 0.78 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.378 . . . . 0.0 110.821 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.64 28.34 1.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.787 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 5.4 t80 -69.85 141.06 53.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.056 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.92 172.39 13.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.55 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -137.92 117.56 13.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.847 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -145.85 149.65 21.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.849 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.438 ' CE2' HD21 ' A' ' 81' ' ' LEU . 67.4 m95 -88.32 153.62 21.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.13 0.49 . . . . 0.0 111.175 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.3 m-85 -132.32 -178.88 5.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.588 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.406 ' CG ' ' CG ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -151.97 157.21 41.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.157 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.45 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -157.69 141.4 15.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 111.416 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.53 161.63 53.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.535 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.36 137.09 42.21 Favored 'Trans proline' 0 CA--C 1.518 -0.315 0 C-N-CA 122.287 1.991 . . . . 0.0 112.384 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.37 3.74 40.8 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.671 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -112.51 -176.06 2.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.872 0.368 . . . . 0.0 111.056 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -111.53 157.27 20.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.45 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 15.8 ptt-85 -74.47 133.15 42.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.12 0.486 . . . . 0.0 111.732 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 16.4 pt-20 -134.54 165.11 25.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.903 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 12.1 t -101.03 172.64 6.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.194 0.521 . . . . 0.0 111.164 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 t -128.95 -67.51 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.367 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.02 135.42 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.0 111.367 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.414 ' HA ' ' CA ' ' A' ' 35' ' ' GLY . . . -131.65 144.75 51.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.11 143.69 40.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.251 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -69.72 -165.24 0.08 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.189 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.19 -58.49 2.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.73 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -54.54 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.187 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 p 173.48 69.12 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.901 0.381 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.84 -72.3 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.77 -170.18 1.0 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.062 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.86 -177.79 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -139.41 92.27 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.805 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -78.7 159.55 27.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.82 161.51 15.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 0.0 111.304 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' SER . 32.8 t -69.28 152.21 45.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.477 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.8 t 88.83 -14.4 0.36 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.515 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.41 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 34.9 m -150.49 16.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.432 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.72 81.3 5.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.523 0.678 . . . . 0.0 111.151 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.89 -11.2 2.36 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.185 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.41 ' CG ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -109.46 -51.37 2.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.777 0.323 . . . . 0.0 111.247 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CE2' ' HG2' ' A' ' 83' ' ' MET . 3.1 m-85 -69.93 140.15 53.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.905 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 m -110.82 146.08 37.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.778 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 71' ' ' SER . 1.1 tp -136.42 140.94 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.88 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -151.13 -174.44 4.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.81 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -130.83 168.06 17.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.005 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.414 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 34.3 t0 -97.32 -37.56 10.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.844 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.41 35.92 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.81 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.32 -67.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.098 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 29.82 7.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.36 44.99 14.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.68 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.43 HG22 ' CE1' ' A' ' 80' ' ' TYR . 46.6 m -112.64 151.5 30.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.173 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.22 158.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.381 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.43 ' CE1' HG22 ' A' ' 78' ' ' THR . 33.9 m-85 -141.71 129.88 22.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.026 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.438 HD21 ' CE2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -125.21 122.15 36.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.094 0.473 . . . . 0.0 110.898 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -95.57 95.96 8.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.438 ' HG2' ' CE2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -77.08 88.43 3.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.855 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.4 176.26 7.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 36.41 40.76 0.13 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.588 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.14 158.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.182 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 6.2 mptt -127.64 162.91 46.24 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.78 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 74.2 Cg_endo -74.91 5.71 3.78 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.457 2.105 . . . . 0.0 112.927 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -109.73 -6.82 15.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.134 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.34 -19.4 46.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.7 m -50.42 106.83 0.13 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.864 0.364 . . . . 0.0 111.25 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.34 -176.2 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.977 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -87.51 103.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.854 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -82.75 108.75 16.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.468 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.2 m -107.5 130.68 54.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.316 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 50.6 t -92.35 138.73 31.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.623 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -146.98 176.36 25.89 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.826 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.484 ' CB ' ' CZ ' ' A' ' 32' ' ' TYR . . . -126.7 172.94 9.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 0.0 111.011 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -124.84 178.21 16.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.185 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -171.38 122.48 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.379 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.66 15.7 54.39 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.642 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.83 -9.4 47.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.826 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.3 m -100.16 178.67 4.71 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 110.775 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.434 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 80.0 m95 -140.89 90.95 2.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -110.26 -6.62 14.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.372 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.85 131.26 36.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.706 0.288 . . . . 0.0 110.782 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -141.3 164.09 31.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.001 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.34 -136.66 8.43 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.46 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -102.96 -35.65 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.928 0.394 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.6 151.1 12.59 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.68 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 t -144.26 104.77 4.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.852 0.358 . . . . 0.0 110.457 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.77 141.12 58.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 111.113 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.79 130.34 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.304 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.1 m -115.72 133.28 56.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.115 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.44 168.01 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.306 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.2 t -145.33 -165.37 2.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.968 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.828 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.817 0.342 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.2 m -69.98 147.85 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.247 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -76.51 170.12 16.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mp -156.44 119.26 4.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.133 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -122.9 165.7 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.576 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.44 163.32 15.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.774 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.45 131.23 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.11 -28.36 11.22 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.663 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -53.23 164.23 2.14 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.869 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.64 171.29 25.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.41 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mp -69.07 137.2 53.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.928 0.394 . . . . 0.0 111.398 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.23 128.57 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.991 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -64.2 149.35 48.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.35 144.32 5.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.382 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.98 -14.95 63.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.635 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.29 129.67 9.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.37 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.08 135.54 49.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 111.03 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tp -119.51 132.12 55.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.292 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -114.04 116.53 29.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.828 0.347 . . . . 0.0 111.369 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.429 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 14.5 mt -107.6 138.31 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.403 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 90.9 p -124.96 120.08 30.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.962 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.426 ' HB3' ' CG1' ' A' ' 79' ' ' VAL . 26.8 t -117.89 131.35 56.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.022 0.439 . . . . 0.0 110.595 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.91 149.14 31.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.287 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.97 -168.97 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.022 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -100.34 147.38 25.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.841 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.55 69.73 3.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.553 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -169.8 76.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 0.0 110.843 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 t -156.89 -168.75 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.29 38.36 0.23 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.615 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.75 54.1 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.97 0.414 . . . . 0.0 110.745 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.5 m 72.74 13.79 5.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -69.44 147.28 51.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.928 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.418 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 23.4 m-20 -129.15 -169.13 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.16 120.73 8.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.098 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -144.95 168.87 26.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.861 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.427 ' CH2' ' HB3' ' A' ' 20' ' ' LEU . 74.8 m95 -107.14 159.5 16.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 111.19 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 11.0 m-85 -137.74 178.3 7.21 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.726 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -156.34 154.04 29.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.398 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.406 ' HB3' ' CG1' ' A' ' 93' ' ' VAL . 5.0 tp60 -157.02 119.32 3.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.953 0.406 . . . . 0.0 111.449 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -102.91 169.79 7.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.575 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.73 138.96 32.86 Favored 'Trans proline' 0 CA--C 1.517 -0.328 0 C-N-CA 122.241 1.961 . . . . 0.0 112.447 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.92 3.44 35.84 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.712 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -118.1 158.41 25.08 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.947 0.403 . . . . 0.0 110.984 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.47 157.23 19.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.215 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.441 ' NE ' ' CZ3' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -69.92 144.36 52.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.165 0.507 . . . . 0.0 111.13 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.29 146.91 27.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.407 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 2.6 t -77.01 173.11 12.17 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.456 0.646 . . . . 0.0 111.421 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.423 ' N ' ' OG ' ' A' ' 47' ' ' SER . 15.9 t -127.21 -60.63 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.235 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.99 123.23 7.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.957 0.408 . . . . 0.0 111.197 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -120.34 147.47 44.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.231 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 52' ' ' ASN . 3.1 tp -132.03 141.54 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.027 0.441 . . . . 0.0 111.459 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.418 ' N ' HG13 ' A' ' 51' ' ' ILE . 10.3 m120 -71.21 170.1 13.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.815 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -100.19 30.02 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.871 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -140.3 15.92 2.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.183 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.7 p 50.08 43.12 25.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.876 0.369 . . . . 0.0 111.092 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.65 -65.68 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.344 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -153.56 160.77 42.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.998 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.92 -179.3 3.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.777 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 50' ' ' ALA . 9.5 t80 -138.6 85.93 2.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.666 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 58.5 m-85 -72.39 161.74 30.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.06 162.76 15.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 63' ' ' SER . 7.1 m -69.46 151.53 45.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.556 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.3 t 86.33 -12.23 0.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.584 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' HB ' ' CG ' ' A' ' 68' ' ' PHE . 34.2 m -145.33 10.27 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.484 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.2 81.08 6.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.514 0.673 . . . . 0.0 110.971 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 139.51 -3.62 2.68 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.364 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.86 -51.9 1.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.637 0.256 . . . . 0.0 111.297 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 5.4 m-30 -69.93 159.16 34.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.554 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.9 m -124.17 148.35 47.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.375 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.411 HG22 ' CZ ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -138.99 136.31 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.678 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.8 p -153.44 -173.76 4.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 111.076 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.45 160.39 39.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.982 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.425 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 13.6 t0 -90.55 -44.77 9.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 69.72 11.69 7.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.71 -34.96 6.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.891 0.377 . . . . 0.0 110.776 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -142.5 26.89 1.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.633 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.65 52.44 5.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.68 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.9 m -116.06 152.2 34.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.095 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 21' ' ' SER . 8.6 p -117.05 143.47 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.453 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 42.5 m-85 -126.64 110.06 12.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.852 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.429 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -112.82 112.29 23.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.46 . . . . 0.0 110.191 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.74 100.29 12.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.269 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 4.7 mtp -81.66 90.48 6.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.829 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 177.09 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 37.46 47.1 0.71 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.671 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.63 165.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.067 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.486 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 18.6 mmtt -144.99 164.89 24.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.764 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 55.3 Cg_endo -69.47 2.23 3.56 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.418 2.079 . . . . 0.0 113.222 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -104.34 -0.4 28.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.246 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -89.95 -9.95 46.89 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.41 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 87.1 m -50.35 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.724 0.297 . . . . 0.0 111.156 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.22 169.5 7.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.528 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 5.4 p -82.59 107.22 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.291 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.458 ' CD1' ' CG2' ' A' ' 113' ' ' VAL . 13.7 m-85 -85.77 105.74 16.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.602 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 37' ' ' PHE . 21.6 m -109.31 138.62 45.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.156 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.4 p -97.64 142.34 29.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.826 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.17 177.16 21.71 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.294 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . . . -130.29 167.45 18.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.942 0.401 . . . . 0.0 111.098 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.83 175.11 19.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.831 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.86 113.56 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.371 . . . . 0.0 110.735 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.88 16.06 50.83 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.784 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.35 -14.83 33.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.487 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.1 m -97.92 -179.84 4.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.676 0.274 . . . . 0.0 110.426 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.418 ' CH2' ' HB2' ' A' ' 33' ' ' ASP . 77.0 m95 -140.83 98.99 3.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -133.54 10.6 4.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.501 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.38 62.19 0.85 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.308 0.575 . . . . 0.0 110.736 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.441 ' CZ3' ' NE ' ' A' ' 45' ' ' ARG . 29.8 m95 -68.7 165.18 20.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.136 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.77 -121.42 4.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.515 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 -67.79 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 134.41 151.87 6.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.668 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 t -151.84 108.35 3.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.551 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -59.23 141.06 55.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.199 0.524 . . . . 0.0 111.13 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 91' ' ' THR . 37.6 t -121.92 82.85 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.7 m -73.25 141.26 47.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -138.71 177.15 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.321 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.5 p -147.65 -171.37 3.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.832 0.349 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.91 155.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.202 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.93 160.31 16.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.92 141.16 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.43 164.35 15.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.794 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.85 163.26 17.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.0 t -163.98 119.1 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.63 -22.81 8.11 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.666 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -47.29 140.62 7.7 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.882 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.39 169.03 37.34 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.375 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.21 145.37 53.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.807 0.337 . . . . 0.0 111.399 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.02 132.78 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.38 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.07 139.98 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.452 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.76 130.36 9.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.588 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.65 -20.84 48.87 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.602 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.24 179.66 53.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.571 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 t -120.5 139.0 53.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.992 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.7 tp -125.6 132.75 52.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.457 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.37 131.17 56.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.0 111.629 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 3.3 mt -121.24 141.29 51.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.311 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' A' ' 80' ' ' TYR . 95.4 p -124.03 113.53 18.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.6 t -108.18 134.56 50.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.636 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.9 145.46 39.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.155 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.42 113.76 26.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.52 89.05 6.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 153.32 154.52 6.78 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.568 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -76.36 130.71 38.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.078 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.437 ' HA ' ' CZ ' ' A' ' 32' ' ' TYR . 44.9 p -85.92 90.28 8.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.26 -34.51 26.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.51 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.86 4.66 47.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.62 0.248 . . . . 0.0 111.392 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.8 p 54.88 50.13 16.29 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.834 0.349 . . . . 0.0 111.065 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.437 ' CZ ' ' HA ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -69.7 132.94 46.92 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -59.61 174.86 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.031 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -143.87 126.59 16.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.17 156.15 26.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.823 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' CYS . 69.9 m95 -87.31 153.74 21.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.144 0.497 . . . . 0.0 111.315 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.7 m-85 -131.63 178.25 6.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.422 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 7.6 ptt180 -152.34 155.24 37.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.815 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -167.03 148.85 6.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.945 0.402 . . . . 0.0 111.273 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.29 167.19 17.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.606 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.15 137.52 48.3 Favored 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 122.228 1.952 . . . . 0.0 112.216 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.92 3.98 45.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.603 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -110.75 -179.61 3.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.819 0.342 . . . . 0.0 110.837 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.01 167.63 9.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.045 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.42 135.19 34.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.098 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HG3' ' CG ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -138.88 166.21 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.657 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 11.4 t -104.47 173.43 6.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.091 0.472 . . . . 0.0 111.078 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.52 -66.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.258 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.62 132.04 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.277 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -132.29 145.3 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.276 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.404 ' CA ' HG21 ' A' ' 58' ' ' THR . 19.1 tt -122.78 142.32 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.459 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -81.06 -176.51 5.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.645 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -97.05 68.67 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.966 0.412 . . . . 0.0 110.575 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.83 30.4 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.453 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -85.08 -61.77 1.69 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.084 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.98 -74.52 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.436 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.05 -159.03 0.86 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.178 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.416 ' CG2' HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -97.48 -177.27 3.75 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.967 0.413 . . . . 0.0 110.975 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 50' ' ' ALA . 63.2 t80 -139.41 93.03 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.725 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.424 ' CE1' HG21 ' A' ' 70' ' ' ILE . 89.7 m-85 -80.14 158.0 26.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.39 176.13 5.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.282 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.34 152.03 45.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.578 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 62' ' ' SER . 4.0 t 85.82 -11.64 0.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.522 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.433 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 35.9 m -154.32 17.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.442 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 79.32 0.96 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.557 0.694 . . . . 0.0 110.799 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.46 3.47 9.43 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -111.67 -43.65 3.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.0 m-30 -83.36 151.95 25.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.958 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.3 m -112.25 149.22 32.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.647 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.485 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -163.33 136.84 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.876 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.485 ' N ' HD13 ' A' ' 70' ' ' ILE . 8.0 p -168.35 154.02 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -77.68 139.62 39.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.597 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.5 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 0.4 OUTLIER -79.75 -34.06 40.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.106 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t30 68.21 28.01 6.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.189 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.2 -41.66 4.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.891 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.04 37.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.619 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.5 mttt 61.48 53.12 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.699 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.51 ' CG2' ' CE1' ' A' ' 80' ' ' TYR . 74.6 m -122.96 147.93 46.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.053 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.7 m -111.57 138.68 39.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.413 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.51 ' CE1' ' CG2' ' A' ' 78' ' ' THR . 7.3 m-85 -126.21 125.62 42.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.653 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.453 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -122.29 121.68 37.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.181 0.515 . . . . 0.0 110.926 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -100.47 96.79 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.732 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.444 ' HG2' ' CD2' ' A' ' 68' ' ' PHE . 31.1 mtm -82.21 91.85 6.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.984 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -82.32 176.39 9.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 84' ' ' ASN . 67.1 p 28.99 59.99 0.14 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.754 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.54 162.2 15.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.17 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.516 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.2 OUTLIER -126.62 164.42 34.64 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.545 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 74.3 Cg_endo -75.49 6.05 3.84 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.38 2.053 . . . . 0.0 112.956 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -108.51 -6.15 16.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.847 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.31 -16.05 50.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.287 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.5 m -52.76 106.96 0.18 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.771 0.32 . . . . 0.0 111.19 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.5 -170.72 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.436 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 85.6 t -94.33 106.74 18.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.425 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -86.88 103.38 15.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.199 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.3 m -108.49 127.2 53.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 31.9 p -89.78 146.32 24.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.825 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.92 -173.09 20.61 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.463 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -138.17 149.6 46.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 111.107 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.441 ' N ' ' CE3' ' A' ' 104' ' ' TRP . . . -105.15 148.9 16.65 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.608 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.28 122.71 19.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.826 0.346 . . . . 0.0 110.955 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.59 18.38 51.51 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.79 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.75 -10.69 45.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.695 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.431 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 5.3 m -100.16 -179.96 4.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.441 ' CE3' ' N ' ' A' ' 99' ' ' GLY . 77.2 m95 -145.34 93.92 2.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.884 0.373 . . . . 0.0 110.814 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.4 ' O ' ' CD1' ' A' ' 107' ' ' TRP . 3.8 t70 -112.9 -12.08 13.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.369 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.82 128.76 34.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.768 0.318 . . . . 0.0 110.66 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 105' ' ' ASP . 21.5 m95 -137.87 164.22 29.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.959 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.57 -160.92 19.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -74.23 -38.17 63.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.817 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.52 152.68 26.39 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.647 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.2 t -154.28 122.71 6.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -78.17 143.07 37.54 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.966 0.413 . . . . 0.0 111.131 -179.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 91' ' ' THR . 55.4 t -114.8 132.25 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.159 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.3 m -108.48 132.69 53.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.9 168.23 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.344 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.7 p -135.39 -177.13 4.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.785 0.326 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.27 165.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.988 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -101.01 149.77 23.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp -148.4 152.17 36.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -164.22 163.42 22.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.801 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.23 162.52 15.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.4 t -158.08 123.04 4.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.81 -30.17 10.51 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.583 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -50.92 139.86 23.26 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.008 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.82 -159.64 24.22 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.379 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mp -69.25 151.1 46.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.473 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.22 109.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.872 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.41 152.2 46.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.118 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.89 129.98 21.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.386 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.35 22.65 50.75 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.57 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.17 116.04 2.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.377 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 92.9 p -69.94 123.67 22.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 111.047 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 tp -126.96 130.78 50.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.525 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -107.61 131.78 54.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.424 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 2.9 mt -116.97 148.28 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.098 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB3' ' CD2' ' A' ' 80' ' ' TYR . 82.7 p -127.85 126.69 42.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -121.38 109.1 14.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.596 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.66 164.46 22.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.381 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -146.42 -168.21 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.04 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.08 147.35 38.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.97 83.21 0.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.395 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -152.83 106.52 3.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.957 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.417 HG23 ' CD1' ' A' ' 32' ' ' TYR . 18.0 p -141.62 -176.49 4.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.765 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.78 -22.74 5.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.438 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' ' CG2' ' A' ' 31' ' ' THR . 2.3 t -114.28 51.36 0.88 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.049 0.452 . . . . 0.0 110.207 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 30' ' ' SER . 7.1 t 52.9 32.5 12.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.864 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CE2' ' CB ' ' A' ' 98' ' ' ALA . 9.3 t80 -69.69 112.27 6.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.701 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.404 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 7.5 m-20 -111.89 -176.87 3.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.673 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.09 113.97 7.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.978 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -139.97 158.74 25.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.905 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.422 ' CE2' HD22 ' A' ' 81' ' ' LEU . 63.8 m95 -92.36 154.86 18.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.282 0.563 . . . . 0.0 111.329 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.7 m-85 -135.67 -178.32 5.07 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.455 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.43 ' HG2' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -148.44 156.13 42.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.89 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.414 ' CB ' ' CG1' ' A' ' 93' ' ' VAL . 2.0 mm-40 -153.41 171.07 19.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.9 149.23 14.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.617 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.99 134.72 51.17 Favored 'Trans proline' 0 CA--C 1.517 -0.342 0 C-N-CA 122.273 1.982 . . . . 0.0 112.184 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.53 3.91 35.75 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.479 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.08 178.78 4.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.873 0.368 . . . . 0.0 110.897 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 pm0 -96.22 -176.82 3.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.781 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.82 140.77 39.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.829 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.404 ' HG3' ' HD3' ' A' ' 38' ' ' ARG . 12.0 pt-20 -140.46 164.28 30.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.628 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.565 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.9 t -107.25 171.66 7.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.141 0.496 . . . . 0.0 111.085 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.43 ' CG2' ' HG2' ' A' ' 38' ' ' ARG . 2.8 t -129.51 -69.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.677 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -141.05 147.6 38.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 0.0 111.579 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' HA ' ' CA ' ' A' ' 35' ' ' GLY . . . -136.89 141.34 42.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.193 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 tt -117.66 141.59 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.047 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -87.91 -176.5 5.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.125 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -109.17 -32.49 7.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.846 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -161.58 30.2 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 t -86.37 -78.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.778 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.25 -72.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.017 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.6 mpp_? -141.93 -126.9 0.1 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.401 ' CG2' HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -116.11 -177.58 3.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.948 0.404 . . . . 0.0 111.096 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 50.9 t80 -135.99 91.33 2.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.853 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.502 ' CZ ' HG21 ' A' ' 70' ' ' ILE . 56.0 m-85 -80.39 152.19 28.99 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.98 163.53 14.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.366 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.81 33.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.017 0.437 . . . . 0.0 111.674 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.9 t -118.54 -20.15 8.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.116 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.0 m -152.41 21.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.969 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.91 80.7 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.72 0.771 . . . . 0.0 110.9 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 131.42 3.55 4.22 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.162 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -111.11 -45.91 3.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.744 0.306 . . . . 0.0 111.056 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 83' ' ' MET . 9.7 m-30 -97.21 161.14 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.128 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.6 m -129.72 94.98 3.86 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.578 0.704 . . . . 0.0 111.371 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.502 HG21 ' CZ ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -91.18 137.37 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.614 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.416 ' N ' HG13 ' A' ' 70' ' ' ILE . 1.7 m -162.96 170.81 17.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 110.959 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -116.75 139.87 50.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.764 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.419 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 45.5 t0 -72.71 -31.23 64.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.946 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 58.9 23.34 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.051 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.72 -39.77 3.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.97 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -135.81 25.89 3.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.927 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.67 49.15 10.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.01 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.424 HG22 ' CE1' ' A' ' 80' ' ' TYR . 89.0 m -125.09 145.99 49.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -109.74 146.5 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.661 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' A' ' 21' ' ' SER . 4.2 m-85 -137.61 134.94 36.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.92 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.424 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -128.59 119.16 24.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.068 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -92.51 108.21 19.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.461 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 30.8 mtm -94.39 90.21 6.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.334 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -85.49 175.13 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.67 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 33.16 39.43 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.934 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.51 158.76 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 111.204 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.48 164.25 16.95 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.816 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.74 8.13 4.45 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.66 2.24 . . . . 0.0 112.721 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 10.9 tt0 -119.21 -0.4 11.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.41 -11.04 59.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.658 0.266 . . . . 0.0 111.085 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.9 m -52.14 108.93 0.33 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 111.345 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.71 174.18 5.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.005 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 9.0 p -78.89 104.2 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 111.061 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.447 ' CD1' ' CG2' ' A' ' 113' ' ' VAL . 6.0 m-85 -81.22 98.35 8.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.46 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 37' ' ' PHE . 5.0 m -107.33 129.98 54.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.013 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 28.7 p -99.77 142.57 31.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.682 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -143.05 177.36 22.02 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.318 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.462 ' CB ' ' CE2' ' A' ' 32' ' ' TYR . . . -126.25 164.91 19.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.003 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.18 176.97 22.94 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.724 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.8 117.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.332 . . . . 0.0 110.635 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.34 15.0 50.75 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.759 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.42 -11.67 43.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.644 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.0 m -102.29 179.45 4.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.551 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.404 ' CH2' ' HB2' ' A' ' 33' ' ' ASP . 81.2 m95 -136.75 83.58 2.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.06 -9.58 23.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.496 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -89.66 134.64 34.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.773 0.32 . . . . 0.0 110.81 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -146.0 165.15 29.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.745 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.05 -170.34 21.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.434 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -70.67 -32.12 69.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.95 0.405 . . . . 0.0 110.696 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.72 151.95 25.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 1.5 t -144.39 102.15 3.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 110.407 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -63.26 138.56 58.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 0.0 111.264 -179.426 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.447 ' CG2' ' CD1' ' A' ' 94' ' ' TYR . 52.4 t -112.47 118.25 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.981 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 m -97.65 122.29 40.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.346 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 t -150.99 163.79 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.327 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t 168.79 -57.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.803 0.335 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.24 156.11 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -153.04 174.19 14.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mp -156.35 134.99 11.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.969 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 1.5 tt0 -145.39 129.46 17.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.146 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.21 165.09 15.3 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 p -169.66 112.67 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.006 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.67 -26.02 4.93 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.659 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.78 141.09 29.06 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.931 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.18 -178.37 46.82 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.376 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.27 140.19 54.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.897 0.38 . . . . 0.0 111.409 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.44 122.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.078 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -58.86 140.31 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.312 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.61 150.64 6.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.309 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.04 -2.15 82.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.837 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.06 -154.77 26.83 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.439 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -140.94 138.0 33.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.944 0.402 . . . . 0.0 111.214 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.402 HD23 ' CD2' ' A' ' 20' ' ' LEU . 15.2 tp -131.87 148.6 52.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.326 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -124.42 125.72 44.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.377 . . . . 0.0 111.55 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.422 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 4.0 mt -116.3 138.84 50.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.234 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.436 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 24.0 p -123.25 132.57 54.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.034 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 31.6 t -131.53 130.96 42.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.747 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.79 165.9 13.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.197 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.82 -169.25 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.5 p -83.76 157.68 22.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.28 -48.41 1.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.52 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.6 mtp85 -70.5 82.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.03 137.5 44.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.04 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.45 30.49 1.72 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.322 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.4 t -126.8 45.67 2.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.779 0.323 . . . . 0.0 110.863 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 p 56.11 33.96 22.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.41 . . . . 0.0 110.541 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.48 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 62.0 t80 -69.24 79.77 0.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.025 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -75.43 178.96 5.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.369 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.77 130.54 16.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 111.366 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -153.11 155.52 26.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.621 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.435 ' CE2' HD21 ' A' ' 81' ' ' LEU . 75.5 m95 -86.97 156.22 19.87 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.359 0.599 . . . . 0.0 111.307 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.521 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 6.5 m-85 -140.16 -178.35 5.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.575 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.405 ' CG ' ' CG2' ' A' ' 48' ' ' VAL . 1.6 mtp180 -145.81 158.42 43.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.017 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -161.33 160.56 29.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.952 0.406 . . . . 0.0 111.303 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.6 155.01 22.14 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.606 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.14 137.42 44.01 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.273 1.982 . . . . 0.0 112.297 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.04 1.07 38.48 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.635 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.83 -177.33 3.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.879 0.371 . . . . 0.0 111.155 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -109.54 159.03 17.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.384 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.14 143.28 32.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 111.123 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.86 140.95 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.431 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.521 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.4 t -81.32 172.13 13.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.183 0.516 . . . . 0.0 110.919 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.405 ' CG2' ' CG ' ' A' ' 38' ' ' ARG . 3.1 t -129.99 -68.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.55 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -146.01 126.67 14.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 0.0 111.368 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -126.2 144.73 50.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.422 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.418 HG23 ' NE ' ' A' ' 72' ' ' ARG . 8.0 tt -125.33 148.47 29.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.022 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.438 ' ND2' ' CB ' ' A' ' 55' ' ' SER . 5.3 t30 -99.42 167.73 10.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.89 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.436 ' N ' ' ND2' ' A' ' 52' ' ' ASN . 3.5 t-105 -91.41 78.57 5.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.731 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.66 92.83 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.166 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.438 ' CB ' ' ND2' ' A' ' 52' ' ' ASN . 40.1 t -163.91 -74.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.714 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -116.82 -76.43 0.57 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.432 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 4.4 mmm180 -171.18 -103.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.538 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.41 -175.09 3.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.072 0.463 . . . . 0.0 111.028 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' N ' ' O ' ' A' ' 50' ' ' ALA . 75.1 t80 -139.82 92.48 2.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.542 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -75.0 160.97 29.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.999 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.94 158.69 17.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 63' ' ' SER . 36.5 t -69.35 150.46 47.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.711 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 87.36 -12.94 0.49 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.671 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 m -151.67 14.21 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.566 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.13 81.0 4.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.61 0.719 . . . . 0.0 110.464 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.9 -4.97 2.2 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.427 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.17 -36.67 3.72 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 111.201 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.2 m-30 -82.83 135.87 34.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.83 0.348 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 3.7 m -99.65 145.43 27.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.195 0.521 . . . . 0.0 111.32 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.541 HD11 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -133.53 135.94 55.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.251 -179.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.541 ' N ' HD11 ' A' ' 70' ' ' ILE . 28.7 t -166.29 146.74 6.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.968 0.413 . . . . 0.0 111.302 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.53 ' CZ ' ' HB ' ' A' ' 79' ' ' VAL . 9.2 mpt_? -114.79 144.5 43.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.658 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -64.93 -30.15 71.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.899 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 57.36 24.9 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.977 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.79 -46.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.916 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.99 19.47 16.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp 56.31 46.94 20.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.905 0.383 . . . . 0.0 110.806 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.434 HG22 ' CE1' ' A' ' 80' ' ' TYR . 42.1 m -120.53 143.32 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.315 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.53 ' HB ' ' CZ ' ' A' ' 72' ' ' ARG . 28.9 m -101.99 150.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.481 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 21' ' ' SER . 28.9 m-85 -145.55 124.25 12.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.279 . . . . 0.0 110.866 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.435 HD21 ' CE2' ' A' ' 36' ' ' TRP . 0.4 OUTLIER -124.99 121.37 34.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.074 0.464 . . . . 0.0 110.584 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -99.74 94.96 6.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.792 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.438 ' HG2' ' CD2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -79.72 95.29 5.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 -179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -88.96 176.89 6.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.619 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 t 36.23 41.94 0.16 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.549 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.81 166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.385 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.503 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 3.5 mmtp -126.18 162.26 47.08 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.706 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 64.7 Cg_endo -73.94 8.04 2.19 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.411 2.074 . . . . 0.0 113.104 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -119.42 8.94 11.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.258 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.3 -19.08 30.38 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.592 0.234 . . . . 0.0 111.229 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 63.6 m -49.91 103.66 0.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 111.463 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.02 -174.86 1.87 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.9 t -90.01 105.05 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.654 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.425 ' CG ' HG21 ' A' ' 113' ' ' VAL . 4.1 m-85 -87.03 107.75 18.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.086 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.406 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 4.7 m -106.86 167.21 10.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.3 p -129.91 133.64 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.421 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.01 -177.12 15.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.695 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.48 ' CB ' ' CZ ' ' A' ' 32' ' ' TYR . . . -136.36 167.2 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 111.077 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -108.58 -175.22 21.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.565 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.69 115.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.818 0.342 . . . . 0.0 110.594 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.1 15.66 50.91 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.701 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.83 -12.44 38.32 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.749 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.404 ' CG2' ' H ' ' A' ' 104' ' ' TRP . 4.5 m -100.46 178.93 4.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.694 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.404 ' H ' ' CG2' ' A' ' 103' ' ' THR . 73.9 m95 -140.67 96.62 3.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.684 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -117.9 -5.87 11.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.483 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.63 130.82 37.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.851 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -142.28 164.94 28.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.983 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -101.37 -135.63 8.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.425 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -26.69 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 98.06 148.86 24.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.669 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 t -148.15 119.24 7.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.884 0.373 . . . . 0.0 110.38 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 139.63 57.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.319 0.58 . . . . 0.0 111.351 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 91' ' ' THR . 37.9 t -123.92 86.52 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.1 m -77.71 148.48 34.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.994 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.08 168.58 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.883 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.2 t -77.42 -72.93 0.33 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.179 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.903 -179.82 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.78 0.324 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.69 155.78 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -139.89 177.8 7.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp -151.63 107.39 3.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -93.65 168.2 11.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.823 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -120.93 163.35 18.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.822 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.36 124.88 4.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.994 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.23 -29.28 10.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.609 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -50.92 138.61 25.64 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.847 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.54 -159.62 29.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.352 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.38 149.08 48.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.814 0.34 . . . . 0.0 111.375 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.88 126.48 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -70.09 127.05 31.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.012 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.45 125.14 13.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.464 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.03 -1.64 33.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.939 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.84 -153.02 10.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.531 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -139.37 142.51 37.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 tp -124.87 130.12 51.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.283 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.85 128.16 54.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.397 . . . . 0.0 111.562 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 5.5 mt -116.09 136.67 52.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.244 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.405 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 90.5 p -119.31 115.34 23.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.022 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.95 116.45 29.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.11 148.69 21.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.64 95.82 6.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.3 p -69.94 149.37 47.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.55 -139.23 15.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.461 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.41 123.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 0.0 110.827 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 t -157.18 115.63 3.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.37 30.57 7.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.982 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 t -97.04 37.05 1.34 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.827 0.346 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.6 m 65.25 34.15 8.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.406 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -69.25 111.64 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.973 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.415 ' OD1' ' CH2' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -86.67 178.31 7.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.032 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.9 mtm -146.65 132.32 18.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.031 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.34 151.19 23.36 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.658 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -88.29 155.94 19.46 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.206 0.527 . . . . 0.0 111.346 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.546 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -138.99 -179.27 5.74 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.703 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 46' ' ' GLU . 9.9 mtm-85 -143.19 162.09 36.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.922 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -148.45 124.06 10.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.198 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.79 157.61 49.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.733 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.85 137.26 37.73 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.295 1.997 . . . . 0.0 112.383 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 2.26 36.74 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.642 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.97 -175.09 2.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.859 0.361 . . . . 0.0 111.032 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -111.63 -171.73 1.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.636 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -78.2 125.45 29.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -121.53 119.2 31.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.458 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.3 t -71.43 170.69 12.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.269 0.557 . . . . 0.0 110.784 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.94 -69.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.442 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -145.21 128.91 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.035 0.445 . . . . 0.0 111.213 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.411 ' HA ' ' CA ' ' A' ' 35' ' ' GLY . . . -123.55 144.78 49.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.127 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.7 tp -128.96 145.75 35.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.373 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -88.1 -162.11 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.717 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -106.59 -30.22 9.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.339 . . . . 0.0 110.846 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 55' ' ' SER . 73.2 m-20 -125.99 156.21 40.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.818 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 56' ' ' ALA . 1.0 OUTLIER 86.09 -29.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.537 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 55' ' ' SER . . . 82.72 -12.61 0.89 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.858 0.361 . . . . 0.0 111.67 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.34 139.76 35.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.67 -177.9 3.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.902 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 8.2 t80 -137.35 89.67 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.739 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -76.82 156.3 32.36 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.05 167.74 9.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.246 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 63' ' ' SER . 18.7 p -69.33 152.69 44.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.551 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 86.09 -11.99 0.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.486 -178.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.42 HG11 ' CE2' ' A' ' 68' ' ' PHE . 35.4 m -151.05 15.75 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.385 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.02 79.11 0.66 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.514 0.673 . . . . 0.0 110.724 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.47 3.88 8.45 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.896 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -114.3 -40.98 3.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 111.08 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 5.8 m-30 -93.5 117.38 30.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 11.8 m -79.57 152.57 30.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -148.38 136.42 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.012 -178.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.493 ' N ' HD12 ' A' ' 70' ' ' ILE . 4.8 m -161.49 -164.65 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.775 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -139.74 169.65 17.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.968 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.409 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 0.9 OUTLIER -77.75 -12.85 60.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.286 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 44.76 40.24 4.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 111.268 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.9 -49.36 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.064 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 mtmm -115.52 -72.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 167.14 44.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.599 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.2 m -110.33 145.13 38.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.187 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.6 m -108.66 142.0 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.748 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 1.3 m-85 -134.33 128.93 34.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.913 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.439 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 1.3 pt? -127.07 125.82 41.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.064 0.459 . . . . 0.0 110.747 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.81 96.72 8.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.617 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.447 ' HE1' ' CE1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -78.56 88.03 4.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.212 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.62 176.89 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 38.35 48.34 1.17 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.494 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.61 165.72 22.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.327 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.451 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -133.59 178.0 1.98 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.218 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 92.5 Cg_endo -81.31 9.68 3.76 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.316 2.011 . . . . 0.0 112.734 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 7.5 tp10 -109.17 -12.45 14.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.706 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.23 -21.34 58.7 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 110.986 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 98.6 m -50.6 107.73 0.19 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.45 -172.34 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.308 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.5 t -90.28 105.15 15.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.542 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.447 ' CE1' ' HE1' ' A' ' 83' ' ' MET . 13.0 m-85 -88.77 107.66 19.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 83.2 m -113.44 136.54 52.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 11.8 p -100.36 160.4 14.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.818 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -159.2 -170.92 24.34 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.999 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.44 ' HB2' ' CD2' ' A' ' 32' ' ' TYR . . . -143.17 172.49 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.745 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -142.27 -175.69 15.8 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.906 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.456 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 31.1 tt0 -162.33 129.02 3.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.59 15.23 46.22 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.852 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.63 -14.36 32.42 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.68 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.428 ' O ' ' HA3' ' A' ' 99' ' ' GLY . 3.7 m -92.02 176.73 6.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.578 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.45 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 72.2 m95 -147.76 100.21 3.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.768 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -120.71 -3.26 9.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.568 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.89 137.87 34.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.841 0.353 . . . . 0.0 110.86 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -142.89 167.2 22.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.87 -155.8 18.97 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.575 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -87.34 -36.5 17.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 110.853 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.71 153.39 17.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.576 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 t -146.9 107.97 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.653 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.68 141.57 55.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.133 0.492 . . . . 0.0 110.941 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.1 t -121.75 126.6 74.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.387 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.5 m -102.25 133.33 47.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.043 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -149.84 163.03 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.424 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.6 t 177.83 -78.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.929 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.873 0.368 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.21 155.95 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.41 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -146.57 160.63 41.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.48 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.41 ' N ' ' HG3' ' A' ' 3' ' ' GLN . 5.7 mp -142.63 104.27 4.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.83 167.74 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.36 164.98 13.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -162.3 114.3 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.84 -36.3 3.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.656 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -50.03 139.12 19.59 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.913 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.39 -170.69 40.05 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.332 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mp -69.44 155.24 40.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.903 0.382 . . . . 0.0 111.593 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -169.41 120.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.888 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.66 144.32 27.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.69 124.78 11.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.452 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.99 17.76 31.45 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.68 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.72 -166.68 22.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.543 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -129.28 136.63 50.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.956 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 tp -142.66 131.03 22.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.585 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.23 132.91 54.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.185 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 4.1 mt -117.13 135.4 53.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.7 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -120.0 105.77 11.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.769 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.97 116.07 31.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.72 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.87 155.47 17.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.292 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -169.74 86.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -105.36 162.77 13.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.028 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 153.8 -113.2 0.56 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -121.04 93.67 4.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 0.0 110.752 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.94 -175.71 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.192 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.23 13.35 8.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.903 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.72 50.73 2.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.911 0.386 . . . . 0.0 110.592 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.75 26.73 15.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.62 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.457 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 53.5 t80 -69.73 65.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.057 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.422 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 74.6 m-20 -62.75 -175.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.9 124.59 11.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.764 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -147.45 150.8 23.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.986 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.46 ' CZ3' HD13 ' A' ' 20' ' ' LEU . 74.1 m95 -91.44 153.46 19.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.225 0.536 . . . . 0.0 111.371 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.0 m-85 -133.39 -177.15 4.4 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.323 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -156.54 159.93 39.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.743 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -162.37 133.76 5.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.205 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.54 167.63 8.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.613 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.89 138.01 39.55 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.265 1.977 . . . . 0.0 112.328 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.18 4.49 36.4 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.641 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -112.62 -177.12 3.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.868 0.366 . . . . 0.0 111.047 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -102.39 -171.54 1.98 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.581 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.9 ptm85 -100.59 128.89 46.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -131.14 147.92 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.304 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.4 t -82.58 175.68 9.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.263 0.554 . . . . 0.0 111.112 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.435 ' N ' ' OG ' ' A' ' 47' ' ' SER . 3.5 t -132.36 -66.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.143 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.35 123.43 10.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.017 0.437 . . . . 0.0 111.184 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' HA ' ' CA ' ' A' ' 35' ' ' GLY . . . -118.35 148.85 42.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.108 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 tt -133.46 146.54 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.894 0.378 . . . . 0.0 111.534 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -69.93 -173.53 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.922 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.411 ' CE3' ' O ' ' A' ' 32' ' ' TYR . 8.2 t-105 -95.69 22.54 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.324 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -164.54 28.76 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.197 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.3 p 47.58 28.69 1.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.313 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.9 -47.99 41.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.07 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -154.37 137.04 15.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.731 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.89 178.06 4.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.753 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -140.45 90.81 2.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.668 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 4.6 m-85 -78.8 159.09 28.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.06 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.75 166.53 11.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 63' ' ' SER . 3.7 t -69.48 151.69 45.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.759 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 84.65 -11.0 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.617 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 33.2 m -152.75 16.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.314 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -70.64 79.1 0.59 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.559 0.695 . . . . 0.0 110.88 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.96 2.93 8.46 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.88 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -108.34 -33.47 7.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.76 0.314 . . . . 0.0 111.211 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 9.0 m-30 -96.03 127.77 42.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.151 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 56.9 m -83.54 145.04 29.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.375 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -134.74 136.59 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.216 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.9 p -154.92 -175.88 5.65 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.973 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -138.27 165.9 25.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.084 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.416 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 33.8 t70 -86.6 -31.57 21.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t30 60.74 29.5 19.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.9 -57.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.08 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -102.73 11.32 37.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.277 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.49 52.25 4.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.653 ' OG1' ' CZ ' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -115.54 154.93 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.935 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 21' ' ' SER . 6.1 p -119.81 132.11 70.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.84 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.653 ' CZ ' ' OG1' ' A' ' 78' ' ' THR . 17.6 m-85 -118.11 107.96 14.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.132 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 69' ' ' THR . 0.2 OUTLIER -107.74 114.38 28.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.958 179.44 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.31 95.23 8.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.304 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -80.96 89.85 5.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.981 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -76.95 174.16 10.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.856 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 84' ' ' ASN . 0.6 OUTLIER 22.09 53.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.075 179.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.401 ' CD1' ' HB2' ' A' ' 83' ' ' MET . 0.3 OUTLIER -44.56 162.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.537 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 22.3 mmtt -110.75 161.0 26.65 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.787 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 72.1 Cg_endo -76.84 8.15 3.25 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.441 2.094 . . . . 0.0 112.908 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -121.68 2.91 10.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.236 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.66 -12.42 55.96 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.624 0.25 . . . . 0.0 111.23 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.9 m -55.89 104.82 0.15 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 111.17 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.54 -174.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.268 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.9 t -87.63 103.26 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.725 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.439 ' CD1' ' CG2' ' A' ' 113' ' ' VAL . 8.3 m-85 -82.7 105.79 14.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.914 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 88.5 m -111.64 133.18 54.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 28.0 p -100.45 150.09 23.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.014 0.435 . . . . 0.0 111.155 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -143.22 -175.36 16.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.246 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.457 ' CB ' ' CZ ' ' A' ' 32' ' ' TYR . . . -135.39 164.4 27.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 111.028 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -96.06 -171.67 35.47 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 179.42 111.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.713 0.292 . . . . 0.0 110.743 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.74 16.14 50.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.693 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 -13.99 36.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.522 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.404 ' CG2' ' H ' ' A' ' 104' ' ' TRP . 5.0 m -100.01 179.17 4.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.605 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' A' ' 33' ' ' ASP . 82.2 m95 -135.5 93.82 3.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.736 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -118.0 -4.27 11.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.341 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.22 135.69 33.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.756 0.313 . . . . 0.0 110.786 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -141.58 165.45 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.094 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.2 -148.22 11.86 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.486 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.02 -48.63 6.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 116.1 151.28 9.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.763 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 t -142.49 110.33 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.333 . . . . 0.0 110.454 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 141.11 58.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.21 0.528 . . . . 0.0 111.036 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.439 ' CG2' ' CD1' ' A' ' 94' ' ' TYR . 47.0 t -119.12 125.64 74.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.297 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.3 m -101.41 117.94 35.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 111.03 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.4 HG11 ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -133.49 -158.96 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.524 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 t 77.01 169.76 0.24 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.916 0.389 . . . . 0.0 111.077 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.933 -179.878 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.763 0.316 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.97 149.11 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.19 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -100.79 154.0 19.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.99 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 mp -146.78 159.01 44.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.793 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -152.7 175.23 13.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.288 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -128.7 173.22 10.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.988 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.1 t -170.16 143.59 2.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.064 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.67 -33.07 5.95 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.725 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -49.66 140.1 15.85 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.003 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.99 -170.58 43.33 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.396 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mp -69.49 156.01 39.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.782 0.325 . . . . 0.0 111.414 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -170.01 115.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.92 158.82 1.92 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.381 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.95 145.44 3.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.435 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.09 15.87 65.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.603 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.79 112.18 3.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.348 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.93 131.0 43.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -124.21 131.91 53.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.656 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -101.61 128.23 47.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.903 0.382 . . . . 0.0 111.461 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.5 mt -116.06 145.41 43.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.341 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.5 p -125.76 128.51 47.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.899 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.9 t -124.76 136.0 53.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -113.09 144.57 42.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.893 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -121.95 100.31 6.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.321 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.4 p -77.6 109.81 11.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.715 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.25 167.49 12.71 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.226 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.448 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -169.9 99.78 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.348 . . . . 0.0 111.213 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.43 HG21 ' CD2' ' A' ' 32' ' ' TYR . 9.7 t -70.04 -156.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.683 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.87 53.98 0.55 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.287 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 t -124.73 -72.93 0.65 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.072 0.463 . . . . 0.0 111.169 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 175.35 54.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.834 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.448 ' CE2' ' HG3' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -69.05 173.24 5.68 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.752 -179.186 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -157.46 -173.9 4.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.031 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.12 158.47 43.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.691 0.281 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 172.35 145.25 4.87 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.045 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -88.55 155.32 19.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.974 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.2 m-85 -132.31 -179.63 5.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.954 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.413 ' CG ' ' CG ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -151.68 161.9 41.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.755 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -149.06 147.24 28.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.183 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.59 158.13 76.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.655 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.25 136.19 31.1 Favored 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 122.341 2.027 . . . . 0.0 112.415 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.77 -1.01 25.19 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.602 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -121.02 150.87 40.48 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 120.871 0.367 . . . . 0.0 110.958 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -69.88 -177.23 1.25 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.458 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -94.14 144.59 25.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 7.3 pt-20 -136.11 167.1 21.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.325 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 7.9 t -102.68 172.84 6.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.157 0.503 . . . . 0.0 110.989 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.69 -68.78 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.203 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -137.08 144.51 43.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.103 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -144.36 142.43 30.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.414 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.1 tt -121.47 143.68 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -75.13 157.48 34.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.983 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.72 43.95 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.529 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -176.95 36.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.098 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.5 t -169.97 -99.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.803 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 176.56 -37.86 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.088 0 CA-C-O 120.841 0.353 . . . . 0.0 111.313 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -54.18 160.18 1.66 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.557 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.49 -175.96 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.024 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 86.8 t80 -139.61 125.47 19.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.456 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -113.68 162.52 16.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.31 160.43 14.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.231 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 p -80.78 36.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.864 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 t -118.22 -20.93 8.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.153 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 66' ' ' GLY . 29.7 m -157.05 21.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.045 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.94 80.07 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.651 0.739 . . . . 0.0 111.045 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 135.93 1.16 3.02 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.316 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.65 -35.72 3.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 111.24 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 4.6 m-30 -93.3 159.85 15.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.0 m -129.14 155.07 46.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.6 tp -140.53 144.66 26.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.955 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.16 170.87 21.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.971 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -133.91 141.9 47.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.19 -18.49 42.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.214 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.2 p30 44.48 30.26 0.47 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.415 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.13 -74.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.64 23.41 14.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.05 62.54 0.24 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.462 HG21 ' CE1' ' A' ' 80' ' ' TYR . 91.6 m -131.25 143.67 50.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 111.231 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.3 147.87 19.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.341 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CE1' HG21 ' A' ' 78' ' ' THR . 3.8 m-85 -135.17 128.07 31.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.852 0.358 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.93 118.05 27.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.357 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.51 103.51 15.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.063 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 22.1 mtm -81.53 88.22 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.92 176.45 7.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 36.07 44.9 0.28 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.791 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.72 156.53 10.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.57 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -123.74 171.76 6.54 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.085 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 86.1 Cg_endo -81.77 11.12 3.21 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.433 2.089 . . . . 0.0 112.884 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -118.53 -6.31 10.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.355 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -86.32 -13.19 47.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.499 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 99.4 m -54.53 112.52 1.02 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 111.456 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.2 -170.72 1.01 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.172 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.2 t -94.31 105.36 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -86.87 110.67 20.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.051 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.6 t -109.28 127.34 54.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.981 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 46.9 t -77.42 145.62 37.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.08 166.67 30.53 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.693 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -131.08 150.12 52.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.328 . . . . 0.0 110.978 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . -96.36 165.45 23.79 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.805 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -158.27 113.8 2.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.55 16.26 49.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.98 -16.0 28.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.496 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.409 ' CG2' ' H ' ' A' ' 104' ' ' TRP . 5.2 m -97.72 179.75 4.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.659 0.266 . . . . 0.0 110.393 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.431 ' CH2' ' HB3' ' A' ' 50' ' ' ALA . 81.9 m95 -142.13 91.14 2.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 107' ' ' TRP . 7.4 t70 -106.27 -18.4 14.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.142 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 t -75.16 130.3 38.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.799 0.333 . . . . 0.0 110.786 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.403 ' CD1' ' O ' ' A' ' 105' ' ' ASP . 58.0 m95 -139.19 165.04 28.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.708 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.04 -156.37 15.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.539 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -86.21 -25.44 25.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.95 150.31 24.08 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.4 t -152.31 114.03 4.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.823 0.344 . . . . 0.0 110.166 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.443 HE21 ' N ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -79.29 137.75 37.48 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 120.941 0.401 . . . . 0.0 111.034 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 91' ' ' THR . 56.0 t -116.86 110.76 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.734 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.4 m -97.42 132.63 42.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.863 0.363 . . . . 0.0 111.361 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.42 169.18 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.8 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.85 -165.45 2.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.932 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.864 0.364 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.73 156.42 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -153.51 -178.84 7.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 mp -160.94 77.27 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -69.85 151.8 45.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.773 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -110.57 165.46 11.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.871 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.9 t -166.05 121.65 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.72 -40.76 2.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.703 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -50.04 139.72 18.6 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.923 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.93 -161.47 27.8 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.431 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mp -69.43 145.84 52.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.869 0.366 . . . . 0.0 111.514 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -170.16 111.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.998 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.23 151.97 45.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.72 146.95 3.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.332 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.21 -13.67 65.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.55 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.88 114.11 3.95 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.371 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -69.95 136.22 50.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 111.128 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 tp -136.04 129.95 32.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.178 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -102.43 145.55 29.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.117 0.484 . . . . 0.0 111.651 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.447 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 6.4 mt -117.64 147.99 42.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.808 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 90.7 p -125.73 114.21 18.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.274 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 3.8 t -117.16 128.8 55.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.597 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.84 141.64 49.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.371 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.27 131.45 55.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.043 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.0 p -80.99 154.99 26.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.31 137.26 3.02 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.541 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.53 113.14 12.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.413 HG22 ' CD2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -95.28 -169.11 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.01 31.83 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.757 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.8 t -129.3 52.19 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 110.498 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.0 m 65.52 21.28 11.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.729 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -77.76 86.49 4.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.952 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -70.67 161.15 31.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.743 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.6 mtm -132.45 128.39 37.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.479 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 50' ' ' ALA . . . -153.29 159.9 28.85 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.113 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.447 ' CZ2' ' HB2' ' A' ' 20' ' ' LEU . 93.1 m95 -86.73 154.11 21.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.12 0.486 . . . . 0.0 110.93 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.3 m-85 -136.89 -176.53 4.4 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.74 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.497 ' HG2' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -146.99 150.75 35.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.837 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -153.81 176.77 11.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.024 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -174.21 152.92 1.89 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.522 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.7 137.15 62.03 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.29 1.993 . . . . 0.0 112.142 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.09 7.36 37.08 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.512 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.81 -169.58 1.48 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 111.02 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -114.91 176.68 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.771 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -97.65 134.91 40.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 0.0 111.175 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -138.96 163.65 31.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.439 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.545 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.5 t -110.61 171.15 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.246 0.546 . . . . 0.0 111.236 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.497 ' CG2' ' HG2' ' A' ' 38' ' ' ARG . 6.0 t -129.51 -69.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.306 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -136.2 133.87 37.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.385 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . . . -128.43 145.2 51.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.017 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 tt -128.01 147.85 32.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.358 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -97.97 169.12 9.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.76 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.429 ' CZ3' ' HD2' ' A' ' 72' ' ' ARG . 21.8 t-105 -107.0 -31.18 8.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.14 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.17 -75.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.406 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.407 ' CB ' ' HD2' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -92.92 -87.66 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.298 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -178.71 -29.1 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.407 ' HD2' ' CB ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -38.44 151.95 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.767 0.318 . . . . 0.0 111.389 -179.48 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.46 -178.45 3.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 23.3 t80 -138.67 90.31 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.39 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.443 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 8.2 m-85 -80.51 154.9 27.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.18 159.69 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.194 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 63' ' ' SER . 17.9 p -69.09 153.83 43.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.32 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 62' ' ' SER . 2.3 p 87.12 -12.59 0.52 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.462 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -149.11 15.47 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.335 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 65' ' ' ARG . 6.5 tpt180 -77.69 83.5 4.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.779 0.8 . . . . 0.0 110.305 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.61 -7.12 3.31 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.587 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HD2' ' CE1' ' A' ' 68' ' ' PHE . 1.3 ptp180 -116.52 -38.13 3.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.708 0.29 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 3.3 m-30 -90.42 93.82 9.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.49 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 95.5 m -76.53 116.53 17.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.146 0.498 . . . . 0.0 111.313 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.443 HG22 ' CZ ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -109.69 131.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.772 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.36 172.44 18.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.019 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.429 ' HD2' ' CZ3' ' A' ' 53' ' ' TRP . 13.5 ttp-105 -105.92 153.92 21.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.419 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 39.7 t0 -91.36 -29.64 16.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.4 26.19 14.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.023 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -114.34 -33.47 5.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.073 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.5 42.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.722 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.11 40.86 14.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.701 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.1 m -97.55 148.56 23.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.062 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.7 m -122.82 132.08 72.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.428 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 25.1 m-85 -113.1 116.07 29.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.988 0.423 . . . . 0.0 110.801 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -113.35 103.29 11.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.445 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -85.9 98.97 11.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.994 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -83.53 88.24 7.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.936 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 176.16 6.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.777 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 34.78 48.19 0.3 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.698 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.439 HD11 ' CE1' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -62.09 165.84 5.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.459 . . . . 0.0 111.197 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.449 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 33.1 mmtt -135.47 163.54 50.04 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.419 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 63.2 Cg_endo -73.23 9.08 1.54 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.365 2.043 . . . . 0.0 113.091 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.92 9.06 13.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.189 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.66 -7.54 37.25 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.533 0.206 . . . . 0.0 111.401 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.7 m -56.33 113.1 1.43 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.767 0.317 . . . . 0.0 111.271 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.56 -172.53 1.24 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.313 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 84.0 t -96.16 102.63 13.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.183 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.416 ' CD1' HG22 ' A' ' 113' ' ' VAL . 24.7 m-85 -84.91 99.52 11.0 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.764 0.316 . . . . 0.0 111.117 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 62.0 m -106.2 129.97 54.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -99.79 147.77 25.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.456 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -159.65 -169.44 22.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.145 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.447 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . . . -134.51 172.68 12.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.875 0.369 . . . . 0.0 110.968 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -147.05 173.35 27.25 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.778 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -160.01 144.92 14.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.58 16.22 49.77 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.58 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.23 -4.92 58.84 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.671 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.4 m -107.35 179.17 4.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.796 0.331 . . . . 0.0 110.579 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.404 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 77.5 m95 -139.06 105.33 5.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.514 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -12.32 11.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.49 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.31 133.43 36.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -144.86 165.0 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.0 -165.55 22.26 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.578 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -75.02 -29.11 60.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.16 152.51 28.73 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.603 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 t -148.16 114.31 5.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.41 HE21 ' N ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -80.22 142.46 34.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.018 0.437 . . . . 0.0 111.228 -179.168 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' A' ' 94' ' ' TYR . 54.9 t -114.51 131.83 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.961 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.6 m -110.38 132.48 54.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.867 0.365 . . . . 0.0 111.182 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 t -141.27 168.01 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.156 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 55.2 p -167.02 -53.95 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.178 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.832 -179.707 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.786 0.327 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.29 154.79 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -104.46 161.39 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.3 mp -148.05 136.8 21.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.1 169.54 17.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -124.96 164.45 20.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 m -166.24 125.79 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 114.01 -30.6 7.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.602 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -49.86 140.32 16.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.896 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.57 175.84 42.44 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.366 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.15 144.83 53.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.88 0.371 . . . . 0.0 111.468 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.83 126.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -58.97 155.97 12.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.252 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.46 131.7 20.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.388 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.75 3.18 83.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.743 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.63 118.77 6.01 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.471 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.53 140.64 49.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 0.0 111.231 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.413 ' CD2' ' CD2' ' A' ' 20' ' ' LEU . 3.7 tp -136.0 129.1 31.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.703 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.46 119.26 39.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.413 ' CD2' ' CD2' ' A' ' 18' ' ' LEU . 12.7 mt -100.74 138.72 37.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.005 0.431 . . . . 0.0 110.427 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.451 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 7.1 m -117.31 111.11 18.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.213 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.431 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 42.9 t -106.09 133.58 50.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.533 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.26 160.65 21.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -152.25 139.56 19.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 m -114.79 126.6 55.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.05 100.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 122.24 23.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.936 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.0 p -110.9 177.15 4.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.92 33.85 1.81 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.584 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.18 47.27 1.79 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.822 0.344 . . . . 0.0 111.03 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.1 p 55.38 32.98 19.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.461 ' CE2' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -69.63 139.1 53.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.827 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -130.11 179.8 5.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.638 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -136.72 124.71 22.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.754 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.9 160.85 28.34 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.906 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.431 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 77.2 m95 -95.61 157.15 16.03 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.069 0.461 . . . . 0.0 111.303 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 11.7 m-85 -135.38 179.65 6.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.342 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.18 151.08 34.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.719 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.59 148.57 36.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.997 0.427 . . . . 0.0 111.222 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.0 158.6 58.66 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.624 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.11 137.4 44.04 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.318 2.012 . . . . 0.0 112.281 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.64 0.44 48.63 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.649 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.25 -173.77 2.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.874 0.369 . . . . 0.0 111.074 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -118.7 -174.97 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.535 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.46 135.7 40.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 111.113 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.27 119.3 15.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.266 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 1.4 t -68.55 170.03 9.91 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 t -130.06 -57.6 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.958 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -152.6 163.24 40.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.949 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -161.08 147.58 14.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.488 HG22 HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.09 143.47 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 111.597 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.455 ' N ' HD11 ' A' ' 51' ' ' ILE . 7.9 t-20 -72.33 -155.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.267 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -57.25 3.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.745 0.307 . . . . 0.0 110.409 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -175.04 141.37 0.57 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 0.0 111.313 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.1 t 72.66 41.37 0.56 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.688 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 57' ' ' ARG . . . -137.19 -78.73 0.39 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.775 0.322 . . . . 0.0 110.674 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 162.11 -176.19 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.042 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.41 HG22 ' HB ' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -115.8 178.92 4.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.239 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.1 t80 -141.55 135.33 30.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.524 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.434 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 28.7 m-85 -123.23 163.1 21.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 110.895 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -106.5 155.92 19.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.987 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.18 34.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 111.762 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.0 t -121.65 -15.13 8.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.236 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.424 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 15.7 m -156.76 19.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.232 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -65.98 80.15 0.08 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.563 0.697 . . . . 0.0 110.846 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.98 -2.38 1.16 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.809 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.44 ' HG3' ' CD1' ' A' ' 68' ' ' PHE . 2.6 ptp180 -126.58 -36.16 2.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.833 0.316 . . . . 0.0 111.654 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 7.8 m-30 -94.2 146.98 23.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.196 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 82' ' ' GLN . 5.5 m -112.89 154.42 26.39 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.406 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.503 HD11 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -146.02 134.23 16.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.915 -179.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.503 ' N ' HD11 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -162.49 -172.51 3.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.806 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.53 155.65 50.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.433 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 7.4 t0 -69.05 -27.84 66.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.042 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 66.71 23.34 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.022 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.87 -57.78 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.923 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 4.4 ptpp? -130.21 -54.59 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.713 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 1.8 ttmp? 169.6 74.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.647 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.465 ' CG2' ' CE1' ' A' ' 80' ' ' TYR . 33.4 m -137.7 140.62 40.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.085 0.469 . . . . 0.0 111.243 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.03 135.91 54.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.827 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.465 ' CE1' ' CG2' ' A' ' 78' ' ' THR . 1.5 m-85 -124.79 129.54 50.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.758 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -118.09 118.95 33.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 110.404 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.521 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -93.36 102.83 15.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.031 -179.109 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.466 ' CE ' ' CE1' ' A' ' 94' ' ' TYR . 1.6 mtt -91.59 88.73 6.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.444 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.16 175.89 8.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.666 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 35.35 50.4 0.54 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.881 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.09 161.06 9.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.809 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.404 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 4.2 mttp -134.07 172.82 6.65 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.919 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 87' ' ' LYS . 72.0 Cg_endo -76.28 5.0 4.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.546 2.164 . . . . 0.0 113.076 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.2 tp10 -103.25 -16.95 15.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.739 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -78.48 -17.0 56.91 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.097 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.4 m -51.74 102.78 0.05 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.076 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.48 -171.57 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.923 0.392 . . . . 0.0 111.56 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 91.2 t -93.16 109.87 22.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.82 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.466 ' CE1' ' CE ' ' A' ' 83' ' ' MET . 13.2 m-85 -91.89 109.07 20.4 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.651 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 m -108.72 139.2 43.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.0 111.372 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.7 t -94.86 146.04 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.645 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -148.0 -178.82 23.49 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.74 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.461 ' CB ' ' CE2' ' A' ' 32' ' ' TYR . . . -142.46 165.44 27.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.024 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.58 168.87 14.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.812 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -167.74 120.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.728 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.6 14.76 51.54 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.817 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.46 -12.95 43.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.434 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.3 m -101.89 -179.96 4.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.687 0.28 . . . . 0.0 110.538 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' A' ' 33' ' ' ASP . 73.3 m95 -137.41 81.84 1.89 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.767 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.27 13.7 24.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.463 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.54 130.02 53.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.813 0.339 . . . . 0.0 110.853 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -137.62 164.5 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.045 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.89 -118.29 4.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.6 -44.48 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 110.984 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.97 152.03 13.66 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.762 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 t -154.28 117.23 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.263 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -80.17 143.29 33.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.0 0.429 . . . . 0.0 111.007 -179.334 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.42 ' N ' HE21 ' A' ' 112' ' ' GLN . 48.4 t -116.13 128.46 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.21 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.0 m -104.53 122.19 45.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.155 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 116' ' ' SER . 0.9 OUTLIER -119.67 -151.58 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.393 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 115' ' ' VAL . 75.2 m 65.76 156.22 0.09 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.889 0.376 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.99 156.87 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.976 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.72 153.59 45.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.841 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 mp -143.56 122.59 12.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -138.51 163.93 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.09 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.71 163.63 14.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.71 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.06 117.32 3.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.914 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.02 -31.41 6.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -49.51 140.58 14.2 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.878 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.75 -159.2 30.55 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.395 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.45 150.13 47.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.845 0.355 . . . . 0.0 111.427 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -165.53 106.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.975 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -56.26 150.03 15.23 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.308 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.22 141.5 14.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.318 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.16 -4.66 85.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.753 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.4 119.82 6.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.299 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 p -69.87 133.68 47.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 111.229 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.5 tp -118.81 132.09 56.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.425 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.34 121.08 43.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 0.0 111.472 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.429 ' HB3' ' CH2' ' A' ' 36' ' ' TRP . 15.7 mt -109.32 137.88 46.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.409 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -119.99 113.18 20.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.172 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.402 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 17.4 t -111.04 133.91 53.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.361 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.2 147.16 32.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.199 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.18 78.78 1.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.075 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -98.38 163.44 12.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.5 -149.08 20.18 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.513 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.59 105.33 13.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.868 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -152.07 123.22 7.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.01 35.76 1.35 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.611 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.4 -72.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.986 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.5 p -156.88 36.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.659 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.0 t80 -69.51 65.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.078 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.445 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 5.3 m-20 -58.85 178.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.597 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.87 118.36 10.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 111.025 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -154.54 150.47 22.05 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.811 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.429 ' CH2' ' HB3' ' A' ' 20' ' ' LEU . 76.2 m95 -88.82 152.69 21.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.224 0.535 . . . . 0.0 111.176 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -131.98 -177.31 4.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.727 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -151.23 161.48 42.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.723 179.535 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -163.59 158.72 20.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.995 0.426 . . . . 0.0 111.284 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.27 161.33 34.46 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.681 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.73 137.13 48.53 Favored 'Trans proline' 0 CA--C 1.518 -0.322 0 C-N-CA 122.256 1.971 . . . . 0.0 112.343 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.05 3.05 42.71 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.33 -174.73 2.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.78 0.324 . . . . 0.0 111.035 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -111.17 -171.16 1.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -90.62 131.66 36.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.062 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -133.0 129.62 38.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.599 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.545 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.3 t -85.45 171.28 11.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.285 0.564 . . . . 0.0 110.877 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.432 ' CG2' ' CG ' ' A' ' 38' ' ' ARG . 5.8 t -127.2 -68.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.403 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -142.67 129.21 20.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.237 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -132.67 143.16 49.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.377 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.0 tt -120.51 136.6 57.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.32 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.13 171.03 14.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.378 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.7 33.24 5.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.608 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.95 21.78 5.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.9 t 57.9 91.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.01 -71.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.194 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -179.15 -166.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.19 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.417 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -111.47 -178.46 3.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.809 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 50' ' ' ALA . 50.8 t80 -137.61 96.24 3.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.935 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.417 ' CE1' ' HB ' ' A' ' 58' ' ' THR . 6.0 m-30 -85.9 157.14 20.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 111.033 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.75 162.9 13.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.333 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.0 m -81.76 33.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.015 0.436 . . . . 0.0 111.709 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -118.94 -25.3 6.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.838 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.426 HG13 ' CZ ' ' A' ' 68' ' ' PHE . 30.8 m -148.7 18.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.03 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -71.22 81.21 0.72 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.761 0.791 . . . . 0.0 110.451 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 145.52 -6.69 1.47 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 114.431 -1.259 . . . . 0.0 112.495 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -123.56 -37.53 2.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.681 0.277 . . . . 0.0 111.305 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 4.8 m-30 -84.15 152.23 24.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.078 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.9 m -125.22 154.13 42.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.935 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.52 137.91 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.073 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.0 p -163.06 135.76 5.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.922 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.4 166.94 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.023 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.432 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 11.2 t0 -94.05 -31.0 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.985 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.78 28.62 16.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.33 -52.03 2.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.07 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -132.67 31.6 3.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt 61.74 50.55 4.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.42 HG22 ' CE1' ' A' ' 80' ' ' TYR . 59.3 m -114.0 150.19 34.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.821 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.402 ' CG2' ' HB3' ' A' ' 22' ' ' CYS . 34.7 m -122.53 145.24 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.835 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 27.2 m-85 -130.64 118.79 21.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.972 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.429 HD21 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -114.86 113.98 24.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 110.324 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -92.96 99.26 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.158 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -79.88 86.79 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.88 176.35 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 36.6 47.36 0.52 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.805 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.04 161.84 4.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.492 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -122.9 172.24 5.64 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.139 0.495 . . . . 0.0 111.678 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.69 13.44 2.11 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.567 2.178 . . . . 0.0 112.961 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -131.02 13.73 5.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.504 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -89.08 -7.14 56.4 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.529 0.204 . . . . 0.0 111.192 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.0 m -55.81 107.75 0.38 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.664 0.269 . . . . 0.0 111.373 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.42 170.23 7.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.551 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 5.3 p -82.09 107.07 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.454 ' CE1' ' CE ' ' A' ' 83' ' ' MET . 10.4 m-85 -87.7 103.72 15.86 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.832 0.349 . . . . 0.0 111.256 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.475 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 5.6 t -104.99 130.46 53.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.426 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.7 t -84.96 142.56 29.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.281 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.52 162.46 29.31 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.755 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.41 165.49 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.836 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -96.82 179.34 34.11 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.682 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 177.9 118.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 0.0 110.698 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.7 14.48 50.97 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.811 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.66 -11.99 46.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.577 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.404 ' CG2' ' H ' ' A' ' 104' ' ' TRP . 4.5 m -106.08 -179.26 3.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.642 0.258 . . . . 0.0 110.521 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 33' ' ' ASP . 57.0 m95 -137.22 87.1 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.663 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -118.12 10.23 12.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.608 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.01 61.44 1.51 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.191 0.52 . . . . 0.0 110.768 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -69.97 165.46 21.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.104 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.74 -141.74 8.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.567 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -89.68 -48.25 7.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.331 . . . . 0.0 111.0 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 111.12 151.58 12.24 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.766 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.0 t -153.77 113.27 3.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -74.6 142.05 44.66 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.091 0.472 . . . . 0.0 111.272 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 91' ' ' THR . 55.8 t -114.65 117.79 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.037 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.8 m -96.69 119.35 35.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.094 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -110.68 -167.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.4 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 54.4 p -176.38 -166.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.813 0.34 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.924 0.392 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.08 155.17 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -158.22 172.57 18.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.911 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 mp -153.89 148.94 26.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.32 166.76 29.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.957 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.28 162.79 23.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.782 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.6 p -170.0 118.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.8 -27.67 4.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.596 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -53.69 179.83 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.716 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.12 177.9 25.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.317 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.03 126.05 28.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.074 0.464 . . . . 0.0 111.33 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 29.5 m -126.75 140.33 49.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.606 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -70.13 138.58 52.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.922 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.17 126.09 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.405 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.94 19.38 36.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.681 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -113.31 -156.43 12.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.405 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 t -138.64 137.89 37.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.933 0.397 . . . . 0.0 111.116 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 12.9 tp -135.18 133.29 38.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.589 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -110.68 126.74 54.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.338 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.449 ' CB ' ' CH2' ' A' ' 36' ' ' TRP . 5.7 mt -113.81 139.34 49.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.242 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.8 p -115.98 114.82 25.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.994 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.7 t -106.54 134.69 49.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.617 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -122.89 142.03 51.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.127 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -116.6 -178.41 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.45 156.55 33.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.78 111.35 1.78 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.65 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -71.16 113.42 8.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 110.665 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.7 172.03 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 110.927 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.32 -29.91 2.2 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.625 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -69.87 -9.79 56.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.578 0.228 . . . . 0.0 111.548 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.3 m 71.07 60.2 0.18 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.976 0.417 . . . . 0.0 110.834 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.442 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -69.14 132.33 46.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.622 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -83.95 -176.64 6.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.084 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.1 mtp -144.02 126.61 16.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.33 154.45 25.87 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.928 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.449 ' CH2' ' CB ' ' A' ' 20' ' ' LEU . 73.9 m95 -86.93 153.84 21.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 111.438 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.4 m-85 -135.89 -178.81 5.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.768 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.452 ' CG ' ' CG2' ' A' ' 48' ' ' VAL . 0.9 OUTLIER -147.66 155.05 41.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.976 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -154.34 135.77 14.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.93 147.68 57.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.744 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.65 136.84 51.66 Favored 'Trans proline' 0 CA--C 1.517 -0.351 0 C-N-CA 122.247 1.965 . . . . 0.0 112.273 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.9 3.02 41.43 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.6 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.41 -162.92 0.82 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.692 0.282 . . . . 0.0 110.953 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -118.01 158.2 25.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.789 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.76 149.37 36.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.072 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.29 165.42 34.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.711 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.553 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.8 t -107.04 172.19 6.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.151 0.501 . . . . 0.0 110.865 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.452 ' CG2' ' CG ' ' A' ' 38' ' ' ARG . 2.6 t -128.58 -69.36 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.652 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -147.4 133.5 19.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 0.0 111.356 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -130.96 143.39 50.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.222 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 tp -124.57 141.14 45.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.182 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -81.67 -163.15 0.6 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.57 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.35 59.03 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.994 0.426 . . . . 0.0 110.467 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 60.19 29.91 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.5 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.3 p -89.66 -53.09 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.235 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.67 -73.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.809 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.18 -161.06 0.35 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 111.19 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.75 -178.44 4.24 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.022 0.439 . . . . 0.0 110.974 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' N ' ' O ' ' A' ' 50' ' ' ALA . 7.0 t80 -140.18 93.06 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.719 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -76.98 159.42 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.844 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.87 165.97 12.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.133 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 63' ' ' SER . 2.5 p -69.48 150.94 46.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.666 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 86.7 -12.38 0.56 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.618 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.43 HG13 ' CE2' ' A' ' 68' ' ' PHE . 16.9 m -149.15 12.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.525 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -81.39 81.85 7.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.634 0.73 . . . . 0.0 110.513 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.87 -6.81 2.38 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.309 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.412 ' NE ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -119.08 -46.71 2.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.669 0.271 . . . . 0.0 111.257 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.44 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.7 m-30 -69.94 139.85 52.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.702 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.9 m -111.55 153.45 26.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.887 0.375 . . . . 0.0 111.02 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -139.45 140.34 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.834 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.424 ' N ' HG13 ' A' ' 70' ' ' ILE . 9.9 t -154.69 123.65 6.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 162.08 29.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.961 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.441 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 42.6 t0 -91.89 -38.26 12.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 59.7 47.78 10.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.743 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.3 -60.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -126.82 33.1 5.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.21 54.17 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 110.598 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.417 HG23 ' CZ ' ' A' ' 80' ' ' TYR . 92.7 m -119.17 148.83 42.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.073 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.44 144.09 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.673 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 28.5 m-85 -127.45 120.14 27.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.821 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.428 HD23 ' CE2' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -115.28 116.66 28.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.103 0.478 . . . . 0.0 110.644 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -95.9 96.09 8.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.962 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.44 ' HG2' ' CD2' ' A' ' 68' ' ' PHE . 15.6 mtm -80.41 95.42 6.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.95 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.35 176.71 6.62 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.734 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 t 35.9 40.59 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.739 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.34 163.72 1.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.211 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.74 160.96 48.94 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.802 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.1 3.73 5.92 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.49 2.127 . . . . 0.0 112.848 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 12.7 tp10 -107.01 -10.38 15.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.782 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.66 -10.53 59.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.932 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 73.3 m -48.31 106.07 0.09 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.403 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.51 177.92 3.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.328 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 5.0 p -83.95 107.35 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.447 ' CD1' ' CG2' ' A' ' 113' ' ' VAL . 6.1 m-85 -83.99 99.36 10.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.975 0.417 . . . . 0.0 110.679 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 m -103.04 132.05 49.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.282 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.7 t -90.42 135.62 33.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.657 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -136.16 176.0 20.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.402 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 32' ' ' TYR . . . -131.57 148.01 52.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.82 151.1 16.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.606 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -143.8 126.61 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.31 15.8 52.53 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.784 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.19 -9.77 46.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.791 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.7 m -102.22 179.98 4.16 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.598 0.237 . . . . 0.0 110.419 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -145.28 92.29 2.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -115.34 -2.76 12.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.406 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.41 132.39 39.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -136.55 164.67 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.28 -141.65 10.12 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.48 -45.49 8.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 113.11 153.82 11.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.532 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 1.8 t -152.58 106.93 3.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 110.526 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -60.21 141.66 55.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.136 0.493 . . . . 0.0 110.996 -179.565 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.4 t -119.91 88.01 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.181 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.1 m -76.67 132.87 39.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.218 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.79 156.51 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.396 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 m 172.31 169.78 0.11 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.967 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.884 0.373 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.53 156.79 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.966 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.33 139.67 21.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mp -114.83 138.87 50.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 11.2 mt-30 -144.89 134.28 23.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.667 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.13 163.52 13.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.859 0.361 . . . . 0.0 110.897 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.9 t -163.79 118.93 1.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.16 -37.57 3.04 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.715 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -49.12 139.16 14.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.095 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.43 -165.7 34.0 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.413 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.35 148.64 49.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.882 0.372 . . . . 0.0 111.595 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -170.12 106.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -56.68 159.59 3.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.347 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.2 153.71 1.9 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.304 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.48 9.2 68.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.647 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.74 113.62 2.92 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.383 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 m -69.95 135.96 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tp -133.4 131.64 40.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.66 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -108.07 129.58 55.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.162 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HB2' ' CH2' ' A' ' 36' ' ' TRP . 3.7 mt -113.68 144.87 42.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.131 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.473 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 1.9 m -126.97 118.98 25.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.498 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 19.3 p -125.07 121.34 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.999 0.428 . . . . 0.0 110.354 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.26 171.66 9.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.349 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.98 55.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.0 p -70.08 154.38 42.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.23 -110.02 0.38 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.488 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.52 65.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.73 -167.55 1.77 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.69 39.32 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.797 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.6 t -124.44 -70.77 0.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.803 0.335 . . . . 0.0 110.73 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.63 27.45 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.0 t80 -69.76 65.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.065 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.404 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 12.8 m-20 -48.58 164.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.846 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -145.5 126.28 14.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.821 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -155.82 155.13 26.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.818 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' A' ' 20' ' ' LEU . 78.4 m95 -84.34 153.36 23.53 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.066 0.46 . . . . 0.0 111.022 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 8.9 m-85 -133.2 -176.38 4.11 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.389 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.429 ' CG ' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -146.81 156.67 43.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.668 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -153.94 111.39 3.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.125 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.96 160.74 27.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.685 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.53 136.99 35.04 Favored 'Trans proline' 0 CA--C 1.518 -0.315 0 C-N-CA 122.294 1.996 . . . . 0.0 112.322 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.33 1.89 30.6 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.665 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.56 -174.8 2.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 110.974 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -103.18 -172.76 2.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.598 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -99.26 124.99 44.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -123.18 137.91 54.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.711 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.5 t -75.43 172.19 12.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.517 0.675 . . . . 0.0 111.526 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.429 ' CG2' ' CG ' ' A' ' 38' ' ' ARG . 2.7 t -131.02 -67.7 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.107 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -142.8 128.16 18.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.119 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -136.29 145.99 46.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.743 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.12 140.82 45.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.239 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -78.5 158.64 28.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.029 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.82 46.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.599 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -144.45 21.73 1.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.58 56.41 7.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.03 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.34 -72.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.242 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -175.57 172.95 2.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.986 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.87 179.74 4.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.745 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 50' ' ' ALA . 57.4 t80 -140.42 95.59 2.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.574 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 68' ' ' PHE . 78.3 m-85 -78.99 169.84 17.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.45 170.73 7.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.67 150.86 46.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.715 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.0 t 81.96 -8.04 1.33 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.752 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -151.29 11.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.434 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 79.23 0.86 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.534 0.683 . . . . 0.0 110.681 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.9 1.71 5.8 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.07 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.39 -52.92 2.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 4.4 m-30 -74.86 133.65 41.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.668 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 25.0 m -95.68 153.33 17.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.03 0.443 . . . . 0.0 110.975 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.475 HD11 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -152.78 136.12 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.596 -179.194 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.475 ' N ' HD11 ' A' ' 70' ' ' ILE . 10.3 t -156.14 153.39 29.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.958 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.65 141.42 34.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.822 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -74.67 -30.37 61.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.916 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 m120 59.59 27.38 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.94 -54.63 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.018 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -122.76 27.33 7.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp 59.49 51.09 6.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.852 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.44 HG22 ' CE1' ' A' ' 80' ' ' TYR . 69.3 m -122.16 148.67 44.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.125 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.0 142.35 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.699 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.473 ' CE2' ' HB3' ' A' ' 21' ' ' SER . 1.2 m-85 -128.36 138.15 52.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.46 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 1.1 pt? -131.35 124.26 30.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.095 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -96.78 99.74 11.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.165 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -84.69 89.69 7.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.64 174.28 11.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 0.0 111.184 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 32.4 47.08 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.951 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.56 158.95 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 111.125 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.494 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -126.42 174.34 4.23 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.632 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 86.3 Cg_endo -81.18 8.22 4.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.436 2.091 . . . . 0.0 112.855 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -109.69 -8.66 14.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.8 -20.01 43.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.234 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 95.5 m -54.22 101.99 0.05 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 111.305 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.54 -175.61 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.8 t -87.37 102.89 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.623 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.412 ' CD1' HG23 ' A' ' 113' ' ' VAL . 8.1 m-85 -83.65 104.38 13.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.429 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 19.0 m -105.3 132.35 51.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.328 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.0 t -96.16 135.73 37.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.601 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.3 177.3 20.79 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.706 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -131.59 167.56 19.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.357 . . . . 0.0 111.012 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -119.45 -165.63 13.1 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.825 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.62 113.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.798 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.99 52.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.62 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.83 -12.41 34.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.752 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -96.15 177.52 5.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.891 0.377 . . . . 0.0 110.8 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.504 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 76.8 m95 -145.42 107.26 4.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.741 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -133.35 10.67 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.396 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -112.19 134.67 53.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.817 0.341 . . . . 0.0 110.896 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -141.6 165.05 28.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.05 -152.62 16.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -85.54 -31.86 22.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 95.72 156.44 31.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.65 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.8 t -147.99 112.7 5.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.341 . . . . 0.0 110.527 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.02 141.37 56.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 110.992 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.412 HG23 ' CD1' ' A' ' 94' ' ' TYR . 42.4 t -120.02 136.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.445 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 48.1 m -121.18 137.43 54.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.857 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.69 168.37 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.248 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.36 -167.17 2.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.059 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.897 -179.969 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.96 155.06 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.224 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -91.85 162.35 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.0 mp -145.72 130.61 18.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -118.06 157.03 27.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.777 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.26 168.3 9.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.072 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.15 131.82 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.969 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.21 -18.59 57.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.749 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.07 138.27 31.29 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.874 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.85 -169.63 39.74 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.435 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.51 154.33 42.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.902 0.382 . . . . 0.0 111.58 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.39 113.92 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.927 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.0 144.18 7.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.384 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.81 121.35 5.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.314 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.8 15.32 58.22 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.599 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.72 133.36 11.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.371 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.12 126.2 28.95 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.099 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.404 ' CD2' ' CD2' ' A' ' 20' ' ' LEU . 5.2 tp -120.52 131.34 54.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.523 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -110.23 122.44 47.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 111.607 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.424 ' HB2' ' CH2' ' A' ' 36' ' ' TRP . 6.8 mt -113.21 138.06 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.193 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.464 ' HB2' ' CD2' ' A' ' 80' ' ' TYR . 12.6 t -121.47 118.62 29.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.967 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 5.9 p -126.66 133.56 50.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.984 0.421 . . . . 0.0 111.174 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -113.87 172.85 6.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.234 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.34 120.63 15.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.6 t -82.55 110.35 17.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.46 -176.5 40.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.446 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ttm-85 -107.1 137.41 45.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.811 0.339 . . . . 0.0 110.937 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.423 HG22 ' CH2' ' A' ' 53' ' ' TRP . 16.8 p -102.4 -178.07 3.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.776 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.37 -26.0 2.97 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.806 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 t -94.52 36.33 1.17 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.602 0.239 . . . . 0.0 111.225 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.91 33.47 7.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.952 0.406 . . . . 0.0 110.567 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.479 ' CE2' ' CB ' ' A' ' 98' ' ' ALA . 1.5 t80 -69.45 122.87 19.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.722 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 46.7 m-20 -110.1 178.76 4.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.775 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 ttm -150.11 129.6 13.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.123 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -150.15 154.47 25.69 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.839 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' A' ' 20' ' ' LEU . 84.8 m95 -83.57 155.61 23.19 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.1 0.476 . . . . 0.0 111.312 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.4 m-85 -137.82 -178.28 5.18 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.473 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.436 ' CG ' ' CG2' ' A' ' 48' ' ' VAL . 2.0 mtm180 -148.41 159.33 44.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.993 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -153.63 109.12 3.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.107 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.66 154.06 38.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.714 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.2 140.43 44.75 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.369 2.046 . . . . 0.0 112.426 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.0 -8.17 39.2 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.728 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -117.87 -179.1 3.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.842 0.353 . . . . 0.0 110.914 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.26 170.63 8.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.552 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.88 130.66 35.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.802 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.14 144.34 51.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.608 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.533 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.0 t -80.76 174.82 11.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.211 0.529 . . . . 0.0 111.054 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.436 ' CG2' ' CG ' ' A' ' 38' ' ' ARG . 2.1 t -131.45 -70.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.358 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -141.26 133.78 28.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -130.33 143.39 50.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.417 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 tp -123.4 142.42 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.045 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -80.05 -164.42 0.67 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.951 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.423 ' CH2' HG22 ' A' ' 28' ' ' THR . 10.6 t-105 -109.97 64.91 0.61 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.714 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 61.82 56.85 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.65 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 m -123.34 -71.38 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -115.41 -72.57 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.498 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -172.71 -153.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.901 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.16 -179.94 4.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.991 0.424 . . . . 0.0 110.95 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 45.2 t80 -137.92 97.8 3.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.783 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -78.65 155.5 29.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.826 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.13 176.1 5.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.225 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -69.57 151.68 45.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.655 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.7 m 81.99 -9.0 1.25 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.571 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.44 HG12 ' CE2' ' A' ' 68' ' ' PHE . 35.4 m -151.56 13.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.352 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.74 80.11 1.12 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.707 0.765 . . . . 0.0 110.387 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.16 6.91 17.78 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.812 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -110.96 -45.31 3.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.814 0.34 . . . . 0.0 111.192 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 83' ' ' MET . 7.8 m-30 -93.02 149.59 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.018 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 14.2 m -107.33 155.5 19.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.487 HD11 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -158.13 136.45 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.116 -179.018 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.487 ' N ' HD11 ' A' ' 70' ' ' ILE . 1.9 p -154.74 170.69 21.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.405 ' NH1' ' HB3' ' A' ' 72' ' ' ARG . 16.9 mtp-105 -113.62 146.19 40.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.926 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.411 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 22.5 t0 -89.9 -11.02 43.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.339 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 43.65 30.97 0.4 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.767 0.317 . . . . 0.0 111.558 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.7 -64.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.32 39.0 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.79 52.18 2.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.828 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.474 ' CG2' ' CE1' ' A' ' 80' ' ' TYR . 79.9 m -115.92 143.92 44.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.116 0.484 . . . . 0.0 111.358 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.98 132.3 71.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.033 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.474 ' CE1' ' CG2' ' A' ' 78' ' ' THR . 2.5 m-85 -115.32 119.43 36.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -115.17 115.47 26.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 0.0 110.48 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.01 92.48 6.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.785 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.441 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -73.09 92.1 1.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.009 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.74 176.02 7.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 35.96 47.22 0.4 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.723 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.404 ' CD1' ' CB ' ' A' ' 83' ' ' MET . 0.2 OUTLIER -64.94 158.49 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.844 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.12 166.52 10.76 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.686 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.92 11.99 2.38 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.616 2.21 . . . . 0.0 112.959 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -131.76 11.42 4.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.495 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -87.08 -5.18 59.12 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.634 0.254 . . . . 0.0 111.195 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 89.5 m -55.39 118.01 4.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 111.028 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.52 -172.26 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.499 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.0 t -92.99 106.26 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.496 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -88.57 103.06 15.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.874 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 37' ' ' PHE . 6.1 t -105.75 142.22 35.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.226 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.57 144.36 25.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.92 175.89 20.07 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.313 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.479 ' CB ' ' CE2' ' A' ' 32' ' ' TYR . . . -143.59 167.65 21.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.902 0.382 . . . . 0.0 111.312 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -121.26 178.39 16.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.848 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -164.52 117.89 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.751 0.31 . . . . 0.0 110.416 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.8 16.41 51.54 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.729 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.66 -12.63 35.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.83 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -97.19 178.71 5.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.762 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.434 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 78.5 m95 -141.56 103.96 4.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -136.66 21.26 3.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.114 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.03 138.16 51.18 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.801 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -137.34 166.87 22.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.003 0.43 . . . . 0.0 111.117 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -111.03 -155.97 14.02 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.443 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -82.32 -41.1 20.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.948 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 104.86 151.37 21.0 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.799 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.0 t -152.62 121.06 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.7 144.38 37.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.957 0.408 . . . . 0.0 111.045 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 91' ' ' THR . 54.1 t -115.03 128.11 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.321 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.7 m -100.93 130.48 46.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.992 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.403 HG12 ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -136.2 -162.0 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.611 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.0 t 76.0 171.38 0.25 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.857 0.36 . . . . 0.0 110.825 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.959 -179.835 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.823 0.344 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.46 122.06 9.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -115.95 158.67 22.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -123.17 170.42 10.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -160.74 133.9 6.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.031 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.31 -32.16 6.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.567 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.29 138.77 27.03 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.948 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.41 -161.8 35.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.289 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.693 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.3 mp -69.39 143.85 53.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.889 0.376 . . . . 0.0 111.485 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.6 p -162.29 113.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.077 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.01 148.04 36.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.84 145.9 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.391 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.38 -7.34 79.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.678 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.21 118.64 5.91 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.318 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -70.01 135.58 49.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 111.126 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.663 ' CD2' HD21 ' A' ' 20' ' ' LEU . 14.2 tp -116.81 134.01 55.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.379 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.442 ' NE ' ' HB3' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -107.42 119.66 40.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.505 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.673 ' HB2' HD23 ' A' ' 81' ' ' LEU . 14.4 mt -111.28 139.14 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.36 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.8 p -126.28 98.79 5.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.968 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 41.4 t -95.19 135.23 37.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.711 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.77 145.66 43.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.273 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.981 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.601 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 120.925 0.393 . . . . 0.0 111.094 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 52' ' ' ASN . 0.4 OUTLIER -153.39 178.49 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.552 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.523 ' HB3' HG11 ' A' ' 79' ' ' VAL . 1.6 mtm -140.98 123.05 15.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.287 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -150.55 150.52 22.54 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.247 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.475 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 79.1 m95 -84.51 152.79 23.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.141 0.496 . . . . 0.0 110.939 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.6 m-85 -132.14 -178.77 5.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.396 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HD3' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -154.91 161.08 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.976 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.538 ' O ' HG12 ' A' ' 93' ' ' VAL . 8.1 tt0 -161.6 147.49 13.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -127.69 163.46 42.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.656 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.59 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 55.6 Cg_endo -70.19 138.28 36.11 Favored 'Trans proline' 0 CA--C 1.518 -0.318 0 C-N-CA 122.275 1.983 . . . . 0.0 112.372 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.41 -0.73 39.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.752 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.89 -177.45 3.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -100.13 -172.14 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HD2' ' CH2' ' A' ' 107' ' ' TRP . 10.2 ptt-85 -102.79 136.06 43.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.365 . . . . 0.0 111.046 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 1.7 pt-20 -131.6 163.65 27.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.331 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.1 t -104.26 171.08 7.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.267 0.556 . . . . 0.0 111.089 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.615 HG22 ' HD3' ' A' ' 38' ' ' ARG . 6.0 t -126.9 -67.09 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.491 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.6 136.82 26.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.325 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -141.88 146.33 35.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.94 HG23 HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -114.87 143.29 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.846 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 26.1 t-20 . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 121.177 0.513 . . . . 0.0 110.444 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.935 0.397 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.94 HG23 HG23 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -98.72 -177.42 3.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.484 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.2 t80 -138.73 92.32 2.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.787 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 49' ' ' ALA . 12.8 m-85 -93.53 166.27 12.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.013 0.435 . . . . 0.0 111.071 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.24 159.45 19.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.366 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.48 37.19 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 0.0 111.838 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.4 t -116.35 -24.99 7.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.96 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.487 ' HA ' ' NH1' ' A' ' 67' ' ' ARG . 26.9 m -156.82 21.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.046 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 65' ' ' ARG . 16.2 ttp85 -75.26 86.32 2.47 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.884 0.849 . . . . 0.0 110.689 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.84 -17.93 0.85 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.314 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.487 ' NH1' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -115.26 -33.16 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.642 0.258 . . . . 0.0 111.304 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.477 ' CE2' ' HG2' ' A' ' 83' ' ' MET . 2.6 m-85 -88.88 137.02 32.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.128 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 10.1 m -106.82 153.63 22.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.907 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -141.35 136.14 32.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.942 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.907 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -152.66 178.72 9.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.671 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.83 167.59 18.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.019 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.606 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 16.8 t0 -79.4 -37.01 38.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.788 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 m120 62.97 35.5 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.819 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.606 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -134.46 -47.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.18 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.4 tttp -130.07 -64.36 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt 167.66 70.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 64.9 m -135.65 144.78 46.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.006 0.432 . . . . 0.0 111.063 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.523 HG11 ' HB3' ' A' ' 34' ' ' MET . 33.8 m -116.54 147.6 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.696 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 2.2 m-85 -136.72 128.65 29.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.906 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -124.7 121.7 35.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.167 0.508 . . . . 0.0 110.808 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -94.59 99.21 11.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.583 ' O ' HD13 ' A' ' 86' ' ' LEU . 1.5 mtp -80.51 87.82 5.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.003 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.65 176.06 7.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.738 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 34.96 48.96 0.37 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.594 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 83' ' ' MET . 1.2 mp -58.2 165.88 1.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.313 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.435 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -145.3 167.89 13.35 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.817 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 54.8 Cg_endo -69.71 1.59 4.26 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.553 2.169 . . . . 0.0 113.148 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -98.76 -20.3 16.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.874 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.15 -21.18 46.86 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.083 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 114' ' ' THR . 99.9 m -51.79 101.55 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.782 0.325 . . . . 0.0 111.198 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.41 177.66 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.345 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.709 ' O ' HG13 ' A' ' 93' ' ' VAL . 9.4 p -80.88 101.57 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.197 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.441 ' O ' HG22 ' A' ' 111' ' ' THR . 3.9 m-85 -81.65 101.71 10.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.026 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.493 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 6.3 t -103.23 125.42 49.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.466 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.9 t -81.93 136.5 35.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.171 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.47 176.69 22.14 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.118 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.601 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -139.37 167.81 21.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.355 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -126.52 170.42 18.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.239 -0.982 . . . . 0.0 113.172 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -156.82 132.52 9.45 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.98 13.48 48.26 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.73 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.52 -9.47 45.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.886 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.662 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -101.82 179.56 4.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.849 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.662 ' H ' HG22 ' A' ' 103' ' ' THR . 84.3 m95 -136.72 86.23 2.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.576 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.56 19.04 17.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.96 132.42 56.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.426 ' CH2' ' HD2' ' A' ' 45' ' ' ARG . 19.5 m95 -139.24 164.02 30.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.025 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.87 -142.84 10.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.574 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.63 -35.32 15.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.382 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 99.8 150.69 25.38 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.863 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 111' ' ' THR . 7.9 t -145.27 114.67 7.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -76.63 132.36 39.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.971 0.415 . . . . 0.0 111.272 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 91' ' ' THR . 60.7 t -110.14 124.08 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.901 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.693 ' HB ' HD23 ' A' ' 11' ' ' LEU . 89.7 m -112.49 117.26 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.585 HG12 ' H ' ' A' ' 116' ' ' SER . 0.4 OUTLIER -121.62 -168.84 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.083 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.585 ' H ' HG12 ' A' ' 115' ' ' VAL . 77.5 p . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.605 0.241 . . . . 0.0 111.262 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.837 0.351 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.464 HD23 ' HB2' ' A' ' 24' ' ' ALA . 1.7 mp -142.48 -179.57 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -169.13 169.07 9.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.04 163.31 18.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 p -167.74 126.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.62 -31.83 6.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.664 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' HD22 ' A' ' 20' ' ' LEU . . . -55.39 179.11 0.34 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.766 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.12 -157.79 27.49 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.076 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.755 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.2 mp -69.45 145.36 52.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.812 0.339 . . . . 0.0 111.262 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.594 HG11 HD22 ' A' ' 86' ' ' LEU . 7.7 p -146.54 132.97 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.171 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.96 129.48 41.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.187 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' HA ' HG12 ' A' ' 115' ' ' VAL . . . -51.61 128.2 22.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.401 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.25 -3.04 82.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.8 -144.56 14.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.444 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.58 140.97 33.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.934 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.807 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.8 tp -129.84 141.46 50.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.446 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.563 ' C ' HD23 ' A' ' 20' ' ' LEU . 31.5 ttt85 -122.09 131.38 53.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.489 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.807 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.9 mt -121.53 145.1 48.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.291 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.471 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 98.5 p -126.11 108.84 11.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.278 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 50.0 t -101.22 135.88 41.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.507 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -122.0 147.85 45.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.939 0.399 . . . . 0.0 111.424 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB3' ' HE1' ' A' ' 34' ' ' MET . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.822 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.46 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 43.8 t80 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 121.022 0.439 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.45 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 71.6 m-20 -84.47 -176.88 6.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.258 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.576 ' HB3' HG11 ' A' ' 79' ' ' VAL . 2.9 mtt -141.21 117.78 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.33 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -141.22 168.16 25.49 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.039 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.45 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 77.7 m95 -103.0 158.76 16.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 111.163 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 13.8 m-85 -134.72 178.49 6.97 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' HG2' HG22 ' A' ' 48' ' ' VAL . 10.0 ptm180 -148.58 155.22 40.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.929 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.422 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.8 OUTLIER -145.85 110.69 5.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.5 153.24 48.09 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.37 136.46 40.07 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.325 2.016 . . . . 0.0 112.454 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.09 -1.36 33.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.657 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.74 -179.34 3.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.909 0.385 . . . . 0.0 111.048 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.45 -171.58 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.449 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -96.7 154.57 17.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.37 0.605 . . . . 0.0 111.329 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' CG ' ' HG3' ' A' ' 38' ' ' ARG . 7.8 pt-20 -157.46 139.24 14.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.241 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 1.6 t -67.99 171.98 6.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.478 0.656 . . . . 0.0 111.446 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.497 HG21 ' CE1' ' A' ' 94' ' ' TYR . 2.8 t -130.0 -67.8 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.221 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.14 124.42 13.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -120.62 147.3 45.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.337 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 34' ' ' MET . 0.6 OUTLIER -127.31 141.34 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.924 0.392 . . . . 0.0 111.286 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.403 ' N ' HG13 ' A' ' 51' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.785 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.785 0.326 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 1.012 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -107.63 -179.03 3.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.002 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 50' ' ' ALA . 12.8 t80 -139.04 86.58 2.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.713 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.448 ' CE2' HG22 ' A' ' 70' ' ' ILE . 9.3 m-85 -86.79 143.57 27.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.38 165.14 24.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.442 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.4 p -82.33 33.66 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 0.0 111.701 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.4 p -118.99 -21.56 7.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.126 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.536 HG11 ' CE1' ' A' ' 68' ' ' PHE . 17.4 m -148.46 19.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.019 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.5 ttt85 -62.49 79.25 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.63 0.729 . . . . 0.0 110.832 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 134.09 3.16 3.24 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.175 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -119.1 -52.87 2.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.816 0.341 . . . . 0.0 111.069 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CE1' HG11 ' A' ' 64' ' ' VAL . 5.2 m-30 -75.5 150.85 38.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.1 m -113.32 157.87 21.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.007 0.432 . . . . 0.0 110.98 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.012 HG21 HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -151.58 135.18 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.96 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.892 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -164.8 152.04 11.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.716 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 164.31 11.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.07 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.457 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 54.2 t0 -76.93 -30.33 56.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.989 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.35 25.61 13.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.25 -52.59 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.892 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 2.6 pttt -134.16 -57.53 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 173.42 70.96 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.779 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.469 HG22 ' CE1' ' A' ' 80' ' ' TYR . 25.8 m -134.92 139.42 44.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.114 0.483 . . . . 0.0 111.336 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 34' ' ' MET . 35.6 m -115.92 146.16 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.336 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 1.9 m-85 -135.1 155.16 51.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.72 0.295 . . . . 0.0 111.035 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.526 HD21 HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -146.31 125.62 13.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.952 0.406 . . . . 0.0 110.941 179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.61 96.5 7.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.536 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.502 ' SD ' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -79.38 91.25 5.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.271 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.44 178.53 6.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 t 38.99 40.75 0.48 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.441 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.594 HD22 HG11 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -60.38 159.49 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.145 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.556 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 16.5 mmmt -128.62 163.67 43.36 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.411 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 57.8 Cg_endo -70.99 6.96 1.49 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.37 2.047 . . . . 0.0 113.271 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -109.2 -8.1 15.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.009 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.27 -11.15 58.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.652 0.263 . . . . 0.0 111.308 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.434 ' OG1' HG23 ' A' ' 115' ' ' VAL . 97.6 m -53.18 107.7 0.26 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.057 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.61 -177.65 2.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.525 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 93.5 t -89.75 105.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.792 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.51 ' O ' HG22 ' A' ' 111' ' ' THR . 11.3 m-85 -87.91 110.2 20.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 7.2 m -111.15 136.08 50.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.718 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.423 ' HB3' ' CE3' ' A' ' 36' ' ' TRP . 15.7 p -98.91 138.66 35.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 111.175 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.73 -169.3 11.69 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.361 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -136.92 167.41 21.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 111.193 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -104.01 -175.8 25.57 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.629 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -173.75 108.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.73 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.09 16.69 49.32 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.764 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.0 -16.51 25.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.558 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.667 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -96.49 179.81 4.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.769 0.319 . . . . 0.0 110.475 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.667 ' H ' HG22 ' A' ' 103' ' ' THR . 79.9 m95 -141.88 92.51 2.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.766 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -117.43 -2.18 11.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.586 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.676 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 1.2 t -93.28 132.49 37.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -137.28 162.63 33.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.38 -92.49 2.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.403 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -140.36 -69.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 110.845 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 141.54 151.08 5.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.738 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.6 t -147.25 106.46 3.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.899 0.38 . . . . 0.0 110.45 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 2.1 tp60 -66.17 142.22 57.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.203 0.525 . . . . 0.0 111.04 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 91' ' ' THR . 41.1 t -117.62 116.43 51.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.182 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.755 ' CB ' HD23 ' A' ' 11' ' ' LEU . 90.1 m -100.58 108.55 20.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.075 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 116' ' ' SER . 0.3 OUTLIER -108.31 -158.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.396 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.495 ' H ' HG12 ' A' ' 115' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.873 0.368 . . . . 0.0 111.031 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.823 0.344 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 mp -147.82 151.54 36.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -154.32 173.11 16.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.06 164.31 14.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.792 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.92 101.3 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.28 87.17 1.97 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.423 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.62 152.87 16.22 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.447 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.71 -155.25 26.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.41 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.74 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.7 mp -69.03 134.67 49.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.908 0.385 . . . . 0.0 111.247 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG1' HD22 ' A' ' 86' ' ' LEU . 8.0 p -142.33 128.96 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.282 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 132.56 46.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.309 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.54 154.26 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.582 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.18 -9.14 73.93 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.792 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.78 -163.14 25.98 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.608 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.48 141.37 41.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.856 ' CD2' HD21 ' A' ' 20' ' ' LEU . 7.1 tp -128.77 132.27 47.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.612 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -111.57 116.9 31.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.381 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.856 HD21 ' CD2' ' A' ' 18' ' ' LEU . 9.9 mt -104.69 133.74 49.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.626 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 p -112.25 134.94 53.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.659 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -134.29 126.12 29.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.92 0.39 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.19 152.75 21.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.971 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.406 ' HB3' ' HE2' ' A' ' 34' ' ' MET . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.619 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.996 0.427 . . . . 0.0 111.026 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.442 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 39.1 m-20 -123.45 -176.38 3.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.703 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.406 ' HE2' ' HB3' ' A' ' 24' ' ' ALA . 3.9 ttm -145.63 126.43 14.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.192 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.86 162.71 28.97 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.733 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.435 ' CH2' ' CB ' ' A' ' 20' ' ' LEU . 79.7 m95 -91.63 155.12 18.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 111.487 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -137.69 -177.94 5.02 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.785 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.533 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -151.49 163.14 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.559 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.723 ' O ' HG12 ' A' ' 93' ' ' VAL . 4.5 tp60 -165.91 128.37 2.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.03 0.443 . . . . 0.0 111.621 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -113.45 167.94 8.57 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.496 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.725 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 59.6 Cg_endo -72.3 137.56 28.64 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.233 1.955 . . . . 0.0 112.476 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.33 2.0 24.22 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.703 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -119.48 152.0 37.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -77.21 156.1 31.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.387 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.9 143.0 52.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.951 0.405 . . . . 0.0 111.245 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.43 143.25 48.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.211 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.533 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.6 t -83.57 172.79 12.0 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 111.183 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.533 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.0 t -129.19 -66.64 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.976 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.09 161.67 40.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -160.24 144.4 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.995 0.426 . . . . 0.0 111.511 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.661 HD13 ' HD2' ' A' ' 72' ' ' ARG . 1.4 tt -123.24 143.67 35.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 . . . . . 0 N--CA 1.449 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.016 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.86 0.362 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.71 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -108.99 -179.36 3.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.022 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -140.6 142.18 35.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.382 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.466 ' HH ' ' HA ' ' A' ' 69' ' ' THR . 3.7 m-85 -128.86 168.32 16.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.84 0.353 . . . . 0.0 111.026 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.0 168.07 13.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 63' ' ' SER . 56.3 m -69.24 153.07 44.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.498 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 t 84.38 -10.23 0.89 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.522 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.435 HG21 ' CG1' ' A' ' 48' ' ' VAL . 28.6 m -154.2 16.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.462 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 65' ' ' ARG . 8.9 tpt180 -82.08 83.15 7.41 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.665 0.745 . . . . 0.0 109.962 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.09 -0.65 7.71 Favored Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.158 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -110.81 -52.63 2.77 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.837 0.351 . . . . 0.0 110.794 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.3 m-30 -76.86 149.34 36.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.466 ' HA ' ' HH ' ' A' ' 60' ' ' TYR . 6.8 m -111.05 152.37 26.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.71 HG21 HG21 ' A' ' 58' ' ' THR . 6.2 tp -137.49 146.19 28.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.761 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.08 172.33 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 111.032 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.661 ' HD2' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -130.85 143.61 50.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.913 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.409 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 7.2 t0 -83.57 -38.07 22.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.09 26.75 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.43 -42.71 2.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.963 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.25 29.09 2.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.876 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt 61.93 53.97 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.9 m -118.36 148.72 42.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.026 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.75 141.02 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.843 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 24.9 m-85 -125.96 126.69 44.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.977 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -120.63 116.81 26.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 0.0 110.51 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -94.76 94.59 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.156 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.575 ' CE ' HD23 ' A' ' 18' ' ' LEU . 25.9 mtm -78.02 92.91 4.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.798 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.83 176.44 6.63 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 37.21 43.32 0.34 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.695 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.403 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -55.98 156.65 5.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.02 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.508 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.24 170.77 8.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.855 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 89.8 Cg_endo -77.96 8.15 3.62 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.515 2.143 . . . . 0.0 112.954 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -116.92 7.52 13.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.257 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -92.4 -10.06 39.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.304 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 97.9 m -53.97 107.79 0.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.256 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.29 177.0 4.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 39' ' ' GLN . 4.2 p -85.69 106.33 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.027 0.441 . . . . 0.0 110.846 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.96 101.8 13.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.137 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 9.1 m -113.13 136.03 53.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.609 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 25.6 p -100.65 147.12 26.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.029 0.442 . . . . 0.0 111.365 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.83 -171.28 12.45 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.214 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.619 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -138.19 166.73 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 111.269 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -111.61 176.26 18.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.665 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.49 113.69 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 110.575 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.66 16.97 52.86 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.695 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.87 -14.17 31.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -96.32 179.31 5.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.548 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.66 ' H ' HG22 ' A' ' 103' ' ' THR . 78.0 m95 -143.76 102.64 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.795 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.11 11.02 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.439 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.87 137.91 42.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.642 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -140.73 164.11 31.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.964 0.412 . . . . 0.0 111.034 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.18 -130.71 6.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.337 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -98.81 -63.23 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 0.0 110.807 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.89 151.07 8.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.665 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 111' ' ' THR . 15.4 t -145.28 109.72 4.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.359 . . . . 0.0 110.428 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -68.54 141.63 55.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.208 0.528 . . . . 0.0 111.035 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 91' ' ' THR . 41.3 t -119.21 131.82 70.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.254 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.74 ' CB ' HD23 ' A' ' 11' ' ' LEU . 83.9 m -116.85 138.67 51.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.207 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 116' ' ' SER . 2.0 t -139.11 168.17 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.28 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.518 ' H ' HG12 ' A' ' 115' ' ' VAL . 51.5 m . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.104 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.606 ' C ' HD12 ' A' ' 4' ' ' LEU . 3.6 pt20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.832 0.348 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.606 HD12 ' C ' ' A' ' 3' ' ' GLN . 6.5 mp -140.07 135.32 32.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.17 131.41 44.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.75 164.68 17.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.7 p -158.19 111.73 2.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.03 84.51 1.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.355 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.44 143.81 8.96 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.547 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.83 -156.19 21.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.528 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.764 HD23 ' CG2' ' A' ' 114' ' ' THR . 1.7 mp -69.08 143.19 54.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.919 0.39 . . . . 0.0 111.362 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.97 126.88 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.135 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.57 139.95 56.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -52.32 137.06 29.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.323 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.5 -15.73 60.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.703 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.61 -154.65 7.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.42 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.62 139.29 31.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.011 0.434 . . . . 0.0 111.213 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.837 HD21 HD21 ' A' ' 20' ' ' LEU . 10.8 tp -124.45 135.31 53.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.554 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.06 115.31 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 111.557 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.837 HD21 HD21 ' A' ' 18' ' ' LEU . 12.4 mt -112.61 132.48 55.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.577 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -120.67 113.34 20.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.67 123.14 49.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.791 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.71 165.76 11.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.298 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.912 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.638 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.992 0.425 . . . . 0.0 110.741 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.474 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 46.9 m-20 -115.47 -173.65 2.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.86 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.638 ' HB3' HG11 ' A' ' 79' ' ' VAL . 9.3 mtm -145.87 124.71 12.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.055 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.88 152.93 24.88 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.829 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 96' ' ' CYS . 73.1 m95 -88.46 154.82 20.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.114 0.483 . . . . 0.0 111.427 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.63 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.1 m-85 -133.65 -178.69 5.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.266 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.486 ' CD ' HG22 ' A' ' 48' ' ' VAL . 1.6 ptm180 -152.94 157.86 41.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.752 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.422 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 2.2 tm0? -145.46 145.4 31.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.946 0.403 . . . . 0.0 111.336 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.37 151.77 78.11 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.44 139.6 41.75 Favored 'Trans proline' 0 CA--C 1.517 -0.345 0 C-N-CA 122.362 2.041 . . . . 0.0 112.537 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.76 -7.08 43.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.764 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.45 -166.68 1.21 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.798 0.333 . . . . 0.0 110.9 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.86 -171.71 1.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -98.19 133.77 42.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.935 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HG2' ' HG3' ' A' ' 38' ' ' ARG . 4.1 pt-20 -131.79 152.28 51.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.423 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 6.6 t -83.41 174.66 10.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.382 0.61 . . . . 0.0 111.079 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.547 ' CG1' HG21 ' A' ' 64' ' ' VAL . 3.8 t -130.12 -62.47 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.071 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -151.88 129.83 11.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.509 ' O ' HG22 ' A' ' 58' ' ' THR . . . -127.98 145.26 51.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.386 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 58' ' ' THR . 11.0 tt -126.98 142.29 43.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.32 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.74 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 120.387 0.137 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 1.065 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -97.85 -179.77 4.54 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.987 0.423 . . . . 0.0 111.19 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 50' ' ' ALA . 65.3 t80 -139.7 91.0 2.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.64 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.428 ' OH ' HG22 ' A' ' 70' ' ' ILE . 47.3 m-85 -76.83 158.06 31.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.2 172.01 7.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.167 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -69.57 150.87 46.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.618 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.0 OUTLIER 84.72 -11.19 0.81 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.623 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' A' ' 68' ' ' PHE . 16.4 m -149.21 12.45 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.48 79.2 1.05 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.537 0.684 . . . . 0.0 110.7 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.73 3.11 10.26 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.825 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -108.01 -41.32 4.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.732 0.301 . . . . 0.0 111.09 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.592 ' CE2' HG11 ' A' ' 64' ' ' VAL . 9.5 m-30 -94.27 146.72 23.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.124 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.7 m -105.12 158.03 16.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.812 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.065 HG21 HG21 ' A' ' 58' ' ' THR . 2.7 tp -144.79 139.92 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.106 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 m -154.42 137.35 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.679 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.449 ' HB3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -90.13 152.01 21.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.245 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.467 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 39.4 t0 -84.43 -36.5 22.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.793 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m120 58.99 29.98 19.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.95 -46.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.09 31.76 1.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.482 ' HB3' ' HE1' ' A' ' 34' ' ' MET . 22.5 mtmt 62.77 56.14 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 73' ' ' ASP . 60.6 m -116.04 150.31 37.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.638 HG11 ' HB3' ' A' ' 34' ' ' MET . 31.5 m -128.5 131.95 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.928 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.577 ' CD1' ' HB3' ' A' ' 21' ' ' SER . 25.6 m-85 -113.09 120.58 41.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.195 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.618 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -114.09 112.61 23.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.068 179.499 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -96.35 96.84 9.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.203 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.674 ' SD ' HD23 ' A' ' 18' ' ' LEU . 1.3 mtp -81.94 88.3 6.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.03 177.66 6.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.57 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 t 37.98 40.85 0.32 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.516 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 162.62 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.628 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -128.99 170.83 9.84 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.779 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 84.5 Cg_endo -77.67 10.82 2.4 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 113.089 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -122.02 10.98 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.342 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -95.94 -15.46 22.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.608 0.242 . . . . 0.0 111.36 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.556 ' OG1' HG23 ' A' ' 115' ' ' VAL . 82.9 m -49.27 112.86 0.69 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.435 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.34 173.65 5.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.969 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 93' ' ' VAL . 7.4 p -81.1 105.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.979 0.419 . . . . 0.0 110.925 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -83.95 99.08 10.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.959 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 4.3 m -105.63 128.03 53.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 14.0 p -95.15 143.78 26.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.964 0.411 . . . . 0.0 111.224 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.451 ' HA2' HD22 ' A' ' 4' ' ' LEU . . . -139.81 -173.06 13.03 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.158 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.638 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -144.69 166.37 25.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.957 0.408 . . . . 0.0 111.264 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.93 171.68 18.21 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.676 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.01 115.5 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.621 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.89 15.8 50.05 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.782 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.77 -14.67 31.98 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.528 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.5 m -99.1 178.79 4.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.789 0.328 . . . . 0.0 110.608 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.651 ' H ' HG22 ' A' ' 103' ' ' THR . 71.5 m95 -138.2 93.06 2.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.655 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -119.2 2.33 11.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.52 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -96.04 132.72 41.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 110.898 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -140.91 164.93 28.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.71 -154.81 18.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -30.75 20.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.333 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.94 151.0 26.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.883 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 111' ' ' THR . 12.4 t -145.34 109.45 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.262 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 2.1 tp60 -67.61 141.55 56.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.158 0.504 . . . . 0.0 111.052 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 91' ' ' THR . 43.5 t -119.87 126.23 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.329 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.764 ' CG2' HD23 ' A' ' 11' ' ' LEU . 94.8 m -109.99 142.62 41.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.955 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 87' ' ' LYS . 2.6 t -127.52 169.54 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.155 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.689 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.813 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.819 0.343 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 mp -149.12 155.1 40.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -150.66 161.11 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.714 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.81 164.72 12.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.83 0.348 . . . . 0.0 110.978 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -164.76 95.65 0.72 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.59 -28.43 2.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.638 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.825 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.0 138.43 20.89 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.9 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.0 -172.49 43.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.089 -0.576 . . . . 0.0 112.373 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.794 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.5 mp -69.35 150.03 47.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.863 0.363 . . . . 0.0 111.554 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.665 ' CG1' HD22 ' A' ' 86' ' ' LEU . 7.8 p -153.39 116.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.941 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.74 139.77 25.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.426 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.17 123.3 7.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.82 0.56 60.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.834 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.31 138.55 14.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.449 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 t -79.68 141.54 36.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 110.966 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.646 HD23 HD21 ' A' ' 20' ' ' LEU . 14.9 tp -132.92 150.44 52.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.309 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.404 ' C ' HD23 ' A' ' 20' ' ' LEU . 4.9 ttt180 -125.45 126.56 45.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.402 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.825 HD22 ' HA2' ' A' ' 9' ' ' GLY . 2.2 mt -114.49 149.72 35.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.799 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 71.1 m -131.21 118.63 20.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.05 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 19.0 p -125.37 131.34 52.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.58 169.11 9.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.311 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.035 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.108 0 CA-C-O 120.919 0.39 . . . . 0.0 111.275 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.436 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 44.2 m-20 -101.6 -172.45 2.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.941 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.406 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -143.6 124.1 13.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.733 0.301 . . . . 0.0 111.273 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.52 166.11 29.62 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.939 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.518 ' CE2' HD22 ' A' ' 81' ' ' LEU . 52.6 m95 -91.9 156.2 17.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.133 0.492 . . . . 0.0 111.307 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 8.1 m-85 -136.45 179.18 6.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.938 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 16.7 ptm180 -152.86 160.56 43.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.723 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.645 ' O ' HG12 ' A' ' 93' ' ' VAL . 12.6 tt0 -165.5 159.83 17.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.064 0.459 . . . . 0.0 111.459 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -136.01 162.33 57.32 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.506 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 52.2 Cg_endo -69.59 137.39 35.86 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.387 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.54 3.07 38.67 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.722 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 -172.87 2.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.783 0.325 . . . . 0.0 111.058 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.85 -178.84 3.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.739 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.408 ' HD2' ' CH2' ' A' ' 107' ' ' TRP . 18.2 ptt-85 -103.28 139.65 38.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.173 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HG3' ' CG ' ' A' ' 38' ' ' ARG . 18.1 pt-20 -140.73 146.74 38.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.236 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.7 t -83.85 175.2 9.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.316 0.579 . . . . 0.0 111.363 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.4 -57.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.786 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.29 157.66 43.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.719 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -158.19 140.97 14.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.06 0.457 . . . . 0.0 111.484 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.679 HD13 HG23 ' A' ' 58' ' ' THR . 7.5 tp -121.21 139.82 47.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.835 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.447 -0.579 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.933 -179.841 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.428 ' O ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.291 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.679 HG23 HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -117.48 -178.13 3.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.599 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.6 t80 -136.93 142.59 42.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.561 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.431 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 5.8 m-85 -126.44 165.77 18.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.976 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.6 166.41 11.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.5 152.13 45.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.703 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 83.62 -10.15 0.98 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.571 -178.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.422 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 35.6 m -152.08 15.39 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.237 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -70.48 78.91 0.56 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.576 0.703 . . . . 0.0 110.752 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.51 3.35 5.63 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.0 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -112.29 -44.04 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.754 0.311 . . . . 0.0 111.016 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 5.9 m-30 -78.79 140.2 38.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.786 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 28.9 m -105.45 151.06 24.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 111.164 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.911 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -145.54 136.8 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.634 -179.156 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.911 ' N ' HD13 ' A' ' 70' ' ' ILE . 19.3 p -162.41 141.59 9.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.091 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -73.25 165.42 25.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.958 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.415 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 37.1 t0 -97.19 -33.5 11.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.826 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 60.34 58.36 2.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.17 -46.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -140.38 29.29 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.72 55.48 2.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.62 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.494 ' CG2' ' CE1' ' A' ' 80' ' ' TYR . 6.4 m -123.3 158.94 29.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.109 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.19 143.66 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.715 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 21' ' ' SER . 15.2 m-85 -124.5 135.11 52.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.506 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -127.19 121.04 30.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.084 0.469 . . . . 0.0 110.812 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -99.23 101.15 12.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.838 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.577 ' HE1' HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -87.75 95.22 10.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.181 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.92 175.36 8.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.833 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 34.4 48.33 0.27 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.794 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.665 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -54.34 164.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.004 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.671 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -128.68 164.46 38.24 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.813 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 87' ' ' LYS . 63.1 Cg_endo -72.82 6.32 2.5 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.533 2.155 . . . . 0.0 113.155 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -111.89 -0.03 15.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.282 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -84.91 -11.73 54.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.576 0.227 . . . . 0.0 111.237 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 90.8 m -56.02 103.5 0.1 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.67 175.65 4.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.381 . . . . 0.0 111.583 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.678 ' O ' HG13 ' A' ' 93' ' ' VAL . 7.7 p -80.84 105.37 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.082 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 111' ' ' THR . 9.8 m-85 -84.42 105.04 14.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.656 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.4 m -110.96 127.38 55.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.9 t -81.17 127.4 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.485 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -128.15 -177.41 14.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.471 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 34' ' ' MET . . . -146.13 147.77 31.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.848 0.356 . . . . 0.0 111.213 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.458 ' N ' ' CE3' ' A' ' 104' ' ' TRP . . . -78.77 -170.07 37.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.374 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.28 100.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.67 18.54 45.71 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.761 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.19 -20.28 11.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -97.62 -179.81 4.59 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 110.426 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.664 ' H ' HG22 ' A' ' 103' ' ' THR . 71.8 m95 -145.55 102.54 3.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.945 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -134.96 15.6 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.298 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.37 133.22 51.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.786 0.326 . . . . 0.0 110.66 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.408 ' CH2' ' HD2' ' A' ' 45' ' ' ARG . 9.4 m95 -136.25 162.15 33.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.28 -137.19 9.13 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.494 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -87.07 -51.02 6.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.334 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.39 151.28 12.88 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.661 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 111' ' ' THR . 13.9 t -158.56 118.57 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -79.44 142.64 35.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.004 0.43 . . . . 0.0 111.176 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 91' ' ' THR . 52.6 t -116.31 136.48 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.159 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.794 ' CB ' HD23 ' A' ' 11' ' ' LEU . 99.6 m -109.31 130.0 55.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.011 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.671 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -126.18 -158.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.55 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.469 ' H ' HG12 ' A' ' 115' ' ' VAL . 1.3 t . . . . . 0 C--N 1.332 -0.156 0 CA-C-O 120.869 0.366 . . . . 0.0 110.87 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.609 ' C ' HD12 ' A' ' 4' ' ' LEU . 5.0 pt20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.818 0.342 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 3' ' ' GLN . 4.0 mp -160.61 99.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.02 174.01 8.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.012 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.37 163.97 22.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.733 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -169.62 135.94 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.08 -18.36 26.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.729 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.403 ' HA2' ' CD2' ' A' ' 20' ' ' LEU . . . -54.07 -173.83 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.831 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.12 164.36 10.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.509 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.789 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.5 mp -69.28 146.51 52.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.85 0.357 . . . . 0.0 111.376 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 12' ' ' VAL . 8.5 p -165.53 119.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.174 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -54.76 154.5 5.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.24 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -49.64 138.3 14.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.358 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.99 -21.79 44.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.487 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.52 122.98 6.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.305 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.531 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . 11.4 p -70.0 130.53 42.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 111.131 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.779 ' CD2' HD21 ' A' ' 20' ' ' LEU . 12.7 tp -109.74 133.74 52.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.494 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -107.29 119.2 38.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 0.0 111.422 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.779 HD21 ' CD2' ' A' ' 18' ' ' LEU . 13.9 mt -114.53 136.32 53.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.534 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.5 p -122.34 111.05 16.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.122 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.4 t -107.29 134.52 50.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.514 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.29 152.4 26.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.253 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.055 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.614 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.98 0.419 . . . . 0.0 110.854 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -120.26 -171.45 2.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.715 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -139.67 160.32 40.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.923 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . 179.56 141.62 4.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.0 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.526 ' CD2' HD22 ' A' ' 81' ' ' LEU . 81.4 m95 -82.72 154.7 24.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.15 0.5 . . . . 0.0 111.285 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.5 m-85 -137.89 -178.27 5.18 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.296 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.523 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -148.85 161.04 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.494 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.725 ' O ' HG12 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -162.7 137.51 6.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.005 0.431 . . . . 0.0 111.387 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.709 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -121.15 166.77 14.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.49 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.709 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 38.0 Cg_endo -66.21 135.77 41.42 Favored 'Trans proline' 0 CA--C 1.517 -0.355 0 C-N-CA 122.169 1.913 . . . . 0.0 112.248 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.43 6.35 33.92 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.458 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.51 -177.23 3.18 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.832 0.348 . . . . 0.0 111.022 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -109.7 -171.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.775 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -86.12 134.43 33.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.078 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -131.74 116.45 17.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.412 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 1.5 t -68.09 169.22 10.56 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.599 0.714 . . . . 0.0 111.328 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.523 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.3 t -132.63 -68.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.372 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -140.94 145.99 36.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.71 0.29 . . . . 0.0 111.307 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.544 ' O ' HG22 ' A' ' 58' ' ' THR . . . -140.85 142.18 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.466 ' HB ' HG23 ' A' ' 58' ' ' THR . 2.4 tt -125.23 145.75 32.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.249 -179.877 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.958 0.408 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.725 HG21 ' CG2' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -118.42 -178.02 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.978 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 52.9 t80 -139.19 96.2 3.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.892 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.37 158.16 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.842 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . -98.13 157.16 16.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 63' ' ' SER . 17.3 p -69.38 151.57 45.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.572 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 86.47 -12.3 0.59 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.556 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.673 HG12 ' HD2' ' A' ' 67' ' ' ARG . 14.8 m -141.97 7.67 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.497 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 80.23 0.55 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.561 0.696 . . . . 0.0 110.781 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 139.49 1.77 1.86 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.619 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.673 ' HD2' HG12 ' A' ' 64' ' ' VAL . 13.4 ptp180 -117.96 -40.03 3.03 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.779 0.289 . . . . 0.0 111.303 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 83' ' ' MET . 14.4 m-30 -90.23 159.0 16.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.115 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.8 m -125.23 157.19 37.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.867 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -156.32 134.47 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.997 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.867 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -160.13 140.25 11.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.842 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -78.24 173.3 12.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.95 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.413 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 33.3 t0 -98.99 -33.59 10.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.034 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.22 28.7 17.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.54 -59.82 1.51 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.953 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -128.06 28.47 5.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.5 60.02 0.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.149 0.5 . . . . 0.0 110.729 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -122.84 147.93 45.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.047 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.6 m -119.78 139.37 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 41.1 m-85 -124.45 115.88 21.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 0.0 111.197 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.691 HD23 ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -112.24 111.77 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.139 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.531 ' NE2' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -95.42 97.29 9.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.769 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.496 ' HE1' ' CZ ' ' A' ' 94' ' ' TYR . 5.3 mtp -77.18 87.66 3.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.258 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -82.02 176.37 9.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.702 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 37.4 48.55 0.86 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.753 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.514 HD23 ' CG2' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -65.98 157.77 29.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.978 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.69 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -129.33 173.83 5.25 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.773 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.38 9.16 3.53 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.613 2.208 . . . . 0.0 113.034 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -113.04 -4.95 13.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.1 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.29 -12.25 58.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.239 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 76.2 m -48.94 104.06 0.06 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.46 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.4 166.62 8.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.365 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 39' ' ' GLN . 9.8 p -76.33 105.26 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.038 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.496 ' CZ ' ' HE1' ' A' ' 83' ' ' MET . 5.0 m-85 -82.54 100.26 10.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.4 m -109.11 134.48 51.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 26.7 p -96.49 146.14 25.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.033 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.16 -178.35 16.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.555 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -131.65 170.18 15.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -118.26 172.56 14.49 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.802 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -159.09 118.08 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.504 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.11 16.03 51.98 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.696 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.31 -12.78 36.73 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.673 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.668 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -98.13 180.0 4.57 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.744 0.307 . . . . 0.0 110.672 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.668 ' H ' HG22 ' A' ' 103' ' ' THR . 83.6 m95 -138.45 101.61 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.815 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -123.21 -8.49 8.19 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.474 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.506 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -91.42 140.4 29.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.827 0.346 . . . . 0.0 111.112 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -141.88 165.47 27.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.795 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.27 -149.25 13.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.524 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.03 -55.63 3.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.686 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.91 150.98 9.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.763 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 111' ' ' THR . 12.4 t -146.84 112.21 5.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.375 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 1.9 tp60 -61.95 140.52 58.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.222 0.534 . . . . 0.0 111.012 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.9 t -119.13 97.64 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.037 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.789 ' CB ' HD23 ' A' ' 11' ' ' LEU . 60.5 m -86.13 135.69 33.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 111.285 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 87' ' ' LYS . 2.0 t -130.87 168.0 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.184 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.674 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.99 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.828 0.347 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mp -145.6 162.87 36.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.42 141.96 27.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -94.52 167.79 11.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -168.85 115.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.869 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.23 -34.77 4.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.555 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.83 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -51.42 138.94 27.33 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.817 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.42 -162.88 31.11 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.44 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.597 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.3 mp -69.45 152.23 45.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.846 0.355 . . . . 0.0 111.404 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.578 ' O ' HG13 ' A' ' 12' ' ' VAL . 9.7 p -170.12 109.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -57.56 152.29 15.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.338 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -52.45 153.65 2.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.376 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.08 5.18 75.16 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.722 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.71 119.78 4.37 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.395 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.2 136.82 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 111.032 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.682 HD23 HD21 ' A' ' 20' ' ' LEU . 6.7 tp -127.34 131.3 50.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.403 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.611 ' C ' HD23 ' A' ' 20' ' ' LEU . 4.0 ttt-85 -107.42 133.0 52.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.901 0.381 . . . . 0.0 111.418 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.83 HD22 ' HA2' ' A' ' 9' ' ' GLY . 1.1 mt -120.15 150.78 40.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.072 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.3 p -123.23 140.31 53.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.204 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 48.4 t -134.1 135.15 43.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.697 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.3 157.09 20.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.051 179.912 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 5.4 t80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.962 0.41 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.92 172.39 13.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.55 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.465 ' O ' HG22 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -137.92 117.56 13.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.847 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -145.85 149.65 21.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.849 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.469 ' CE2' HD22 ' A' ' 81' ' ' LEU . 67.4 m95 -88.32 153.62 21.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.13 0.49 . . . . 0.0 111.175 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.3 m-85 -132.32 -178.88 5.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.588 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.676 ' CD ' HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -151.97 157.21 41.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.157 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -157.69 141.4 15.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 111.416 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -127.53 161.63 53.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.535 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 41.0 Cg_endo -67.36 137.09 42.21 Favored 'Trans proline' 0 CA--C 1.518 -0.315 0 C-N-CA 122.287 1.991 . . . . 0.0 112.384 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.37 3.74 40.8 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.671 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -112.51 -176.06 2.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.872 0.368 . . . . 0.0 111.056 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -111.53 157.27 20.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.483 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 15.8 ptt-85 -74.47 133.15 42.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.12 0.486 . . . . 0.0 111.732 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 16.4 pt-20 -134.54 165.11 25.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.903 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 12.1 t -101.03 172.64 6.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.194 0.521 . . . . 0.0 111.164 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.676 HG22 ' CD ' ' A' ' 38' ' ' ARG . 2.8 t -128.95 -67.51 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.367 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.02 135.42 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.0 111.367 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.704 ' O ' HG22 ' A' ' 58' ' ' THR . . . -131.65 144.75 51.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.627 HD12 HG23 ' A' ' 58' ' ' THR . 0.7 OUTLIER -128.11 143.69 40.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.251 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.1 p30 . . . . . 0 N--CA 1.448 -0.561 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.189 -179.82 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.891 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -115.86 -177.79 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 77.1 t80 -139.41 92.27 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.805 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.401 ' CB ' ' HG2' ' A' ' 65' ' ' ARG . 74.9 m-85 -78.7 159.55 27.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.89 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.82 161.51 15.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 0.0 111.304 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' SER . 32.8 t -69.28 152.21 45.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.477 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.8 t 88.83 -14.4 0.36 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.515 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.405 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 34.9 m -150.49 16.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.432 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.401 ' HG2' ' CB ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -78.72 81.3 5.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.523 0.678 . . . . 0.0 111.151 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.89 -11.2 2.36 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.185 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' CG ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -109.46 -51.37 2.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.777 0.323 . . . . 0.0 111.247 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CE2' ' HG2' ' A' ' 83' ' ' MET . 3.1 m-85 -69.93 140.15 53.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.905 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 7.5 m -110.82 146.08 37.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.778 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.891 HG21 HG21 ' A' ' 58' ' ' THR . 1.1 tp -136.42 140.94 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.88 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.451 ' N ' HG13 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -151.13 -174.44 4.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.81 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.523 ' HG3' HG12 ' A' ' 79' ' ' VAL . 6.6 ttm180 -130.83 168.06 17.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.005 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.4 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 34.3 t0 -97.32 -37.56 10.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.844 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.41 35.92 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.81 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.32 -67.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.098 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 29.82 7.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.36 44.99 14.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.68 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 46.6 m -112.64 151.5 30.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.173 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.523 HG12 ' HG3' ' A' ' 72' ' ' ARG . 33.5 m -121.22 158.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.381 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 33.9 m-85 -141.71 129.88 22.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.026 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.469 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -125.21 122.15 36.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.094 0.473 . . . . 0.0 110.898 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -95.57 95.96 8.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.522 ' SD ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -77.08 88.43 3.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.855 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.4 176.26 7.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 36.41 40.76 0.13 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.588 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.614 HD23 ' CG2' ' A' ' 115' ' ' VAL . 0.1 OUTLIER -51.14 158.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.182 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 6.2 mptt -127.64 162.91 46.24 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.78 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 74.2 Cg_endo -74.91 5.71 3.78 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.457 2.105 . . . . 0.0 112.927 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -109.73 -6.82 15.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.134 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.34 -19.4 46.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 89.7 m -50.42 106.83 0.13 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.864 0.364 . . . . 0.0 111.25 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.34 -176.2 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.977 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -87.51 103.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.854 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.537 ' O ' HG22 ' A' ' 111' ' ' THR . 4.1 m-85 -82.75 108.75 16.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.468 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.2 m -107.5 130.68 54.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.316 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 50.6 t -92.35 138.73 31.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.623 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -146.98 176.36 25.89 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.826 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.621 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -126.7 172.94 9.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 0.0 111.011 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -124.84 178.21 16.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.185 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -171.38 122.48 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.379 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.66 15.7 54.39 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.642 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.83 -9.4 47.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.826 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.653 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.3 m -100.16 178.67 4.71 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 110.775 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.653 ' H ' HG22 ' A' ' 103' ' ' THR . 80.0 m95 -140.89 90.95 2.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -110.26 -6.62 14.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.372 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.621 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -90.85 131.26 36.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.706 0.288 . . . . 0.0 110.782 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -141.3 164.09 31.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.001 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.34 -136.66 8.43 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.46 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -102.96 -35.65 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.928 0.394 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.6 151.1 12.59 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.68 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.7 t -144.26 104.77 4.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.852 0.358 . . . . 0.0 110.457 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -63.77 141.12 58.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 111.113 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 91' ' ' THR . 46.4 t -119.79 130.34 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.304 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.597 ' CB ' HD23 ' A' ' 11' ' ' LEU . 69.1 m -115.72 133.28 56.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.115 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.614 ' CG2' HD23 ' A' ' 86' ' ' LEU . 2.1 t -133.44 168.01 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.306 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.756 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 8.2 t . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.968 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.733 0.301 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 106' ' ' SER . 1.7 mp -156.44 119.26 4.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.133 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -122.9 165.7 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.576 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.44 163.32 15.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.774 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.45 131.23 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.11 -28.36 11.22 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.663 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.401 ' HA2' ' CD2' ' A' ' 20' ' ' LEU . . . -53.23 164.23 2.14 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.869 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.64 171.29 25.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.41 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.839 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.9 mp -69.07 137.2 53.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.928 0.394 . . . . 0.0 111.398 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.23 128.57 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.991 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -64.2 149.35 48.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -49.35 144.32 5.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.382 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.98 -14.95 63.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.635 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.29 129.67 9.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.37 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.08 135.54 49.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 111.03 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.886 HD21 HD21 ' A' ' 20' ' ' LEU . 7.1 tp -119.51 132.12 55.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.292 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -114.04 116.53 29.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.828 0.347 . . . . 0.0 111.369 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.886 HD21 HD21 ' A' ' 18' ' ' LEU . 14.5 mt -107.6 138.31 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.403 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 90.9 p -124.96 120.08 30.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.962 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.439 ' HB3' ' CG1' ' A' ' 79' ' ' VAL . 26.8 t -117.89 131.35 56.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.022 0.439 . . . . 0.0 110.595 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.91 149.14 31.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.287 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.022 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.586 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.44 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 23.4 m-20 -129.15 -169.13 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.471 ' O ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -148.16 120.73 8.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.098 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -144.95 168.87 26.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.861 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.515 ' CD2' HD22 ' A' ' 81' ' ' LEU . 74.8 m95 -107.14 159.5 16.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 111.19 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 11.0 m-85 -137.74 178.3 7.21 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.726 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 10.6 ptm180 -156.34 154.04 29.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.398 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.505 ' O ' HG12 ' A' ' 93' ' ' VAL . 5.0 tp60 -157.02 119.32 3.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.953 0.406 . . . . 0.0 111.449 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -102.91 169.79 7.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.575 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.782 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 58.4 Cg_endo -71.73 138.96 32.86 Favored 'Trans proline' 0 CA--C 1.517 -0.328 0 C-N-CA 122.241 1.961 . . . . 0.0 112.447 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.92 3.44 35.84 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.712 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -118.1 158.41 25.08 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.947 0.403 . . . . 0.0 110.984 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.47 157.23 19.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.215 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.441 ' NE ' ' CZ3' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -69.92 144.36 52.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.165 0.507 . . . . 0.0 111.13 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' ' HG3' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -149.29 146.91 27.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.407 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 2.6 t -77.01 173.11 12.17 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.456 0.646 . . . . 0.0 111.421 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.423 ' N ' ' OG ' ' A' ' 47' ' ' SER . 15.9 t -127.21 -60.63 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.235 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.523 ' CB ' HD13 ' A' ' 70' ' ' ILE . . . -151.99 123.23 7.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.957 0.408 . . . . 0.0 111.197 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.612 ' O ' HG22 ' A' ' 58' ' ' THR . . . -120.34 147.47 44.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.231 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.713 ' CD1' HG23 ' A' ' 58' ' ' THR . 3.1 tp -132.03 141.54 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.027 0.441 . . . . 0.0 111.459 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.422 ' N ' HG13 ' A' ' 51' ' ' ILE . 10.3 m120 . . . . . 0 N--CA 1.448 -0.563 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.815 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.713 HG23 ' CD1' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -105.92 -179.3 3.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.777 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 9.5 t80 -138.6 85.93 2.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.666 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.485 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 58.5 m-85 -72.39 161.74 30.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.06 162.76 15.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 63' ' ' SER . 7.1 m -69.46 151.53 45.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.556 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.3 t 86.33 -12.23 0.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.584 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.464 HG11 ' CE2' ' A' ' 68' ' ' PHE . 34.2 m -145.33 10.27 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.484 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.413 ' HG2' ' CB ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -80.2 81.08 6.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.514 0.673 . . . . 0.0 110.971 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 139.51 -3.62 2.68 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.364 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.86 -51.9 1.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.637 0.256 . . . . 0.0 111.297 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CE2' HG11 ' A' ' 64' ' ' VAL . 5.4 m-30 -69.93 159.16 34.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.554 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 28.9 m -124.17 148.35 47.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.375 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.628 ' CG2' HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -138.99 136.31 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.678 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.472 ' O ' HG23 ' A' ' 79' ' ' VAL . 16.8 p -153.44 -173.76 4.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 111.076 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.45 160.39 39.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.982 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.41 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 13.6 t0 -90.55 -44.77 9.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 69.72 11.69 7.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.71 -34.96 6.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.891 0.377 . . . . 0.0 110.776 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -142.5 26.89 1.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.633 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.65 52.44 5.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.68 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.9 m -116.06 152.2 34.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.095 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 71' ' ' SER . 8.6 p -117.05 143.47 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.453 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 42.5 m-85 -126.64 110.06 12.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.852 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.66 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -112.82 112.29 23.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.46 . . . . 0.0 110.191 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.74 100.29 12.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.269 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.506 ' HE2' HD11 ' A' ' 86' ' ' LEU . 4.7 mtp -81.66 90.48 6.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.829 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 177.09 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 37.46 47.1 0.71 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.671 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.506 HD11 ' HE2' ' A' ' 83' ' ' MET . 0.1 OUTLIER -57.63 165.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.067 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 18.6 mmtt -144.99 164.89 24.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.764 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 55.3 Cg_endo -69.47 2.23 3.56 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.418 2.079 . . . . 0.0 113.222 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -104.34 -0.4 28.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.246 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -89.95 -9.95 46.89 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.41 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 87.1 m -50.35 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.724 0.297 . . . . 0.0 111.156 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.22 169.5 7.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.528 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 93' ' ' VAL . 5.4 p -82.59 107.22 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.291 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.465 ' O ' HG22 ' A' ' 111' ' ' THR . 13.7 m-85 -85.77 105.74 16.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.602 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 37' ' ' PHE . 21.6 m -109.31 138.62 45.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.156 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.4 p -97.64 142.34 29.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.826 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.17 177.16 21.71 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.294 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.663 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -130.29 167.45 18.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.942 0.401 . . . . 0.0 111.098 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.83 175.11 19.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.831 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.86 113.56 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.371 . . . . 0.0 110.735 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.88 16.06 50.83 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.784 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.35 -14.83 33.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.487 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.657 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.1 m -97.92 -179.84 4.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.676 0.274 . . . . 0.0 110.426 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.657 ' H ' HG22 ' A' ' 103' ' ' THR . 77.0 m95 -140.83 98.99 3.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -133.54 10.6 4.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.501 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.663 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -102.38 62.19 0.85 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.308 0.575 . . . . 0.0 110.736 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.441 ' CZ3' ' NE ' ' A' ' 45' ' ' ARG . 29.8 m95 -68.7 165.18 20.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.136 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.77 -121.42 4.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.515 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 -67.79 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 134.41 151.87 6.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.668 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.6 t -151.84 108.35 3.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.551 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 2.0 tp60 -59.23 141.06 55.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.199 0.524 . . . . 0.0 111.13 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 113' ' ' VAL . 37.6 t -121.92 82.85 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.839 ' CB ' HD23 ' A' ' 11' ' ' LEU . 92.7 m -73.25 141.26 47.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 116' ' ' SER . 0.6 OUTLIER -138.71 177.15 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.321 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.658 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 10.5 p . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.788 0.328 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.92 141.16 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -118.43 164.35 15.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.794 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.85 163.26 17.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.0 t -163.98 119.1 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.63 -22.81 8.11 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.666 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.478 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -47.29 140.62 7.7 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.882 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.39 169.03 37.34 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.375 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.775 HD23 HG21 ' A' ' 114' ' ' THR . 1.8 mp -69.21 145.37 53.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.807 0.337 . . . . 0.0 111.399 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.743 ' CG1' HD22 ' A' ' 86' ' ' LEU . 9.3 p -141.02 132.78 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.38 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.07 139.98 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.452 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.764 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -45.76 130.36 9.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.588 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.65 -20.84 48.87 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.602 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.24 179.66 53.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.571 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 t -120.5 139.0 53.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.992 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.746 HD23 ' CE ' ' A' ' 83' ' ' MET . 9.7 tp -125.6 132.75 52.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.457 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.463 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -114.37 131.17 56.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.0 111.629 -179.315 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.588 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.3 mt -121.24 141.29 51.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.311 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 80' ' ' TYR . 95.4 p -124.03 113.53 18.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' HG23 ' A' ' 78' ' ' THR . 32.6 t -108.18 134.56 50.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.636 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.9 145.46 39.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.155 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' HB3' ' HG3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 120.831 0.348 . . . . 0.0 111.053 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -59.61 174.86 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.031 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.576 ' HB3' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -143.87 126.59 16.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.17 156.15 26.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.823 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.592 ' CE2' HD22 ' A' ' 81' ' ' LEU . 69.9 m95 -87.31 153.74 21.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.144 0.497 . . . . 0.0 111.315 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.7 m-85 -131.63 178.25 6.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.422 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.608 ' NE ' HG22 ' A' ' 48' ' ' VAL . 7.6 ptt180 -152.34 155.24 37.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.815 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -167.03 148.85 6.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.945 0.402 . . . . 0.0 111.273 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.727 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -126.29 167.19 17.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.606 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.727 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 37.6 Cg_endo -66.15 137.52 48.3 Favored 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 122.228 1.952 . . . . 0.0 112.216 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.92 3.98 45.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.603 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -110.75 -179.61 3.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.819 0.342 . . . . 0.0 110.837 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.01 167.63 9.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.045 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.42 135.19 34.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.098 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HG3' ' CG ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -138.88 166.21 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.657 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 11.4 t -104.47 173.43 6.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.091 0.472 . . . . 0.0 111.078 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.608 HG22 ' NE ' ' A' ' 38' ' ' ARG . 2.4 t -131.52 -66.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.258 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.62 132.04 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.277 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 58' ' ' THR . . . -132.29 145.3 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.276 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.698 ' HB ' HG23 ' A' ' 58' ' ' THR . 19.1 tt -122.78 142.32 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.459 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.645 179.562 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.426 ' HB3' ' H ' ' A' ' 58' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 120.726 0.298 . . . . 0.0 111.178 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.977 HG21 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -97.48 -177.27 3.75 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.967 0.413 . . . . 0.0 110.975 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 63.2 t80 -139.41 93.03 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.725 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CE1' HG22 ' A' ' 70' ' ' ILE . 89.7 m-85 -80.14 158.0 26.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.39 176.13 5.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.282 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.34 152.03 45.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.578 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 62' ' ' SER . 4.0 t 85.82 -11.64 0.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.522 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.9 m -154.32 17.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.442 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 79.32 0.96 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.557 0.694 . . . . 0.0 110.799 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.46 3.47 9.43 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -111.67 -43.65 3.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.0 m-30 -83.36 151.95 25.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.958 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 7.3 m -112.25 149.22 32.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.647 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.977 HG23 HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -163.33 136.84 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.876 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.903 ' N ' HD13 ' A' ' 70' ' ' ILE . 8.0 p -168.35 154.02 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -77.68 139.62 39.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.597 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.506 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 0.4 OUTLIER -79.75 -34.06 40.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.106 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t30 68.21 28.01 6.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.189 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.2 -41.66 4.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.891 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.04 37.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.619 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.5 mttt 61.48 53.12 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.699 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.616 HG22 ' CE1' ' A' ' 80' ' ' TYR . 74.6 m -122.96 147.93 46.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.053 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.7 m -111.57 138.68 39.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.413 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.616 ' CE1' HG22 ' A' ' 78' ' ' THR . 7.3 m-85 -126.21 125.62 42.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.653 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.592 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -122.29 121.68 37.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.181 0.515 . . . . 0.0 110.926 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -100.47 96.79 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.732 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.746 ' CE ' HD23 ' A' ' 18' ' ' LEU . 31.1 mtm -82.21 91.85 6.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.984 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -82.32 176.39 9.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 84' ' ' ASN . 67.1 p 28.99 59.99 0.14 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.754 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.841 HD23 HG22 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -64.54 162.2 15.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.17 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.592 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -126.62 164.42 34.64 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.545 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 74.3 Cg_endo -75.49 6.05 3.84 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.38 2.053 . . . . 0.0 112.956 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -108.51 -6.15 16.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.847 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.31 -16.05 50.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.287 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.5 m -52.76 106.96 0.18 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.771 0.32 . . . . 0.0 111.19 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.5 -170.72 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.436 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 85.6 t -94.33 106.74 18.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.425 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -86.88 103.38 15.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.199 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.3 m -108.49 127.2 53.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 31.9 p -89.78 146.32 24.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.825 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.92 -173.09 20.61 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.463 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -138.17 149.6 46.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 111.107 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . -105.15 148.9 16.65 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.608 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -137.28 122.71 19.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.826 0.346 . . . . 0.0 110.955 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.59 18.38 51.51 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.79 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.75 -10.69 45.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.695 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.667 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.3 m -100.16 -179.96 4.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.667 ' H ' HG22 ' A' ' 103' ' ' THR . 77.2 m95 -145.34 93.92 2.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.884 0.373 . . . . 0.0 110.814 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.4 ' O ' ' CD1' ' A' ' 107' ' ' TRP . 3.8 t70 -112.9 -12.08 13.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.369 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.82 128.76 34.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.768 0.318 . . . . 0.0 110.66 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 105' ' ' ASP . 21.5 m95 -137.87 164.22 29.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.959 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.57 -160.92 19.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -74.23 -38.17 63.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.817 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.52 152.68 26.39 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.647 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.2 t -154.28 122.71 6.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -78.17 143.07 37.54 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.966 0.413 . . . . 0.0 111.131 -179.361 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 91' ' ' THR . 55.4 t -114.8 132.25 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.159 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.775 HG21 HD23 ' A' ' 11' ' ' LEU . 92.3 m -108.48 132.69 53.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.841 HG22 HD23 ' A' ' 86' ' ' LEU . 2.1 t -130.9 168.23 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.344 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.764 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 2.7 p . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.817 0.342 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp -148.4 152.17 36.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -164.22 163.42 22.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.801 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.23 162.52 15.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.4 t -158.08 123.04 4.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.81 -30.17 10.51 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.583 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.835 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.92 139.86 23.26 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.008 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.82 -159.64 24.22 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.379 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.495 HD23 HG21 ' A' ' 114' ' ' THR . 2.0 mp -69.25 151.1 46.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.473 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.845 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.3 p -159.22 109.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.872 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.41 152.2 46.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.118 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.89 129.98 21.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.386 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.35 22.65 50.75 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.57 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.17 116.04 2.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.377 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 92.9 p -69.94 123.67 22.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 111.047 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.751 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.3 tp -126.96 130.78 50.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.525 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -107.61 131.78 54.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.835 HD22 ' HA2' ' A' ' 9' ' ' GLY . 2.9 mt -116.97 148.28 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.098 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB3' ' CD2' ' A' ' 80' ' ' TYR . 82.7 p -127.85 126.69 42.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.567 ' O ' HG22 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -121.38 109.1 14.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.596 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.66 164.46 22.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.381 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.04 179.908 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.505 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 9.3 t80 . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.949 0.404 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.422 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 7.5 m-20 -111.89 -176.87 3.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.673 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.75 ' O ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -143.09 113.97 7.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.978 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -139.97 158.74 25.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.905 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.448 ' CE2' HD22 ' A' ' 81' ' ' LEU . 63.8 m95 -92.36 154.86 18.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.282 0.563 . . . . 0.0 111.329 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.7 m-85 -135.67 -178.32 5.07 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.455 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.456 ' HG2' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -148.44 156.13 42.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.89 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.439 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 2.0 mm-40 -153.41 171.07 19.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.9 149.23 14.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.617 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.99 134.72 51.17 Favored 'Trans proline' 0 CA--C 1.517 -0.342 0 C-N-CA 122.273 1.982 . . . . 0.0 112.184 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.53 3.91 35.75 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.479 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.08 178.78 4.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.873 0.368 . . . . 0.0 110.897 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 pm0 -96.22 -176.82 3.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.781 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.82 140.77 39.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.829 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' ' HD3' ' A' ' 38' ' ' ARG . 12.0 pt-20 -140.46 164.28 30.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.628 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.565 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.9 t -107.25 171.66 7.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.141 0.496 . . . . 0.0 111.085 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.456 ' CG2' ' HG2' ' A' ' 38' ' ' ARG . 2.8 t -129.51 -69.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.677 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.82 ' HB1' HG21 ' A' ' 70' ' ' ILE . . . -141.05 147.6 38.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 0.0 111.579 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.577 ' O ' HG22 ' A' ' 58' ' ' THR . . . -136.89 141.34 42.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.193 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 34' ' ' MET . 1.6 tt -117.66 141.59 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.047 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.125 -179.857 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.6 mpp_? . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 120.407 0.146 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -116.11 -177.58 3.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.948 0.404 . . . . 0.0 111.096 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 50.9 t80 -135.99 91.33 2.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.853 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.802 ' CE2' HG22 ' A' ' 70' ' ' ILE . 56.0 m-85 -80.39 152.19 28.99 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.98 163.53 14.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.366 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.81 33.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.017 0.437 . . . . 0.0 111.674 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.9 t -118.54 -20.15 8.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.116 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.0 m -152.41 21.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.969 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.91 80.7 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.72 0.771 . . . . 0.0 110.9 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 131.42 3.55 4.22 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.162 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -111.11 -45.91 3.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.744 0.306 . . . . 0.0 111.056 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 83' ' ' MET . 9.7 m-30 -97.21 161.14 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.128 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 97.6 m -129.72 94.98 3.86 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.578 0.704 . . . . 0.0 111.371 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.82 HG21 ' HB1' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -91.18 137.37 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.614 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.434 ' N ' HG13 ' A' ' 70' ' ' ILE . 1.7 m -162.96 170.81 17.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 110.959 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -116.75 139.87 50.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.764 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 45.5 t0 -72.71 -31.23 64.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.946 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 58.9 23.34 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.051 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.457 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -115.72 -39.77 3.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.97 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -135.81 25.89 3.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.927 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.67 49.15 10.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.01 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.415 HG22 ' CE1' ' A' ' 80' ' ' TYR . 89.0 m -125.09 145.99 49.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.3 m -109.74 146.5 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.661 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CD2' ' HB3' ' A' ' 21' ' ' SER . 4.2 m-85 -137.61 134.94 36.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.92 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.481 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -128.59 119.16 24.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.068 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -92.51 108.21 19.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.468 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 30.8 mtm -94.39 90.21 6.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.334 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -85.49 175.13 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.67 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 33.16 39.43 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.934 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.605 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -47.51 158.76 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 111.204 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.48 164.25 16.95 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.816 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.74 8.13 4.45 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.66 2.24 . . . . 0.0 112.721 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 10.9 tt0 -119.21 -0.4 11.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.41 -11.04 59.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.658 0.266 . . . . 0.0 111.085 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 113' ' ' VAL . 98.9 m -52.14 108.93 0.33 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 111.345 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.71 174.18 5.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.005 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 93' ' ' VAL . 9.0 p -78.89 104.2 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 111.061 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.504 ' O ' HG22 ' A' ' 111' ' ' THR . 6.0 m-85 -81.22 98.35 8.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.46 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 5.0 m -107.33 129.98 54.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.013 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 28.7 p -99.77 142.57 31.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.682 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -143.05 177.36 22.02 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.318 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.529 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -126.25 164.91 19.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.003 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.18 176.97 22.94 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.724 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.8 117.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.332 . . . . 0.0 110.635 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.34 15.0 50.75 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.759 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.42 -11.67 43.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.644 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.65 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.0 m -102.29 179.45 4.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.551 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.65 ' H ' HG22 ' A' ' 103' ' ' THR . 81.2 m95 -136.75 83.58 2.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.06 -9.58 23.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.496 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.529 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -89.66 134.64 34.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.773 0.32 . . . . 0.0 110.81 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -146.0 165.15 29.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.745 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.05 -170.34 21.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.434 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -70.67 -32.12 69.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.95 0.405 . . . . 0.0 110.696 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.72 151.95 25.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.5 t -144.39 102.15 3.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 110.407 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 1.8 tp60 -63.26 138.56 58.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 0.0 111.264 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.489 HG21 ' CD1' ' A' ' 94' ' ' TYR . 52.4 t -112.47 118.25 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.981 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.495 HG21 HD23 ' A' ' 11' ' ' LEU . 70.4 m -97.65 122.29 40.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.346 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.845 HG13 ' O ' ' A' ' 12' ' ' VAL . 1.4 t -150.99 163.79 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.327 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.845 179.996 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.783 0.325 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mp -156.35 134.99 11.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.969 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 1.5 tt0 -145.39 129.46 17.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.146 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.21 165.09 15.3 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 p -169.66 112.67 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.006 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.67 -26.02 4.93 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.659 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.657 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -52.78 141.09 29.06 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.931 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.18 -178.37 46.82 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.376 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.677 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.3 mp -69.27 140.19 54.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.897 0.38 . . . . 0.0 111.409 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.9 p -149.44 122.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.078 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -58.86 140.31 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.312 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 115' ' ' VAL . . . -53.61 150.64 6.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.309 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.04 -2.15 82.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.837 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.06 -154.77 26.83 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.439 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -140.94 138.0 33.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.944 0.402 . . . . 0.0 111.214 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.593 ' CD2' HD21 ' A' ' 20' ' ' LEU . 15.2 tp -131.87 148.6 52.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.326 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -124.42 125.72 44.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.377 . . . . 0.0 111.55 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.657 HD22 ' HA2' ' A' ' 9' ' ' GLY . 4.0 mt -116.3 138.84 50.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.234 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 24.0 p -123.25 132.57 54.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.034 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.632 ' O ' HG22 ' A' ' 79' ' ' VAL . 31.6 t -131.53 130.96 42.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.747 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.79 165.9 13.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.197 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.48 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 62.0 t80 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.976 0.417 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.486 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 75.0 m-20 -75.43 178.96 5.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.369 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.402 ' HE2' HG11 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -147.77 130.54 16.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 111.366 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -153.11 155.52 26.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.621 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.473 ' CE2' HD22 ' A' ' 81' ' ' LEU . 75.5 m95 -86.97 156.22 19.87 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.359 0.599 . . . . 0.0 111.307 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 6.5 m-85 -140.16 -178.35 5.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.575 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HD2' HG22 ' A' ' 48' ' ' VAL . 1.6 mtp180 -145.81 158.42 43.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.017 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.42 ' HG2' ' CB ' ' A' ' 45' ' ' ARG . 1.8 tm0? -161.33 160.56 29.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.952 0.406 . . . . 0.0 111.303 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.6 155.01 22.14 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.606 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.14 137.42 44.01 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.273 1.982 . . . . 0.0 112.297 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.04 1.07 38.48 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.635 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.83 -177.33 3.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.879 0.371 . . . . 0.0 111.155 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -109.54 159.03 17.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.384 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.42 ' CB ' ' HG2' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -81.14 143.28 32.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 111.123 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.86 140.95 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.431 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.4 t -81.32 172.13 13.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.183 0.516 . . . . 0.0 110.919 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.441 HG22 ' HD2' ' A' ' 38' ' ' ARG . 3.1 t -129.99 -68.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.55 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -146.01 126.67 14.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 0.0 111.368 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.657 ' O ' HG22 ' A' ' 58' ' ' THR . . . -126.2 144.73 50.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.422 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.547 ' HB ' HG23 ' A' ' 58' ' ' THR . 8.0 tt -125.33 148.47 29.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.022 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.89 179.716 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.422 ' O ' HG13 ' A' ' 51' ' ' ILE . 4.4 mmm180 . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.741 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -137.41 -175.09 3.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.072 0.463 . . . . 0.0 111.028 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.478 ' N ' ' O ' ' A' ' 50' ' ' ALA . 75.1 t80 -139.82 92.48 2.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.542 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -75.0 160.97 29.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.999 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.94 158.69 17.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 63' ' ' SER . 36.5 t -69.35 150.46 47.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.711 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 87.36 -12.94 0.49 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.671 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 m -151.67 14.21 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.566 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.13 81.0 4.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.61 0.719 . . . . 0.0 110.464 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.9 -4.97 2.2 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.427 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.483 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -117.17 -36.67 3.72 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 111.201 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.2 m-30 -82.83 135.87 34.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.83 0.348 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 3.7 m -99.65 145.43 27.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.195 0.521 . . . . 0.0 111.32 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.896 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -133.53 135.94 55.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.251 -179.482 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.896 ' N ' HD13 ' A' ' 70' ' ' ILE . 28.7 t -166.29 146.74 6.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.968 0.413 . . . . 0.0 111.302 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.693 ' NE ' HG12 ' A' ' 79' ' ' VAL . 9.2 mpt_? -114.79 144.5 43.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.658 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -64.93 -30.15 71.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.899 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 57.36 24.9 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.977 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.79 -46.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.916 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.99 19.47 16.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp 56.31 46.94 20.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.905 0.383 . . . . 0.0 110.806 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.409 ' CG2' ' CZ ' ' A' ' 80' ' ' TYR . 42.1 m -120.53 143.32 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.315 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.693 HG12 ' NE ' ' A' ' 72' ' ' ARG . 28.9 m -101.99 150.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.481 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 21' ' ' SER . 28.9 m-85 -145.55 124.25 12.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.279 . . . . 0.0 110.866 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.486 HD21 HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -124.99 121.37 34.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.074 0.464 . . . . 0.0 110.584 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -99.74 94.96 6.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.792 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.573 ' HE1' HD23 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -79.72 95.29 5.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 -179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -88.96 176.89 6.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.619 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 t 36.23 41.94 0.16 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.549 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.81 166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.385 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 3.5 mmtp -126.18 162.26 47.08 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.706 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 64.7 Cg_endo -73.94 8.04 2.19 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.411 2.074 . . . . 0.0 113.104 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -119.42 8.94 11.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.258 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.3 -19.08 30.38 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.592 0.234 . . . . 0.0 111.229 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 63.6 m -49.91 103.66 0.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 111.463 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.02 -174.86 1.87 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.9 t -90.01 105.05 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.654 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.55 ' O ' HG22 ' A' ' 111' ' ' THR . 4.1 m-85 -87.03 107.75 18.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.086 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.413 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 4.7 m -106.86 167.21 10.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.4 ' N ' HG22 ' A' ' 95' ' ' THR . 4.3 p -129.91 133.64 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.421 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.01 -177.12 15.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.695 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 33' ' ' ASP . . . -136.36 167.2 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 111.077 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -108.58 -175.22 21.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.565 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.69 115.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.818 0.342 . . . . 0.0 110.594 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.1 15.66 50.91 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.701 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.83 -12.44 38.32 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.749 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.663 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.5 m -100.46 178.93 4.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.694 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.663 ' H ' HG22 ' A' ' 103' ' ' THR . 73.9 m95 -140.67 96.62 3.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.684 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -117.9 -5.87 11.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.483 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.63 130.82 37.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.851 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -142.28 164.94 28.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.983 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -101.37 -135.63 8.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.425 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -26.69 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 98.06 148.86 24.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.669 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 94' ' ' TYR . 3.7 t -148.15 119.24 7.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.884 0.373 . . . . 0.0 110.38 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -66.83 139.63 57.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.319 0.58 . . . . 0.0 111.351 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 91' ' ' THR . 37.9 t -123.92 86.52 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.677 ' HB ' HD23 ' A' ' 11' ' ' LEU . 74.1 m -77.71 148.48 34.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.994 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 116' ' ' SER . 2.2 t -126.08 168.58 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.883 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 115' ' ' VAL . 29.2 t . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.179 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.809 0.338 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp -151.63 107.39 3.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 71.7 mt-30 -93.65 168.2 11.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.823 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -120.93 163.35 18.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.822 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.36 124.88 4.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.994 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.23 -29.28 10.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.609 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.645 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.92 138.61 25.64 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.847 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.54 -159.62 29.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.352 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.662 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.2 mp -69.38 149.08 48.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.814 0.34 . . . . 0.0 111.375 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.704 HG11 HD22 ' A' ' 86' ' ' LEU . 7.1 p -142.88 126.48 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -70.09 127.05 31.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.012 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.45 125.14 13.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.464 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.03 -1.64 33.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.939 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.84 -153.02 10.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.531 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -139.37 142.51 37.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.886 ' CD2' HD21 ' A' ' 20' ' ' LEU . 3.7 tp -124.87 130.12 51.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.283 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.85 128.16 54.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.397 . . . . 0.0 111.562 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.886 HD21 ' CD2' ' A' ' 18' ' ' LEU . 5.5 mt -116.09 136.67 52.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.244 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.431 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 90.5 p -119.31 115.34 23.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.022 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.458 ' O ' HG22 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -113.95 116.45 29.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.11 148.69 21.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.56 ' HB2' ' SD ' ' A' ' 34' ' ' MET . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.875 0.369 . . . . 0.0 110.973 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.429 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 1.0 OUTLIER -86.67 178.31 7.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.032 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.788 ' HB3' HG11 ' A' ' 79' ' ' VAL . 3.9 mtm -146.65 132.32 18.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.031 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.34 151.19 23.36 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.658 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.704 ' CE2' HD22 ' A' ' 81' ' ' LEU . 74.3 m95 -88.29 155.94 19.46 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.206 0.527 . . . . 0.0 111.346 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -138.99 -179.27 5.74 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.703 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.552 ' CG ' HG22 ' A' ' 48' ' ' VAL . 9.9 mtm-85 -143.19 162.09 36.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.922 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -148.45 124.06 10.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.198 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -118.79 157.61 49.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.733 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 48.6 Cg_endo -68.85 137.26 37.73 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.295 1.997 . . . . 0.0 112.383 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 2.26 36.74 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.642 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.97 -175.09 2.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.859 0.361 . . . . 0.0 111.032 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -111.63 -171.73 1.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.636 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -78.2 125.45 29.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -121.53 119.2 31.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.458 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.3 t -71.43 170.69 12.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.269 0.557 . . . . 0.0 110.784 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.1 t -130.94 -69.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.442 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -145.21 128.91 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.035 0.445 . . . . 0.0 111.213 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.682 ' O ' HG22 ' A' ' 58' ' ' THR . . . -123.55 144.78 49.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.127 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 57' ' ' ARG . 8.7 tp -128.96 145.75 35.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.373 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.1 t30 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.717 179.794 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.67 ' O ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.917 0.389 . . . . 0.0 111.168 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.688 HG21 ' CG2' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -119.67 -177.9 3.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.902 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' ALA . 8.2 t80 -137.35 89.67 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.739 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -76.82 156.3 32.36 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.05 167.74 9.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.246 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 63' ' ' SER . 18.7 p -69.33 152.69 44.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.551 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 86.09 -11.99 0.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.486 -178.815 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.417 HG11 ' CE2' ' A' ' 68' ' ' PHE . 35.4 m -151.05 15.75 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.385 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.02 79.11 0.66 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.514 0.673 . . . . 0.0 110.724 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.47 3.88 8.45 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.896 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -114.3 -40.98 3.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 111.08 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 5.8 m-30 -93.5 117.38 30.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 11.8 m -79.57 152.57 30.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.907 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -148.38 136.42 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.012 -178.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.907 ' N ' HD13 ' A' ' 70' ' ' ILE . 4.8 m -161.49 -164.65 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.775 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -139.74 169.65 17.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.968 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.405 ' HB2' ' HE1' ' A' ' 80' ' ' TYR . 0.9 OUTLIER -77.75 -12.85 60.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.286 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 44.76 40.24 4.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 111.268 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.9 -49.36 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.064 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 mtmm -115.52 -72.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 167.14 44.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.599 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.2 m -110.33 145.13 38.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.187 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.788 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.6 m -108.66 142.0 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.748 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 1.3 m-85 -134.33 128.93 34.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.913 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.704 HD22 ' CE2' ' A' ' 36' ' ' TRP . 1.3 pt? -127.07 125.82 41.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.064 0.459 . . . . 0.0 110.747 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.81 96.72 8.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.617 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -78.56 88.03 4.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.212 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.62 176.89 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 38.35 48.34 1.17 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.494 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.704 HD22 HG11 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -70.61 165.72 22.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.327 -179.499 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -133.59 178.0 1.98 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.218 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 92.5 Cg_endo -81.31 9.68 3.76 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.316 2.011 . . . . 0.0 112.734 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 7.5 tp10 -109.17 -12.45 14.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.706 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.23 -21.34 58.7 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 110.986 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.532 HG23 ' HA ' ' A' ' 114' ' ' THR . 98.6 m -50.6 107.73 0.19 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.45 -172.34 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.308 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.5 t -90.28 105.15 15.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.542 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.473 ' O ' HG22 ' A' ' 111' ' ' THR . 13.0 m-85 -88.77 107.66 19.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 83.2 m -113.44 136.54 52.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 11.8 p -100.36 160.4 14.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.818 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -159.2 -170.92 24.34 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.999 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 33' ' ' ASP . . . -143.17 172.49 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.745 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -142.27 -175.69 15.8 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.906 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.463 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 31.1 tt0 -162.33 129.02 3.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.59 15.23 46.22 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.852 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.63 -14.36 32.42 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.68 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.6 HG22 ' H ' ' A' ' 104' ' ' TRP . 3.7 m -92.02 176.73 6.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.578 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.6 ' H ' HG22 ' A' ' 103' ' ' THR . 72.2 m95 -147.76 100.21 3.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.768 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -120.71 -3.26 9.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.568 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.89 137.87 34.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.841 0.353 . . . . 0.0 110.86 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -142.89 167.2 22.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.87 -155.8 18.97 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.575 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -87.34 -36.5 17.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 110.853 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.71 153.39 17.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.576 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.6 t -146.9 107.97 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.653 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -68.68 141.57 55.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.133 0.492 . . . . 0.0 110.941 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.1 t -121.75 126.6 74.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.387 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.662 ' HB ' HD23 ' A' ' 11' ' ' LEU . 88.5 m -102.25 133.33 47.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.043 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.431 HG21 HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -149.84 163.03 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.424 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.909 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.469 ' C ' HD12 ' A' ' 4' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.028 0.442 . . . . 0.0 110.48 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.485 HD11 ' OH ' ' A' ' 32' ' ' TYR . 5.7 mp -142.63 104.27 4.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.83 167.74 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.36 164.98 13.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -162.3 114.3 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.84 -36.3 3.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.656 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.516 ' CA ' HD22 ' A' ' 20' ' ' LEU . . . -50.03 139.12 19.59 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.913 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.39 -170.69 40.05 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.332 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.619 HD23 HG21 ' A' ' 114' ' ' THR . 1.9 mp -69.44 155.24 40.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.903 0.382 . . . . 0.0 111.593 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.53 ' CG1' HD22 ' A' ' 86' ' ' LEU . 8.1 p -169.41 120.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.888 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.66 144.32 27.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.69 124.78 11.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.452 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.99 17.76 31.45 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.68 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.72 -166.68 22.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.543 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -129.28 136.63 50.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.956 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.806 ' CD2' HD21 ' A' ' 20' ' ' LEU . 3.5 tp -142.66 131.03 22.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.585 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.479 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -112.23 132.91 54.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.185 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.806 HD21 ' CD2' ' A' ' 18' ' ' LEU . 4.1 mt -117.13 135.4 53.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.7 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -120.0 105.77 11.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.769 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.97 116.07 31.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.72 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.87 155.47 17.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.292 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HB2' ' HG ' ' A' ' 4' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.485 ' OH ' HD11 ' A' ' 4' ' ' LEU . 53.5 t80 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.945 0.402 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 74.6 m-20 -62.75 -175.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.455 ' O ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -146.9 124.59 11.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.764 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -147.45 150.8 23.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.986 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.451 ' CH2' ' CB ' ' A' ' 20' ' ' LEU . 74.1 m95 -91.44 153.46 19.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.225 0.536 . . . . 0.0 111.371 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.0 m-85 -133.39 -177.15 4.4 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.323 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.772 ' HD3' HG22 ' A' ' 48' ' ' VAL . 14.9 ptt180 -156.54 159.93 39.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.743 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -162.37 133.76 5.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.205 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.736 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -110.54 167.63 8.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.613 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.736 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 48.8 Cg_endo -68.89 138.01 39.55 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.265 1.977 . . . . 0.0 112.328 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.18 4.49 36.4 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.641 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -112.62 -177.12 3.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.868 0.366 . . . . 0.0 111.047 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -102.39 -171.54 1.98 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.581 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.9 ptm85 -100.59 128.89 46.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -131.14 147.92 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.304 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.4 t -82.58 175.68 9.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.263 0.554 . . . . 0.0 111.112 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.772 HG22 ' HD3' ' A' ' 38' ' ' ARG . 3.5 t -132.36 -66.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.143 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.35 123.43 10.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.017 0.437 . . . . 0.0 111.184 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 59' ' ' TYR . . . -118.35 148.85 42.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.108 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 34' ' ' MET . 4.0 tt -133.46 146.54 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.894 0.378 . . . . 0.0 111.534 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.922 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.725 0.298 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.995 HG21 HG21 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -102.89 178.06 4.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.753 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.769 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 86.2 t80 -140.45 90.81 2.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.668 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.452 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 4.6 m-85 -78.8 159.09 28.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.06 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.75 166.53 11.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 63' ' ' SER . 3.7 t -69.48 151.69 45.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.759 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 84.65 -11.0 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.617 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -152.75 16.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.314 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.452 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -70.64 79.1 0.59 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.559 0.695 . . . . 0.0 110.88 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.96 2.93 8.46 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.88 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -108.34 -33.47 7.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.76 0.314 . . . . 0.0 111.211 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 9.0 m-30 -96.03 127.77 42.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.151 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 56.9 m -83.54 145.04 29.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.375 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.995 HG21 HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -134.74 136.59 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.216 -179.322 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.408 ' N ' HG13 ' A' ' 70' ' ' ILE . 76.9 p -154.92 -175.88 5.65 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.973 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -138.27 165.9 25.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.084 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.718 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 33.8 t70 -86.6 -31.57 21.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t30 60.74 29.5 19.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.718 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -151.9 -57.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.08 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -102.73 11.32 37.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.277 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.49 52.25 4.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.647 ' OG1' ' CZ ' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -115.54 154.93 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.935 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 21' ' ' SER . 6.1 p -119.81 132.11 70.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.84 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.647 ' CZ ' ' OG1' ' A' ' 78' ' ' THR . 17.6 m-85 -118.11 107.96 14.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.132 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 69' ' ' THR . 0.2 OUTLIER -107.74 114.38 28.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.958 179.44 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -94.31 95.23 8.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.304 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.49 ' HB2' HD11 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -80.96 89.85 5.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.981 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -76.95 174.16 10.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.856 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 84' ' ' ASN . 0.6 OUTLIER 22.09 53.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.075 179.643 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.53 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.3 OUTLIER -44.56 162.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.537 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.503 ' O ' HG11 ' A' ' 115' ' ' VAL . 22.3 mmtt -110.75 161.0 26.65 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.787 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 72.1 Cg_endo -76.84 8.15 3.25 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.441 2.094 . . . . 0.0 112.908 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -121.68 2.91 10.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.236 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.66 -12.42 55.96 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.624 0.25 . . . . 0.0 111.23 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 88.9 m -55.89 104.82 0.15 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 111.17 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.54 -174.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.268 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.9 t -87.63 103.26 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.725 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.502 ' CD1' HG21 ' A' ' 113' ' ' VAL . 8.3 m-85 -82.7 105.79 14.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.914 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 88.5 m -111.64 133.18 54.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 28.0 p -100.45 150.09 23.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.014 0.435 . . . . 0.0 111.155 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -143.22 -175.36 16.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.246 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.517 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -135.39 164.4 27.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 111.028 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -96.06 -171.67 35.47 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 179.42 111.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.713 0.292 . . . . 0.0 110.743 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.74 16.14 50.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.693 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 -13.99 36.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.522 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.0 m -100.01 179.17 4.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.605 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.655 ' H ' HG22 ' A' ' 103' ' ' THR . 82.2 m95 -135.5 93.82 3.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.736 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -118.0 -4.27 11.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.341 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.517 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -90.22 135.69 33.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.756 0.313 . . . . 0.0 110.786 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -141.58 165.45 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.094 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.2 -148.22 11.86 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.486 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.02 -48.63 6.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 116.1 151.28 9.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.763 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 t -142.49 110.33 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.333 . . . . 0.0 110.454 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -64.31 141.11 58.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.21 0.528 . . . . 0.0 111.036 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 94' ' ' TYR . 47.0 t -119.12 125.64 74.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.297 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.619 HG21 HD23 ' A' ' 11' ' ' LEU . 75.3 m -101.41 117.94 35.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 111.03 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -133.49 -158.96 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.524 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.412 ' H ' HG12 ' A' ' 115' ' ' VAL . 6.1 t . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.916 0.389 . . . . 0.0 111.077 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.918 0.39 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 mp -146.78 159.01 44.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.793 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -152.7 175.23 13.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.288 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -128.7 173.22 10.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.988 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.1 t -170.16 143.59 2.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.064 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.67 -33.07 5.95 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.725 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.499 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -49.66 140.1 15.85 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.003 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.99 -170.58 43.33 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.396 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.561 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.6 mp -69.49 156.01 39.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.782 0.325 . . . . 0.0 111.414 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.9 p -170.01 115.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.92 158.82 1.92 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.381 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -48.95 145.44 3.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.435 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.09 15.87 65.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.603 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.42 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -105.79 112.18 3.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.348 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.93 131.0 43.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.825 HD23 HD21 ' A' ' 20' ' ' LEU . 6.0 tp -124.21 131.91 53.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.656 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -101.61 128.23 47.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.903 0.382 . . . . 0.0 111.461 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.825 HD21 HD23 ' A' ' 18' ' ' LEU . 8.5 mt -116.06 145.41 43.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.341 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.5 p -125.76 128.51 47.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.899 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 43.9 t -124.76 136.0 53.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -113.09 144.57 42.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.893 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.486 ' HB3' ' CD ' ' A' ' 77' ' ' LYS . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.321 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 121.089 0.471 . . . . 0.0 111.752 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -157.46 -173.9 4.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.031 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.12 158.47 43.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.691 0.281 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . 172.35 145.25 4.87 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.045 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.404 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 60.4 m95 -88.55 155.32 19.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.974 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.2 m-85 -132.31 -179.63 5.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.954 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.754 ' HD3' HG22 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -151.68 161.9 41.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.755 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.438 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 2.1 tm0? -149.06 147.24 28.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.183 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.442 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -132.59 158.13 76.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.655 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.442 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 56.0 Cg_endo -70.25 136.19 31.1 Favored 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 122.341 2.027 . . . . 0.0 112.415 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.77 -1.01 25.19 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.602 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -121.02 150.87 40.48 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 120.871 0.367 . . . . 0.0 110.958 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -69.88 -177.23 1.25 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.458 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -94.14 144.59 25.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 7.3 pt-20 -136.11 167.1 21.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.325 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 7.9 t -102.68 172.84 6.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.157 0.503 . . . . 0.0 110.989 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.754 HG22 ' HD3' ' A' ' 38' ' ' ARG . 3.1 t -128.69 -68.78 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.203 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -137.08 144.51 43.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.103 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 58' ' ' THR . . . -144.36 142.43 30.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.414 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.572 ' HB ' HG23 ' A' ' 58' ' ' THR . 2.1 tt -121.47 143.68 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.983 -179.781 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.004 0.43 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 1.04 HG21 HG21 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -127.49 -175.96 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.024 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.525 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 86.8 t80 -139.61 125.47 19.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.456 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.432 ' OH ' HG22 ' A' ' 70' ' ' ILE . 7.2 m-30 -113.68 162.52 16.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.31 160.43 14.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.231 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 p -80.78 36.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.864 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 t -118.22 -20.93 8.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.153 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 66' ' ' GLY . 29.7 m -157.05 21.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.045 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.94 80.07 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.651 0.739 . . . . 0.0 111.045 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 135.93 1.16 3.02 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.316 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.65 -35.72 3.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 111.24 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 4.6 m-30 -93.3 159.85 15.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 62.0 m -129.14 155.07 46.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.04 HG21 HG21 ' A' ' 58' ' ' THR . 5.6 tp -140.53 144.66 26.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.955 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.16 170.87 21.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.971 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -133.91 141.9 47.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.19 -18.49 42.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.214 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.2 p30 44.48 30.26 0.47 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.415 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.13 -74.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.64 23.41 14.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.486 ' CD ' ' HB3' ' A' ' 24' ' ' ALA . 0.1 OUTLIER 70.05 62.54 0.24 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.599 HG22 ' CE1' ' A' ' 80' ' ' TYR . 91.6 m -131.25 143.67 50.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 111.231 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.3 147.87 19.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.341 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.599 ' CE1' HG22 ' A' ' 78' ' ' THR . 3.8 m-85 -135.17 128.07 31.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.852 0.358 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.619 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -121.93 118.05 27.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.357 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.51 103.51 15.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.063 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.559 ' HE1' HG21 ' A' ' 113' ' ' VAL . 22.1 mtm -81.53 88.22 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.92 176.45 7.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 36.07 44.9 0.28 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.791 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.669 HD23 HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -58.72 156.53 10.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -123.74 171.76 6.54 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.085 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 86.1 Cg_endo -81.77 11.12 3.21 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.433 2.089 . . . . 0.0 112.884 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -118.53 -6.31 10.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.355 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.586 ' OD2' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -86.32 -13.19 47.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.499 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.763 ' OG1' HG23 ' A' ' 115' ' ' VAL . 99.4 m -54.53 112.52 1.02 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 111.456 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.2 -170.72 1.01 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.172 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.2 t -94.31 105.36 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.586 ' CE2' HG21 ' A' ' 48' ' ' VAL . 11.0 m-85 -86.87 110.67 20.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.051 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.6 t -109.28 127.34 54.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.981 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 46.9 t -77.42 145.62 37.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.08 166.67 30.53 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.693 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.732 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -131.08 150.12 52.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.328 . . . . 0.0 110.978 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . -96.36 165.45 23.79 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.805 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -158.27 113.8 2.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.55 16.26 49.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.98 -16.0 28.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.496 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.2 m -97.72 179.75 4.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.659 0.266 . . . . 0.0 110.393 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.67 ' H ' HG22 ' A' ' 103' ' ' THR . 81.9 m95 -142.13 91.14 2.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 107' ' ' TRP . 7.4 t70 -106.27 -18.4 14.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.142 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.732 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 2.9 t -75.16 130.3 38.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.799 0.333 . . . . 0.0 110.786 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.403 ' CD1' ' O ' ' A' ' 105' ' ' ASP . 58.0 m95 -139.19 165.04 28.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.708 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.04 -156.37 15.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.539 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -86.21 -25.44 25.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.95 150.31 24.08 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 94' ' ' TYR . 2.4 t -152.31 114.03 4.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.823 0.344 . . . . 0.0 110.166 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.29 137.75 37.48 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 120.941 0.401 . . . . 0.0 111.034 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.559 HG21 ' HE1' ' A' ' 83' ' ' MET . 56.0 t -116.86 110.76 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.734 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.643 ' HA ' HG23 ' A' ' 91' ' ' THR . 86.4 m -97.42 132.63 42.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.863 0.363 . . . . 0.0 111.361 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.763 HG23 ' OG1' ' A' ' 91' ' ' THR . 2.5 t -112.42 169.18 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.8 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.841 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.932 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.409 ' C ' HD12 ' A' ' 4' ' ' LEU . 2.3 mt-30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.811 0.338 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.603 HD13 ' HA2' ' A' ' 97' ' ' GLY . 1.4 mp -160.94 77.27 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -69.85 151.8 45.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.773 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -110.57 165.46 11.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.871 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.9 t -166.05 121.65 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.72 -40.76 2.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.703 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.664 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.04 139.72 18.6 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.923 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.93 -161.47 27.8 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.431 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.734 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.5 mp -69.43 145.84 52.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.869 0.366 . . . . 0.0 111.514 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.549 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.9 p -170.16 111.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.998 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.23 151.97 45.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.72 146.95 3.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.332 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.21 -13.67 65.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.55 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.88 114.11 3.95 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.371 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -69.95 136.22 50.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 111.128 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.41 HD23 HD21 ' A' ' 20' ' ' LEU . 2.3 tp -136.04 129.95 32.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.178 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.515 ' C ' HD23 ' A' ' 20' ' ' LEU . 5.0 ttp180 -102.43 145.55 29.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.117 0.484 . . . . 0.0 111.651 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.682 ' HG ' HD23 ' A' ' 81' ' ' LEU . 6.4 mt -117.64 147.99 42.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.808 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 90.7 p -125.73 114.21 18.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.274 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.513 ' HB3' HG22 ' A' ' 79' ' ' VAL . 3.8 t -117.16 128.8 55.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.597 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.84 141.64 49.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.371 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.043 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.603 ' CD1' ' HB1' ' A' ' 98' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 110.952 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -70.67 161.15 31.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.743 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.669 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.6 mtm -132.45 128.39 37.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.479 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 50' ' ' ALA . . . -153.29 159.9 28.85 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.113 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.464 ' CZ2' ' HB2' ' A' ' 20' ' ' LEU . 93.1 m95 -86.73 154.11 21.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.12 0.486 . . . . 0.0 110.93 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.3 m-85 -136.89 -176.53 4.4 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.74 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.52 ' HG2' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -146.99 150.75 35.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.837 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.41 ' HG2' ' HG2' ' A' ' 45' ' ' ARG . 1.6 mm-40 -153.81 176.77 11.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.024 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -174.21 152.92 1.89 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.522 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.7 137.15 62.03 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.29 1.993 . . . . 0.0 112.142 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.09 7.36 37.08 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.512 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.81 -169.58 1.48 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 111.02 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -114.91 176.68 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.771 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HG2' ' HG2' ' A' ' 39' ' ' GLN . 2.1 mtm-85 -97.65 134.91 40.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 0.0 111.175 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -138.96 163.65 31.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.439 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.544 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.5 t -110.61 171.15 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.246 0.546 . . . . 0.0 111.236 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.52 ' CG2' ' HG2' ' A' ' 38' ' ' ARG . 6.0 t -129.51 -69.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.306 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 70' ' ' ILE . . . -136.2 133.87 37.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.385 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.722 ' O ' HG22 ' A' ' 58' ' ' THR . . . -128.43 145.2 51.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.017 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 34' ' ' MET . 3.5 tt -128.01 147.85 32.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.358 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.76 179.941 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 120.767 0.318 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.8 HG21 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -122.46 -178.45 3.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.473 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 23.3 t80 -138.67 90.31 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.39 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.458 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 8.2 m-85 -80.51 154.9 27.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.18 159.69 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.194 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 63' ' ' SER . 17.9 p -69.09 153.83 43.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.32 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 62' ' ' SER . 2.3 p 87.12 -12.59 0.52 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.462 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -149.11 15.47 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.335 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 65' ' ' ARG . 6.5 tpt180 -77.69 83.5 4.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.779 0.8 . . . . 0.0 110.305 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.61 -7.12 3.31 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.587 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.466 ' HD2' ' CE1' ' A' ' 68' ' ' PHE . 1.3 ptp180 -116.52 -38.13 3.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.708 0.29 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.466 ' CE1' ' HD2' ' A' ' 67' ' ' ARG . 3.3 m-30 -90.42 93.82 9.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.49 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 95.5 m -76.53 116.53 17.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.146 0.498 . . . . 0.0 111.313 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -109.69 131.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.772 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.36 172.44 18.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.019 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 72' ' ' ARG . 13.5 ttp-105 -105.92 153.92 21.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.407 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 39.7 t0 -91.36 -29.64 16.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.4 26.19 14.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.023 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -114.34 -33.47 5.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.073 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.5 42.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.722 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.11 40.86 14.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.701 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.1 m -97.55 148.56 23.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.062 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 22' ' ' CYS . 30.7 m -122.82 132.08 72.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.428 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 25.1 m-85 -113.1 116.07 29.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.988 0.423 . . . . 0.0 110.801 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.682 HD23 ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -113.35 103.29 11.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.445 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -85.9 98.97 11.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.994 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.586 ' HB3' HD11 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -83.53 88.24 7.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.936 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 176.16 6.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.777 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 34.78 48.19 0.3 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.698 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' A' ' 83' ' ' MET . 0.5 OUTLIER -62.09 165.84 5.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.459 . . . . 0.0 111.197 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 33.1 mmtt -135.47 163.54 50.04 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.419 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 63.2 Cg_endo -73.23 9.08 1.54 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.365 2.043 . . . . 0.0 113.091 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.92 9.06 13.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.189 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.66 -7.54 37.25 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.533 0.206 . . . . 0.0 111.401 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.7 m -56.33 113.1 1.43 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.767 0.317 . . . . 0.0 111.271 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 112' ' ' GLN . . . -170.56 -172.53 1.24 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.313 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 84.0 t -96.16 102.63 13.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.183 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.504 ' O ' HG22 ' A' ' 111' ' ' THR . 24.7 m-85 -84.91 99.52 11.0 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.764 0.316 . . . . 0.0 111.117 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 62.0 m -106.2 129.97 54.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -99.79 147.77 25.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.456 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.603 ' HA2' HD13 ' A' ' 4' ' ' LEU . . . -159.65 -169.44 22.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.145 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.603 ' HB1' ' CD1' ' A' ' 32' ' ' TYR . . . -134.51 172.68 12.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.875 0.369 . . . . 0.0 110.968 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -147.05 173.35 27.25 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.778 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -160.01 144.92 14.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.58 16.22 49.77 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.58 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.23 -4.92 58.84 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.671 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.656 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -107.35 179.17 4.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.796 0.331 . . . . 0.0 110.579 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.656 ' H ' HG22 ' A' ' 103' ' ' THR . 77.5 m95 -139.06 105.33 5.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.514 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -12.32 11.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.49 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -93.31 133.43 36.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -144.86 165.0 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.0 -165.55 22.26 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.578 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -75.02 -29.11 60.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.16 152.51 28.73 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.603 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.9 t -148.16 114.31 5.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -80.22 142.46 34.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.018 0.437 . . . . 0.0 111.228 -179.168 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.423 HG21 ' CE ' ' A' ' 83' ' ' MET . 54.9 t -114.51 131.83 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.961 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.734 ' CB ' HD23 ' A' ' 11' ' ' LEU . 97.6 m -110.38 132.48 54.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.867 0.365 . . . . 0.0 111.182 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 116' ' ' SER . 2.0 t -141.27 168.01 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.156 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.49 ' H ' HG12 ' A' ' 115' ' ' VAL . 55.2 p . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.178 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.771 0.32 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.3 mp -148.05 136.8 21.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.1 169.54 17.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -124.96 164.45 20.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 m -166.24 125.79 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 114.01 -30.6 7.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.602 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -49.86 140.32 16.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.896 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.57 175.84 42.44 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.366 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.795 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.8 mp -69.15 144.83 53.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.88 0.371 . . . . 0.0 111.468 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.83 126.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -58.97 155.97 12.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.252 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.46 131.7 20.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.388 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.75 3.18 83.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.743 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.63 118.77 6.01 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.471 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.53 140.64 49.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 0.0 111.231 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.807 ' CD2' HD21 ' A' ' 20' ' ' LEU . 3.7 tp -136.0 129.1 31.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.703 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.46 119.26 39.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.807 HD21 ' CD2' ' A' ' 18' ' ' LEU . 12.7 mt -100.74 138.72 37.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.005 0.431 . . . . 0.0 110.427 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.442 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 7.1 m -117.31 111.11 18.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.213 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' HG23 ' A' ' 78' ' ' THR . 42.9 t -106.09 133.58 50.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.533 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.26 160.65 21.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.51 ' HB3' ' HD3' ' A' ' 77' ' ' LYS . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.719 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.95 0.405 . . . . 0.0 110.827 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.459 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -130.11 179.8 5.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.638 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.65 ' HB3' HG11 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -136.72 124.71 22.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.754 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.9 160.85 28.34 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.906 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 77.2 m95 -95.61 157.15 16.03 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.069 0.461 . . . . 0.0 111.303 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 11.7 m-85 -135.38 179.65 6.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.342 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.18 151.08 34.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.719 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.678 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -143.59 148.57 36.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.997 0.427 . . . . 0.0 111.222 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -143.0 158.6 58.66 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.624 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 39.7 Cg_endo -67.11 137.4 44.04 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.318 2.012 . . . . 0.0 112.281 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.64 0.44 48.63 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.649 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.25 -173.77 2.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.874 0.369 . . . . 0.0 111.074 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -118.7 -174.97 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.535 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.46 135.7 40.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 111.113 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.27 119.3 15.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.266 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 1.4 t -68.55 170.03 9.91 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.426 HG21 ' HE1' ' A' ' 94' ' ' TYR . 21.2 t -130.06 -57.6 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.958 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -152.6 163.24 40.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.949 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.568 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -161.08 147.58 14.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.665 HD13 ' N ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -140.09 143.47 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 111.597 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.665 ' N ' HD13 ' A' ' 51' ' ' ILE . 7.9 t-20 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.267 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.901 0.381 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.733 HG21 HG23 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -115.8 178.92 4.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.239 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.1 t80 -141.55 135.33 30.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.524 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.499 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 28.7 m-85 -123.23 163.1 21.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 110.895 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -106.5 155.92 19.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.987 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.18 34.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 111.762 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 64' ' ' VAL . 41.0 t -121.65 -15.13 8.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.236 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.562 HG12 ' HD2' ' A' ' 67' ' ' ARG . 15.7 m -156.76 19.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.232 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -65.98 80.15 0.08 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.563 0.697 . . . . 0.0 110.846 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.98 -2.38 1.16 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.809 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HD2' HG12 ' A' ' 64' ' ' VAL . 2.6 ptp180 -126.58 -36.16 2.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.833 0.316 . . . . 0.0 111.654 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CE2' HG11 ' A' ' 64' ' ' VAL . 7.8 m-30 -94.2 146.98 23.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.196 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 82' ' ' GLN . 5.5 m -112.89 154.42 26.39 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.406 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.895 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -146.02 134.23 16.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.915 -179.107 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.895 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -162.49 -172.51 3.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.806 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.557 ' CD ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -134.53 155.65 50.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.573 ' OD1' ' HB2' ' A' ' 75' ' ' ALA . 7.4 t0 -69.05 -27.84 66.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.042 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 66.71 23.34 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.022 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HB2' ' OD1' ' A' ' 73' ' ' ASP . . . -102.87 -57.78 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.923 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 4.4 ptpp? -130.21 -54.59 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.713 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 1.8 ttmp? 169.6 74.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.647 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.605 HG22 ' CE1' ' A' ' 80' ' ' TYR . 33.4 m -137.7 140.62 40.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.085 0.469 . . . . 0.0 111.243 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 34' ' ' MET . 35.3 m -116.03 135.91 54.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.827 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.605 ' CE1' HG22 ' A' ' 78' ' ' THR . 1.5 m-85 -124.79 129.54 50.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.758 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.733 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -118.09 118.95 33.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 110.404 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.554 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -93.36 102.83 15.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.031 -179.109 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.544 ' HE3' HD11 ' A' ' 81' ' ' LEU . 1.6 mtt -91.59 88.73 6.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.444 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.16 175.89 8.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.666 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 35.35 50.4 0.54 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.881 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.475 HD23 ' CG2' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -61.09 161.06 9.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.809 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.63 ' O ' HG11 ' A' ' 115' ' ' VAL . 4.2 mttp -134.07 172.82 6.65 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.919 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 87' ' ' LYS . 72.0 Cg_endo -76.28 5.0 4.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.546 2.164 . . . . 0.0 113.076 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.2 tp10 -103.25 -16.95 15.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.739 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -78.48 -17.0 56.91 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.097 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 99.4 m -51.74 102.78 0.05 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.076 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.48 -171.57 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.923 0.392 . . . . 0.0 111.56 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.483 HG22 ' HG3' ' A' ' 112' ' ' GLN . 91.2 t -93.16 109.87 22.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.82 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.51 ' CE1' ' HE1' ' A' ' 83' ' ' MET . 13.2 m-85 -91.89 109.07 20.4 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.651 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 m -108.72 139.2 43.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.0 111.372 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.7 t -94.86 146.04 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.645 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 107' ' ' TRP . . . -148.0 -178.82 23.49 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.74 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.719 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -142.46 165.44 27.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.024 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.58 168.87 14.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.812 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -167.74 120.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.728 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.6 14.76 51.54 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.817 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.46 -12.95 43.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.434 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.658 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.3 m -101.89 -179.96 4.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.687 0.28 . . . . 0.0 110.538 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.658 ' H ' HG22 ' A' ' 103' ' ' THR . 73.3 m95 -137.41 81.84 1.89 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.767 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.27 13.7 24.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.463 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.684 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -105.54 130.02 53.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.813 0.339 . . . . 0.0 110.853 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.406 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 31.5 m95 -137.62 164.5 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.045 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.89 -118.29 4.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.6 -44.48 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 110.984 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.97 152.03 13.66 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.762 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 111' ' ' THR . 15.3 t -154.28 117.23 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.263 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.483 ' HG3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -80.17 143.29 33.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.0 0.429 . . . . 0.0 111.007 -179.334 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.423 HG11 HD21 ' A' ' 86' ' ' LEU . 48.4 t -116.13 128.46 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.21 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.795 ' CB ' HD23 ' A' ' 11' ' ' LEU . 95.0 m -104.53 122.19 45.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.155 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.63 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -119.67 -151.58 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.393 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 115' ' ' VAL . 75.2 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.769 0.319 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.443 HD11 ' OH ' ' A' ' 32' ' ' TYR . 3.4 mp -143.56 122.59 12.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.868 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -138.51 163.93 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.09 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.71 163.63 14.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.71 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.06 117.32 3.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.914 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.02 -31.41 6.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.498 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -49.51 140.58 14.2 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.878 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.75 -159.2 30.55 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.395 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.404 HD23 HG21 ' A' ' 114' ' ' THR . 1.7 mp -69.45 150.13 47.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.845 0.355 . . . . 0.0 111.427 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.593 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.1 p -165.53 106.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.975 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -56.26 150.03 15.23 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.308 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.77 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -51.22 141.5 14.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.318 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.16 -4.66 85.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.753 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.4 119.82 6.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.299 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 p -69.87 133.68 47.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 111.229 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.869 ' CD2' HD21 ' A' ' 20' ' ' LEU . 6.5 tp -118.81 132.09 56.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.425 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.34 121.08 43.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 0.0 111.472 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.869 HD21 ' CD2' ' A' ' 18' ' ' LEU . 15.7 mt -109.32 137.88 46.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.409 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -119.99 113.18 20.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.172 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 17.4 t -111.04 133.91 53.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.361 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.2 147.16 32.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.199 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.51 ' HB3' ' HE3' ' A' ' 34' ' ' MET . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.075 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.0 t80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.0 0.429 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.473 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 5.3 m-20 -58.85 178.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.597 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.688 ' HB3' HG11 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -141.87 118.36 10.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 111.025 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -154.54 150.47 22.05 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.811 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.479 ' CD2' HD22 ' A' ' 81' ' ' LEU . 76.2 m95 -88.82 152.69 21.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.224 0.535 . . . . 0.0 111.176 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.543 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -131.98 -177.31 4.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.727 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HD2' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -151.23 161.48 42.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.723 179.535 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.614 ' O ' HG12 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -163.59 158.72 20.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.995 0.426 . . . . 0.0 111.284 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -148.27 161.33 34.46 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.681 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.549 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 37.1 Cg_endo -65.73 137.13 48.53 Favored 'Trans proline' 0 CA--C 1.518 -0.322 0 C-N-CA 122.256 1.971 . . . . 0.0 112.343 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.05 3.05 42.71 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.33 -174.73 2.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.78 0.324 . . . . 0.0 111.035 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -111.17 -171.16 1.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -90.62 131.66 36.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.062 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -133.0 129.62 38.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.599 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.543 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.3 t -85.45 171.28 11.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.285 0.564 . . . . 0.0 110.877 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.565 HG21 ' HE1' ' A' ' 94' ' ' TYR . 5.8 t -127.2 -68.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.403 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -142.67 129.21 20.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.237 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.57 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -132.67 143.16 49.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.377 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.838 ' HB ' HG23 ' A' ' 58' ' ' THR . 2.0 tt -120.51 136.6 57.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.32 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.654 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.378 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.838 HG23 ' HB ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -111.47 -178.46 3.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.809 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 50.8 t80 -137.61 96.24 3.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.935 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -85.9 157.14 20.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 111.033 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.75 162.9 13.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.333 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.0 m -81.76 33.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.015 0.436 . . . . 0.0 111.709 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -118.94 -25.3 6.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.838 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 30.8 m -148.7 18.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.03 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -71.22 81.21 0.72 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.761 0.791 . . . . 0.0 110.451 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 145.52 -6.69 1.47 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 114.431 -1.259 . . . . 0.0 112.495 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.446 ' CZ ' HG12 ' A' ' 64' ' ' VAL . 3.4 ptt180 -123.56 -37.53 2.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.681 0.277 . . . . 0.0 111.305 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.526 ' CZ ' HG11 ' A' ' 64' ' ' VAL . 4.8 m-30 -84.15 152.23 24.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.078 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 28.9 m -125.22 154.13 42.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.935 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.781 HG21 HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -144.52 137.91 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.073 -179.565 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.413 ' N ' HG13 ' A' ' 70' ' ' ILE . 90.0 p -163.06 135.76 5.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.628 ' HE ' HD13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -88.4 166.94 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.023 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.423 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 11.2 t0 -94.05 -31.0 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.985 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.78 28.62 16.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.33 -52.03 2.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.07 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -132.67 31.6 3.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt 61.74 50.55 4.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 59.3 m -114.0 150.19 34.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.821 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.688 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.7 m -122.53 145.24 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.835 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 27.2 m-85 -130.64 118.79 21.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.972 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.629 HD23 ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -114.86 113.98 24.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 110.324 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -92.96 99.26 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.158 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.516 ' HE2' ' CZ ' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -79.88 86.79 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.88 176.35 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 36.6 47.36 0.52 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.805 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.462 HD23 ' OD2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -59.04 161.84 4.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.788 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -122.9 172.24 5.64 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.139 0.495 . . . . 0.0 111.678 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.69 13.44 2.11 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.567 2.178 . . . . 0.0 112.961 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -131.02 13.73 5.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.504 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.563 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -89.08 -7.14 56.4 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.529 0.204 . . . . 0.0 111.192 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.0 m -55.81 107.75 0.38 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.664 0.269 . . . . 0.0 111.373 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.42 170.23 7.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.551 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 93' ' ' VAL . 5.3 p -82.09 107.07 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.565 ' HE1' HG21 ' A' ' 48' ' ' VAL . 10.4 m-85 -87.7 103.72 15.86 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.832 0.349 . . . . 0.0 111.256 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.493 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 5.6 t -104.99 130.46 53.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.426 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.7 t -84.96 142.56 29.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.281 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.52 162.46 29.31 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.755 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.41 165.49 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.836 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -96.82 179.34 34.11 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.682 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 177.9 118.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 0.0 110.698 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.7 14.48 50.97 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.811 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.66 -11.99 46.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.577 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.5 m -106.08 -179.26 3.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.642 0.258 . . . . 0.0 110.521 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.684 ' H ' HG22 ' A' ' 103' ' ' THR . 57.0 m95 -137.22 87.1 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.663 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -118.12 10.23 12.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.608 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.01 61.44 1.51 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.191 0.52 . . . . 0.0 110.768 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -69.97 165.46 21.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.104 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.74 -141.74 8.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.567 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -89.68 -48.25 7.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.331 . . . . 0.0 111.0 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 111.12 151.58 12.24 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.766 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 111' ' ' THR . 12.0 t -153.77 113.27 3.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -74.6 142.05 44.66 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.091 0.472 . . . . 0.0 111.272 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 91' ' ' THR . 55.8 t -114.65 117.79 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.037 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.404 HG21 HD23 ' A' ' 11' ' ' LEU . 88.8 m -96.69 119.35 35.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.094 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.788 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -110.68 -167.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.4 179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 54.4 p . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 120.813 0.34 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.492 ' C ' HD12 ' A' ' 4' ' ' LEU . 50.6 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.782 0.325 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 3' ' ' GLN . 4.7 mp -153.89 148.94 26.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.32 166.76 29.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.957 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.28 162.79 23.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.782 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.6 p -170.0 118.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.8 -27.67 4.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.596 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -53.69 179.83 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.716 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.12 177.9 25.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.317 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.805 HD23 HG21 ' A' ' 114' ' ' THR . 1.4 mp -69.03 126.05 28.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.074 0.464 . . . . 0.0 111.33 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.966 HG11 ' HB2' ' A' ' 18' ' ' LEU . 29.5 m -126.75 140.33 49.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.606 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -70.13 138.58 52.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.922 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -53.17 126.09 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.405 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.94 19.38 36.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.681 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -113.31 -156.43 12.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.405 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 t -138.64 137.89 37.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.933 0.397 . . . . 0.0 111.116 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.966 ' HB2' HG11 ' A' ' 12' ' ' VAL . 12.9 tp -135.18 133.29 38.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.589 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -110.68 126.74 54.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.338 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.587 HD21 ' CD2' ' A' ' 18' ' ' LEU . 5.7 mt -113.81 139.34 49.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.242 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.8 p -115.98 114.82 25.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.994 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.7 t -106.54 134.69 49.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.617 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -122.89 142.03 51.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.127 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.984 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.546 ' CD2' ' HB1' ' A' ' 98' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.433 -1.298 0 CA-C-O 120.977 0.418 . . . . 0.0 111.622 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -83.95 -176.64 6.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.084 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.1 mtp -144.02 126.61 16.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.33 154.45 25.87 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.928 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.544 ' CE2' HD22 ' A' ' 81' ' ' LEU . 73.9 m95 -86.93 153.84 21.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 111.438 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.4 m-85 -135.89 -178.81 5.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.768 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.494 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.9 OUTLIER -147.66 155.05 41.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.976 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.641 ' O ' HG12 ' A' ' 93' ' ' VAL . 2.1 tm0? -154.34 135.77 14.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.93 147.68 57.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.744 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.65 136.84 51.66 Favored 'Trans proline' 0 CA--C 1.517 -0.351 0 C-N-CA 122.247 1.965 . . . . 0.0 112.273 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.9 3.02 41.43 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.6 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.41 -162.92 0.82 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.692 0.282 . . . . 0.0 110.953 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -118.01 158.2 25.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.789 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.416 ' CG ' ' HG2' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -76.76 149.37 36.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.072 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.29 165.42 34.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.711 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.549 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.8 t -107.04 172.19 6.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.151 0.501 . . . . 0.0 110.865 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.494 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.6 t -128.58 -69.36 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.652 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -147.4 133.5 19.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 0.0 111.356 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.534 ' O ' HG22 ' A' ' 58' ' ' THR . . . -130.96 143.39 50.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.222 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.652 ' HB ' HG23 ' A' ' 58' ' ' THR . 7.3 tp -124.57 141.14 45.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.182 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.57 179.703 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 1.036 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -96.75 -178.44 4.24 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.022 0.439 . . . . 0.0 110.974 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' N ' ' O ' ' A' ' 50' ' ' ALA . 7.0 t80 -140.18 93.06 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.719 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -76.98 159.42 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.844 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.87 165.97 12.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.133 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 63' ' ' SER . 2.5 p -69.48 150.94 46.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.666 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 86.7 -12.38 0.56 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.618 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' A' ' 68' ' ' PHE . 16.9 m -149.15 12.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.525 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -81.39 81.85 7.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.634 0.73 . . . . 0.0 110.513 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.87 -6.81 2.38 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.309 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -119.08 -46.71 2.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.669 0.271 . . . . 0.0 111.257 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CE2' HG11 ' A' ' 64' ' ' VAL . 6.7 m-30 -69.94 139.85 52.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.702 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 6.9 m -111.55 153.45 26.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.887 0.375 . . . . 0.0 111.02 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.036 HG21 HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -139.45 140.34 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.834 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.439 ' N ' HG13 ' A' ' 70' ' ' ILE . 9.9 t -154.69 123.65 6.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 162.08 29.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.961 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 42.6 t0 -91.89 -38.26 12.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 59.7 47.78 10.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.743 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.3 -60.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -126.82 33.1 5.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.21 54.17 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 110.598 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.407 ' HB ' ' CB ' ' A' ' 73' ' ' ASP . 92.7 m -119.17 148.83 42.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.073 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.44 144.09 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.673 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 28.5 m-85 -127.45 120.14 27.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.821 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.587 HD21 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -115.28 116.66 28.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.103 0.478 . . . . 0.0 110.644 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -95.9 96.09 8.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.962 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.574 ' HE1' HD11 ' A' ' 20' ' ' LEU . 15.6 mtm -80.41 95.42 6.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.95 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.35 176.71 6.62 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.734 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 t 35.9 40.59 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.739 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -55.34 163.72 1.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.211 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.74 160.96 48.94 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.802 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.1 3.73 5.92 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.49 2.127 . . . . 0.0 112.848 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 12.7 tp10 -107.01 -10.38 15.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.782 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.66 -10.53 59.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.932 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 73.3 m -48.31 106.07 0.09 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.403 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.51 177.92 3.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.328 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 39' ' ' GLN . 5.0 p -83.95 107.35 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.454 ' CD1' HG21 ' A' ' 113' ' ' VAL . 6.1 m-85 -83.99 99.36 10.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.975 0.417 . . . . 0.0 110.679 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 m -103.04 132.05 49.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.282 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.7 t -90.42 135.62 33.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.657 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -136.16 176.0 20.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.402 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.546 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -131.57 148.01 52.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . -107.82 151.1 16.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.606 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -143.8 126.61 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.31 15.8 52.53 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.784 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.19 -9.77 46.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.791 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.7 m -102.22 179.98 4.16 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.598 0.237 . . . . 0.0 110.419 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.67 ' H ' HG22 ' A' ' 103' ' ' THR . 76.6 m95 -145.28 92.29 2.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -115.34 -2.76 12.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.406 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -94.41 132.39 39.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -136.55 164.67 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.28 -141.65 10.12 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.48 -45.49 8.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 113.11 153.82 11.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.532 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 1.8 t -152.58 106.93 3.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 110.526 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 2.1 tp60 -60.21 141.66 55.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.136 0.493 . . . . 0.0 110.996 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.4 t -119.91 88.01 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.181 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.805 HG21 HD23 ' A' ' 11' ' ' LEU . 59.1 m -76.67 132.87 39.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.218 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.541 HG21 HD23 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -144.79 156.51 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.396 179.673 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 1.1 m . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.798 0.332 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mp -114.83 138.87 50.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 11.2 mt-30 -144.89 134.28 23.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.667 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.13 163.52 13.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.859 0.361 . . . . 0.0 110.897 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.9 t -163.79 118.93 1.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.16 -37.57 3.04 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.715 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.712 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -49.12 139.16 14.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.095 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.43 -165.7 34.0 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.413 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.566 HD23 HG21 ' A' ' 114' ' ' THR . 1.8 mp -69.35 148.64 49.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.882 0.372 . . . . 0.0 111.595 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.673 HG13 HD22 ' A' ' 86' ' ' LEU . 7.2 p -170.12 106.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -56.68 159.59 3.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.347 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -51.2 153.71 1.9 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.304 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.48 9.2 68.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.647 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.74 113.62 2.92 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.383 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 m -69.95 135.96 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.737 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.8 tp -133.4 131.64 40.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.66 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -108.07 129.58 55.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.162 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.737 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.7 mt -113.68 144.87 42.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.131 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.474 ' HG ' ' HD2' ' A' ' 80' ' ' TYR . 1.9 m -126.97 118.98 25.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.498 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.511 ' SG ' HG23 ' A' ' 79' ' ' VAL . 19.3 p -125.07 121.34 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.999 0.428 . . . . 0.0 110.354 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.26 171.66 9.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.349 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.847 179.958 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.0 t80 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.427 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 12.8 m-20 -48.58 164.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.846 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.425 ' CE ' HG13 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -145.5 126.28 14.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.821 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.423 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -155.82 155.13 26.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.818 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.866 ' CE2' HD22 ' A' ' 81' ' ' LEU . 78.4 m95 -84.34 153.36 23.53 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.066 0.46 . . . . 0.0 111.022 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 8.9 m-85 -133.2 -176.38 4.11 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.389 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.532 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -146.81 156.67 43.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.668 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -153.94 111.39 3.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.125 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -97.96 160.74 27.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.685 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 53.8 Cg_endo -69.53 136.99 35.04 Favored 'Trans proline' 0 CA--C 1.518 -0.315 0 C-N-CA 122.294 1.996 . . . . 0.0 112.322 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.33 1.89 30.6 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.665 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.56 -174.8 2.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 110.974 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -103.18 -172.76 2.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.598 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -99.26 124.99 44.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -123.18 137.91 54.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.711 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.5 t -75.43 172.19 12.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.517 0.675 . . . . 0.0 111.526 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.532 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.7 t -131.02 -67.7 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.107 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -142.8 128.16 18.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.119 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -136.29 145.99 46.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.743 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.826 ' HB ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -123.12 140.82 45.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.239 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 . . . . . 0 N--CA 1.448 -0.57 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.029 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.849 0.357 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.826 HG23 ' HB ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -96.87 179.74 4.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.745 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 57.4 t80 -140.42 95.59 2.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.574 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 68' ' ' PHE . 78.3 m-85 -78.99 169.84 17.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.45 170.73 7.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.67 150.86 46.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.715 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.0 t 81.96 -8.04 1.33 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.752 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -151.29 11.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.434 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 79.23 0.86 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.534 0.683 . . . . 0.0 110.681 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.9 1.71 5.8 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.07 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.39 -52.92 2.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 4.4 m-30 -74.86 133.65 41.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.668 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 25.0 m -95.68 153.33 17.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.03 0.443 . . . . 0.0 110.975 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.898 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -152.78 136.12 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.596 -179.194 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.898 ' N ' HD13 ' A' ' 70' ' ' ILE . 10.3 t -156.14 153.39 29.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.958 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.413 ' HG3' HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -101.65 141.42 34.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.822 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.596 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 26.5 t0 -74.67 -30.37 61.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.916 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 m120 59.59 27.38 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.596 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -119.94 -54.63 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.018 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -122.76 27.33 7.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp 59.49 51.09 6.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.852 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.61 HG22 ' CE1' ' A' ' 80' ' ' TYR . 69.3 m -122.16 148.67 44.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.125 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.511 HG23 ' SG ' ' A' ' 22' ' ' CYS . 17.3 m -119.0 142.35 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.699 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.61 ' CE1' HG22 ' A' ' 78' ' ' THR . 1.2 m-85 -128.36 138.15 52.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.866 HD22 ' CE2' ' A' ' 36' ' ' TRP . 1.1 pt? -131.35 124.26 30.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.095 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -96.78 99.74 11.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.165 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -84.69 89.69 7.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.64 174.28 11.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 0.0 111.184 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 32.4 47.08 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.951 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.673 HD22 HG13 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -48.56 158.95 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 111.125 -179.758 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -126.42 174.34 4.23 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.632 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 86.3 Cg_endo -81.18 8.22 4.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.436 2.091 . . . . 0.0 112.855 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -109.69 -8.66 14.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.8 -20.01 43.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.234 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 114' ' ' THR . 95.5 m -54.22 101.99 0.05 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 111.305 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.54 -175.61 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.8 t -87.37 102.89 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.623 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -83.65 104.38 13.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.454 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 19.0 m -105.3 132.35 51.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.328 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.0 t -96.16 135.73 37.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.601 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.3 177.3 20.79 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.706 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -131.59 167.56 19.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.357 . . . . 0.0 111.012 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -119.45 -165.63 13.1 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.825 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.62 113.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.798 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.99 52.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.62 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.83 -12.41 34.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.752 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.634 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.2 m -96.15 177.52 5.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.891 0.377 . . . . 0.0 110.8 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.634 ' H ' HG22 ' A' ' 103' ' ' THR . 76.8 m95 -145.42 107.26 4.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.741 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -133.35 10.67 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.396 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 1.4 t -112.19 134.67 53.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.817 0.341 . . . . 0.0 110.896 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -141.6 165.05 28.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.05 -152.62 16.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -85.54 -31.86 22.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 95.72 156.44 31.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.65 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 111' ' ' THR . 14.8 t -147.99 112.7 5.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.341 . . . . 0.0 110.527 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -68.02 141.37 56.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 110.992 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.4 t -120.02 136.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.445 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.566 HG21 HD23 ' A' ' 11' ' ' LEU . 48.1 m -121.18 137.43 54.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.857 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.659 ' CG2' HD23 ' A' ' 86' ' ' LEU . 2.1 t -135.69 168.37 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.248 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.059 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.811 0.338 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 24' ' ' ALA . 5.0 mp -145.72 130.61 18.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -118.06 157.03 27.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.777 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.26 168.3 9.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.072 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.15 131.82 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.969 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.21 -18.59 57.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.749 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.588 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -52.07 138.27 31.29 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.874 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.85 -169.63 39.74 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.435 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.83 HD23 HG21 ' A' ' 114' ' ' THR . 1.7 mp -69.51 154.33 42.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.902 0.382 . . . . 0.0 111.58 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.654 ' HB ' HD13 ' A' ' 18' ' ' LEU . 7.2 p -154.39 113.92 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.927 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.0 144.18 7.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.384 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.577 ' HA ' HG12 ' A' ' 115' ' ' VAL . . . -49.81 121.35 5.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.314 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.8 15.32 58.22 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.599 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.415 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -109.72 133.36 11.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.371 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER -71.12 126.2 28.95 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.099 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.918 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.2 tp -120.52 131.34 54.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.523 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -110.23 122.44 47.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 111.607 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.918 HD21 ' CD2' ' A' ' 18' ' ' LEU . 6.8 mt -113.21 138.06 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.193 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.465 ' HB2' ' CD2' ' A' ' 80' ' ' TYR . 12.6 t -121.47 118.62 29.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.967 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 5.9 p -126.66 133.56 50.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.984 0.421 . . . . 0.0 111.174 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -113.87 172.85 6.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.234 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.41 ' HB2' ' HG ' ' A' ' 4' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.738 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 1.5 t80 . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.905 0.383 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 46.7 m-20 -110.1 178.76 4.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.775 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.516 ' HB3' HG11 ' A' ' 79' ' ' VAL . 1.8 ttm -150.11 129.6 13.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.123 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -150.15 154.47 25.69 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.839 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.665 ' CE2' HD22 ' A' ' 81' ' ' LEU . 84.8 m95 -83.57 155.61 23.19 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.1 0.476 . . . . 0.0 111.312 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.4 m-85 -137.82 -178.28 5.18 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.473 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.556 ' CG ' HG22 ' A' ' 48' ' ' VAL . 2.0 mtm180 -148.41 159.33 44.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.993 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -153.63 109.12 3.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.107 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.66 154.06 38.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.714 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.2 140.43 44.75 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.369 2.046 . . . . 0.0 112.426 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.0 -8.17 39.2 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.728 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -117.87 -179.1 3.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.842 0.353 . . . . 0.0 110.914 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.26 170.63 8.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.552 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.88 130.66 35.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.802 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.14 144.34 51.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.608 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.526 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.0 t -80.76 174.82 11.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.211 0.529 . . . . 0.0 111.054 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.556 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.1 t -131.45 -70.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.358 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -141.26 133.78 28.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 58' ' ' THR . . . -130.33 143.39 50.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.417 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.664 ' HB ' HG23 ' A' ' 58' ' ' THR . 6.5 tp -123.4 142.42 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.045 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.951 179.864 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.634 0.255 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.729 HG21 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -99.16 -179.94 4.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.991 0.424 . . . . 0.0 110.95 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 45.2 t80 -137.92 97.8 3.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.783 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -78.65 155.5 29.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.826 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.13 176.1 5.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.225 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -69.57 151.68 45.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.655 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.7 m 81.99 -9.0 1.25 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.571 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.53 HG21 ' CG1' ' A' ' 48' ' ' VAL . 35.4 m -151.56 13.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.352 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.74 80.11 1.12 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.707 0.765 . . . . 0.0 110.387 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.16 6.91 17.78 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.812 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.437 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 16.9 mtm180 -110.96 -45.31 3.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.814 0.34 . . . . 0.0 111.192 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CE2' HG11 ' A' ' 64' ' ' VAL . 7.8 m-30 -93.02 149.59 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.018 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 14.2 m -107.33 155.5 19.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.909 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -158.13 136.45 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.116 -179.018 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.909 ' N ' HD13 ' A' ' 70' ' ' ILE . 1.9 p -154.74 170.69 21.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' A' ' 72' ' ' ARG . 16.9 mtp-105 -113.62 146.19 40.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.926 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 22.5 t0 -89.9 -11.02 43.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.339 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 43.65 30.97 0.4 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.767 0.317 . . . . 0.0 111.558 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.7 -64.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.32 39.0 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.79 52.18 2.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.828 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.562 HG22 ' CE1' ' A' ' 80' ' ' TYR . 79.9 m -115.92 143.92 44.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.116 0.484 . . . . 0.0 111.358 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 34' ' ' MET . 32.7 m -121.98 132.3 71.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.033 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.562 ' CE1' HG22 ' A' ' 78' ' ' THR . 2.5 m-85 -115.32 119.43 36.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.665 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -115.17 115.47 26.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 0.0 110.48 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.01 92.48 6.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.785 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.435 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -73.09 92.1 1.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.009 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -86.74 176.02 7.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 35.96 47.22 0.4 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.723 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.404 ' CD1' ' CB ' ' A' ' 83' ' ' MET . 0.2 OUTLIER -64.94 158.49 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.844 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.503 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -112.12 166.52 10.76 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.686 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.92 11.99 2.38 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.616 2.21 . . . . 0.0 112.959 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -131.76 11.42 4.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.495 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -87.08 -5.18 59.12 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.634 0.254 . . . . 0.0 111.195 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 89.5 m -55.39 118.01 4.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 111.028 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.52 -172.26 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.499 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 93.0 t -92.99 106.26 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.496 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -88.57 103.06 15.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.874 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.421 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 6.1 t -105.75 142.22 35.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.226 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.57 144.36 25.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.92 175.89 20.07 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.313 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.738 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -143.59 167.65 21.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.902 0.382 . . . . 0.0 111.312 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -121.26 178.39 16.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.848 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -164.52 117.89 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.751 0.31 . . . . 0.0 110.416 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.8 16.41 51.54 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.729 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.66 -12.63 35.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.83 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.635 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.2 m -97.19 178.71 5.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.762 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.635 ' H ' HG22 ' A' ' 103' ' ' THR . 78.5 m95 -141.56 103.96 4.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -136.66 21.26 3.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.114 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.655 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -115.03 138.16 51.18 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.801 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -137.34 166.87 22.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.003 0.43 . . . . 0.0 111.117 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -111.03 -155.97 14.02 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.443 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -82.32 -41.1 20.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.948 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 104.86 151.37 21.0 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.799 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 111' ' ' THR . 11.0 t -152.62 121.06 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.7 144.38 37.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.957 0.408 . . . . 0.0 111.045 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 91' ' ' THR . 54.1 t -115.03 128.11 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.321 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.83 HG21 HD23 ' A' ' 11' ' ' LEU . 93.7 m -100.93 130.48 46.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.992 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -136.2 -162.0 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.611 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.501 ' H ' HG12 ' A' ' 115' ' ' VAL . 6.0 t . . . . . 0 C--N 1.333 -0.128 0 CA-C-O 120.857 0.36 . . . . 0.0 110.825 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.752 0.31 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.76 154.39 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.788 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -148.77 174.14 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.994 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.46 122.06 9.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -115.95 158.67 22.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -123.17 170.42 10.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -160.74 133.9 6.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.031 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.31 -32.16 6.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.567 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.29 138.77 27.03 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.948 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.41 -161.8 35.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.289 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.693 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.3 mp -69.39 143.85 53.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.889 0.376 . . . . 0.0 111.485 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.6 p -162.29 113.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.077 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.01 148.04 36.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.84 145.9 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.391 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.38 -7.34 79.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.678 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.21 118.64 5.91 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.318 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -70.01 135.58 49.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 111.126 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.663 ' CD2' HD21 ' A' ' 20' ' ' LEU . 14.2 tp -116.81 134.01 55.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.379 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.442 ' NE ' ' HB3' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -107.42 119.66 40.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.505 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.673 ' HB2' HD23 ' A' ' 81' ' ' LEU . 14.4 mt -111.28 139.14 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.36 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.8 p -126.28 98.79 5.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.968 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 41.4 t -95.19 135.23 37.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.711 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.77 145.66 43.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.273 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.75 133.24 45.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.97 132.31 15.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.99 -92.73 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.528 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.99 107.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 110.93 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 28' ' ' THR . 12.8 t -170.1 120.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.853 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.76 36.58 0.84 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.98 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.1 t -110.16 -81.51 0.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.759 0.314 . . . . 0.0 110.823 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.526 HG23 ' H ' ' A' ' 101' ' ' GLY . 5.2 t -139.68 29.63 2.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.108 0.48 . . . . 0.0 110.496 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.601 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -69.71 166.91 18.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.094 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 52' ' ' ASN . 0.4 OUTLIER -153.39 178.49 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.552 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.523 ' HB3' HG11 ' A' ' 79' ' ' VAL . 1.6 mtm -140.98 123.05 15.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.287 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -150.55 150.52 22.54 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.247 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.475 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 79.1 m95 -84.51 152.79 23.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.141 0.496 . . . . 0.0 110.939 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.6 m-85 -132.14 -178.77 5.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.396 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HD3' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -154.91 161.08 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.976 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.538 ' O ' HG12 ' A' ' 93' ' ' VAL . 8.1 tt0 -161.6 147.49 13.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -127.69 163.46 42.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.656 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.59 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 55.6 Cg_endo -70.19 138.28 36.11 Favored 'Trans proline' 0 CA--C 1.518 -0.318 0 C-N-CA 122.275 1.983 . . . . 0.0 112.372 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.41 -0.73 39.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.752 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.89 -177.45 3.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -100.13 -172.14 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HD2' ' CH2' ' A' ' 107' ' ' TRP . 10.2 ptt-85 -102.79 136.06 43.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.365 . . . . 0.0 111.046 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 1.7 pt-20 -131.6 163.65 27.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.331 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.1 t -104.26 171.08 7.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.267 0.556 . . . . 0.0 111.089 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.615 HG22 ' HD3' ' A' ' 38' ' ' ARG . 6.0 t -126.9 -67.09 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.491 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.6 136.82 26.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.325 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -141.88 146.33 35.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.94 HG23 HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -114.87 143.29 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.846 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 26.1 t-20 -86.88 167.82 13.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.177 0.513 . . . . 0.0 110.444 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -117.04 84.04 2.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.131 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.48 -79.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.691 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 169.88 64.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.36 -75.98 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.927 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.39 -164.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.94 HG23 HG23 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -98.72 -177.42 3.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.484 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.2 t80 -138.73 92.32 2.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.787 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 49' ' ' ALA . 12.8 m-85 -93.53 166.27 12.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.013 0.435 . . . . 0.0 111.071 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.24 159.45 19.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.366 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.48 37.19 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 0.0 111.838 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.4 t -116.35 -24.99 7.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.96 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.487 ' HA ' ' NH1' ' A' ' 67' ' ' ARG . 26.9 m -156.82 21.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.046 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 65' ' ' ARG . 16.2 ttp85 -75.26 86.32 2.47 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.884 0.849 . . . . 0.0 110.689 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.84 -17.93 0.85 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.314 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.487 ' NH1' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -115.26 -33.16 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.642 0.258 . . . . 0.0 111.304 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.477 ' CE2' ' HG2' ' A' ' 83' ' ' MET . 2.6 m-85 -88.88 137.02 32.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.128 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 10.1 m -106.82 153.63 22.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.907 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -141.35 136.14 32.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.942 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.907 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -152.66 178.72 9.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.671 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.83 167.59 18.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.019 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.606 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 16.8 t0 -79.4 -37.01 38.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.788 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 m120 62.97 35.5 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.819 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.606 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -134.46 -47.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.18 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.4 tttp -130.07 -64.36 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt 167.66 70.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 64.9 m -135.65 144.78 46.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.006 0.432 . . . . 0.0 111.063 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.523 HG11 ' HB3' ' A' ' 34' ' ' MET . 33.8 m -116.54 147.6 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.696 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 2.2 m-85 -136.72 128.65 29.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.906 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -124.7 121.7 35.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.167 0.508 . . . . 0.0 110.808 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -94.59 99.21 11.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.583 ' O ' HD13 ' A' ' 86' ' ' LEU . 1.5 mtp -80.51 87.82 5.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.003 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.65 176.06 7.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.738 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 34.96 48.96 0.37 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.594 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 83' ' ' MET . 1.2 mp -58.2 165.88 1.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.313 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.435 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -145.3 167.89 13.35 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.817 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 54.8 Cg_endo -69.71 1.59 4.26 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.553 2.169 . . . . 0.0 113.148 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -98.76 -20.3 16.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.874 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.15 -21.18 46.86 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.083 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 114' ' ' THR . 99.9 m -51.79 101.55 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.782 0.325 . . . . 0.0 111.198 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.41 177.66 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.345 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.709 ' O ' HG13 ' A' ' 93' ' ' VAL . 9.4 p -80.88 101.57 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.197 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.441 ' O ' HG22 ' A' ' 111' ' ' THR . 3.9 m-85 -81.65 101.71 10.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.026 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.493 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 6.3 t -103.23 125.42 49.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.466 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.9 t -81.93 136.5 35.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.171 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.47 176.69 22.14 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.118 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.601 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -139.37 167.81 21.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.355 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -126.52 170.42 18.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.239 -0.982 . . . . 0.0 113.172 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -156.82 132.52 9.45 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.526 ' H ' HG23 ' A' ' 31' ' ' THR . . . 62.98 13.48 48.26 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.73 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.52 -9.47 45.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.886 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.662 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -101.82 179.56 4.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.849 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.662 ' H ' HG22 ' A' ' 103' ' ' THR . 84.3 m95 -136.72 86.23 2.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.576 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.56 19.04 17.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.96 132.42 56.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.426 ' CH2' ' HD2' ' A' ' 45' ' ' ARG . 19.5 m95 -139.24 164.02 30.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.025 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.87 -142.84 10.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.574 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.63 -35.32 15.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.382 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 99.8 150.69 25.38 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.863 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 111' ' ' THR . 7.9 t -145.27 114.67 7.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -76.63 132.36 39.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.971 0.415 . . . . 0.0 111.272 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 91' ' ' THR . 60.7 t -110.14 124.08 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.901 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.693 ' HB ' HD23 ' A' ' 11' ' ' LEU . 89.7 m -112.49 117.26 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.585 HG12 ' H ' ' A' ' 116' ' ' SER . 0.4 OUTLIER -121.62 -168.84 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.083 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.585 ' H ' HG12 ' A' ' 115' ' ' VAL . 77.5 p -165.34 -87.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.605 0.241 . . . . 0.0 111.262 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.862 -179.929 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.779 0.324 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -106.42 158.87 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -122.79 164.13 18.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.04 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.464 HD23 ' HB2' ' A' ' 24' ' ' ALA . 1.7 mp -142.48 -179.57 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -169.13 169.07 9.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.04 163.31 18.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 p -167.74 126.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.62 -31.83 6.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.664 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' HD22 ' A' ' 20' ' ' LEU . . . -55.39 179.11 0.34 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.766 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.12 -157.79 27.49 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.076 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.755 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.2 mp -69.45 145.36 52.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.812 0.339 . . . . 0.0 111.262 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.594 HG11 HD22 ' A' ' 86' ' ' LEU . 7.7 p -146.54 132.97 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.171 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.96 129.48 41.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.187 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' HA ' HG12 ' A' ' 115' ' ' VAL . . . -51.61 128.2 22.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.401 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.25 -3.04 82.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.8 -144.56 14.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.444 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.58 140.97 33.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.934 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.807 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.8 tp -129.84 141.46 50.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.446 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.563 ' C ' HD23 ' A' ' 20' ' ' LEU . 31.5 ttt85 -122.09 131.38 53.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.489 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.807 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.9 mt -121.53 145.1 48.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.291 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.471 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 98.5 p -126.11 108.84 11.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.278 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 50.0 t -101.22 135.88 41.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.507 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -122.0 147.85 45.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.939 0.399 . . . . 0.0 111.424 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB3' ' HE1' ' A' ' 34' ' ' MET . . . -121.41 163.93 17.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.822 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.768 ' O ' HG12 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -138.07 114.82 10.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.066 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.82 145.39 5.67 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.571 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -79.8 149.66 30.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.0 p -152.94 155.03 36.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.195 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.56 32.23 0.43 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.191 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.93 53.19 1.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.6 23.33 13.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.66 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' CE2' HG21 ' A' ' 2' ' ' VAL . 43.8 t80 -69.42 90.35 0.52 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.521 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.45 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 71.6 m-20 -84.47 -176.88 6.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.258 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.576 ' HB3' HG11 ' A' ' 79' ' ' VAL . 2.9 mtt -141.21 117.78 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.33 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -141.22 168.16 25.49 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.039 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.45 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 77.7 m95 -103.0 158.76 16.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 111.163 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 13.8 m-85 -134.72 178.49 6.97 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' HG2' HG22 ' A' ' 48' ' ' VAL . 10.0 ptm180 -148.58 155.22 40.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.929 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.422 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.8 OUTLIER -145.85 110.69 5.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.5 153.24 48.09 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.37 136.46 40.07 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.325 2.016 . . . . 0.0 112.454 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.09 -1.36 33.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.657 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.74 -179.34 3.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.909 0.385 . . . . 0.0 111.048 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.45 -171.58 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.449 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -96.7 154.57 17.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.37 0.605 . . . . 0.0 111.329 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' CG ' ' HG3' ' A' ' 38' ' ' ARG . 7.8 pt-20 -157.46 139.24 14.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.241 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 1.6 t -67.99 171.98 6.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.478 0.656 . . . . 0.0 111.446 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.497 HG21 ' CE1' ' A' ' 94' ' ' TYR . 2.8 t -130.0 -67.8 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.221 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.14 124.42 13.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -120.62 147.3 45.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.337 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 34' ' ' MET . 0.6 OUTLIER -127.31 141.34 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.924 0.392 . . . . 0.0 111.286 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.403 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.6 t-20 -89.32 -164.02 1.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.785 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.454 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -105.86 -167.33 1.3 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.509 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 t0 44.19 26.27 0.15 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.923 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.5 t 41.88 78.5 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 111.452 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.61 -72.87 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.305 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -162.21 167.66 23.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 1.012 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -107.63 -179.03 3.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.002 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 50' ' ' ALA . 12.8 t80 -139.04 86.58 2.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.713 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.448 ' CE2' HG22 ' A' ' 70' ' ' ILE . 9.3 m-85 -86.79 143.57 27.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.38 165.14 24.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.442 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.4 p -82.33 33.66 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 0.0 111.701 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.4 p -118.99 -21.56 7.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.126 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.536 HG11 ' CE1' ' A' ' 68' ' ' PHE . 17.4 m -148.46 19.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.019 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.5 ttt85 -62.49 79.25 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.63 0.729 . . . . 0.0 110.832 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 134.09 3.16 3.24 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.175 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -119.1 -52.87 2.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.816 0.341 . . . . 0.0 111.069 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CE1' HG11 ' A' ' 64' ' ' VAL . 5.2 m-30 -75.5 150.85 38.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.1 m -113.32 157.87 21.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.007 0.432 . . . . 0.0 110.98 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.012 HG21 HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -151.58 135.18 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.96 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.892 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -164.8 152.04 11.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.716 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 164.31 11.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.07 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.457 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 54.2 t0 -76.93 -30.33 56.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.989 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.35 25.61 13.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.25 -52.59 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.892 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 2.6 pttt -134.16 -57.53 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 173.42 70.96 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.779 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.469 HG22 ' CE1' ' A' ' 80' ' ' TYR . 25.8 m -134.92 139.42 44.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.114 0.483 . . . . 0.0 111.336 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 34' ' ' MET . 35.6 m -115.92 146.16 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.336 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 1.9 m-85 -135.1 155.16 51.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.72 0.295 . . . . 0.0 111.035 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.526 HD21 HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -146.31 125.62 13.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.952 0.406 . . . . 0.0 110.941 179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.61 96.5 7.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.536 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.502 ' SD ' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -79.38 91.25 5.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.271 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.44 178.53 6.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 t 38.99 40.75 0.48 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.441 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.594 HD22 HG11 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -60.38 159.49 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.145 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.556 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 16.5 mmmt -128.62 163.67 43.36 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.411 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 57.8 Cg_endo -70.99 6.96 1.49 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.37 2.047 . . . . 0.0 113.271 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -109.2 -8.1 15.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.009 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.27 -11.15 58.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.652 0.263 . . . . 0.0 111.308 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.434 ' OG1' HG23 ' A' ' 115' ' ' VAL . 97.6 m -53.18 107.7 0.26 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.057 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.61 -177.65 2.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.525 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 93.5 t -89.75 105.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.792 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.51 ' O ' HG22 ' A' ' 111' ' ' THR . 11.3 m-85 -87.91 110.2 20.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 7.2 m -111.15 136.08 50.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.718 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.423 ' HB3' ' CE3' ' A' ' 36' ' ' TRP . 15.7 p -98.91 138.66 35.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 111.175 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.73 -169.3 11.69 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.361 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -136.92 167.41 21.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 111.193 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -104.01 -175.8 25.57 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.629 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -173.75 108.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.73 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.09 16.69 49.32 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.764 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.0 -16.51 25.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.558 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.667 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -96.49 179.81 4.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.769 0.319 . . . . 0.0 110.475 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.667 ' H ' HG22 ' A' ' 103' ' ' THR . 79.9 m95 -141.88 92.51 2.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.766 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -117.43 -2.18 11.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.586 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.676 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 1.2 t -93.28 132.49 37.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -137.28 162.63 33.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.38 -92.49 2.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.403 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -140.36 -69.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 110.845 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 141.54 151.08 5.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.738 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.6 t -147.25 106.46 3.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.899 0.38 . . . . 0.0 110.45 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 2.1 tp60 -66.17 142.22 57.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.203 0.525 . . . . 0.0 111.04 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 91' ' ' THR . 41.1 t -117.62 116.43 51.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.182 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.755 ' CB ' HD23 ' A' ' 11' ' ' LEU . 90.1 m -100.58 108.55 20.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.075 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 116' ' ' SER . 0.3 OUTLIER -108.31 -158.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.396 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.495 ' H ' HG12 ' A' ' 115' ' ' VAL . 0.4 OUTLIER 78.92 -58.4 0.42 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.873 0.368 . . . . 0.0 111.031 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.934 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.829 0.347 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.2 155.37 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -143.41 150.14 38.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 mp -147.82 151.54 36.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -154.32 173.11 16.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.06 164.31 14.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.792 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.92 101.3 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.28 87.17 1.97 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.423 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.62 152.87 16.22 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.447 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.71 -155.25 26.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.41 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.74 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.7 mp -69.03 134.67 49.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.908 0.385 . . . . 0.0 111.247 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG1' HD22 ' A' ' 86' ' ' LEU . 8.0 p -142.33 128.96 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.282 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 132.56 46.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.309 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.658 ' HB3' ' HA ' ' A' ' 117' ' ' SER . . . -46.54 154.26 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.582 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.18 -9.14 73.93 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.792 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.78 -163.14 25.98 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.608 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.48 141.37 41.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.856 ' CD2' HD21 ' A' ' 20' ' ' LEU . 7.1 tp -128.77 132.27 47.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.612 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -111.57 116.9 31.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.381 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.856 HD21 ' CD2' ' A' ' 18' ' ' LEU . 9.9 mt -104.69 133.74 49.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.626 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 p -112.25 134.94 53.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.659 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -134.29 126.12 29.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.92 0.39 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.19 152.75 21.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.971 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' HB3' ' HE2' ' A' ' 34' ' ' MET . . . -134.39 112.96 11.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -103.39 157.35 17.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.12 146.21 10.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.515 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -70.15 137.75 51.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.742 0.306 . . . . 0.0 110.856 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.7 t -159.9 127.63 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.023 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.89 35.83 1.56 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.147 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 t -116.09 46.34 1.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 110.972 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.86 32.38 21.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.01 0.433 . . . . 0.0 110.441 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.619 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.8 138.46 54.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.026 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.442 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 39.1 m-20 -123.45 -176.38 3.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.703 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.406 ' HE2' ' HB3' ' A' ' 24' ' ' ALA . 3.9 ttm -145.63 126.43 14.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.192 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.86 162.71 28.97 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.733 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.435 ' CH2' ' CB ' ' A' ' 20' ' ' LEU . 79.7 m95 -91.63 155.12 18.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 111.487 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -137.69 -177.94 5.02 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.785 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.533 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -151.49 163.14 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.559 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.723 ' O ' HG12 ' A' ' 93' ' ' VAL . 4.5 tp60 -165.91 128.37 2.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.03 0.443 . . . . 0.0 111.621 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -113.45 167.94 8.57 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.496 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.725 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 59.6 Cg_endo -72.3 137.56 28.64 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.233 1.955 . . . . 0.0 112.476 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.33 2.0 24.22 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.703 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -119.48 152.0 37.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -77.21 156.1 31.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.387 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.9 143.0 52.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.951 0.405 . . . . 0.0 111.245 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.43 143.25 48.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.211 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.533 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.6 t -83.57 172.79 12.0 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 111.183 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.533 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.0 t -129.19 -66.64 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.976 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.09 161.67 40.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -160.24 144.4 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.995 0.426 . . . . 0.0 111.511 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.661 HD13 ' HD2' ' A' ' 72' ' ' ARG . 1.4 tt -123.24 143.67 35.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -81.47 177.9 8.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.016 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -118.84 -37.38 3.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.087 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.27 -52.68 13.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.365 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 26.3 t -87.2 -102.34 0.07 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.066 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 55' ' ' SER . . . 177.25 -35.05 0.01 OUTLIER 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.735 0.302 . . . . 0.0 111.339 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.13 148.64 0.41 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.515 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.71 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -108.99 -179.36 3.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.022 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -140.6 142.18 35.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.382 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.466 ' HH ' ' HA ' ' A' ' 69' ' ' THR . 3.7 m-85 -128.86 168.32 16.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.84 0.353 . . . . 0.0 111.026 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.0 168.07 13.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 63' ' ' SER . 56.3 m -69.24 153.07 44.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.498 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 t 84.38 -10.23 0.89 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.522 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.435 HG21 ' CG1' ' A' ' 48' ' ' VAL . 28.6 m -154.2 16.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.462 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 65' ' ' ARG . 8.9 tpt180 -82.08 83.15 7.41 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.665 0.745 . . . . 0.0 109.962 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.09 -0.65 7.71 Favored Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.158 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -110.81 -52.63 2.77 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.837 0.351 . . . . 0.0 110.794 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.3 m-30 -76.86 149.34 36.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.466 ' HA ' ' HH ' ' A' ' 60' ' ' TYR . 6.8 m -111.05 152.37 26.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.71 HG21 HG21 ' A' ' 58' ' ' THR . 6.2 tp -137.49 146.19 28.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.761 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.08 172.33 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 111.032 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.661 ' HD2' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -130.85 143.61 50.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.913 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.409 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 7.2 t0 -83.57 -38.07 22.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.09 26.75 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.43 -42.71 2.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.963 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.25 29.09 2.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.876 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt 61.93 53.97 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.9 m -118.36 148.72 42.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.026 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.75 141.02 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.843 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 24.9 m-85 -125.96 126.69 44.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.977 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -120.63 116.81 26.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 0.0 110.51 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -94.76 94.59 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.156 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.575 ' CE ' HD23 ' A' ' 18' ' ' LEU . 25.9 mtm -78.02 92.91 4.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.798 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.83 176.44 6.63 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 37.21 43.32 0.34 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.695 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.403 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -55.98 156.65 5.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.02 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.508 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.24 170.77 8.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.855 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 89.8 Cg_endo -77.96 8.15 3.62 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.515 2.143 . . . . 0.0 112.954 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -116.92 7.52 13.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.257 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -92.4 -10.06 39.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.304 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 97.9 m -53.97 107.79 0.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.256 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.29 177.0 4.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 39' ' ' GLN . 4.2 p -85.69 106.33 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.027 0.441 . . . . 0.0 110.846 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.96 101.8 13.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.137 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 9.1 m -113.13 136.03 53.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.609 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 25.6 p -100.65 147.12 26.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.029 0.442 . . . . 0.0 111.365 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.83 -171.28 12.45 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.214 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.619 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -138.19 166.73 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 111.269 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -111.61 176.26 18.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.665 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.49 113.69 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 110.575 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.66 16.97 52.86 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.695 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.87 -14.17 31.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -96.32 179.31 5.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.548 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.66 ' H ' HG22 ' A' ' 103' ' ' THR . 78.0 m95 -143.76 102.64 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.795 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.11 11.02 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.439 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.87 137.91 42.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.642 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -140.73 164.11 31.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.964 0.412 . . . . 0.0 111.034 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.18 -130.71 6.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.337 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -98.81 -63.23 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 0.0 110.807 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.89 151.07 8.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.665 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 111' ' ' THR . 15.4 t -145.28 109.72 4.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.359 . . . . 0.0 110.428 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -68.54 141.63 55.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.208 0.528 . . . . 0.0 111.035 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 91' ' ' THR . 41.3 t -119.21 131.82 70.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.254 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.74 ' CB ' HD23 ' A' ' 11' ' ' LEU . 83.9 m -116.85 138.67 51.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.207 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 116' ' ' SER . 2.0 t -139.11 168.17 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.28 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.518 ' H ' HG12 ' A' ' 115' ' ' VAL . 51.5 m -150.76 -54.53 0.15 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.104 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.658 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 6.2 p . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.88 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.77 0.319 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.558 HG23 ' OG ' ' A' ' 106' ' ' SER . 2.9 m -69.96 152.11 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.236 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.606 ' C ' HD12 ' A' ' 4' ' ' LEU . 3.6 pt20 -133.77 165.3 25.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.606 HD12 ' C ' ' A' ' 3' ' ' GLN . 6.5 mp -140.07 135.32 32.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.17 131.41 44.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.75 164.68 17.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.7 p -158.19 111.73 2.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.03 84.51 1.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.355 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.44 143.81 8.96 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.547 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.83 -156.19 21.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.528 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.764 HD23 ' CG2' ' A' ' 114' ' ' THR . 1.7 mp -69.08 143.19 54.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.919 0.39 . . . . 0.0 111.362 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.97 126.88 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.135 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.57 139.95 56.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -52.32 137.06 29.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.323 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.5 -15.73 60.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.703 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.61 -154.65 7.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.42 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.62 139.29 31.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.011 0.434 . . . . 0.0 111.213 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.837 HD21 HD21 ' A' ' 20' ' ' LEU . 10.8 tp -124.45 135.31 53.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.554 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.06 115.31 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 111.557 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.837 HD21 HD21 ' A' ' 18' ' ' LEU . 12.4 mt -112.61 132.48 55.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.577 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -120.67 113.34 20.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.67 123.14 49.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.791 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.71 165.76 11.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.298 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.96 137.82 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.5 m -122.62 162.74 21.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.986 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.5 152.11 10.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 125.14 25.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.695 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.444 HG21 ' CD2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -149.05 86.41 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.293 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.31 30.95 7.79 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.911 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 t -109.15 33.66 4.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.752 0.31 . . . . 0.0 110.965 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 m 71.69 32.02 2.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.975 0.417 . . . . 0.0 110.424 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.638 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.64 130.27 42.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.741 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.474 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 46.9 m-20 -115.47 -173.65 2.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.86 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.638 ' HB3' HG11 ' A' ' 79' ' ' VAL . 9.3 mtm -145.87 124.71 12.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.055 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.88 152.93 24.88 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.829 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 96' ' ' CYS . 73.1 m95 -88.46 154.82 20.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.114 0.483 . . . . 0.0 111.427 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.63 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.1 m-85 -133.65 -178.69 5.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.266 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.486 ' CD ' HG22 ' A' ' 48' ' ' VAL . 1.6 ptm180 -152.94 157.86 41.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.752 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.422 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 2.2 tm0? -145.46 145.4 31.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.946 0.403 . . . . 0.0 111.336 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.37 151.77 78.11 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.44 139.6 41.75 Favored 'Trans proline' 0 CA--C 1.517 -0.345 0 C-N-CA 122.362 2.041 . . . . 0.0 112.537 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.76 -7.08 43.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.764 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.45 -166.68 1.21 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.798 0.333 . . . . 0.0 110.9 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.86 -171.71 1.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -98.19 133.77 42.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.935 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HG2' ' HG3' ' A' ' 38' ' ' ARG . 4.1 pt-20 -131.79 152.28 51.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.423 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 6.6 t -83.41 174.66 10.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.382 0.61 . . . . 0.0 111.079 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.547 ' CG1' HG21 ' A' ' 64' ' ' VAL . 3.8 t -130.12 -62.47 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.071 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -151.88 129.83 11.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.509 ' O ' HG22 ' A' ' 58' ' ' THR . . . -127.98 145.26 51.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.386 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 58' ' ' THR . 11.0 tt -126.98 142.29 43.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.32 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -88.05 -163.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.74 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -109.01 -33.64 6.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.702 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -178.83 38.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.65 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 t -93.44 -62.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.062 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.24 -62.87 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.339 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.74 -142.52 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.861 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 1.065 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -97.85 -179.77 4.54 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.987 0.423 . . . . 0.0 111.19 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 50' ' ' ALA . 65.3 t80 -139.7 91.0 2.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.64 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.428 ' OH ' HG22 ' A' ' 70' ' ' ILE . 47.3 m-85 -76.83 158.06 31.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.2 172.01 7.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.167 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -69.57 150.87 46.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.618 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.0 OUTLIER 84.72 -11.19 0.81 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.623 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' A' ' 68' ' ' PHE . 16.4 m -149.21 12.45 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.48 79.2 1.05 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.537 0.684 . . . . 0.0 110.7 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.73 3.11 10.26 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.825 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -108.01 -41.32 4.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.732 0.301 . . . . 0.0 111.09 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.592 ' CE2' HG11 ' A' ' 64' ' ' VAL . 9.5 m-30 -94.27 146.72 23.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.124 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.7 m -105.12 158.03 16.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.812 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.065 HG21 HG21 ' A' ' 58' ' ' THR . 2.7 tp -144.79 139.92 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.106 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 m -154.42 137.35 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.679 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.449 ' HB3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -90.13 152.01 21.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.245 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.467 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 39.4 t0 -84.43 -36.5 22.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.793 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m120 58.99 29.98 19.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.95 -46.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.09 31.76 1.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.482 ' HB3' ' HE1' ' A' ' 34' ' ' MET . 22.5 mtmt 62.77 56.14 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 73' ' ' ASP . 60.6 m -116.04 150.31 37.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.638 HG11 ' HB3' ' A' ' 34' ' ' MET . 31.5 m -128.5 131.95 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.928 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.577 ' CD1' ' HB3' ' A' ' 21' ' ' SER . 25.6 m-85 -113.09 120.58 41.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.195 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.618 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -114.09 112.61 23.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.068 179.499 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -96.35 96.84 9.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.203 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.674 ' SD ' HD23 ' A' ' 18' ' ' LEU . 1.3 mtp -81.94 88.3 6.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.03 177.66 6.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.57 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 t 37.98 40.85 0.32 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.516 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 162.62 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.628 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -128.99 170.83 9.84 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.779 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 84.5 Cg_endo -77.67 10.82 2.4 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 113.089 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -122.02 10.98 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.342 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -95.94 -15.46 22.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.608 0.242 . . . . 0.0 111.36 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.556 ' OG1' HG23 ' A' ' 115' ' ' VAL . 82.9 m -49.27 112.86 0.69 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.435 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.34 173.65 5.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.969 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 93' ' ' VAL . 7.4 p -81.1 105.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.979 0.419 . . . . 0.0 110.925 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -83.95 99.08 10.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.959 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 4.3 m -105.63 128.03 53.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 14.0 p -95.15 143.78 26.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.964 0.411 . . . . 0.0 111.224 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' HA2' HD22 ' A' ' 4' ' ' LEU . . . -139.81 -173.06 13.03 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.158 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.638 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -144.69 166.37 25.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.957 0.408 . . . . 0.0 111.264 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.93 171.68 18.21 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.676 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.01 115.5 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.621 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.89 15.8 50.05 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.782 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.77 -14.67 31.98 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.528 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.5 m -99.1 178.79 4.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.789 0.328 . . . . 0.0 110.608 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.651 ' H ' HG22 ' A' ' 103' ' ' THR . 71.5 m95 -138.2 93.06 2.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.655 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -119.2 2.33 11.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.52 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.558 ' OG ' HG23 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -96.04 132.72 41.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 110.898 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -140.91 164.93 28.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.71 -154.81 18.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -30.75 20.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.333 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.94 151.0 26.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.883 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 111' ' ' THR . 12.4 t -145.34 109.45 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.262 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 2.1 tp60 -67.61 141.55 56.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.158 0.504 . . . . 0.0 111.052 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 91' ' ' THR . 43.5 t -119.87 126.23 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.329 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.764 ' CG2' HD23 ' A' ' 11' ' ' LEU . 94.8 m -109.99 142.62 41.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.955 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 87' ' ' LYS . 2.6 t -127.52 169.54 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.155 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.689 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -149.01 -162.9 1.66 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.813 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.881 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.8 162.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.78 150.23 39.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 mp -149.12 155.1 40.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -150.66 161.11 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.714 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.81 164.72 12.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.83 0.348 . . . . 0.0 110.978 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -164.76 95.65 0.72 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.59 -28.43 2.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.638 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.825 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.0 138.43 20.89 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.9 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.0 -172.49 43.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.089 -0.576 . . . . 0.0 112.373 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.794 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.5 mp -69.35 150.03 47.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.863 0.363 . . . . 0.0 111.554 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.665 ' CG1' HD22 ' A' ' 86' ' ' LEU . 7.8 p -153.39 116.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.941 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.74 139.77 25.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.426 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.17 123.3 7.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.82 0.56 60.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.834 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.31 138.55 14.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.449 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 t -79.68 141.54 36.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 110.966 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.646 HD23 HD21 ' A' ' 20' ' ' LEU . 14.9 tp -132.92 150.44 52.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.309 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' C ' HD23 ' A' ' 20' ' ' LEU . 4.9 ttt180 -125.45 126.56 45.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.402 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.825 HD22 ' HA2' ' A' ' 9' ' ' GLY . 2.2 mt -114.49 149.72 35.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.799 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 71.1 m -131.21 118.63 20.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.05 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 19.0 p -125.37 131.34 52.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.58 169.11 9.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.311 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.61 105.29 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.9 p -97.89 103.03 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.52 161.49 13.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -69.94 92.94 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.579 ' O ' HG23 ' A' ' 28' ' ' THR . 12.6 t -154.3 105.35 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.001 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' A' ' 53' ' ' TRP . . . -165.86 34.23 0.24 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.485 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.5 t -121.86 -74.06 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 111.326 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.1 p -114.0 -27.42 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.404 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -69.45 130.84 43.63 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.919 0.39 . . . . 0.0 111.275 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.436 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 44.2 m-20 -101.6 -172.45 2.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.941 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.406 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -143.6 124.1 13.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.733 0.301 . . . . 0.0 111.273 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.52 166.11 29.62 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.939 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.518 ' CE2' HD22 ' A' ' 81' ' ' LEU . 52.6 m95 -91.9 156.2 17.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.133 0.492 . . . . 0.0 111.307 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 8.1 m-85 -136.45 179.18 6.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.938 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 16.7 ptm180 -152.86 160.56 43.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.723 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.645 ' O ' HG12 ' A' ' 93' ' ' VAL . 12.6 tt0 -165.5 159.83 17.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.064 0.459 . . . . 0.0 111.459 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -136.01 162.33 57.32 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.506 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 52.2 Cg_endo -69.59 137.39 35.86 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.387 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.54 3.07 38.67 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.722 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 -172.87 2.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.783 0.325 . . . . 0.0 111.058 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.85 -178.84 3.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.739 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.408 ' HD2' ' CH2' ' A' ' 107' ' ' TRP . 18.2 ptt-85 -103.28 139.65 38.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.173 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HG3' ' CG ' ' A' ' 38' ' ' ARG . 18.1 pt-20 -140.73 146.74 38.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.236 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.7 t -83.85 175.2 9.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.316 0.579 . . . . 0.0 111.363 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.4 -57.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.786 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.29 157.66 43.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.719 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -158.19 140.97 14.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.06 0.457 . . . . 0.0 111.484 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.679 HD13 HG23 ' A' ' 58' ' ' THR . 7.5 tp -121.21 139.82 47.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.835 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -72.83 157.65 37.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.933 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.445 ' CD1' ' HA2' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -88.65 81.61 7.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.533 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.414 ' O ' ' CB ' ' A' ' 55' ' ' SER . 4.8 p-10 173.75 -27.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.974 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER 80.37 86.38 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.759 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.36 -44.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.139 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.428 ' O ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -149.04 149.4 31.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.998 0.428 . . . . 0.0 111.291 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.679 HG23 HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -117.48 -178.13 3.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.599 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.6 t80 -136.93 142.59 42.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.561 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.431 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 5.8 m-85 -126.44 165.77 18.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.976 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.6 166.41 11.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.5 152.13 45.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.703 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 83.62 -10.15 0.98 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.571 -178.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.422 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 35.6 m -152.08 15.39 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.237 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -70.48 78.91 0.56 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.576 0.703 . . . . 0.0 110.752 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.51 3.35 5.63 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.0 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -112.29 -44.04 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.754 0.311 . . . . 0.0 111.016 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 5.9 m-30 -78.79 140.2 38.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.786 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 28.9 m -105.45 151.06 24.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 111.164 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.911 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -145.54 136.8 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.634 -179.156 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.911 ' N ' HD13 ' A' ' 70' ' ' ILE . 19.3 p -162.41 141.59 9.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.091 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -73.25 165.42 25.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.958 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.415 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 37.1 t0 -97.19 -33.5 11.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.826 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 60.34 58.36 2.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.17 -46.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -140.38 29.29 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.72 55.48 2.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.62 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.494 ' CG2' ' CE1' ' A' ' 80' ' ' TYR . 6.4 m -123.3 158.94 29.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.109 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.19 143.66 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.715 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 21' ' ' SER . 15.2 m-85 -124.5 135.11 52.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.506 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -127.19 121.04 30.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.084 0.469 . . . . 0.0 110.812 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -99.23 101.15 12.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.838 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.577 ' HE1' HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -87.75 95.22 10.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.181 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.92 175.36 8.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.833 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 34.4 48.33 0.27 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.794 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.665 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -54.34 164.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.004 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.671 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -128.68 164.46 38.24 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.813 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 87' ' ' LYS . 63.1 Cg_endo -72.82 6.32 2.5 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.533 2.155 . . . . 0.0 113.155 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -111.89 -0.03 15.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.282 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -84.91 -11.73 54.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.576 0.227 . . . . 0.0 111.237 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 90.8 m -56.02 103.5 0.1 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.67 175.65 4.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.381 . . . . 0.0 111.583 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.678 ' O ' HG13 ' A' ' 93' ' ' VAL . 7.7 p -80.84 105.37 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.082 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 111' ' ' THR . 9.8 m-85 -84.42 105.04 14.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.656 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.4 m -110.96 127.38 55.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.9 t -81.17 127.4 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.485 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -128.15 -177.41 14.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.471 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 34' ' ' MET . . . -146.13 147.77 31.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.848 0.356 . . . . 0.0 111.213 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.458 ' N ' ' CE3' ' A' ' 104' ' ' TRP . . . -78.77 -170.07 37.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.374 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.28 100.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.67 18.54 45.71 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.761 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.19 -20.28 11.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -97.62 -179.81 4.59 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 110.426 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.664 ' H ' HG22 ' A' ' 103' ' ' THR . 71.8 m95 -145.55 102.54 3.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.945 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -134.96 15.6 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.298 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.37 133.22 51.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.786 0.326 . . . . 0.0 110.66 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.408 ' CH2' ' HD2' ' A' ' 45' ' ' ARG . 9.4 m95 -136.25 162.15 33.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.28 -137.19 9.13 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.494 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -87.07 -51.02 6.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.334 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.39 151.28 12.88 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.661 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 111' ' ' THR . 13.9 t -158.56 118.57 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -79.44 142.64 35.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.004 0.43 . . . . 0.0 111.176 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 91' ' ' THR . 52.6 t -116.31 136.48 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.159 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.794 ' CB ' HD23 ' A' ' 11' ' ' LEU . 99.6 m -109.31 130.0 55.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.011 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.671 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -126.18 -158.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.55 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.469 ' H ' HG12 ' A' ' 115' ' ' VAL . 1.3 t 65.66 169.96 0.21 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.869 0.366 . . . . 0.0 110.87 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.945 -179.9 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.448 ' HG2' HG22 ' A' ' 2' ' ' VAL . 40.3 tt0 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.541 0.21 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.869 HG12 ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER -112.33 151.76 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.634 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.609 ' C ' HD12 ' A' ' 4' ' ' LEU . 5.0 pt20 -89.62 155.1 19.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.124 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 3' ' ' GLN . 4.0 mp -160.61 99.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.02 174.01 8.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.012 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.37 163.97 22.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.733 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -169.62 135.94 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.08 -18.36 26.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.729 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.403 ' HA2' ' CD2' ' A' ' 20' ' ' LEU . . . -54.07 -173.83 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.831 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.12 164.36 10.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.509 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.789 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.5 mp -69.28 146.51 52.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.85 0.357 . . . . 0.0 111.376 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 12' ' ' VAL . 8.5 p -165.53 119.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.174 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -54.76 154.5 5.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.24 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -49.64 138.3 14.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.358 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.99 -21.79 44.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.487 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.52 122.98 6.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.305 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.531 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . 11.4 p -70.0 130.53 42.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 111.131 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.779 ' CD2' HD21 ' A' ' 20' ' ' LEU . 12.7 tp -109.74 133.74 52.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.494 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -107.29 119.2 38.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 0.0 111.422 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.779 HD21 ' CD2' ' A' ' 18' ' ' LEU . 13.9 mt -114.53 136.32 53.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.534 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.5 p -122.34 111.05 16.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.122 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.4 t -107.29 134.52 50.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.514 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.29 152.4 26.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.253 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.32 154.0 38.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.869 ' HB3' HG12 ' A' ' 2' ' ' VAL . 12.2 t -69.93 121.56 17.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.08 56.99 5.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.541 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -125.3 62.14 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.851 HG21 ' CD1' ' A' ' 32' ' ' TYR . 16.5 p -117.9 -161.1 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.706 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.36 -33.84 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.141 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.0 t -69.95 -75.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.4 t -174.36 41.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.851 ' CD1' HG21 ' A' ' 28' ' ' THR . 0.0 OUTLIER -69.6 130.72 43.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.854 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -120.26 -171.45 2.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.715 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -139.67 160.32 40.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.923 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . 179.56 141.62 4.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.0 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.526 ' CD2' HD22 ' A' ' 81' ' ' LEU . 81.4 m95 -82.72 154.7 24.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.15 0.5 . . . . 0.0 111.285 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.5 m-85 -137.89 -178.27 5.18 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.296 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.523 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -148.85 161.04 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.494 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.725 ' O ' HG12 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -162.7 137.51 6.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.005 0.431 . . . . 0.0 111.387 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.709 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -121.15 166.77 14.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.49 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.709 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 38.0 Cg_endo -66.21 135.77 41.42 Favored 'Trans proline' 0 CA--C 1.517 -0.355 0 C-N-CA 122.169 1.913 . . . . 0.0 112.248 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.43 6.35 33.92 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.458 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.51 -177.23 3.18 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.832 0.348 . . . . 0.0 111.022 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -109.7 -171.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.775 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -86.12 134.43 33.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.078 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -131.74 116.45 17.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.412 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 1.5 t -68.09 169.22 10.56 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.599 0.714 . . . . 0.0 111.328 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.523 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.3 t -132.63 -68.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.372 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -140.94 145.99 36.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.71 0.29 . . . . 0.0 111.307 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.544 ' O ' HG22 ' A' ' 58' ' ' THR . . . -140.85 142.18 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.466 ' HB ' HG23 ' A' ' 58' ' ' THR . 2.4 tt -125.23 145.75 32.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.56 -167.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.249 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.32 59.49 1.02 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.008 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -177.28 32.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.37 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 m 41.67 33.76 0.34 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.441 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.34 -57.1 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.147 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.81 178.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.06 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.725 HG21 ' CG2' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -118.42 -178.02 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.978 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 52.9 t80 -139.19 96.2 3.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.892 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.37 158.16 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.842 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . -98.13 157.16 16.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 63' ' ' SER . 17.3 p -69.38 151.57 45.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.572 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 86.47 -12.3 0.59 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.556 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.673 HG12 ' HD2' ' A' ' 67' ' ' ARG . 14.8 m -141.97 7.67 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.497 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 80.23 0.55 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.561 0.696 . . . . 0.0 110.781 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 139.49 1.77 1.86 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.619 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.673 ' HD2' HG12 ' A' ' 64' ' ' VAL . 13.4 ptp180 -117.96 -40.03 3.03 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.779 0.289 . . . . 0.0 111.303 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 83' ' ' MET . 14.4 m-30 -90.23 159.0 16.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.115 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.8 m -125.23 157.19 37.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.867 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -156.32 134.47 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.997 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.867 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -160.13 140.25 11.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.842 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -78.24 173.3 12.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.95 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.413 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 33.3 t0 -98.99 -33.59 10.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.034 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.22 28.7 17.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.54 -59.82 1.51 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.953 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -128.06 28.47 5.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.5 60.02 0.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.149 0.5 . . . . 0.0 110.729 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -122.84 147.93 45.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.047 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.6 m -119.78 139.37 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 41.1 m-85 -124.45 115.88 21.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 0.0 111.197 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.691 HD23 ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -112.24 111.77 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.139 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.531 ' NE2' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -95.42 97.29 9.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.769 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.496 ' HE1' ' CZ ' ' A' ' 94' ' ' TYR . 5.3 mtp -77.18 87.66 3.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.258 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -82.02 176.37 9.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.702 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 37.4 48.55 0.86 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.753 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.514 HD23 ' CG2' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -65.98 157.77 29.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.978 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.69 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -129.33 173.83 5.25 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.773 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.38 9.16 3.53 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.613 2.208 . . . . 0.0 113.034 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -113.04 -4.95 13.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.1 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.29 -12.25 58.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.239 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 76.2 m -48.94 104.06 0.06 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.46 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.4 166.62 8.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.365 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 39' ' ' GLN . 9.8 p -76.33 105.26 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.038 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.496 ' CZ ' ' HE1' ' A' ' 83' ' ' MET . 5.0 m-85 -82.54 100.26 10.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.4 m -109.11 134.48 51.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 26.7 p -96.49 146.14 25.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.033 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.16 -178.35 16.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.555 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -131.65 170.18 15.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -118.26 172.56 14.49 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.802 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -159.09 118.08 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.504 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.11 16.03 51.98 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.696 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.31 -12.78 36.73 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.673 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.668 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -98.13 180.0 4.57 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.744 0.307 . . . . 0.0 110.672 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.668 ' H ' HG22 ' A' ' 103' ' ' THR . 83.6 m95 -138.45 101.61 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.815 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -123.21 -8.49 8.19 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.474 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.506 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -91.42 140.4 29.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.827 0.346 . . . . 0.0 111.112 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -141.88 165.47 27.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.795 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.27 -149.25 13.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.524 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.03 -55.63 3.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.686 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.91 150.98 9.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.763 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 111' ' ' THR . 12.4 t -146.84 112.21 5.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.375 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 1.9 tp60 -61.95 140.52 58.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.222 0.534 . . . . 0.0 111.012 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.9 t -119.13 97.64 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.037 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.789 ' CB ' HD23 ' A' ' 11' ' ' LEU . 60.5 m -86.13 135.69 33.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 111.285 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 87' ' ' LYS . 2.0 t -130.87 168.0 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.184 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -136.46 -167.53 2.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.99 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.259 -0.876 . . . . 0.0 110.853 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.814 0.34 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.656 HG12 ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER -113.21 156.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -149.73 173.05 14.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.954 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mp -145.6 162.87 36.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.42 141.96 27.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -94.52 167.79 11.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -168.85 115.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.869 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.23 -34.77 4.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.555 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.83 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -51.42 138.94 27.33 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.817 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.42 -162.88 31.11 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.44 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.597 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.3 mp -69.45 152.23 45.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.846 0.355 . . . . 0.0 111.404 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.578 ' O ' HG13 ' A' ' 12' ' ' VAL . 9.7 p -170.12 109.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -57.56 152.29 15.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.338 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -52.45 153.65 2.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.376 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.08 5.18 75.16 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.722 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.71 119.78 4.37 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.395 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.2 136.82 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 111.032 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.682 HD23 HD21 ' A' ' 20' ' ' LEU . 6.7 tp -127.34 131.3 50.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.403 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.611 ' C ' HD23 ' A' ' 20' ' ' LEU . 4.0 ttt-85 -107.42 133.0 52.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.901 0.381 . . . . 0.0 111.418 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.83 HD22 ' HA2' ' A' ' 9' ' ' GLY . 1.1 mt -120.15 150.78 40.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.072 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.3 p -123.23 140.31 53.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.204 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 48.4 t -134.1 135.15 43.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.697 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.3 157.09 20.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.11 -168.81 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.051 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.656 ' HB3' HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -110.21 152.94 25.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.897 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.23 23.3 35.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.667 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -94.14 55.96 2.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.924 0.392 . . . . 0.0 110.836 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.2 t -167.19 -166.46 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.6 42.2 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.763 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.0 t -122.92 -70.31 0.78 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.378 . . . . 0.0 110.821 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.64 28.34 1.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.787 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 5.4 t80 -69.85 141.06 53.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.056 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.92 172.39 13.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.55 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.465 ' O ' HG22 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -137.92 117.56 13.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.847 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -145.85 149.65 21.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.849 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.469 ' CE2' HD22 ' A' ' 81' ' ' LEU . 67.4 m95 -88.32 153.62 21.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.13 0.49 . . . . 0.0 111.175 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.3 m-85 -132.32 -178.88 5.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.588 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.676 ' CD ' HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -151.97 157.21 41.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.157 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -157.69 141.4 15.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 111.416 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -127.53 161.63 53.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.535 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 41.0 Cg_endo -67.36 137.09 42.21 Favored 'Trans proline' 0 CA--C 1.518 -0.315 0 C-N-CA 122.287 1.991 . . . . 0.0 112.384 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.37 3.74 40.8 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.671 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -112.51 -176.06 2.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.872 0.368 . . . . 0.0 111.056 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -111.53 157.27 20.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.483 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 15.8 ptt-85 -74.47 133.15 42.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.12 0.486 . . . . 0.0 111.732 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 16.4 pt-20 -134.54 165.11 25.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.903 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 12.1 t -101.03 172.64 6.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.194 0.521 . . . . 0.0 111.164 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.676 HG22 ' CD ' ' A' ' 38' ' ' ARG . 2.8 t -128.95 -67.51 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.367 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.02 135.42 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.0 111.367 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.704 ' O ' HG22 ' A' ' 58' ' ' THR . . . -131.65 144.75 51.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.627 HD12 HG23 ' A' ' 58' ' ' THR . 0.7 OUTLIER -128.11 143.69 40.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.251 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -69.72 -165.24 0.08 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.189 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.19 -58.49 2.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.73 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -54.54 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.187 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 p 173.48 69.12 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.901 0.381 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.84 -72.3 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.77 -170.18 1.0 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.062 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.891 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -115.86 -177.79 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 77.1 t80 -139.41 92.27 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.805 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.401 ' CB ' ' HG2' ' A' ' 65' ' ' ARG . 74.9 m-85 -78.7 159.55 27.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.89 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.82 161.51 15.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 0.0 111.304 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' SER . 32.8 t -69.28 152.21 45.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.477 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.8 t 88.83 -14.4 0.36 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.515 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.405 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 34.9 m -150.49 16.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.432 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.401 ' HG2' ' CB ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -78.72 81.3 5.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.523 0.678 . . . . 0.0 111.151 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.89 -11.2 2.36 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.185 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' CG ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -109.46 -51.37 2.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.777 0.323 . . . . 0.0 111.247 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CE2' ' HG2' ' A' ' 83' ' ' MET . 3.1 m-85 -69.93 140.15 53.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.905 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 7.5 m -110.82 146.08 37.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.778 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.891 HG21 HG21 ' A' ' 58' ' ' THR . 1.1 tp -136.42 140.94 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.88 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.451 ' N ' HG13 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -151.13 -174.44 4.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.81 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.523 ' HG3' HG12 ' A' ' 79' ' ' VAL . 6.6 ttm180 -130.83 168.06 17.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.005 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 34.3 t0 -97.32 -37.56 10.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.844 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.41 35.92 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.81 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.32 -67.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.098 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 29.82 7.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.36 44.99 14.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.68 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 46.6 m -112.64 151.5 30.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.173 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.523 HG12 ' HG3' ' A' ' 72' ' ' ARG . 33.5 m -121.22 158.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.381 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 33.9 m-85 -141.71 129.88 22.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.026 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.469 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -125.21 122.15 36.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.094 0.473 . . . . 0.0 110.898 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -95.57 95.96 8.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.522 ' SD ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -77.08 88.43 3.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.855 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.4 176.26 7.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 36.41 40.76 0.13 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.588 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.614 HD23 ' CG2' ' A' ' 115' ' ' VAL . 0.1 OUTLIER -51.14 158.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.182 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 6.2 mptt -127.64 162.91 46.24 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.78 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 74.2 Cg_endo -74.91 5.71 3.78 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.457 2.105 . . . . 0.0 112.927 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -109.73 -6.82 15.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.134 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.34 -19.4 46.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 89.7 m -50.42 106.83 0.13 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.864 0.364 . . . . 0.0 111.25 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.34 -176.2 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.977 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -87.51 103.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.854 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.537 ' O ' HG22 ' A' ' 111' ' ' THR . 4.1 m-85 -82.75 108.75 16.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.468 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.2 m -107.5 130.68 54.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.316 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 50.6 t -92.35 138.73 31.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.623 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -146.98 176.36 25.89 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.826 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.621 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -126.7 172.94 9.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 0.0 111.011 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -124.84 178.21 16.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.185 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -171.38 122.48 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.379 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.66 15.7 54.39 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.642 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.83 -9.4 47.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.826 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.653 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.3 m -100.16 178.67 4.71 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 110.775 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.653 ' H ' HG22 ' A' ' 103' ' ' THR . 80.0 m95 -140.89 90.95 2.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -110.26 -6.62 14.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.372 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.621 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -90.85 131.26 36.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.706 0.288 . . . . 0.0 110.782 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -141.3 164.09 31.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.001 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.34 -136.66 8.43 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.46 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -102.96 -35.65 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.928 0.394 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.6 151.1 12.59 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.68 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.7 t -144.26 104.77 4.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.852 0.358 . . . . 0.0 110.457 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -63.77 141.12 58.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 111.113 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 91' ' ' THR . 46.4 t -119.79 130.34 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.304 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.597 ' CB ' HD23 ' A' ' 11' ' ' LEU . 69.1 m -115.72 133.28 56.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.115 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.614 ' CG2' HD23 ' A' ' 86' ' ' LEU . 2.1 t -133.44 168.01 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.306 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.756 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 8.2 t -145.33 -165.37 2.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.968 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.828 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.817 0.342 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 2' ' ' VAL . 3.2 m -69.98 147.85 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.247 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -76.51 170.12 16.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 106' ' ' SER . 1.7 mp -156.44 119.26 4.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.133 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -122.9 165.7 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.576 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.44 163.32 15.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.774 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.45 131.23 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.11 -28.36 11.22 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.663 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.401 ' HA2' ' CD2' ' A' ' 20' ' ' LEU . . . -53.23 164.23 2.14 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.869 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.64 171.29 25.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.41 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.839 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.9 mp -69.07 137.2 53.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.928 0.394 . . . . 0.0 111.398 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.23 128.57 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.991 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -64.2 149.35 48.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -49.35 144.32 5.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.382 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.98 -14.95 63.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.635 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.29 129.67 9.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.37 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.08 135.54 49.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 111.03 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.886 HD21 HD21 ' A' ' 20' ' ' LEU . 7.1 tp -119.51 132.12 55.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.292 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -114.04 116.53 29.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.828 0.347 . . . . 0.0 111.369 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.886 HD21 HD21 ' A' ' 18' ' ' LEU . 14.5 mt -107.6 138.31 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.403 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 90.9 p -124.96 120.08 30.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.962 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.439 ' HB3' ' CG1' ' A' ' 79' ' ' VAL . 26.8 t -117.89 131.35 56.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.022 0.439 . . . . 0.0 110.595 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.91 149.14 31.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.287 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.97 -168.97 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.022 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -100.34 147.38 25.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.841 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.55 69.73 3.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.553 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -169.8 76.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 0.0 110.843 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 t -156.89 -168.75 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.29 38.36 0.23 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.615 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.75 54.1 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.97 0.414 . . . . 0.0 110.745 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.5 m 72.74 13.79 5.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.586 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -69.44 147.28 51.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.928 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.44 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 23.4 m-20 -129.15 -169.13 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.471 ' O ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -148.16 120.73 8.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.098 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -144.95 168.87 26.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.861 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.515 ' CD2' HD22 ' A' ' 81' ' ' LEU . 74.8 m95 -107.14 159.5 16.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 111.19 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 11.0 m-85 -137.74 178.3 7.21 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.726 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 10.6 ptm180 -156.34 154.04 29.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.398 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.505 ' O ' HG12 ' A' ' 93' ' ' VAL . 5.0 tp60 -157.02 119.32 3.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.953 0.406 . . . . 0.0 111.449 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -102.91 169.79 7.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.575 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.782 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 58.4 Cg_endo -71.73 138.96 32.86 Favored 'Trans proline' 0 CA--C 1.517 -0.328 0 C-N-CA 122.241 1.961 . . . . 0.0 112.447 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.92 3.44 35.84 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.712 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -118.1 158.41 25.08 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.947 0.403 . . . . 0.0 110.984 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.47 157.23 19.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.215 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.441 ' NE ' ' CZ3' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -69.92 144.36 52.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.165 0.507 . . . . 0.0 111.13 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' ' HG3' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -149.29 146.91 27.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.407 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 2.6 t -77.01 173.11 12.17 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.456 0.646 . . . . 0.0 111.421 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.423 ' N ' ' OG ' ' A' ' 47' ' ' SER . 15.9 t -127.21 -60.63 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.235 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.523 ' CB ' HD13 ' A' ' 70' ' ' ILE . . . -151.99 123.23 7.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.957 0.408 . . . . 0.0 111.197 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.612 ' O ' HG22 ' A' ' 58' ' ' THR . . . -120.34 147.47 44.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.231 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.713 ' CD1' HG23 ' A' ' 58' ' ' THR . 3.1 tp -132.03 141.54 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.027 0.441 . . . . 0.0 111.459 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' N ' HG13 ' A' ' 51' ' ' ILE . 10.3 m120 -71.21 170.1 13.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.815 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -100.19 30.02 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.871 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -140.3 15.92 2.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.183 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.7 p 50.08 43.12 25.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.876 0.369 . . . . 0.0 111.092 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.65 -65.68 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.344 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -153.56 160.77 42.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.998 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.713 HG23 ' CD1' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -105.92 -179.3 3.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.777 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 9.5 t80 -138.6 85.93 2.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.666 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.485 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 58.5 m-85 -72.39 161.74 30.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.06 162.76 15.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 63' ' ' SER . 7.1 m -69.46 151.53 45.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.556 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.3 t 86.33 -12.23 0.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.584 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.464 HG11 ' CE2' ' A' ' 68' ' ' PHE . 34.2 m -145.33 10.27 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.484 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.413 ' HG2' ' CB ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -80.2 81.08 6.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.514 0.673 . . . . 0.0 110.971 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 139.51 -3.62 2.68 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.364 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.86 -51.9 1.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.637 0.256 . . . . 0.0 111.297 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CE2' HG11 ' A' ' 64' ' ' VAL . 5.4 m-30 -69.93 159.16 34.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.554 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 28.9 m -124.17 148.35 47.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.375 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.628 ' CG2' HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -138.99 136.31 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.678 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.472 ' O ' HG23 ' A' ' 79' ' ' VAL . 16.8 p -153.44 -173.76 4.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 111.076 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.45 160.39 39.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.982 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.41 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 13.6 t0 -90.55 -44.77 9.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 69.72 11.69 7.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.71 -34.96 6.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.891 0.377 . . . . 0.0 110.776 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -142.5 26.89 1.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.633 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.65 52.44 5.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.68 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.9 m -116.06 152.2 34.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.095 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 71' ' ' SER . 8.6 p -117.05 143.47 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.453 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 42.5 m-85 -126.64 110.06 12.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.852 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.66 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -112.82 112.29 23.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.46 . . . . 0.0 110.191 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.74 100.29 12.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.269 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.506 ' HE2' HD11 ' A' ' 86' ' ' LEU . 4.7 mtp -81.66 90.48 6.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.829 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 177.09 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 37.46 47.1 0.71 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.671 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.506 HD11 ' HE2' ' A' ' 83' ' ' MET . 0.1 OUTLIER -57.63 165.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.067 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 18.6 mmtt -144.99 164.89 24.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.764 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 55.3 Cg_endo -69.47 2.23 3.56 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.418 2.079 . . . . 0.0 113.222 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -104.34 -0.4 28.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.246 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -89.95 -9.95 46.89 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.41 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 87.1 m -50.35 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.724 0.297 . . . . 0.0 111.156 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.22 169.5 7.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.528 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 93' ' ' VAL . 5.4 p -82.59 107.22 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.291 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.465 ' O ' HG22 ' A' ' 111' ' ' THR . 13.7 m-85 -85.77 105.74 16.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.602 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 37' ' ' PHE . 21.6 m -109.31 138.62 45.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.156 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.4 p -97.64 142.34 29.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.826 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.17 177.16 21.71 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.294 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.663 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -130.29 167.45 18.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.942 0.401 . . . . 0.0 111.098 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.83 175.11 19.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.831 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.86 113.56 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.371 . . . . 0.0 110.735 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.88 16.06 50.83 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.784 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.35 -14.83 33.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.487 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.657 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.1 m -97.92 -179.84 4.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.676 0.274 . . . . 0.0 110.426 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.657 ' H ' HG22 ' A' ' 103' ' ' THR . 77.0 m95 -140.83 98.99 3.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -133.54 10.6 4.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.501 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.663 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -102.38 62.19 0.85 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.308 0.575 . . . . 0.0 110.736 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.441 ' CZ3' ' NE ' ' A' ' 45' ' ' ARG . 29.8 m95 -68.7 165.18 20.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.136 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.77 -121.42 4.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.515 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 -67.79 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 134.41 151.87 6.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.668 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.6 t -151.84 108.35 3.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.551 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 2.0 tp60 -59.23 141.06 55.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.199 0.524 . . . . 0.0 111.13 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 113' ' ' VAL . 37.6 t -121.92 82.85 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.839 ' CB ' HD23 ' A' ' 11' ' ' LEU . 92.7 m -73.25 141.26 47.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 116' ' ' SER . 0.6 OUTLIER -138.71 177.15 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.321 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.658 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 10.5 p -147.65 -171.37 3.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.832 0.349 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.91 155.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.202 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.93 160.31 16.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.92 141.16 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -118.43 164.35 15.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.794 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.85 163.26 17.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.0 t -163.98 119.1 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.63 -22.81 8.11 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.666 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.478 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -47.29 140.62 7.7 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.882 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.39 169.03 37.34 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.375 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.775 HD23 HG21 ' A' ' 114' ' ' THR . 1.8 mp -69.21 145.37 53.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.807 0.337 . . . . 0.0 111.399 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.743 ' CG1' HD22 ' A' ' 86' ' ' LEU . 9.3 p -141.02 132.78 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.38 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.07 139.98 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.452 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.764 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -45.76 130.36 9.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.588 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.65 -20.84 48.87 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.602 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.24 179.66 53.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.571 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 t -120.5 139.0 53.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.992 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.746 HD23 ' CE ' ' A' ' 83' ' ' MET . 9.7 tp -125.6 132.75 52.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.457 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.463 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -114.37 131.17 56.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.0 111.629 -179.315 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.588 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.3 mt -121.24 141.29 51.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.311 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 80' ' ' TYR . 95.4 p -124.03 113.53 18.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' HG23 ' A' ' 78' ' ' THR . 32.6 t -108.18 134.56 50.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.636 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.9 145.46 39.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.155 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.42 113.76 26.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.52 89.05 6.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 153.32 154.52 6.78 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.568 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -76.36 130.71 38.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.078 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 32' ' ' TYR . 44.9 p -85.92 90.28 8.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.26 -34.51 26.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.51 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.86 4.66 47.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.62 0.248 . . . . 0.0 111.392 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.8 p 54.88 50.13 16.29 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.834 0.349 . . . . 0.0 111.065 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -69.7 132.94 46.92 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -59.61 174.86 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.031 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.576 ' HB3' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -143.87 126.59 16.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.17 156.15 26.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.823 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.592 ' CE2' HD22 ' A' ' 81' ' ' LEU . 69.9 m95 -87.31 153.74 21.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.144 0.497 . . . . 0.0 111.315 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.7 m-85 -131.63 178.25 6.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.422 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.608 ' NE ' HG22 ' A' ' 48' ' ' VAL . 7.6 ptt180 -152.34 155.24 37.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.815 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -167.03 148.85 6.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.945 0.402 . . . . 0.0 111.273 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.727 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -126.29 167.19 17.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.606 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.727 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 37.6 Cg_endo -66.15 137.52 48.3 Favored 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 122.228 1.952 . . . . 0.0 112.216 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.92 3.98 45.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.603 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -110.75 -179.61 3.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.819 0.342 . . . . 0.0 110.837 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.01 167.63 9.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.045 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.42 135.19 34.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.098 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HG3' ' CG ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -138.88 166.21 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.657 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 11.4 t -104.47 173.43 6.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.091 0.472 . . . . 0.0 111.078 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.608 HG22 ' NE ' ' A' ' 38' ' ' ARG . 2.4 t -131.52 -66.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.258 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.62 132.04 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.277 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 58' ' ' THR . . . -132.29 145.3 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.276 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.698 ' HB ' HG23 ' A' ' 58' ' ' THR . 19.1 tt -122.78 142.32 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.459 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -81.06 -176.51 5.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.645 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -97.05 68.67 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.966 0.412 . . . . 0.0 110.575 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.83 30.4 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.453 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -85.08 -61.77 1.69 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.084 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.98 -74.52 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.436 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.426 ' HB3' ' H ' ' A' ' 58' ' ' THR . 0.3 OUTLIER -156.05 -159.03 0.86 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.178 -179.365 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.977 HG21 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -97.48 -177.27 3.75 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.967 0.413 . . . . 0.0 110.975 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 63.2 t80 -139.41 93.03 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.725 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CE1' HG22 ' A' ' 70' ' ' ILE . 89.7 m-85 -80.14 158.0 26.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.39 176.13 5.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.282 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.34 152.03 45.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.578 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 62' ' ' SER . 4.0 t 85.82 -11.64 0.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.522 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.9 m -154.32 17.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.442 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 79.32 0.96 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.557 0.694 . . . . 0.0 110.799 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.46 3.47 9.43 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -111.67 -43.65 3.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.0 m-30 -83.36 151.95 25.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.958 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 7.3 m -112.25 149.22 32.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.647 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.977 HG23 HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -163.33 136.84 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.876 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.903 ' N ' HD13 ' A' ' 70' ' ' ILE . 8.0 p -168.35 154.02 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -77.68 139.62 39.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.597 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.506 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 0.4 OUTLIER -79.75 -34.06 40.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.106 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t30 68.21 28.01 6.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.189 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.2 -41.66 4.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.891 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.04 37.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.619 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.5 mttt 61.48 53.12 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.699 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.616 HG22 ' CE1' ' A' ' 80' ' ' TYR . 74.6 m -122.96 147.93 46.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.053 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.7 m -111.57 138.68 39.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.413 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.616 ' CE1' HG22 ' A' ' 78' ' ' THR . 7.3 m-85 -126.21 125.62 42.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.653 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.592 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -122.29 121.68 37.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.181 0.515 . . . . 0.0 110.926 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -100.47 96.79 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.732 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.746 ' CE ' HD23 ' A' ' 18' ' ' LEU . 31.1 mtm -82.21 91.85 6.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.984 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -82.32 176.39 9.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 84' ' ' ASN . 67.1 p 28.99 59.99 0.14 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.754 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.841 HD23 HG22 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -64.54 162.2 15.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.17 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.592 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -126.62 164.42 34.64 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.545 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 74.3 Cg_endo -75.49 6.05 3.84 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.38 2.053 . . . . 0.0 112.956 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -108.51 -6.15 16.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.847 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.31 -16.05 50.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.287 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.5 m -52.76 106.96 0.18 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.771 0.32 . . . . 0.0 111.19 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.5 -170.72 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.436 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 85.6 t -94.33 106.74 18.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.425 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -86.88 103.38 15.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.199 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.3 m -108.49 127.2 53.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 31.9 p -89.78 146.32 24.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.825 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.92 -173.09 20.61 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.463 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -138.17 149.6 46.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 111.107 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . -105.15 148.9 16.65 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.608 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -137.28 122.71 19.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.826 0.346 . . . . 0.0 110.955 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.59 18.38 51.51 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.79 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.75 -10.69 45.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.695 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.667 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.3 m -100.16 -179.96 4.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.667 ' H ' HG22 ' A' ' 103' ' ' THR . 77.2 m95 -145.34 93.92 2.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.884 0.373 . . . . 0.0 110.814 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.4 ' O ' ' CD1' ' A' ' 107' ' ' TRP . 3.8 t70 -112.9 -12.08 13.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.369 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.82 128.76 34.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.768 0.318 . . . . 0.0 110.66 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 105' ' ' ASP . 21.5 m95 -137.87 164.22 29.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.959 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.57 -160.92 19.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -74.23 -38.17 63.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.817 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.52 152.68 26.39 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.647 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.2 t -154.28 122.71 6.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -78.17 143.07 37.54 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.966 0.413 . . . . 0.0 111.131 -179.361 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 91' ' ' THR . 55.4 t -114.8 132.25 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.159 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.775 HG21 HD23 ' A' ' 11' ' ' LEU . 92.3 m -108.48 132.69 53.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.841 HG22 HD23 ' A' ' 86' ' ' LEU . 2.1 t -130.9 168.23 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.344 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.764 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 2.7 p -135.39 -177.13 4.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.785 0.326 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.601 HG12 ' CB ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -133.27 165.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.988 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -101.01 149.77 23.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp -148.4 152.17 36.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -164.22 163.42 22.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.801 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.23 162.52 15.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.4 t -158.08 123.04 4.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.81 -30.17 10.51 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.583 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.835 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.92 139.86 23.26 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.008 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.82 -159.64 24.22 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.379 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.495 HD23 HG21 ' A' ' 114' ' ' THR . 2.0 mp -69.25 151.1 46.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.473 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.845 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.3 p -159.22 109.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.872 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.41 152.2 46.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.118 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.89 129.98 21.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.386 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.35 22.65 50.75 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.57 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.17 116.04 2.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.377 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 92.9 p -69.94 123.67 22.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 111.047 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.751 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.3 tp -126.96 130.78 50.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.525 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -107.61 131.78 54.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.835 HD22 ' HA2' ' A' ' 9' ' ' GLY . 2.9 mt -116.97 148.28 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.098 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB3' ' CD2' ' A' ' 80' ' ' TYR . 82.7 p -127.85 126.69 42.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.567 ' O ' HG22 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -121.38 109.1 14.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.596 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.66 164.46 22.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.381 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -146.42 -168.21 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.04 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.601 ' CB ' HG12 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -114.08 147.35 38.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.97 83.21 0.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.395 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -152.83 106.52 3.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.957 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.557 HG22 ' CD1' ' A' ' 32' ' ' TYR . 18.0 p -141.62 -176.49 4.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.765 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.78 -22.74 5.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.438 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.697 ' O ' HG22 ' A' ' 31' ' ' THR . 2.3 t -114.28 51.36 0.88 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.049 0.452 . . . . 0.0 110.207 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 30' ' ' SER . 7.1 t 52.9 32.5 12.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.864 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.557 ' CD1' HG22 ' A' ' 28' ' ' THR . 9.3 t80 -69.69 112.27 6.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.701 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.422 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 7.5 m-20 -111.89 -176.87 3.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.673 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.75 ' O ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -143.09 113.97 7.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.978 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -139.97 158.74 25.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.905 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.448 ' CE2' HD22 ' A' ' 81' ' ' LEU . 63.8 m95 -92.36 154.86 18.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.282 0.563 . . . . 0.0 111.329 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.7 m-85 -135.67 -178.32 5.07 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.455 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.456 ' HG2' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -148.44 156.13 42.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.89 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.439 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 2.0 mm-40 -153.41 171.07 19.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.9 149.23 14.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.617 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.99 134.72 51.17 Favored 'Trans proline' 0 CA--C 1.517 -0.342 0 C-N-CA 122.273 1.982 . . . . 0.0 112.184 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.53 3.91 35.75 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.479 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.08 178.78 4.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.873 0.368 . . . . 0.0 110.897 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 pm0 -96.22 -176.82 3.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.781 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.82 140.77 39.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.829 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' ' HD3' ' A' ' 38' ' ' ARG . 12.0 pt-20 -140.46 164.28 30.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.628 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.565 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.9 t -107.25 171.66 7.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.141 0.496 . . . . 0.0 111.085 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.456 ' CG2' ' HG2' ' A' ' 38' ' ' ARG . 2.8 t -129.51 -69.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.677 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.82 ' HB1' HG21 ' A' ' 70' ' ' ILE . . . -141.05 147.6 38.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 0.0 111.579 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.577 ' O ' HG22 ' A' ' 58' ' ' THR . . . -136.89 141.34 42.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.193 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 34' ' ' MET . 1.6 tt -117.66 141.59 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.047 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -87.91 -176.5 5.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.125 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -109.17 -32.49 7.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.846 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -161.58 30.2 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 t -86.37 -78.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.778 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.25 -72.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.017 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.6 mpp_? -141.93 -126.9 0.1 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -116.11 -177.58 3.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.948 0.404 . . . . 0.0 111.096 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 50.9 t80 -135.99 91.33 2.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.853 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.802 ' CE2' HG22 ' A' ' 70' ' ' ILE . 56.0 m-85 -80.39 152.19 28.99 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.98 163.53 14.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.366 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.81 33.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.017 0.437 . . . . 0.0 111.674 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.9 t -118.54 -20.15 8.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.116 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.0 m -152.41 21.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.969 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.91 80.7 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.72 0.771 . . . . 0.0 110.9 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 131.42 3.55 4.22 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.162 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -111.11 -45.91 3.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.744 0.306 . . . . 0.0 111.056 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 83' ' ' MET . 9.7 m-30 -97.21 161.14 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.128 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 97.6 m -129.72 94.98 3.86 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.578 0.704 . . . . 0.0 111.371 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.82 HG21 ' HB1' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -91.18 137.37 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.614 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.434 ' N ' HG13 ' A' ' 70' ' ' ILE . 1.7 m -162.96 170.81 17.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 110.959 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -116.75 139.87 50.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.764 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 45.5 t0 -72.71 -31.23 64.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.946 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 58.9 23.34 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.051 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.457 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -115.72 -39.77 3.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.97 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -135.81 25.89 3.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.927 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.67 49.15 10.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.01 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.415 HG22 ' CE1' ' A' ' 80' ' ' TYR . 89.0 m -125.09 145.99 49.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.3 m -109.74 146.5 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.661 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CD2' ' HB3' ' A' ' 21' ' ' SER . 4.2 m-85 -137.61 134.94 36.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.92 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.481 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -128.59 119.16 24.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.068 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -92.51 108.21 19.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.468 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 30.8 mtm -94.39 90.21 6.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.334 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -85.49 175.13 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.67 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 33.16 39.43 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.934 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.605 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -47.51 158.76 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 111.204 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.48 164.25 16.95 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.816 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.74 8.13 4.45 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.66 2.24 . . . . 0.0 112.721 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 10.9 tt0 -119.21 -0.4 11.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.41 -11.04 59.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.658 0.266 . . . . 0.0 111.085 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 113' ' ' VAL . 98.9 m -52.14 108.93 0.33 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 111.345 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.71 174.18 5.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.005 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 93' ' ' VAL . 9.0 p -78.89 104.2 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 111.061 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.504 ' O ' HG22 ' A' ' 111' ' ' THR . 6.0 m-85 -81.22 98.35 8.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.46 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 5.0 m -107.33 129.98 54.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.013 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 28.7 p -99.77 142.57 31.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.682 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -143.05 177.36 22.02 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.318 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.529 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -126.25 164.91 19.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.003 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.18 176.97 22.94 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.724 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.8 117.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.332 . . . . 0.0 110.635 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.58 ' H ' HG22 ' A' ' 31' ' ' THR . . . 62.34 15.0 50.75 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.759 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.42 -11.67 43.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.644 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.65 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.0 m -102.29 179.45 4.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.551 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.65 ' H ' HG22 ' A' ' 103' ' ' THR . 81.2 m95 -136.75 83.58 2.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.06 -9.58 23.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.496 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.529 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -89.66 134.64 34.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.773 0.32 . . . . 0.0 110.81 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -146.0 165.15 29.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.745 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.05 -170.34 21.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.434 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -70.67 -32.12 69.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.95 0.405 . . . . 0.0 110.696 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.72 151.95 25.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.5 t -144.39 102.15 3.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 110.407 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 1.8 tp60 -63.26 138.56 58.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 0.0 111.264 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.489 HG21 ' CD1' ' A' ' 94' ' ' TYR . 52.4 t -112.47 118.25 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.981 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.495 HG21 HD23 ' A' ' 11' ' ' LEU . 70.4 m -97.65 122.29 40.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.346 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.845 HG13 ' O ' ' A' ' 12' ' ' VAL . 1.4 t -150.99 163.79 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.327 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t 168.79 -57.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.803 0.335 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER -112.24 156.11 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.975 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -153.04 174.19 14.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mp -156.35 134.99 11.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.969 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 1.5 tt0 -145.39 129.46 17.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.146 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.21 165.09 15.3 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 p -169.66 112.67 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.006 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.67 -26.02 4.93 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.659 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.657 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -52.78 141.09 29.06 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.931 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.18 -178.37 46.82 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.376 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.677 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.3 mp -69.27 140.19 54.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.897 0.38 . . . . 0.0 111.409 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.9 p -149.44 122.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.078 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -58.86 140.31 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.312 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 115' ' ' VAL . . . -53.61 150.64 6.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.309 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.04 -2.15 82.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.837 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.06 -154.77 26.83 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.439 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -140.94 138.0 33.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.944 0.402 . . . . 0.0 111.214 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.593 ' CD2' HD21 ' A' ' 20' ' ' LEU . 15.2 tp -131.87 148.6 52.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.326 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -124.42 125.72 44.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.377 . . . . 0.0 111.55 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.657 HD22 ' HA2' ' A' ' 9' ' ' GLY . 4.0 mt -116.3 138.84 50.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.234 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 24.0 p -123.25 132.57 54.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.034 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.632 ' O ' HG22 ' A' ' 79' ' ' VAL . 31.6 t -131.53 130.96 42.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.747 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.79 165.9 13.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.197 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.82 -169.25 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.509 ' HB3' HG12 ' A' ' 2' ' ' VAL . 17.5 p -83.76 157.68 22.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.28 -48.41 1.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.52 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.6 mtp85 -70.5 82.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.485 HG21 ' CG ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -134.03 137.5 44.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.04 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.45 30.49 1.72 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.322 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.4 t -126.8 45.67 2.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.779 0.323 . . . . 0.0 110.863 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.451 ' HG1' ' H ' ' A' ' 101' ' ' GLY . 6.5 p 56.11 33.96 22.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.41 . . . . 0.0 110.541 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CG ' HG21 ' A' ' 28' ' ' THR . 62.0 t80 -69.24 79.77 0.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.025 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.486 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 75.0 m-20 -75.43 178.96 5.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.369 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.402 ' HE2' HG11 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -147.77 130.54 16.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 111.366 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -153.11 155.52 26.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.621 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.473 ' CE2' HD22 ' A' ' 81' ' ' LEU . 75.5 m95 -86.97 156.22 19.87 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.359 0.599 . . . . 0.0 111.307 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 6.5 m-85 -140.16 -178.35 5.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.575 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HD2' HG22 ' A' ' 48' ' ' VAL . 1.6 mtp180 -145.81 158.42 43.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.017 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.42 ' HG2' ' CB ' ' A' ' 45' ' ' ARG . 1.8 tm0? -161.33 160.56 29.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.952 0.406 . . . . 0.0 111.303 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.6 155.01 22.14 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.606 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.14 137.42 44.01 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.273 1.982 . . . . 0.0 112.297 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.04 1.07 38.48 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.635 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.83 -177.33 3.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.879 0.371 . . . . 0.0 111.155 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -109.54 159.03 17.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.384 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.42 ' CB ' ' HG2' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -81.14 143.28 32.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 111.123 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.86 140.95 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.431 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.4 t -81.32 172.13 13.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.183 0.516 . . . . 0.0 110.919 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.441 HG22 ' HD2' ' A' ' 38' ' ' ARG . 3.1 t -129.99 -68.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.55 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -146.01 126.67 14.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 0.0 111.368 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.657 ' O ' HG22 ' A' ' 58' ' ' THR . . . -126.2 144.73 50.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.422 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.547 ' HB ' HG23 ' A' ' 58' ' ' THR . 8.0 tt -125.33 148.47 29.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.022 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -99.42 167.73 10.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.89 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -91.41 78.57 5.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.731 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.66 92.83 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.166 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 t -163.91 -74.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.714 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -116.82 -76.43 0.57 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.432 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 4.4 mmm180 -171.18 -103.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.538 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.741 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -137.41 -175.09 3.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.072 0.463 . . . . 0.0 111.028 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.478 ' N ' ' O ' ' A' ' 50' ' ' ALA . 75.1 t80 -139.82 92.48 2.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.542 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -75.0 160.97 29.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.999 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.94 158.69 17.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 63' ' ' SER . 36.5 t -69.35 150.46 47.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.711 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 87.36 -12.94 0.49 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.671 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 m -151.67 14.21 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.566 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.13 81.0 4.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.61 0.719 . . . . 0.0 110.464 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.9 -4.97 2.2 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.427 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.483 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -117.17 -36.67 3.72 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 111.201 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.2 m-30 -82.83 135.87 34.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.83 0.348 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 3.7 m -99.65 145.43 27.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.195 0.521 . . . . 0.0 111.32 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.896 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -133.53 135.94 55.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.251 -179.482 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.896 ' N ' HD13 ' A' ' 70' ' ' ILE . 28.7 t -166.29 146.74 6.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.968 0.413 . . . . 0.0 111.302 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.693 ' NE ' HG12 ' A' ' 79' ' ' VAL . 9.2 mpt_? -114.79 144.5 43.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.658 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -64.93 -30.15 71.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.899 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 57.36 24.9 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.977 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.79 -46.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.916 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.99 19.47 16.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp 56.31 46.94 20.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.905 0.383 . . . . 0.0 110.806 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.409 ' CG2' ' CZ ' ' A' ' 80' ' ' TYR . 42.1 m -120.53 143.32 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.315 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.693 HG12 ' NE ' ' A' ' 72' ' ' ARG . 28.9 m -101.99 150.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.481 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 21' ' ' SER . 28.9 m-85 -145.55 124.25 12.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.279 . . . . 0.0 110.866 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.486 HD21 HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -124.99 121.37 34.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.074 0.464 . . . . 0.0 110.584 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -99.74 94.96 6.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.792 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.573 ' HE1' HD23 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -79.72 95.29 5.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 -179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -88.96 176.89 6.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.619 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 t 36.23 41.94 0.16 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.549 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.81 166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.385 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 3.5 mmtp -126.18 162.26 47.08 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.706 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 64.7 Cg_endo -73.94 8.04 2.19 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.411 2.074 . . . . 0.0 113.104 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -119.42 8.94 11.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.258 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.3 -19.08 30.38 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.592 0.234 . . . . 0.0 111.229 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 63.6 m -49.91 103.66 0.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 111.463 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.02 -174.86 1.87 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.9 t -90.01 105.05 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.654 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.55 ' O ' HG22 ' A' ' 111' ' ' THR . 4.1 m-85 -87.03 107.75 18.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.086 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.413 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 4.7 m -106.86 167.21 10.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.4 ' N ' HG22 ' A' ' 95' ' ' THR . 4.3 p -129.91 133.64 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.421 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.01 -177.12 15.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.695 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 33' ' ' ASP . . . -136.36 167.2 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 111.077 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -108.58 -175.22 21.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.565 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.69 115.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.818 0.342 . . . . 0.0 110.594 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.451 ' H ' ' HG1' ' A' ' 31' ' ' THR . . . 62.1 15.66 50.91 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.701 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.83 -12.44 38.32 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.749 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.663 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.5 m -100.46 178.93 4.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.694 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.663 ' H ' HG22 ' A' ' 103' ' ' THR . 73.9 m95 -140.67 96.62 3.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.684 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -117.9 -5.87 11.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.483 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.63 130.82 37.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.851 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -142.28 164.94 28.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.983 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -101.37 -135.63 8.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.425 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -26.69 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 98.06 148.86 24.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.669 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 94' ' ' TYR . 3.7 t -148.15 119.24 7.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.884 0.373 . . . . 0.0 110.38 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -66.83 139.63 57.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.319 0.58 . . . . 0.0 111.351 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 91' ' ' THR . 37.9 t -123.92 86.52 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.677 ' HB ' HD23 ' A' ' 11' ' ' LEU . 74.1 m -77.71 148.48 34.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.994 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 116' ' ' SER . 2.2 t -126.08 168.58 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.883 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 115' ' ' VAL . 29.2 t -77.42 -72.93 0.33 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.179 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.903 -179.82 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.78 0.324 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -110.69 155.78 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -139.89 177.8 7.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp -151.63 107.39 3.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 71.7 mt-30 -93.65 168.2 11.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.823 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -120.93 163.35 18.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.822 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.36 124.88 4.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.994 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.23 -29.28 10.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.609 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.645 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.92 138.61 25.64 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.847 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.54 -159.62 29.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.352 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.662 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.2 mp -69.38 149.08 48.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.814 0.34 . . . . 0.0 111.375 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.704 HG11 HD22 ' A' ' 86' ' ' LEU . 7.1 p -142.88 126.48 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -70.09 127.05 31.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.012 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 117' ' ' SER . . . -51.45 125.14 13.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.464 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.03 -1.64 33.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.939 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.84 -153.02 10.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.531 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -139.37 142.51 37.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.886 ' CD2' HD21 ' A' ' 20' ' ' LEU . 3.7 tp -124.87 130.12 51.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.283 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.85 128.16 54.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.397 . . . . 0.0 111.562 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.886 HD21 ' CD2' ' A' ' 18' ' ' LEU . 5.5 mt -116.09 136.67 52.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.244 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.431 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 90.5 p -119.31 115.34 23.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.022 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.458 ' O ' HG22 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -113.95 116.45 29.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.11 148.69 21.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.56 ' HB2' ' SD ' ' A' ' 34' ' ' MET . . . -105.64 95.82 6.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.602 ' O ' HG12 ' A' ' 2' ' ' VAL . 77.3 p -69.94 149.37 47.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.55 -139.23 15.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.461 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.41 123.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 0.0 110.827 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 t -157.18 115.63 3.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.37 30.57 7.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.982 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 t -97.04 37.05 1.34 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.827 0.346 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.6 m 65.25 34.15 8.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.406 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -69.25 111.64 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.973 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.429 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 1.0 OUTLIER -86.67 178.31 7.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.032 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.788 ' HB3' HG11 ' A' ' 79' ' ' VAL . 3.9 mtm -146.65 132.32 18.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.031 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.34 151.19 23.36 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.658 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.704 ' CE2' HD22 ' A' ' 81' ' ' LEU . 74.3 m95 -88.29 155.94 19.46 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.206 0.527 . . . . 0.0 111.346 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -138.99 -179.27 5.74 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.703 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.552 ' CG ' HG22 ' A' ' 48' ' ' VAL . 9.9 mtm-85 -143.19 162.09 36.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.922 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -148.45 124.06 10.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.198 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -118.79 157.61 49.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.733 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 48.6 Cg_endo -68.85 137.26 37.73 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.295 1.997 . . . . 0.0 112.383 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 2.26 36.74 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.642 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.97 -175.09 2.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.859 0.361 . . . . 0.0 111.032 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -111.63 -171.73 1.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.636 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -78.2 125.45 29.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -121.53 119.2 31.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.458 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.3 t -71.43 170.69 12.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.269 0.557 . . . . 0.0 110.784 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.1 t -130.94 -69.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.442 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -145.21 128.91 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.035 0.445 . . . . 0.0 111.213 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.682 ' O ' HG22 ' A' ' 58' ' ' THR . . . -123.55 144.78 49.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.127 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 57' ' ' ARG . 8.7 tp -128.96 145.75 35.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.373 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -88.1 -162.11 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.717 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -106.59 -30.22 9.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.339 . . . . 0.0 110.846 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 55' ' ' SER . 73.2 m-20 -125.99 156.21 40.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.818 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.657 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 1.0 OUTLIER 86.09 -29.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.537 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 55' ' ' SER . . . 82.72 -12.61 0.89 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.858 0.361 . . . . 0.0 111.67 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.67 ' O ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -54.34 139.76 35.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.688 HG21 ' CG2' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -119.67 -177.9 3.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.902 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' ALA . 8.2 t80 -137.35 89.67 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.739 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -76.82 156.3 32.36 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.05 167.74 9.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.246 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 63' ' ' SER . 18.7 p -69.33 152.69 44.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.551 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 86.09 -11.99 0.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.486 -178.815 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.417 HG11 ' CE2' ' A' ' 68' ' ' PHE . 35.4 m -151.05 15.75 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.385 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.02 79.11 0.66 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.514 0.673 . . . . 0.0 110.724 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.47 3.88 8.45 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.896 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -114.3 -40.98 3.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 111.08 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 5.8 m-30 -93.5 117.38 30.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 11.8 m -79.57 152.57 30.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.907 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -148.38 136.42 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.012 -178.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.907 ' N ' HD13 ' A' ' 70' ' ' ILE . 4.8 m -161.49 -164.65 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.775 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -139.74 169.65 17.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.968 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.405 ' HB2' ' HE1' ' A' ' 80' ' ' TYR . 0.9 OUTLIER -77.75 -12.85 60.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.286 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 44.76 40.24 4.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 111.268 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.9 -49.36 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.064 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 mtmm -115.52 -72.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 167.14 44.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.599 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.2 m -110.33 145.13 38.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.187 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.788 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.6 m -108.66 142.0 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.748 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 1.3 m-85 -134.33 128.93 34.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.913 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.704 HD22 ' CE2' ' A' ' 36' ' ' TRP . 1.3 pt? -127.07 125.82 41.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.064 0.459 . . . . 0.0 110.747 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.81 96.72 8.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.617 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -78.56 88.03 4.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.212 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.62 176.89 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 38.35 48.34 1.17 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.494 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.704 HD22 HG11 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -70.61 165.72 22.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.327 -179.499 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -133.59 178.0 1.98 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.218 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 92.5 Cg_endo -81.31 9.68 3.76 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.316 2.011 . . . . 0.0 112.734 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 7.5 tp10 -109.17 -12.45 14.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.706 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.23 -21.34 58.7 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 110.986 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.532 HG23 ' HA ' ' A' ' 114' ' ' THR . 98.6 m -50.6 107.73 0.19 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.45 -172.34 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.308 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.5 t -90.28 105.15 15.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.542 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.473 ' O ' HG22 ' A' ' 111' ' ' THR . 13.0 m-85 -88.77 107.66 19.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 83.2 m -113.44 136.54 52.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 11.8 p -100.36 160.4 14.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.818 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -159.2 -170.92 24.34 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.999 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 33' ' ' ASP . . . -143.17 172.49 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.745 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -142.27 -175.69 15.8 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.906 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.463 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 31.1 tt0 -162.33 129.02 3.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.59 15.23 46.22 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.852 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.63 -14.36 32.42 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.68 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.6 HG22 ' H ' ' A' ' 104' ' ' TRP . 3.7 m -92.02 176.73 6.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.578 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.6 ' H ' HG22 ' A' ' 103' ' ' THR . 72.2 m95 -147.76 100.21 3.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.768 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -120.71 -3.26 9.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.568 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.89 137.87 34.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.841 0.353 . . . . 0.0 110.86 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -142.89 167.2 22.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.87 -155.8 18.97 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.575 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -87.34 -36.5 17.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 110.853 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.71 153.39 17.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.576 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.6 t -146.9 107.97 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.653 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -68.68 141.57 55.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.133 0.492 . . . . 0.0 110.941 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.1 t -121.75 126.6 74.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.387 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.662 ' HB ' HD23 ' A' ' 11' ' ' LEU . 88.5 m -102.25 133.33 47.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.043 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.431 HG21 HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -149.84 163.03 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.424 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.6 t 177.83 -78.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.555 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 9.8 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.929 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.873 0.368 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.21 155.95 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.469 ' C ' HD12 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -146.57 160.63 41.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.48 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.485 HD11 ' OH ' ' A' ' 32' ' ' TYR . 5.7 mp -142.63 104.27 4.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.83 167.74 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.36 164.98 13.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -162.3 114.3 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.84 -36.3 3.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.656 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.516 ' CA ' HD22 ' A' ' 20' ' ' LEU . . . -50.03 139.12 19.59 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.913 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.39 -170.69 40.05 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.332 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.619 HD23 HG21 ' A' ' 114' ' ' THR . 1.9 mp -69.44 155.24 40.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.903 0.382 . . . . 0.0 111.593 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.53 ' CG1' HD22 ' A' ' 86' ' ' LEU . 8.1 p -169.41 120.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.888 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.66 144.32 27.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.69 124.78 11.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.452 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.99 17.76 31.45 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.68 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.72 -166.68 22.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.543 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -129.28 136.63 50.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.956 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.806 ' CD2' HD21 ' A' ' 20' ' ' LEU . 3.5 tp -142.66 131.03 22.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.585 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.479 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -112.23 132.91 54.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.185 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.806 HD21 ' CD2' ' A' ' 18' ' ' LEU . 4.1 mt -117.13 135.4 53.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.7 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -120.0 105.77 11.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.769 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.97 116.07 31.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.72 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.87 155.47 17.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.292 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HB2' ' HG ' ' A' ' 4' ' ' LEU . . . -169.74 86.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.951 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -105.36 162.77 13.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.028 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 153.8 -113.2 0.56 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -121.04 93.67 4.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 0.0 110.752 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.918 HG21 ' CZ2' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -102.94 -175.71 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.192 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.23 13.35 8.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.903 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.72 50.73 2.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.911 0.386 . . . . 0.0 110.592 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.75 26.73 15.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.62 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.645 ' HB3' HG22 ' A' ' 28' ' ' THR . 53.5 t80 -69.73 65.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.057 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 74.6 m-20 -62.75 -175.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.455 ' O ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -146.9 124.59 11.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.764 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -147.45 150.8 23.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.986 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.451 ' CH2' ' CB ' ' A' ' 20' ' ' LEU . 74.1 m95 -91.44 153.46 19.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.225 0.536 . . . . 0.0 111.371 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.0 m-85 -133.39 -177.15 4.4 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.323 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.772 ' HD3' HG22 ' A' ' 48' ' ' VAL . 14.9 ptt180 -156.54 159.93 39.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.743 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -162.37 133.76 5.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.205 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.736 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -110.54 167.63 8.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.613 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.736 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 48.8 Cg_endo -68.89 138.01 39.55 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.265 1.977 . . . . 0.0 112.328 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.18 4.49 36.4 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.641 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -112.62 -177.12 3.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.868 0.366 . . . . 0.0 111.047 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -102.39 -171.54 1.98 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.581 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.9 ptm85 -100.59 128.89 46.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -131.14 147.92 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.304 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.4 t -82.58 175.68 9.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.263 0.554 . . . . 0.0 111.112 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.772 HG22 ' HD3' ' A' ' 38' ' ' ARG . 3.5 t -132.36 -66.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.143 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.35 123.43 10.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.017 0.437 . . . . 0.0 111.184 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 59' ' ' TYR . . . -118.35 148.85 42.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.108 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 34' ' ' MET . 4.0 tt -133.46 146.54 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.894 0.378 . . . . 0.0 111.534 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -69.93 -173.53 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.922 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.918 ' CZ2' HG21 ' A' ' 28' ' ' THR . 8.2 t-105 -95.69 22.54 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.324 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -164.54 28.76 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.197 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.3 p 47.58 28.69 1.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.313 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.9 -47.99 41.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.07 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -154.37 137.04 15.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.731 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.995 HG21 HG21 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -102.89 178.06 4.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.753 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.769 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 86.2 t80 -140.45 90.81 2.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.668 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.452 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 4.6 m-85 -78.8 159.09 28.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.06 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.75 166.53 11.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 63' ' ' SER . 3.7 t -69.48 151.69 45.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.759 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 84.65 -11.0 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.617 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -152.75 16.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.314 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.452 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -70.64 79.1 0.59 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.559 0.695 . . . . 0.0 110.88 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.96 2.93 8.46 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.88 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -108.34 -33.47 7.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.76 0.314 . . . . 0.0 111.211 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 9.0 m-30 -96.03 127.77 42.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.151 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 56.9 m -83.54 145.04 29.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.375 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.995 HG21 HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -134.74 136.59 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.216 -179.322 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.408 ' N ' HG13 ' A' ' 70' ' ' ILE . 76.9 p -154.92 -175.88 5.65 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.973 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -138.27 165.9 25.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.084 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.718 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 33.8 t70 -86.6 -31.57 21.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t30 60.74 29.5 19.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.718 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -151.9 -57.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.08 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -102.73 11.32 37.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.277 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.49 52.25 4.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.647 ' OG1' ' CZ ' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -115.54 154.93 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.935 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 21' ' ' SER . 6.1 p -119.81 132.11 70.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.84 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.647 ' CZ ' ' OG1' ' A' ' 78' ' ' THR . 17.6 m-85 -118.11 107.96 14.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.132 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 69' ' ' THR . 0.2 OUTLIER -107.74 114.38 28.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.958 179.44 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -94.31 95.23 8.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.304 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.49 ' HB2' HD11 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -80.96 89.85 5.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.981 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -76.95 174.16 10.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.856 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 84' ' ' ASN . 0.6 OUTLIER 22.09 53.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.075 179.643 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.53 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.3 OUTLIER -44.56 162.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.537 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.503 ' O ' HG11 ' A' ' 115' ' ' VAL . 22.3 mmtt -110.75 161.0 26.65 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.787 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 72.1 Cg_endo -76.84 8.15 3.25 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.441 2.094 . . . . 0.0 112.908 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -121.68 2.91 10.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.236 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.66 -12.42 55.96 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.624 0.25 . . . . 0.0 111.23 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 88.9 m -55.89 104.82 0.15 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 111.17 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.54 -174.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.268 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.9 t -87.63 103.26 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.725 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.502 ' CD1' HG21 ' A' ' 113' ' ' VAL . 8.3 m-85 -82.7 105.79 14.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.914 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 88.5 m -111.64 133.18 54.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 28.0 p -100.45 150.09 23.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.014 0.435 . . . . 0.0 111.155 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -143.22 -175.36 16.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.246 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.517 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -135.39 164.4 27.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 111.028 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -96.06 -171.67 35.47 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 179.42 111.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.713 0.292 . . . . 0.0 110.743 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.74 16.14 50.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.693 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 -13.99 36.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.522 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.0 m -100.01 179.17 4.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.605 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.655 ' H ' HG22 ' A' ' 103' ' ' THR . 82.2 m95 -135.5 93.82 3.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.736 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -118.0 -4.27 11.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.341 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.517 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -90.22 135.69 33.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.756 0.313 . . . . 0.0 110.786 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -141.58 165.45 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.094 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.2 -148.22 11.86 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.486 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.02 -48.63 6.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 116.1 151.28 9.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.763 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 t -142.49 110.33 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.333 . . . . 0.0 110.454 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -64.31 141.11 58.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.21 0.528 . . . . 0.0 111.036 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 94' ' ' TYR . 47.0 t -119.12 125.64 74.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.297 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.619 HG21 HD23 ' A' ' 11' ' ' LEU . 75.3 m -101.41 117.94 35.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 111.03 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -133.49 -158.96 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.524 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.412 ' H ' HG12 ' A' ' 115' ' ' VAL . 6.1 t 77.01 169.76 0.24 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.916 0.389 . . . . 0.0 111.077 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.933 -179.878 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.763 0.316 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.695 HG12 ' HA3' ' A' ' 26' ' ' GLY . 4.2 m -69.97 149.11 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.19 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -100.79 154.0 19.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.99 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 mp -146.78 159.01 44.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.793 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -152.7 175.23 13.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.288 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -128.7 173.22 10.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.988 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.1 t -170.16 143.59 2.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.064 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.67 -33.07 5.95 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.725 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.499 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -49.66 140.1 15.85 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.003 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.99 -170.58 43.33 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.396 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.561 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.6 mp -69.49 156.01 39.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.782 0.325 . . . . 0.0 111.414 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.9 p -170.01 115.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.92 158.82 1.92 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.381 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -48.95 145.44 3.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.435 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.09 15.87 65.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.603 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.42 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -105.79 112.18 3.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.348 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.93 131.0 43.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.825 HD23 HD21 ' A' ' 20' ' ' LEU . 6.0 tp -124.21 131.91 53.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.656 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -101.61 128.23 47.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.903 0.382 . . . . 0.0 111.461 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.825 HD21 HD23 ' A' ' 18' ' ' LEU . 8.5 mt -116.06 145.41 43.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.341 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.5 p -125.76 128.51 47.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.899 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 43.9 t -124.76 136.0 53.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -113.09 144.57 42.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.893 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.486 ' HB3' ' CD ' ' A' ' 77' ' ' LYS . . . -121.95 100.31 6.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.321 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.4 p -77.6 109.81 11.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.715 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.695 ' HA3' HG12 ' A' ' 2' ' ' VAL . . . 124.25 167.49 12.71 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.226 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -169.9 99.78 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.348 . . . . 0.0 111.213 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.78 HG22 ' HD2' ' A' ' 32' ' ' TYR . 9.7 t -70.04 -156.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.683 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.87 53.98 0.55 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.287 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 31' ' ' THR . 34.6 t -124.73 -72.93 0.65 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.072 0.463 . . . . 0.0 111.169 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 30' ' ' SER . 0.2 OUTLIER 175.35 54.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.834 -179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.78 ' HD2' HG22 ' A' ' 28' ' ' THR . 0.1 OUTLIER -69.05 173.24 5.68 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.752 -179.186 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -157.46 -173.9 4.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.031 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.12 158.47 43.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.691 0.281 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . 172.35 145.25 4.87 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.045 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.404 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 60.4 m95 -88.55 155.32 19.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.974 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.2 m-85 -132.31 -179.63 5.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.954 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.754 ' HD3' HG22 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -151.68 161.9 41.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.755 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.438 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 2.1 tm0? -149.06 147.24 28.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.183 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.442 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -132.59 158.13 76.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.655 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.442 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 56.0 Cg_endo -70.25 136.19 31.1 Favored 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 122.341 2.027 . . . . 0.0 112.415 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.77 -1.01 25.19 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.602 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -121.02 150.87 40.48 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 120.871 0.367 . . . . 0.0 110.958 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -69.88 -177.23 1.25 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.458 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -94.14 144.59 25.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 7.3 pt-20 -136.11 167.1 21.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.325 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 7.9 t -102.68 172.84 6.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.157 0.503 . . . . 0.0 110.989 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.754 HG22 ' HD3' ' A' ' 38' ' ' ARG . 3.1 t -128.69 -68.78 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.203 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -137.08 144.51 43.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.103 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 58' ' ' THR . . . -144.36 142.43 30.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.414 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.572 ' HB ' HG23 ' A' ' 58' ' ' THR . 2.1 tt -121.47 143.68 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -75.13 157.48 34.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.983 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.72 43.95 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.529 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -176.95 36.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.098 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 25.5 t -169.97 -99.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.803 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 55' ' ' SER . . . 176.56 -37.86 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.088 0 CA-C-O 120.841 0.353 . . . . 0.0 111.313 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -54.18 160.18 1.66 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.557 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 1.04 HG21 HG21 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -127.49 -175.96 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.024 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.525 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 86.8 t80 -139.61 125.47 19.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.456 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.432 ' OH ' HG22 ' A' ' 70' ' ' ILE . 7.2 m-30 -113.68 162.52 16.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.31 160.43 14.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.231 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 p -80.78 36.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.864 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 t -118.22 -20.93 8.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.153 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 66' ' ' GLY . 29.7 m -157.05 21.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.045 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.94 80.07 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.651 0.739 . . . . 0.0 111.045 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 135.93 1.16 3.02 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.316 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.65 -35.72 3.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 111.24 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 4.6 m-30 -93.3 159.85 15.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 62.0 m -129.14 155.07 46.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.04 HG21 HG21 ' A' ' 58' ' ' THR . 5.6 tp -140.53 144.66 26.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.955 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.16 170.87 21.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.971 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -133.91 141.9 47.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.19 -18.49 42.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.214 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.2 p30 44.48 30.26 0.47 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.415 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.13 -74.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.64 23.41 14.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.486 ' CD ' ' HB3' ' A' ' 24' ' ' ALA . 0.1 OUTLIER 70.05 62.54 0.24 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.599 HG22 ' CE1' ' A' ' 80' ' ' TYR . 91.6 m -131.25 143.67 50.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 111.231 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.3 147.87 19.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.341 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.599 ' CE1' HG22 ' A' ' 78' ' ' THR . 3.8 m-85 -135.17 128.07 31.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.852 0.358 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.619 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -121.93 118.05 27.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.357 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.51 103.51 15.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.063 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.559 ' HE1' HG21 ' A' ' 113' ' ' VAL . 22.1 mtm -81.53 88.22 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.92 176.45 7.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 36.07 44.9 0.28 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.791 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.669 HD23 HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -58.72 156.53 10.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -123.74 171.76 6.54 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.085 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 86.1 Cg_endo -81.77 11.12 3.21 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.433 2.089 . . . . 0.0 112.884 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -118.53 -6.31 10.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.355 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.586 ' OD2' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -86.32 -13.19 47.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.499 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.763 ' OG1' HG23 ' A' ' 115' ' ' VAL . 99.4 m -54.53 112.52 1.02 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 111.456 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.2 -170.72 1.01 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.172 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.2 t -94.31 105.36 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.586 ' CE2' HG21 ' A' ' 48' ' ' VAL . 11.0 m-85 -86.87 110.67 20.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.051 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.6 t -109.28 127.34 54.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.981 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 46.9 t -77.42 145.62 37.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.08 166.67 30.53 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.693 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.732 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -131.08 150.12 52.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.328 . . . . 0.0 110.978 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . -96.36 165.45 23.79 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.805 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -158.27 113.8 2.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.55 16.26 49.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.98 -16.0 28.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.496 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.2 m -97.72 179.75 4.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.659 0.266 . . . . 0.0 110.393 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.67 ' H ' HG22 ' A' ' 103' ' ' THR . 81.9 m95 -142.13 91.14 2.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 107' ' ' TRP . 7.4 t70 -106.27 -18.4 14.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.142 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.732 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 2.9 t -75.16 130.3 38.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.799 0.333 . . . . 0.0 110.786 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.403 ' CD1' ' O ' ' A' ' 105' ' ' ASP . 58.0 m95 -139.19 165.04 28.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.708 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.04 -156.37 15.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.539 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -86.21 -25.44 25.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.95 150.31 24.08 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 94' ' ' TYR . 2.4 t -152.31 114.03 4.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.823 0.344 . . . . 0.0 110.166 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.29 137.75 37.48 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 120.941 0.401 . . . . 0.0 111.034 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.559 HG21 ' HE1' ' A' ' 83' ' ' MET . 56.0 t -116.86 110.76 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.734 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.643 ' HA ' HG23 ' A' ' 91' ' ' THR . 86.4 m -97.42 132.63 42.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.863 0.363 . . . . 0.0 111.361 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.763 HG23 ' OG1' ' A' ' 91' ' ' THR . 2.5 t -112.42 169.18 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.8 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.841 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -144.85 -165.45 2.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.932 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.864 0.364 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.73 156.42 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.409 ' C ' HD12 ' A' ' 4' ' ' LEU . 2.3 mt-30 -153.51 -178.84 7.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.603 HD13 ' HA2' ' A' ' 97' ' ' GLY . 1.4 mp -160.94 77.27 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -69.85 151.8 45.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.773 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -110.57 165.46 11.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.871 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.9 t -166.05 121.65 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.72 -40.76 2.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.703 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.664 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.04 139.72 18.6 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.923 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.93 -161.47 27.8 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.431 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.734 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.5 mp -69.43 145.84 52.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.869 0.366 . . . . 0.0 111.514 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.549 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.9 p -170.16 111.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.998 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.23 151.97 45.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 117' ' ' SER . . . -49.72 146.95 3.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.332 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.21 -13.67 65.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.55 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.88 114.11 3.95 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.371 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -69.95 136.22 50.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 111.128 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD23 HD21 ' A' ' 20' ' ' LEU . 2.3 tp -136.04 129.95 32.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.178 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.515 ' C ' HD23 ' A' ' 20' ' ' LEU . 5.0 ttp180 -102.43 145.55 29.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.117 0.484 . . . . 0.0 111.651 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.682 ' HG ' HD23 ' A' ' 81' ' ' LEU . 6.4 mt -117.64 147.99 42.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.808 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 90.7 p -125.73 114.21 18.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.274 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.513 ' HB3' HG22 ' A' ' 79' ' ' VAL . 3.8 t -117.16 128.8 55.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.597 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.84 141.64 49.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.371 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.27 131.45 55.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.043 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.0 p -80.99 154.99 26.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.31 137.26 3.02 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.541 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.53 113.14 12.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.28 -169.11 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.01 31.83 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.757 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.8 t -129.3 52.19 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 110.498 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 31' ' ' THR . 17.0 m 65.52 21.28 11.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.729 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.603 ' CD1' ' HB1' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -77.76 86.49 4.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.952 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -70.67 161.15 31.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.743 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.669 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.6 mtm -132.45 128.39 37.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.479 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 50' ' ' ALA . . . -153.29 159.9 28.85 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.113 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.464 ' CZ2' ' HB2' ' A' ' 20' ' ' LEU . 93.1 m95 -86.73 154.11 21.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.12 0.486 . . . . 0.0 110.93 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.3 m-85 -136.89 -176.53 4.4 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.74 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.52 ' HG2' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -146.99 150.75 35.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.837 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.41 ' HG2' ' HG2' ' A' ' 45' ' ' ARG . 1.6 mm-40 -153.81 176.77 11.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.024 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -174.21 152.92 1.89 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.522 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.7 137.15 62.03 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.29 1.993 . . . . 0.0 112.142 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.09 7.36 37.08 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.512 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.81 -169.58 1.48 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 111.02 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -114.91 176.68 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.771 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HG2' ' HG2' ' A' ' 39' ' ' GLN . 2.1 mtm-85 -97.65 134.91 40.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 0.0 111.175 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -138.96 163.65 31.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.439 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.544 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.5 t -110.61 171.15 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.246 0.546 . . . . 0.0 111.236 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.52 ' CG2' ' HG2' ' A' ' 38' ' ' ARG . 6.0 t -129.51 -69.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.306 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 70' ' ' ILE . . . -136.2 133.87 37.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.385 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.722 ' O ' HG22 ' A' ' 58' ' ' THR . . . -128.43 145.2 51.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.017 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 34' ' ' MET . 3.5 tt -128.01 147.85 32.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.358 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -97.97 169.12 9.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.76 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.459 ' CZ3' ' HD2' ' A' ' 72' ' ' ARG . 21.8 t-105 -107.0 -31.18 8.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.14 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.17 -75.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.406 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.423 ' CB ' ' HD2' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -92.92 -87.66 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.298 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -178.71 -29.1 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' HD2' ' CB ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -38.44 151.95 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.767 0.318 . . . . 0.0 111.389 -179.48 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.8 HG21 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -122.46 -178.45 3.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.473 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 23.3 t80 -138.67 90.31 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.39 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.458 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 8.2 m-85 -80.51 154.9 27.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.18 159.69 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.194 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 63' ' ' SER . 17.9 p -69.09 153.83 43.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.32 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 62' ' ' SER . 2.3 p 87.12 -12.59 0.52 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.462 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -149.11 15.47 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.335 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 65' ' ' ARG . 6.5 tpt180 -77.69 83.5 4.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.779 0.8 . . . . 0.0 110.305 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.61 -7.12 3.31 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.587 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.466 ' HD2' ' CE1' ' A' ' 68' ' ' PHE . 1.3 ptp180 -116.52 -38.13 3.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.708 0.29 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.466 ' CE1' ' HD2' ' A' ' 67' ' ' ARG . 3.3 m-30 -90.42 93.82 9.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.49 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 95.5 m -76.53 116.53 17.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.146 0.498 . . . . 0.0 111.313 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -109.69 131.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.772 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.36 172.44 18.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.019 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HD2' ' CZ3' ' A' ' 53' ' ' TRP . 13.5 ttp-105 -105.92 153.92 21.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 39.7 t0 -91.36 -29.64 16.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.4 26.19 14.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.023 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -114.34 -33.47 5.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.073 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.5 42.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.722 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.11 40.86 14.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.701 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.1 m -97.55 148.56 23.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.062 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 22' ' ' CYS . 30.7 m -122.82 132.08 72.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.428 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 25.1 m-85 -113.1 116.07 29.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.988 0.423 . . . . 0.0 110.801 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.682 HD23 ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -113.35 103.29 11.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.445 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -85.9 98.97 11.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.994 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.586 ' HB3' HD11 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -83.53 88.24 7.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.936 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 176.16 6.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.777 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 34.78 48.19 0.3 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.698 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' A' ' 83' ' ' MET . 0.5 OUTLIER -62.09 165.84 5.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.459 . . . . 0.0 111.197 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 33.1 mmtt -135.47 163.54 50.04 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.419 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 63.2 Cg_endo -73.23 9.08 1.54 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.365 2.043 . . . . 0.0 113.091 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.92 9.06 13.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.189 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.66 -7.54 37.25 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.533 0.206 . . . . 0.0 111.401 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.7 m -56.33 113.1 1.43 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.767 0.317 . . . . 0.0 111.271 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 112' ' ' GLN . . . -170.56 -172.53 1.24 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.313 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 84.0 t -96.16 102.63 13.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.183 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.504 ' O ' HG22 ' A' ' 111' ' ' THR . 24.7 m-85 -84.91 99.52 11.0 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.764 0.316 . . . . 0.0 111.117 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 62.0 m -106.2 129.97 54.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -99.79 147.77 25.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.456 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.603 ' HA2' HD13 ' A' ' 4' ' ' LEU . . . -159.65 -169.44 22.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.145 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.603 ' HB1' ' CD1' ' A' ' 32' ' ' TYR . . . -134.51 172.68 12.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.875 0.369 . . . . 0.0 110.968 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -147.05 173.35 27.25 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.778 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -160.01 144.92 14.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.58 16.22 49.77 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.58 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.23 -4.92 58.84 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.671 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.656 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -107.35 179.17 4.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.796 0.331 . . . . 0.0 110.579 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.656 ' H ' HG22 ' A' ' 103' ' ' THR . 77.5 m95 -139.06 105.33 5.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.514 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -12.32 11.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.49 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -93.31 133.43 36.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -144.86 165.0 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.0 -165.55 22.26 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.578 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -75.02 -29.11 60.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.16 152.51 28.73 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.603 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.9 t -148.16 114.31 5.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -80.22 142.46 34.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.018 0.437 . . . . 0.0 111.228 -179.168 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.423 HG21 ' CE ' ' A' ' 83' ' ' MET . 54.9 t -114.51 131.83 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.961 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.734 ' CB ' HD23 ' A' ' 11' ' ' LEU . 97.6 m -110.38 132.48 54.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.867 0.365 . . . . 0.0 111.182 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 116' ' ' SER . 2.0 t -141.27 168.01 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.156 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.49 ' H ' HG12 ' A' ' 115' ' ' VAL . 55.2 p -167.02 -53.95 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.178 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 2.7 t . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.832 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.786 0.327 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -109.29 154.79 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -104.46 161.39 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.3 mp -148.05 136.8 21.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.1 169.54 17.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -124.96 164.45 20.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 m -166.24 125.79 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 114.01 -30.6 7.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.602 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -49.86 140.32 16.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.896 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.57 175.84 42.44 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.366 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.795 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.8 mp -69.15 144.83 53.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.88 0.371 . . . . 0.0 111.468 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.83 126.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -58.97 155.97 12.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.252 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.46 131.7 20.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.388 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.75 3.18 83.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.743 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.63 118.77 6.01 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.471 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.53 140.64 49.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 0.0 111.231 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.807 ' CD2' HD21 ' A' ' 20' ' ' LEU . 3.7 tp -136.0 129.1 31.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.703 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.46 119.26 39.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.807 HD21 ' CD2' ' A' ' 18' ' ' LEU . 12.7 mt -100.74 138.72 37.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.005 0.431 . . . . 0.0 110.427 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.442 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 7.1 m -117.31 111.11 18.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.213 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' HG23 ' A' ' 78' ' ' THR . 42.9 t -106.09 133.58 50.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.533 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.26 160.65 21.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.51 ' HB3' ' HD3' ' A' ' 77' ' ' LYS . . . -152.25 139.56 19.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.956 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.698 ' O ' HG12 ' A' ' 2' ' ' VAL . 4.7 m -114.79 126.6 55.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.05 100.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 122.24 23.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.936 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.0 p -110.9 177.15 4.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.92 33.85 1.81 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.584 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.18 47.27 1.79 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.822 0.344 . . . . 0.0 111.03 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.1 p 55.38 32.98 19.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.719 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -69.63 139.1 53.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.827 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.459 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -130.11 179.8 5.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.638 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.65 ' HB3' HG11 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -136.72 124.71 22.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.754 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.9 160.85 28.34 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.906 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 77.2 m95 -95.61 157.15 16.03 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.069 0.461 . . . . 0.0 111.303 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 11.7 m-85 -135.38 179.65 6.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.342 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.18 151.08 34.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.719 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.678 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -143.59 148.57 36.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.997 0.427 . . . . 0.0 111.222 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -143.0 158.6 58.66 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.624 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 39.7 Cg_endo -67.11 137.4 44.04 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.318 2.012 . . . . 0.0 112.281 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.64 0.44 48.63 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.649 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.25 -173.77 2.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.874 0.369 . . . . 0.0 111.074 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -118.7 -174.97 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.535 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.46 135.7 40.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 111.113 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.27 119.3 15.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.266 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 1.4 t -68.55 170.03 9.91 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.426 HG21 ' HE1' ' A' ' 94' ' ' TYR . 21.2 t -130.06 -57.6 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.958 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -152.6 163.24 40.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.949 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.568 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -161.08 147.58 14.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.665 HD13 ' N ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -140.09 143.47 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 111.597 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.665 ' N ' HD13 ' A' ' 51' ' ' ILE . 7.9 t-20 -72.33 -155.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.267 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -57.25 3.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.745 0.307 . . . . 0.0 110.409 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -175.04 141.37 0.57 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 0.0 111.313 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.1 t 72.66 41.37 0.56 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.688 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 57' ' ' ARG . . . -137.19 -78.73 0.39 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.775 0.322 . . . . 0.0 110.674 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 162.11 -176.19 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.042 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.733 HG21 HG23 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -115.8 178.92 4.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.239 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.1 t80 -141.55 135.33 30.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.524 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.499 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 28.7 m-85 -123.23 163.1 21.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 110.895 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -106.5 155.92 19.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.987 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.18 34.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 111.762 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 64' ' ' VAL . 41.0 t -121.65 -15.13 8.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.236 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.562 HG12 ' HD2' ' A' ' 67' ' ' ARG . 15.7 m -156.76 19.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.232 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -65.98 80.15 0.08 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.563 0.697 . . . . 0.0 110.846 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.98 -2.38 1.16 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.809 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HD2' HG12 ' A' ' 64' ' ' VAL . 2.6 ptp180 -126.58 -36.16 2.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.833 0.316 . . . . 0.0 111.654 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CE2' HG11 ' A' ' 64' ' ' VAL . 7.8 m-30 -94.2 146.98 23.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.196 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 82' ' ' GLN . 5.5 m -112.89 154.42 26.39 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.406 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.895 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -146.02 134.23 16.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.915 -179.107 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.895 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -162.49 -172.51 3.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.806 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.557 ' CD ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -134.53 155.65 50.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.573 ' OD1' ' HB2' ' A' ' 75' ' ' ALA . 7.4 t0 -69.05 -27.84 66.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.042 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 66.71 23.34 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.022 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HB2' ' OD1' ' A' ' 73' ' ' ASP . . . -102.87 -57.78 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.923 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 4.4 ptpp? -130.21 -54.59 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.713 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 1.8 ttmp? 169.6 74.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.647 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.605 HG22 ' CE1' ' A' ' 80' ' ' TYR . 33.4 m -137.7 140.62 40.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.085 0.469 . . . . 0.0 111.243 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 34' ' ' MET . 35.3 m -116.03 135.91 54.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.827 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.605 ' CE1' HG22 ' A' ' 78' ' ' THR . 1.5 m-85 -124.79 129.54 50.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.758 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.733 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -118.09 118.95 33.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 110.404 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.554 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -93.36 102.83 15.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.031 -179.109 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.544 ' HE3' HD11 ' A' ' 81' ' ' LEU . 1.6 mtt -91.59 88.73 6.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.444 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.16 175.89 8.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.666 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 35.35 50.4 0.54 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.881 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.475 HD23 ' CG2' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -61.09 161.06 9.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.809 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.63 ' O ' HG11 ' A' ' 115' ' ' VAL . 4.2 mttp -134.07 172.82 6.65 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.919 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 87' ' ' LYS . 72.0 Cg_endo -76.28 5.0 4.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.546 2.164 . . . . 0.0 113.076 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.2 tp10 -103.25 -16.95 15.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.739 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -78.48 -17.0 56.91 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.097 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 99.4 m -51.74 102.78 0.05 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.076 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.48 -171.57 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.923 0.392 . . . . 0.0 111.56 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.483 HG22 ' HG3' ' A' ' 112' ' ' GLN . 91.2 t -93.16 109.87 22.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.82 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.51 ' CE1' ' HE1' ' A' ' 83' ' ' MET . 13.2 m-85 -91.89 109.07 20.4 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.651 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 m -108.72 139.2 43.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.0 111.372 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.7 t -94.86 146.04 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.645 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 107' ' ' TRP . . . -148.0 -178.82 23.49 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.74 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.719 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -142.46 165.44 27.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.024 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.58 168.87 14.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.812 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -167.74 120.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.728 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.6 14.76 51.54 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.817 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.46 -12.95 43.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.434 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.658 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.3 m -101.89 -179.96 4.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.687 0.28 . . . . 0.0 110.538 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.658 ' H ' HG22 ' A' ' 103' ' ' THR . 73.3 m95 -137.41 81.84 1.89 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.767 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.27 13.7 24.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.463 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.684 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -105.54 130.02 53.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.813 0.339 . . . . 0.0 110.853 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.406 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 31.5 m95 -137.62 164.5 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.045 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.89 -118.29 4.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.6 -44.48 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 110.984 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.97 152.03 13.66 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.762 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 111' ' ' THR . 15.3 t -154.28 117.23 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.263 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.483 ' HG3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -80.17 143.29 33.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.0 0.429 . . . . 0.0 111.007 -179.334 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.423 HG11 HD21 ' A' ' 86' ' ' LEU . 48.4 t -116.13 128.46 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.21 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.795 ' CB ' HD23 ' A' ' 11' ' ' LEU . 95.0 m -104.53 122.19 45.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.155 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.63 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -119.67 -151.58 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.393 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 115' ' ' VAL . 75.2 m 65.76 156.22 0.09 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.889 0.376 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.99 156.87 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.976 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.72 153.59 45.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.841 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.443 HD11 ' OH ' ' A' ' 32' ' ' TYR . 3.4 mp -143.56 122.59 12.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.868 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -138.51 163.93 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.09 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.71 163.63 14.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.71 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.06 117.32 3.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.914 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.02 -31.41 6.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.498 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -49.51 140.58 14.2 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.878 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.75 -159.2 30.55 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.395 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.404 HD23 HG21 ' A' ' 114' ' ' THR . 1.7 mp -69.45 150.13 47.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.845 0.355 . . . . 0.0 111.427 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.593 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.1 p -165.53 106.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.975 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -56.26 150.03 15.23 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.308 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.77 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -51.22 141.5 14.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.318 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.16 -4.66 85.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.753 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.4 119.82 6.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.299 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 p -69.87 133.68 47.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 111.229 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.869 ' CD2' HD21 ' A' ' 20' ' ' LEU . 6.5 tp -118.81 132.09 56.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.425 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.34 121.08 43.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 0.0 111.472 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.869 HD21 ' CD2' ' A' ' 18' ' ' LEU . 15.7 mt -109.32 137.88 46.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.409 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -119.99 113.18 20.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.172 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 17.4 t -111.04 133.91 53.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.361 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.2 147.16 32.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.199 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.51 ' HB3' ' HE3' ' A' ' 34' ' ' MET . . . -150.18 78.78 1.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.075 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -98.38 163.44 12.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.5 -149.08 20.18 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.513 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.59 105.33 13.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.868 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -152.07 123.22 7.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.01 35.76 1.35 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.611 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.4 -72.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.986 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.5 p -156.88 36.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.659 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.0 t80 -69.51 65.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.078 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.473 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 5.3 m-20 -58.85 178.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.597 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.688 ' HB3' HG11 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -141.87 118.36 10.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 111.025 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -154.54 150.47 22.05 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.811 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.479 ' CD2' HD22 ' A' ' 81' ' ' LEU . 76.2 m95 -88.82 152.69 21.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.224 0.535 . . . . 0.0 111.176 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.543 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -131.98 -177.31 4.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.727 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HD2' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -151.23 161.48 42.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.723 179.535 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.614 ' O ' HG12 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -163.59 158.72 20.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.995 0.426 . . . . 0.0 111.284 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -148.27 161.33 34.46 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.681 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.549 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 37.1 Cg_endo -65.73 137.13 48.53 Favored 'Trans proline' 0 CA--C 1.518 -0.322 0 C-N-CA 122.256 1.971 . . . . 0.0 112.343 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.05 3.05 42.71 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.33 -174.73 2.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.78 0.324 . . . . 0.0 111.035 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -111.17 -171.16 1.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -90.62 131.66 36.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.062 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -133.0 129.62 38.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.599 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.543 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.3 t -85.45 171.28 11.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.285 0.564 . . . . 0.0 110.877 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.565 HG21 ' HE1' ' A' ' 94' ' ' TYR . 5.8 t -127.2 -68.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.403 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -142.67 129.21 20.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.237 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.57 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -132.67 143.16 49.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.377 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.838 ' HB ' HG23 ' A' ' 58' ' ' THR . 2.0 tt -120.51 136.6 57.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.32 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.13 171.03 14.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.378 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.7 33.24 5.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.608 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.95 21.78 5.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.9 t 57.9 91.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.01 -71.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.194 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -179.15 -166.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.19 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.838 HG23 ' HB ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -111.47 -178.46 3.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.809 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 50.8 t80 -137.61 96.24 3.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.935 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -85.9 157.14 20.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 111.033 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.75 162.9 13.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.333 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.0 m -81.76 33.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.015 0.436 . . . . 0.0 111.709 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -118.94 -25.3 6.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.838 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 30.8 m -148.7 18.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.03 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -71.22 81.21 0.72 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.761 0.791 . . . . 0.0 110.451 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 145.52 -6.69 1.47 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 114.431 -1.259 . . . . 0.0 112.495 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.446 ' CZ ' HG12 ' A' ' 64' ' ' VAL . 3.4 ptt180 -123.56 -37.53 2.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.681 0.277 . . . . 0.0 111.305 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.526 ' CZ ' HG11 ' A' ' 64' ' ' VAL . 4.8 m-30 -84.15 152.23 24.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.078 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 28.9 m -125.22 154.13 42.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.935 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.781 HG21 HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -144.52 137.91 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.073 -179.565 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.413 ' N ' HG13 ' A' ' 70' ' ' ILE . 90.0 p -163.06 135.76 5.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.628 ' HE ' HD13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -88.4 166.94 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.023 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.423 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 11.2 t0 -94.05 -31.0 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.985 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.78 28.62 16.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.33 -52.03 2.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.07 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -132.67 31.6 3.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt 61.74 50.55 4.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 59.3 m -114.0 150.19 34.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.821 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.688 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.7 m -122.53 145.24 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.835 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 27.2 m-85 -130.64 118.79 21.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.972 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.629 HD23 ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -114.86 113.98 24.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 110.324 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -92.96 99.26 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.158 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.516 ' HE2' ' CZ ' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -79.88 86.79 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.88 176.35 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 36.6 47.36 0.52 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.805 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.462 HD23 ' OD2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -59.04 161.84 4.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.788 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -122.9 172.24 5.64 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.139 0.495 . . . . 0.0 111.678 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.69 13.44 2.11 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.567 2.178 . . . . 0.0 112.961 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -131.02 13.73 5.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.504 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.563 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -89.08 -7.14 56.4 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.529 0.204 . . . . 0.0 111.192 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.0 m -55.81 107.75 0.38 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.664 0.269 . . . . 0.0 111.373 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.42 170.23 7.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.551 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 93' ' ' VAL . 5.3 p -82.09 107.07 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.565 ' HE1' HG21 ' A' ' 48' ' ' VAL . 10.4 m-85 -87.7 103.72 15.86 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.832 0.349 . . . . 0.0 111.256 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.493 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 5.6 t -104.99 130.46 53.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.426 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.7 t -84.96 142.56 29.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.281 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.52 162.46 29.31 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.755 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.41 165.49 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.836 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -96.82 179.34 34.11 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.682 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 177.9 118.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 0.0 110.698 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.7 14.48 50.97 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.811 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.66 -11.99 46.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.577 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.5 m -106.08 -179.26 3.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.642 0.258 . . . . 0.0 110.521 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.684 ' H ' HG22 ' A' ' 103' ' ' THR . 57.0 m95 -137.22 87.1 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.663 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -118.12 10.23 12.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.608 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.01 61.44 1.51 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.191 0.52 . . . . 0.0 110.768 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -69.97 165.46 21.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.104 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.74 -141.74 8.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.567 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -89.68 -48.25 7.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.331 . . . . 0.0 111.0 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 111.12 151.58 12.24 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.766 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 111' ' ' THR . 12.0 t -153.77 113.27 3.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -74.6 142.05 44.66 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.091 0.472 . . . . 0.0 111.272 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 91' ' ' THR . 55.8 t -114.65 117.79 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.037 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.404 HG21 HD23 ' A' ' 11' ' ' LEU . 88.8 m -96.69 119.35 35.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.094 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.788 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -110.68 -167.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.4 179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 54.4 p -176.38 -166.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.813 0.34 . . . . 0.0 110.883 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.924 0.392 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -112.08 155.17 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.492 ' C ' HD12 ' A' ' 4' ' ' LEU . 50.6 mm-40 -158.22 172.57 18.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 3' ' ' GLN . 4.7 mp -153.89 148.94 26.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.32 166.76 29.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.957 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.28 162.79 23.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.782 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.6 p -170.0 118.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.8 -27.67 4.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.596 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -53.69 179.83 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.716 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.12 177.9 25.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.317 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.805 HD23 HG21 ' A' ' 114' ' ' THR . 1.4 mp -69.03 126.05 28.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.074 0.464 . . . . 0.0 111.33 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.966 HG11 ' HB2' ' A' ' 18' ' ' LEU . 29.5 m -126.75 140.33 49.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.606 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -70.13 138.58 52.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.922 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -53.17 126.09 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.405 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.94 19.38 36.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.681 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -113.31 -156.43 12.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.405 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 t -138.64 137.89 37.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.933 0.397 . . . . 0.0 111.116 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.966 ' HB2' HG11 ' A' ' 12' ' ' VAL . 12.9 tp -135.18 133.29 38.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.589 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -110.68 126.74 54.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.338 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.587 HD21 ' CD2' ' A' ' 18' ' ' LEU . 5.7 mt -113.81 139.34 49.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.242 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.8 p -115.98 114.82 25.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.994 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.7 t -106.54 134.69 49.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.617 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -122.89 142.03 51.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.127 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -116.6 -178.41 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.512 ' O ' HG12 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -156.45 156.55 33.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.78 111.35 1.78 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.65 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -71.16 113.42 8.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 110.665 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.7 172.03 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 110.927 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.32 -29.91 2.2 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.625 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -69.87 -9.79 56.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.578 0.228 . . . . 0.0 111.548 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.3 m 71.07 60.2 0.18 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.976 0.417 . . . . 0.0 110.834 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.546 ' CD2' ' HB1' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -69.14 132.33 46.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.622 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -83.95 -176.64 6.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.084 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.1 mtp -144.02 126.61 16.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.33 154.45 25.87 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.928 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.544 ' CE2' HD22 ' A' ' 81' ' ' LEU . 73.9 m95 -86.93 153.84 21.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 111.438 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.4 m-85 -135.89 -178.81 5.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.768 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.494 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.9 OUTLIER -147.66 155.05 41.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.976 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.641 ' O ' HG12 ' A' ' 93' ' ' VAL . 2.1 tm0? -154.34 135.77 14.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.93 147.68 57.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.744 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.65 136.84 51.66 Favored 'Trans proline' 0 CA--C 1.517 -0.351 0 C-N-CA 122.247 1.965 . . . . 0.0 112.273 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.9 3.02 41.43 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.6 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.41 -162.92 0.82 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.692 0.282 . . . . 0.0 110.953 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -118.01 158.2 25.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.789 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.416 ' CG ' ' HG2' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -76.76 149.37 36.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.072 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.29 165.42 34.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.711 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.549 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.8 t -107.04 172.19 6.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.151 0.501 . . . . 0.0 110.865 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.494 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.6 t -128.58 -69.36 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.652 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -147.4 133.5 19.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 0.0 111.356 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.534 ' O ' HG22 ' A' ' 58' ' ' THR . . . -130.96 143.39 50.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.222 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.652 ' HB ' HG23 ' A' ' 58' ' ' THR . 7.3 tp -124.57 141.14 45.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.182 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -81.67 -163.15 0.6 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.57 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.35 59.03 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.994 0.426 . . . . 0.0 110.467 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 60.19 29.91 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.5 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.3 p -89.66 -53.09 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.235 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.67 -73.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.809 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.18 -161.06 0.35 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 111.19 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 1.036 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -96.75 -178.44 4.24 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.022 0.439 . . . . 0.0 110.974 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' N ' ' O ' ' A' ' 50' ' ' ALA . 7.0 t80 -140.18 93.06 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.719 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -76.98 159.42 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.844 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.87 165.97 12.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.133 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 63' ' ' SER . 2.5 p -69.48 150.94 46.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.666 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 86.7 -12.38 0.56 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.618 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' A' ' 68' ' ' PHE . 16.9 m -149.15 12.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.525 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -81.39 81.85 7.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.634 0.73 . . . . 0.0 110.513 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.87 -6.81 2.38 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.309 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -119.08 -46.71 2.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.669 0.271 . . . . 0.0 111.257 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CE2' HG11 ' A' ' 64' ' ' VAL . 6.7 m-30 -69.94 139.85 52.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.702 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 6.9 m -111.55 153.45 26.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.887 0.375 . . . . 0.0 111.02 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.036 HG21 HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -139.45 140.34 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.834 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.439 ' N ' HG13 ' A' ' 70' ' ' ILE . 9.9 t -154.69 123.65 6.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 162.08 29.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.961 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 42.6 t0 -91.89 -38.26 12.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 59.7 47.78 10.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.743 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.3 -60.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -126.82 33.1 5.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.21 54.17 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 110.598 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.407 ' HB ' ' CB ' ' A' ' 73' ' ' ASP . 92.7 m -119.17 148.83 42.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.073 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.44 144.09 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.673 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 28.5 m-85 -127.45 120.14 27.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.821 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.587 HD21 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -115.28 116.66 28.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.103 0.478 . . . . 0.0 110.644 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -95.9 96.09 8.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.962 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.574 ' HE1' HD11 ' A' ' 20' ' ' LEU . 15.6 mtm -80.41 95.42 6.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.95 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.35 176.71 6.62 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.734 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 t 35.9 40.59 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.739 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -55.34 163.72 1.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.211 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.74 160.96 48.94 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.802 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.1 3.73 5.92 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.49 2.127 . . . . 0.0 112.848 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 12.7 tp10 -107.01 -10.38 15.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.782 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.66 -10.53 59.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.932 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 73.3 m -48.31 106.07 0.09 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.403 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.51 177.92 3.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.328 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 39' ' ' GLN . 5.0 p -83.95 107.35 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.454 ' CD1' HG21 ' A' ' 113' ' ' VAL . 6.1 m-85 -83.99 99.36 10.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.975 0.417 . . . . 0.0 110.679 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 m -103.04 132.05 49.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.282 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.7 t -90.42 135.62 33.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.657 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -136.16 176.0 20.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.402 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.546 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -131.57 148.01 52.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . -107.82 151.1 16.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.606 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -143.8 126.61 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.31 15.8 52.53 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.784 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.19 -9.77 46.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.791 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.7 m -102.22 179.98 4.16 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.598 0.237 . . . . 0.0 110.419 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.67 ' H ' HG22 ' A' ' 103' ' ' THR . 76.6 m95 -145.28 92.29 2.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -115.34 -2.76 12.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.406 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -94.41 132.39 39.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -136.55 164.67 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.28 -141.65 10.12 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.48 -45.49 8.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 113.11 153.82 11.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.532 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 1.8 t -152.58 106.93 3.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 110.526 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 2.1 tp60 -60.21 141.66 55.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.136 0.493 . . . . 0.0 110.996 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.4 t -119.91 88.01 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.181 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.805 HG21 HD23 ' A' ' 11' ' ' LEU . 59.1 m -76.67 132.87 39.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.218 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.541 HG21 HD23 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -144.79 156.51 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.396 179.673 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 1.1 m 172.31 169.78 0.11 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.917 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.967 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.884 0.373 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.524 HG13 ' HA3' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -113.53 156.79 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.966 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.33 139.67 21.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mp -114.83 138.87 50.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 11.2 mt-30 -144.89 134.28 23.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.667 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.13 163.52 13.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.859 0.361 . . . . 0.0 110.897 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.9 t -163.79 118.93 1.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.16 -37.57 3.04 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.715 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.712 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -49.12 139.16 14.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.095 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.43 -165.7 34.0 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.413 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.566 HD23 HG21 ' A' ' 114' ' ' THR . 1.8 mp -69.35 148.64 49.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.882 0.372 . . . . 0.0 111.595 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.673 HG13 HD22 ' A' ' 86' ' ' LEU . 7.2 p -170.12 106.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -56.68 159.59 3.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.347 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -51.2 153.71 1.9 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.304 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.48 9.2 68.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.647 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.74 113.62 2.92 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.383 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 m -69.95 135.96 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.737 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.8 tp -133.4 131.64 40.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.66 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -108.07 129.58 55.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.162 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.737 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.7 mt -113.68 144.87 42.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.131 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.474 ' HG ' ' HD2' ' A' ' 80' ' ' TYR . 1.9 m -126.97 118.98 25.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.498 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.511 ' SG ' HG23 ' A' ' 79' ' ' VAL . 19.3 p -125.07 121.34 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.999 0.428 . . . . 0.0 110.354 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.26 171.66 9.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.349 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.98 55.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.0 p -70.08 154.38 42.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.524 ' HA3' HG13 ' A' ' 2' ' ' VAL . . . 167.23 -110.02 0.38 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.488 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.52 65.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -127.73 -167.55 1.77 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' H ' HG22 ' A' ' 28' ' ' THR . . . 147.69 39.32 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.797 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.6 t -124.44 -70.77 0.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.803 0.335 . . . . 0.0 110.73 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.63 27.45 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.0 t80 -69.76 65.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.065 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.427 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 12.8 m-20 -48.58 164.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.846 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.425 ' CE ' HG13 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -145.5 126.28 14.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.821 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.423 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -155.82 155.13 26.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.818 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.866 ' CE2' HD22 ' A' ' 81' ' ' LEU . 78.4 m95 -84.34 153.36 23.53 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.066 0.46 . . . . 0.0 111.022 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 8.9 m-85 -133.2 -176.38 4.11 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.389 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.532 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -146.81 156.67 43.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.668 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -153.94 111.39 3.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.125 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -97.96 160.74 27.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.685 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 53.8 Cg_endo -69.53 136.99 35.04 Favored 'Trans proline' 0 CA--C 1.518 -0.315 0 C-N-CA 122.294 1.996 . . . . 0.0 112.322 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.33 1.89 30.6 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.665 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.56 -174.8 2.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 110.974 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -103.18 -172.76 2.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.598 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -99.26 124.99 44.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -123.18 137.91 54.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.711 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.5 t -75.43 172.19 12.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.517 0.675 . . . . 0.0 111.526 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.532 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.7 t -131.02 -67.7 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.107 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -142.8 128.16 18.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.119 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -136.29 145.99 46.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.743 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.826 ' HB ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -123.12 140.82 45.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.239 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -78.5 158.64 28.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.029 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.82 46.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.599 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.443 ' OD2' ' HB2' ' A' ' 56' ' ' ALA . 2.3 p-10 -144.45 21.73 1.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.58 56.41 7.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.03 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.443 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . . . -113.34 -72.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.242 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -175.57 172.95 2.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.986 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.826 HG23 ' HB ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -96.87 179.74 4.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.745 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 57.4 t80 -140.42 95.59 2.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.574 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 68' ' ' PHE . 78.3 m-85 -78.99 169.84 17.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.45 170.73 7.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.67 150.86 46.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.715 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.0 t 81.96 -8.04 1.33 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.752 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -151.29 11.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.434 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 79.23 0.86 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.534 0.683 . . . . 0.0 110.681 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.9 1.71 5.8 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.07 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.39 -52.92 2.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 4.4 m-30 -74.86 133.65 41.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.668 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 25.0 m -95.68 153.33 17.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.03 0.443 . . . . 0.0 110.975 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.898 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -152.78 136.12 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.596 -179.194 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.898 ' N ' HD13 ' A' ' 70' ' ' ILE . 10.3 t -156.14 153.39 29.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.958 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.413 ' HG3' HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -101.65 141.42 34.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.822 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.596 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 26.5 t0 -74.67 -30.37 61.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.916 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 m120 59.59 27.38 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.596 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -119.94 -54.63 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.018 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -122.76 27.33 7.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp 59.49 51.09 6.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.852 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.61 HG22 ' CE1' ' A' ' 80' ' ' TYR . 69.3 m -122.16 148.67 44.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.125 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.511 HG23 ' SG ' ' A' ' 22' ' ' CYS . 17.3 m -119.0 142.35 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.699 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.61 ' CE1' HG22 ' A' ' 78' ' ' THR . 1.2 m-85 -128.36 138.15 52.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.866 HD22 ' CE2' ' A' ' 36' ' ' TRP . 1.1 pt? -131.35 124.26 30.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.095 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -96.78 99.74 11.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.165 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -84.69 89.69 7.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.64 174.28 11.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 0.0 111.184 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 32.4 47.08 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.951 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.673 HD22 HG13 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -48.56 158.95 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 111.125 -179.758 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -126.42 174.34 4.23 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.632 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 86.3 Cg_endo -81.18 8.22 4.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.436 2.091 . . . . 0.0 112.855 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -109.69 -8.66 14.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.8 -20.01 43.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.234 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 114' ' ' THR . 95.5 m -54.22 101.99 0.05 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 111.305 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.54 -175.61 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.8 t -87.37 102.89 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.623 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -83.65 104.38 13.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.454 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 19.0 m -105.3 132.35 51.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.328 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.0 t -96.16 135.73 37.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.601 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.3 177.3 20.79 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.706 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -131.59 167.56 19.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.357 . . . . 0.0 111.012 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -119.45 -165.63 13.1 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.825 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.62 113.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.798 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.99 52.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.62 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.83 -12.41 34.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.752 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.634 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.2 m -96.15 177.52 5.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.891 0.377 . . . . 0.0 110.8 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.634 ' H ' HG22 ' A' ' 103' ' ' THR . 76.8 m95 -145.42 107.26 4.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.741 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -133.35 10.67 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.396 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 1.4 t -112.19 134.67 53.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.817 0.341 . . . . 0.0 110.896 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -141.6 165.05 28.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.05 -152.62 16.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -85.54 -31.86 22.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 95.72 156.44 31.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.65 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 111' ' ' THR . 14.8 t -147.99 112.7 5.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.341 . . . . 0.0 110.527 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -68.02 141.37 56.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 110.992 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.4 t -120.02 136.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.445 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.566 HG21 HD23 ' A' ' 11' ' ' LEU . 48.1 m -121.18 137.43 54.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.857 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.659 ' CG2' HD23 ' A' ' 86' ' ' LEU . 2.1 t -135.69 168.37 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.248 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -136.36 -167.17 2.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.059 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.897 -179.969 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.96 155.06 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.224 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -91.85 162.35 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 24' ' ' ALA . 5.0 mp -145.72 130.61 18.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -118.06 157.03 27.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.777 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.26 168.3 9.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.072 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.15 131.82 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.969 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.21 -18.59 57.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.749 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.588 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -52.07 138.27 31.29 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.874 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.85 -169.63 39.74 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.435 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.83 HD23 HG21 ' A' ' 114' ' ' THR . 1.7 mp -69.51 154.33 42.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.902 0.382 . . . . 0.0 111.58 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.654 ' HB ' HD13 ' A' ' 18' ' ' LEU . 7.2 p -154.39 113.92 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.927 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.0 144.18 7.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.384 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.577 ' HA ' HG12 ' A' ' 115' ' ' VAL . . . -49.81 121.35 5.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.314 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.8 15.32 58.22 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.599 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.415 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -109.72 133.36 11.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.371 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER -71.12 126.2 28.95 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.099 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.918 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.2 tp -120.52 131.34 54.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.523 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -110.23 122.44 47.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 111.607 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.918 HD21 ' CD2' ' A' ' 18' ' ' LEU . 6.8 mt -113.21 138.06 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.193 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.465 ' HB2' ' CD2' ' A' ' 80' ' ' TYR . 12.6 t -121.47 118.62 29.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.967 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 5.9 p -126.66 133.56 50.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.984 0.421 . . . . 0.0 111.174 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -113.87 172.85 6.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.234 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.41 ' HB2' ' HG ' ' A' ' 4' ' ' LEU . . . -138.34 120.63 15.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.6 t -82.55 110.35 17.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.46 -176.5 40.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.446 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ttm-85 -107.1 137.41 45.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.811 0.339 . . . . 0.0 110.937 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.544 HG21 ' CH2' ' A' ' 53' ' ' TRP . 16.8 p -102.4 -178.07 3.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.776 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.37 -26.0 2.97 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.806 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 t -94.52 36.33 1.17 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.602 0.239 . . . . 0.0 111.225 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.91 33.47 7.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.952 0.406 . . . . 0.0 110.567 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.738 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 1.5 t80 -69.45 122.87 19.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.722 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 46.7 m-20 -110.1 178.76 4.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.775 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.516 ' HB3' HG11 ' A' ' 79' ' ' VAL . 1.8 ttm -150.11 129.6 13.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.123 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -150.15 154.47 25.69 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.839 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.665 ' CE2' HD22 ' A' ' 81' ' ' LEU . 84.8 m95 -83.57 155.61 23.19 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.1 0.476 . . . . 0.0 111.312 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.4 m-85 -137.82 -178.28 5.18 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.473 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.556 ' CG ' HG22 ' A' ' 48' ' ' VAL . 2.0 mtm180 -148.41 159.33 44.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.993 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -153.63 109.12 3.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.107 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.66 154.06 38.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.714 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.2 140.43 44.75 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.369 2.046 . . . . 0.0 112.426 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.0 -8.17 39.2 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.728 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -117.87 -179.1 3.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.842 0.353 . . . . 0.0 110.914 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.26 170.63 8.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.552 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.88 130.66 35.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.802 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.14 144.34 51.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.608 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.526 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.0 t -80.76 174.82 11.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.211 0.529 . . . . 0.0 111.054 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.556 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.1 t -131.45 -70.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.358 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -141.26 133.78 28.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 58' ' ' THR . . . -130.33 143.39 50.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.417 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.664 ' HB ' HG23 ' A' ' 58' ' ' THR . 6.5 tp -123.4 142.42 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.045 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -80.05 -164.42 0.67 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.951 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.544 ' CH2' HG21 ' A' ' 28' ' ' THR . 10.6 t-105 -109.97 64.91 0.61 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.714 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 61.82 56.85 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.65 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 m -123.34 -71.38 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -115.41 -72.57 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.498 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -172.71 -153.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.901 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.729 HG21 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -99.16 -179.94 4.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.991 0.424 . . . . 0.0 110.95 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 45.2 t80 -137.92 97.8 3.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.783 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -78.65 155.5 29.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.826 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.13 176.1 5.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.225 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -69.57 151.68 45.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.655 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.7 m 81.99 -9.0 1.25 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.571 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.53 HG21 ' CG1' ' A' ' 48' ' ' VAL . 35.4 m -151.56 13.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.352 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.74 80.11 1.12 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.707 0.765 . . . . 0.0 110.387 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.16 6.91 17.78 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.812 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.437 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 16.9 mtm180 -110.96 -45.31 3.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.814 0.34 . . . . 0.0 111.192 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CE2' HG11 ' A' ' 64' ' ' VAL . 7.8 m-30 -93.02 149.59 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.018 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 14.2 m -107.33 155.5 19.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.909 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -158.13 136.45 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.116 -179.018 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.909 ' N ' HD13 ' A' ' 70' ' ' ILE . 1.9 p -154.74 170.69 21.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' A' ' 72' ' ' ARG . 16.9 mtp-105 -113.62 146.19 40.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.926 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 22.5 t0 -89.9 -11.02 43.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.339 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 43.65 30.97 0.4 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.767 0.317 . . . . 0.0 111.558 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.7 -64.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.32 39.0 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.79 52.18 2.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.828 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.562 HG22 ' CE1' ' A' ' 80' ' ' TYR . 79.9 m -115.92 143.92 44.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.116 0.484 . . . . 0.0 111.358 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 34' ' ' MET . 32.7 m -121.98 132.3 71.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.033 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.562 ' CE1' HG22 ' A' ' 78' ' ' THR . 2.5 m-85 -115.32 119.43 36.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.665 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -115.17 115.47 26.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 0.0 110.48 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.01 92.48 6.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.785 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.435 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -73.09 92.1 1.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.009 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -86.74 176.02 7.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 35.96 47.22 0.4 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.723 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.404 ' CD1' ' CB ' ' A' ' 83' ' ' MET . 0.2 OUTLIER -64.94 158.49 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.844 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.503 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -112.12 166.52 10.76 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.686 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.92 11.99 2.38 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.616 2.21 . . . . 0.0 112.959 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -131.76 11.42 4.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.495 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -87.08 -5.18 59.12 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.634 0.254 . . . . 0.0 111.195 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 89.5 m -55.39 118.01 4.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 111.028 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.52 -172.26 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.499 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 93.0 t -92.99 106.26 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.496 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -88.57 103.06 15.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.874 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.421 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 6.1 t -105.75 142.22 35.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.226 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.57 144.36 25.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.92 175.89 20.07 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.313 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.738 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -143.59 167.65 21.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.902 0.382 . . . . 0.0 111.312 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -121.26 178.39 16.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.848 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -164.52 117.89 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.751 0.31 . . . . 0.0 110.416 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.8 16.41 51.54 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.729 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.66 -12.63 35.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.83 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.635 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.2 m -97.19 178.71 5.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.762 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.635 ' H ' HG22 ' A' ' 103' ' ' THR . 78.5 m95 -141.56 103.96 4.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -136.66 21.26 3.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.114 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.655 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -115.03 138.16 51.18 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.801 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -137.34 166.87 22.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.003 0.43 . . . . 0.0 111.117 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -111.03 -155.97 14.02 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.443 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -82.32 -41.1 20.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.948 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 104.86 151.37 21.0 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.799 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 111' ' ' THR . 11.0 t -152.62 121.06 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.7 144.38 37.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.957 0.408 . . . . 0.0 111.045 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 91' ' ' THR . 54.1 t -115.03 128.11 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.321 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.83 HG21 HD23 ' A' ' 11' ' ' LEU . 93.7 m -100.93 130.48 46.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.992 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -136.2 -162.0 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.611 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.501 ' H ' HG12 ' A' ' 115' ' ' VAL . 6.0 t 76.0 171.38 0.25 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.857 0.36 . . . . 0.0 110.825 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.959 -179.835 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.823 0.344 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.46 122.06 9.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -115.95 158.67 22.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -123.17 170.42 10.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -160.74 133.9 6.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.031 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.31 -32.16 6.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.567 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.29 138.77 27.03 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.948 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.41 -161.8 35.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.289 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.693 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.3 mp -69.39 143.85 53.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.889 0.376 . . . . 0.0 111.485 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.6 p -162.29 113.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.077 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.01 148.04 36.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.84 145.9 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.391 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.38 -7.34 79.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.678 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.21 118.64 5.91 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.318 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -70.01 135.58 49.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 111.126 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.663 ' CD2' HD21 ' A' ' 20' ' ' LEU . 14.2 tp -116.81 134.01 55.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.379 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.442 ' NE ' ' HB3' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -107.42 119.66 40.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.505 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.673 ' HB2' HD23 ' A' ' 81' ' ' LEU . 14.4 mt -111.28 139.14 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.36 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.8 p -126.28 98.79 5.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.968 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 41.4 t -95.19 135.23 37.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.711 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.77 145.66 43.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.273 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.981 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.601 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 120.925 0.393 . . . . 0.0 111.094 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 52' ' ' ASN . 0.4 OUTLIER -153.39 178.49 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.552 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.523 ' HB3' HG11 ' A' ' 79' ' ' VAL . 1.6 mtm -140.98 123.05 15.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.287 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -150.55 150.52 22.54 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.247 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.475 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 79.1 m95 -84.51 152.79 23.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.141 0.496 . . . . 0.0 110.939 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.6 m-85 -132.14 -178.77 5.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.396 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HD3' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -154.91 161.08 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.976 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.538 ' O ' HG12 ' A' ' 93' ' ' VAL . 8.1 tt0 -161.6 147.49 13.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -127.69 163.46 42.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.656 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.59 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 55.6 Cg_endo -70.19 138.28 36.11 Favored 'Trans proline' 0 CA--C 1.518 -0.318 0 C-N-CA 122.275 1.983 . . . . 0.0 112.372 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.41 -0.73 39.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.752 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.89 -177.45 3.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -100.13 -172.14 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HD2' ' CH2' ' A' ' 107' ' ' TRP . 10.2 ptt-85 -102.79 136.06 43.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.365 . . . . 0.0 111.046 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 1.7 pt-20 -131.6 163.65 27.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.331 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.1 t -104.26 171.08 7.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.267 0.556 . . . . 0.0 111.089 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.615 HG22 ' HD3' ' A' ' 38' ' ' ARG . 6.0 t -126.9 -67.09 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.491 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.6 136.82 26.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.325 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -141.88 146.33 35.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.94 HG23 HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -114.87 143.29 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.846 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 26.1 t-20 . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 121.177 0.513 . . . . 0.0 110.444 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.935 0.397 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.94 HG23 HG23 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -98.72 -177.42 3.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.484 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.2 t80 -138.73 92.32 2.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.787 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 49' ' ' ALA . 12.8 m-85 -93.53 166.27 12.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.013 0.435 . . . . 0.0 111.071 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.24 159.45 19.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.366 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.48 37.19 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 0.0 111.838 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.4 t -116.35 -24.99 7.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.96 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.487 ' HA ' ' NH1' ' A' ' 67' ' ' ARG . 26.9 m -156.82 21.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.046 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.424 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 16.2 ttp85 -75.26 86.32 2.47 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.884 0.849 . . . . 0.0 110.689 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.84 -17.93 0.85 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.314 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.487 ' NH1' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -115.26 -33.16 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.642 0.258 . . . . 0.0 111.304 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.477 ' CE2' ' HG2' ' A' ' 83' ' ' MET . 2.6 m-85 -88.88 137.02 32.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.128 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 10.1 m -106.82 153.63 22.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.907 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -141.35 136.14 32.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.942 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.907 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -152.66 178.72 9.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.671 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.83 167.59 18.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.019 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.606 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 16.8 t0 -79.4 -37.01 38.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.788 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 m120 62.97 35.5 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.819 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.606 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -134.46 -47.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.18 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.4 tttp -130.07 -64.36 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt 167.66 70.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 64.9 m -135.65 144.78 46.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.006 0.432 . . . . 0.0 111.063 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.523 HG11 ' HB3' ' A' ' 34' ' ' MET . 33.8 m -116.54 147.6 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.696 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 2.2 m-85 -136.72 128.65 29.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.906 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -124.7 121.7 35.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.167 0.508 . . . . 0.0 110.808 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -94.59 99.21 11.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.583 ' O ' HD13 ' A' ' 86' ' ' LEU . 1.5 mtp -80.51 87.82 5.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.003 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.65 176.06 7.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.738 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 34.96 48.96 0.37 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.594 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 83' ' ' MET . 1.2 mp -58.2 165.88 1.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.313 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.435 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -145.3 167.89 13.35 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.817 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 54.8 Cg_endo -69.71 1.59 4.26 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.553 2.169 . . . . 0.0 113.148 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -98.76 -20.3 16.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.874 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.15 -21.18 46.86 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.083 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 114' ' ' THR . 99.9 m -51.79 101.55 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.782 0.325 . . . . 0.0 111.198 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.41 177.66 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.345 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.709 ' O ' HG13 ' A' ' 93' ' ' VAL . 9.4 p -80.88 101.57 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.197 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.441 ' O ' HG22 ' A' ' 111' ' ' THR . 3.9 m-85 -81.65 101.71 10.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.026 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.493 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 6.3 t -103.23 125.42 49.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.466 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.9 t -81.93 136.5 35.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.171 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.47 176.69 22.14 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.118 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.601 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -139.37 167.81 21.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.355 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -126.52 170.42 18.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.239 -0.982 . . . . 0.0 113.172 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -156.82 132.52 9.45 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.98 13.48 48.26 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.73 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.52 -9.47 45.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.886 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.662 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -101.82 179.56 4.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.849 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.662 ' H ' HG22 ' A' ' 103' ' ' THR . 84.3 m95 -136.72 86.23 2.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.576 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.56 19.04 17.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.96 132.42 56.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.426 ' CH2' ' HD2' ' A' ' 45' ' ' ARG . 19.5 m95 -139.24 164.02 30.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.025 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.87 -142.84 10.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.574 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.63 -35.32 15.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.382 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 99.8 150.69 25.38 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.863 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 111' ' ' THR . 7.9 t -145.27 114.67 7.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.481 HE21 ' N ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -76.63 132.36 39.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.971 0.415 . . . . 0.0 111.272 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.481 ' N ' HE21 ' A' ' 112' ' ' GLN . 60.7 t -110.14 124.08 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.901 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.693 ' HB ' HD23 ' A' ' 11' ' ' LEU . 89.7 m -112.49 117.26 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.585 HG12 ' H ' ' A' ' 116' ' ' SER . 0.4 OUTLIER -121.62 -168.84 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.083 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.585 ' H ' HG12 ' A' ' 115' ' ' VAL . 77.5 p . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.605 0.241 . . . . 0.0 111.262 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.837 0.351 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.464 HD23 ' HB2' ' A' ' 24' ' ' ALA . 1.7 mp -142.48 -179.57 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -169.13 169.07 9.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.04 163.31 18.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 p -167.74 126.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.62 -31.83 6.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.664 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' HD22 ' A' ' 20' ' ' LEU . . . -55.39 179.11 0.34 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.766 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.12 -157.79 27.49 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.076 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.755 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.2 mp -69.45 145.36 52.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.812 0.339 . . . . 0.0 111.262 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.594 HG11 HD22 ' A' ' 86' ' ' LEU . 7.7 p -146.54 132.97 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.171 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.96 129.48 41.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.187 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' HA ' HG12 ' A' ' 115' ' ' VAL . . . -51.61 128.2 22.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.401 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.25 -3.04 82.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.8 -144.56 14.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.444 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.58 140.97 33.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.934 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.807 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.8 tp -129.84 141.46 50.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.446 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.563 ' C ' HD23 ' A' ' 20' ' ' LEU . 31.5 ttt85 -122.09 131.38 53.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.489 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.807 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.9 mt -121.53 145.1 48.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.291 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.471 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 98.5 p -126.11 108.84 11.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.278 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 50.0 t -101.22 135.88 41.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.507 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -122.0 147.85 45.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.939 0.399 . . . . 0.0 111.424 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB3' ' HE1' ' A' ' 34' ' ' MET . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.822 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.46 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 43.8 t80 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 121.022 0.439 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.45 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 71.6 m-20 -84.47 -176.88 6.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.258 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.576 ' HB3' HG11 ' A' ' 79' ' ' VAL . 2.9 mtt -141.21 117.78 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.33 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -141.22 168.16 25.49 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.039 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.45 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 77.7 m95 -103.0 158.76 16.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 111.163 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 13.8 m-85 -134.72 178.49 6.97 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' HG2' HG22 ' A' ' 48' ' ' VAL . 10.0 ptm180 -148.58 155.22 40.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.929 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.422 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.8 OUTLIER -145.85 110.69 5.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.5 153.24 48.09 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.37 136.46 40.07 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.325 2.016 . . . . 0.0 112.454 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.09 -1.36 33.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.657 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.74 -179.34 3.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.909 0.385 . . . . 0.0 111.048 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.45 -171.58 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.449 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -96.7 154.57 17.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.37 0.605 . . . . 0.0 111.329 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' CG ' ' HG3' ' A' ' 38' ' ' ARG . 7.8 pt-20 -157.46 139.24 14.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.241 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 1.6 t -67.99 171.98 6.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.478 0.656 . . . . 0.0 111.446 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.497 HG21 ' CE1' ' A' ' 94' ' ' TYR . 2.8 t -130.0 -67.8 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.221 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.14 124.42 13.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -120.62 147.3 45.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.337 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 34' ' ' MET . 0.6 OUTLIER -127.31 141.34 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.924 0.392 . . . . 0.0 111.286 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.403 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.6 t-20 . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.785 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.785 0.326 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 1.012 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -107.63 -179.03 3.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.002 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 50' ' ' ALA . 12.8 t80 -139.04 86.58 2.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.713 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.448 ' CE2' HG22 ' A' ' 70' ' ' ILE . 9.3 m-85 -86.79 143.57 27.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.38 165.14 24.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.442 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.4 p -82.33 33.66 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 0.0 111.701 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.4 p -118.99 -21.56 7.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.126 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.536 HG11 ' CE1' ' A' ' 68' ' ' PHE . 17.4 m -148.46 19.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.019 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.5 ttt85 -62.49 79.25 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.63 0.729 . . . . 0.0 110.832 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 134.09 3.16 3.24 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.175 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -119.1 -52.87 2.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.816 0.341 . . . . 0.0 111.069 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CE1' HG11 ' A' ' 64' ' ' VAL . 5.2 m-30 -75.5 150.85 38.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.1 m -113.32 157.87 21.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.007 0.432 . . . . 0.0 110.98 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.012 HG21 HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -151.58 135.18 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.96 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.892 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -164.8 152.04 11.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.716 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 164.31 11.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.07 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.457 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 54.2 t0 -76.93 -30.33 56.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.989 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.35 25.61 13.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.25 -52.59 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.892 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 2.6 pttt -134.16 -57.53 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 173.42 70.96 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.779 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.469 HG22 ' CE1' ' A' ' 80' ' ' TYR . 25.8 m -134.92 139.42 44.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.114 0.483 . . . . 0.0 111.336 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 34' ' ' MET . 35.6 m -115.92 146.16 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.336 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 1.9 m-85 -135.1 155.16 51.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.72 0.295 . . . . 0.0 111.035 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.526 HD21 HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -146.31 125.62 13.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.952 0.406 . . . . 0.0 110.941 179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.61 96.5 7.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.536 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.502 ' SD ' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -79.38 91.25 5.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.271 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.44 178.53 6.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 t 38.99 40.75 0.48 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.441 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.594 HD22 HG11 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -60.38 159.49 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.145 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.556 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 16.5 mmmt -128.62 163.67 43.36 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.411 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 57.8 Cg_endo -70.99 6.96 1.49 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.37 2.047 . . . . 0.0 113.271 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -109.2 -8.1 15.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.009 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.27 -11.15 58.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.652 0.263 . . . . 0.0 111.308 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.434 ' OG1' HG23 ' A' ' 115' ' ' VAL . 97.6 m -53.18 107.7 0.26 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.057 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.61 -177.65 2.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.525 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 93.5 t -89.75 105.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.792 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.51 ' O ' HG22 ' A' ' 111' ' ' THR . 11.3 m-85 -87.91 110.2 20.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 7.2 m -111.15 136.08 50.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.718 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.423 ' HB3' ' CE3' ' A' ' 36' ' ' TRP . 15.7 p -98.91 138.66 35.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 111.175 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.73 -169.3 11.69 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.361 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -136.92 167.41 21.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 111.193 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -104.01 -175.8 25.57 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.629 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -173.75 108.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.73 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.09 16.69 49.32 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.764 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.0 -16.51 25.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.558 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.667 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -96.49 179.81 4.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.769 0.319 . . . . 0.0 110.475 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.667 ' H ' HG22 ' A' ' 103' ' ' THR . 79.9 m95 -141.88 92.51 2.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.766 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -117.43 -2.18 11.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.586 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.676 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 1.2 t -93.28 132.49 37.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -137.28 162.63 33.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.38 -92.49 2.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.403 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -140.36 -69.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 110.845 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 141.54 151.08 5.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.738 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.6 t -147.25 106.46 3.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.899 0.38 . . . . 0.0 110.45 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -66.17 142.22 57.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.203 0.525 . . . . 0.0 111.04 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 91' ' ' THR . 41.1 t -117.62 116.43 51.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.182 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.755 ' CB ' HD23 ' A' ' 11' ' ' LEU . 90.1 m -100.58 108.55 20.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.075 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 116' ' ' SER . 0.3 OUTLIER -108.31 -158.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.396 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.495 ' H ' HG12 ' A' ' 115' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.873 0.368 . . . . 0.0 111.031 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.823 0.344 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 mp -147.82 151.54 36.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -154.32 173.11 16.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.06 164.31 14.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.792 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.92 101.3 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.28 87.17 1.97 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.423 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.62 152.87 16.22 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.447 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.71 -155.25 26.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.41 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.74 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.7 mp -69.03 134.67 49.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.908 0.385 . . . . 0.0 111.247 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG1' HD22 ' A' ' 86' ' ' LEU . 8.0 p -142.33 128.96 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.282 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 132.56 46.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.309 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.54 154.26 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.582 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.18 -9.14 73.93 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.792 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.78 -163.14 25.98 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.608 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.48 141.37 41.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.856 ' CD2' HD21 ' A' ' 20' ' ' LEU . 7.1 tp -128.77 132.27 47.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.612 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -111.57 116.9 31.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.381 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.856 HD21 ' CD2' ' A' ' 18' ' ' LEU . 9.9 mt -104.69 133.74 49.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.626 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 p -112.25 134.94 53.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.659 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -134.29 126.12 29.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.92 0.39 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.19 152.75 21.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.971 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.406 ' HB3' ' HE2' ' A' ' 34' ' ' MET . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.619 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.996 0.427 . . . . 0.0 111.026 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.442 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 39.1 m-20 -123.45 -176.38 3.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.703 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.406 ' HE2' ' HB3' ' A' ' 24' ' ' ALA . 3.9 ttm -145.63 126.43 14.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.192 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.86 162.71 28.97 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.733 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.435 ' CH2' ' CB ' ' A' ' 20' ' ' LEU . 79.7 m95 -91.63 155.12 18.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 111.487 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -137.69 -177.94 5.02 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.785 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.533 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -151.49 163.14 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.559 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.723 ' O ' HG12 ' A' ' 93' ' ' VAL . 4.5 tp60 -165.91 128.37 2.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.03 0.443 . . . . 0.0 111.621 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -113.45 167.94 8.57 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.496 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.725 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 59.6 Cg_endo -72.3 137.56 28.64 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.233 1.955 . . . . 0.0 112.476 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.33 2.0 24.22 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.703 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -119.48 152.0 37.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -77.21 156.1 31.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.387 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.9 143.0 52.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.951 0.405 . . . . 0.0 111.245 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.43 143.25 48.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.211 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.533 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.6 t -83.57 172.79 12.0 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 111.183 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.533 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.0 t -129.19 -66.64 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.976 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.09 161.67 40.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -160.24 144.4 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.995 0.426 . . . . 0.0 111.511 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.661 HD13 ' HD2' ' A' ' 72' ' ' ARG . 1.4 tt -123.24 143.67 35.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.0 m120 . . . . . 0 N--CA 1.449 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.016 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.86 0.362 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.71 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -108.99 -179.36 3.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.022 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -140.6 142.18 35.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.382 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.466 ' HH ' ' HA ' ' A' ' 69' ' ' THR . 3.7 m-85 -128.86 168.32 16.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.84 0.353 . . . . 0.0 111.026 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.0 168.07 13.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 63' ' ' SER . 56.3 m -69.24 153.07 44.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.498 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 t 84.38 -10.23 0.89 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.522 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.435 HG21 ' CG1' ' A' ' 48' ' ' VAL . 28.6 m -154.2 16.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.462 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 8.9 tpt180 -82.08 83.15 7.41 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.665 0.745 . . . . 0.0 109.962 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.09 -0.65 7.71 Favored Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.158 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -110.81 -52.63 2.77 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.837 0.351 . . . . 0.0 110.794 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.3 m-30 -76.86 149.34 36.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.466 ' HA ' ' HH ' ' A' ' 60' ' ' TYR . 6.8 m -111.05 152.37 26.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.71 HG21 HG21 ' A' ' 58' ' ' THR . 6.2 tp -137.49 146.19 28.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.761 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.08 172.33 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 111.032 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.661 ' HD2' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -130.85 143.61 50.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.913 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.409 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 7.2 t0 -83.57 -38.07 22.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.09 26.75 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.43 -42.71 2.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.963 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.25 29.09 2.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.876 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt 61.93 53.97 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.9 m -118.36 148.72 42.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.026 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.75 141.02 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.843 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 24.9 m-85 -125.96 126.69 44.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.977 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -120.63 116.81 26.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 0.0 110.51 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -94.76 94.59 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.156 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.575 ' CE ' HD23 ' A' ' 18' ' ' LEU . 25.9 mtm -78.02 92.91 4.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.798 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.83 176.44 6.63 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 37.21 43.32 0.34 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.695 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.403 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -55.98 156.65 5.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.02 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.508 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.24 170.77 8.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.855 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 89.8 Cg_endo -77.96 8.15 3.62 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.515 2.143 . . . . 0.0 112.954 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -116.92 7.52 13.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.257 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -92.4 -10.06 39.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.304 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 97.9 m -53.97 107.79 0.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.256 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.29 177.0 4.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 39' ' ' GLN . 4.2 p -85.69 106.33 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.027 0.441 . . . . 0.0 110.846 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.96 101.8 13.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.137 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 9.1 m -113.13 136.03 53.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.609 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 25.6 p -100.65 147.12 26.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.029 0.442 . . . . 0.0 111.365 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.83 -171.28 12.45 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.214 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.619 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -138.19 166.73 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 111.269 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -111.61 176.26 18.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.665 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.49 113.69 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 110.575 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.66 16.97 52.86 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.695 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.87 -14.17 31.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -96.32 179.31 5.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.548 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.66 ' H ' HG22 ' A' ' 103' ' ' THR . 78.0 m95 -143.76 102.64 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.795 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.11 11.02 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.439 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.87 137.91 42.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.642 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -140.73 164.11 31.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.964 0.412 . . . . 0.0 111.034 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.18 -130.71 6.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.337 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -98.81 -63.23 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 0.0 110.807 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.89 151.07 8.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.665 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 111' ' ' THR . 15.4 t -145.28 109.72 4.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.359 . . . . 0.0 110.428 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.54 141.63 55.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.208 0.528 . . . . 0.0 111.035 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 91' ' ' THR . 41.3 t -119.21 131.82 70.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.254 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.74 ' CB ' HD23 ' A' ' 11' ' ' LEU . 83.9 m -116.85 138.67 51.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.207 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 116' ' ' SER . 2.0 t -139.11 168.17 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.28 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.518 ' H ' HG12 ' A' ' 115' ' ' VAL . 51.5 m . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.104 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.606 ' C ' HD12 ' A' ' 4' ' ' LEU . 3.6 pt20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.832 0.348 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.606 HD12 ' C ' ' A' ' 3' ' ' GLN . 6.5 mp -140.07 135.32 32.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.17 131.41 44.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.75 164.68 17.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.7 p -158.19 111.73 2.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.03 84.51 1.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.355 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.44 143.81 8.96 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.547 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.83 -156.19 21.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.528 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.764 HD23 ' CG2' ' A' ' 114' ' ' THR . 1.7 mp -69.08 143.19 54.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.919 0.39 . . . . 0.0 111.362 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.97 126.88 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.135 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.57 139.95 56.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -52.32 137.06 29.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.323 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.5 -15.73 60.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.703 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.61 -154.65 7.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.42 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.62 139.29 31.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.011 0.434 . . . . 0.0 111.213 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.837 HD21 HD21 ' A' ' 20' ' ' LEU . 10.8 tp -124.45 135.31 53.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.554 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.06 115.31 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 111.557 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.837 HD21 HD21 ' A' ' 18' ' ' LEU . 12.4 mt -112.61 132.48 55.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.577 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -120.67 113.34 20.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.67 123.14 49.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.791 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.71 165.76 11.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.298 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.912 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.638 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.992 0.425 . . . . 0.0 110.741 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.474 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 46.9 m-20 -115.47 -173.65 2.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.86 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.638 ' HB3' HG11 ' A' ' 79' ' ' VAL . 9.3 mtm -145.87 124.71 12.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.055 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.88 152.93 24.88 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.829 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 96' ' ' CYS . 73.1 m95 -88.46 154.82 20.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.114 0.483 . . . . 0.0 111.427 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.63 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.1 m-85 -133.65 -178.69 5.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.266 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.486 ' CD ' HG22 ' A' ' 48' ' ' VAL . 1.6 ptm180 -152.94 157.86 41.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.752 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.422 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 2.2 tm0? -145.46 145.4 31.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.946 0.403 . . . . 0.0 111.336 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.37 151.77 78.11 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.44 139.6 41.75 Favored 'Trans proline' 0 CA--C 1.517 -0.345 0 C-N-CA 122.362 2.041 . . . . 0.0 112.537 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.76 -7.08 43.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.764 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.45 -166.68 1.21 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.798 0.333 . . . . 0.0 110.9 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.86 -171.71 1.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -98.19 133.77 42.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.935 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HG2' ' HG3' ' A' ' 38' ' ' ARG . 4.1 pt-20 -131.79 152.28 51.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.423 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 6.6 t -83.41 174.66 10.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.382 0.61 . . . . 0.0 111.079 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.547 ' CG1' HG21 ' A' ' 64' ' ' VAL . 3.8 t -130.12 -62.47 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.071 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -151.88 129.83 11.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.509 ' O ' HG22 ' A' ' 58' ' ' THR . . . -127.98 145.26 51.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.386 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 58' ' ' THR . 11.0 tt -126.98 142.29 43.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.32 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.74 179.77 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 120.387 0.137 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 1.065 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -97.85 -179.77 4.54 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.987 0.423 . . . . 0.0 111.19 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 50' ' ' ALA . 65.3 t80 -139.7 91.0 2.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.64 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.428 ' OH ' HG22 ' A' ' 70' ' ' ILE . 47.3 m-85 -76.83 158.06 31.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.2 172.01 7.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.167 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -69.57 150.87 46.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.618 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.0 OUTLIER 84.72 -11.19 0.81 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.623 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' A' ' 68' ' ' PHE . 16.4 m -149.21 12.45 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.48 79.2 1.05 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.537 0.684 . . . . 0.0 110.7 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.73 3.11 10.26 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.825 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -108.01 -41.32 4.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.732 0.301 . . . . 0.0 111.09 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.592 ' CE2' HG11 ' A' ' 64' ' ' VAL . 9.5 m-30 -94.27 146.72 23.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.124 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.7 m -105.12 158.03 16.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.812 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.065 HG21 HG21 ' A' ' 58' ' ' THR . 2.7 tp -144.79 139.92 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.106 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 m -154.42 137.35 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.679 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.449 ' HB3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -90.13 152.01 21.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.245 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.467 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 39.4 t0 -84.43 -36.5 22.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.793 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.99 29.98 19.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.95 -46.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.09 31.76 1.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.482 ' HB3' ' HE1' ' A' ' 34' ' ' MET . 22.5 mtmt 62.77 56.14 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 73' ' ' ASP . 60.6 m -116.04 150.31 37.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.638 HG11 ' HB3' ' A' ' 34' ' ' MET . 31.5 m -128.5 131.95 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.928 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.577 ' CD1' ' HB3' ' A' ' 21' ' ' SER . 25.6 m-85 -113.09 120.58 41.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.195 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.618 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -114.09 112.61 23.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.068 179.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -96.35 96.84 9.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.203 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.674 ' SD ' HD23 ' A' ' 18' ' ' LEU . 1.3 mtp -81.94 88.3 6.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.03 177.66 6.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.57 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 t 37.98 40.85 0.32 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.516 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 162.62 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.628 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -128.99 170.83 9.84 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.779 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 84.5 Cg_endo -77.67 10.82 2.4 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 113.089 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -122.02 10.98 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.342 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -95.94 -15.46 22.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.608 0.242 . . . . 0.0 111.36 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.556 ' OG1' HG23 ' A' ' 115' ' ' VAL . 82.9 m -49.27 112.86 0.69 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.435 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.34 173.65 5.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.969 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 93' ' ' VAL . 7.4 p -81.1 105.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.979 0.419 . . . . 0.0 110.925 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -83.95 99.08 10.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.959 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 4.3 m -105.63 128.03 53.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 14.0 p -95.15 143.78 26.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.964 0.411 . . . . 0.0 111.224 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.451 ' HA2' HD22 ' A' ' 4' ' ' LEU . . . -139.81 -173.06 13.03 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.158 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.638 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -144.69 166.37 25.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.957 0.408 . . . . 0.0 111.264 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.93 171.68 18.21 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.676 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.01 115.5 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.621 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.89 15.8 50.05 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.782 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.77 -14.67 31.98 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.528 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.5 m -99.1 178.79 4.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.789 0.328 . . . . 0.0 110.608 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.651 ' H ' HG22 ' A' ' 103' ' ' THR . 71.5 m95 -138.2 93.06 2.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.655 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -119.2 2.33 11.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.52 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -96.04 132.72 41.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 110.898 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -140.91 164.93 28.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.71 -154.81 18.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -30.75 20.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.333 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.94 151.0 26.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.883 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 111' ' ' THR . 12.4 t -145.34 109.45 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.262 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -67.61 141.55 56.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.158 0.504 . . . . 0.0 111.052 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 91' ' ' THR . 43.5 t -119.87 126.23 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.329 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.764 ' CG2' HD23 ' A' ' 11' ' ' LEU . 94.8 m -109.99 142.62 41.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.955 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 87' ' ' LYS . 2.6 t -127.52 169.54 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.155 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.689 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.813 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.819 0.343 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 mp -149.12 155.1 40.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -150.66 161.11 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.714 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.81 164.72 12.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.83 0.348 . . . . 0.0 110.978 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -164.76 95.65 0.72 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.59 -28.43 2.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.638 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.825 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.0 138.43 20.89 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.9 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.0 -172.49 43.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.089 -0.576 . . . . 0.0 112.373 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.794 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.5 mp -69.35 150.03 47.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.863 0.363 . . . . 0.0 111.554 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.665 ' CG1' HD22 ' A' ' 86' ' ' LEU . 7.8 p -153.39 116.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.941 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.74 139.77 25.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.426 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.17 123.3 7.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.82 0.56 60.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.834 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.31 138.55 14.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.449 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 t -79.68 141.54 36.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 110.966 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.646 HD23 HD21 ' A' ' 20' ' ' LEU . 14.9 tp -132.92 150.44 52.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.309 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.404 ' C ' HD23 ' A' ' 20' ' ' LEU . 4.9 ttt180 -125.45 126.56 45.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.402 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.825 HD22 ' HA2' ' A' ' 9' ' ' GLY . 2.2 mt -114.49 149.72 35.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.799 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 71.1 m -131.21 118.63 20.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.05 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 19.0 p -125.37 131.34 52.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.58 169.11 9.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.311 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.035 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.108 0 CA-C-O 120.919 0.39 . . . . 0.0 111.275 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.436 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 44.2 m-20 -101.6 -172.45 2.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.941 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.406 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -143.6 124.1 13.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.733 0.301 . . . . 0.0 111.273 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.52 166.11 29.62 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.939 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.518 ' CE2' HD22 ' A' ' 81' ' ' LEU . 52.6 m95 -91.9 156.2 17.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.133 0.492 . . . . 0.0 111.307 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 8.1 m-85 -136.45 179.18 6.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.938 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 16.7 ptm180 -152.86 160.56 43.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.723 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.645 ' O ' HG12 ' A' ' 93' ' ' VAL . 12.6 tt0 -165.5 159.83 17.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.064 0.459 . . . . 0.0 111.459 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -136.01 162.33 57.32 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.506 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 52.2 Cg_endo -69.59 137.39 35.86 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.387 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.54 3.07 38.67 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.722 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 -172.87 2.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.783 0.325 . . . . 0.0 111.058 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.85 -178.84 3.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.739 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.408 ' HD2' ' CH2' ' A' ' 107' ' ' TRP . 18.2 ptt-85 -103.28 139.65 38.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.173 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HG3' ' CG ' ' A' ' 38' ' ' ARG . 18.1 pt-20 -140.73 146.74 38.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.236 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.7 t -83.85 175.2 9.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.316 0.579 . . . . 0.0 111.363 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.4 -57.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.786 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.29 157.66 43.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.719 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -158.19 140.97 14.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.06 0.457 . . . . 0.0 111.484 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.679 HD13 HG23 ' A' ' 58' ' ' THR . 7.5 tp -121.21 139.82 47.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.835 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.447 -0.579 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.933 -179.841 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.428 ' O ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.291 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.679 HG23 HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -117.48 -178.13 3.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.599 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.6 t80 -136.93 142.59 42.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.561 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.431 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 5.8 m-85 -126.44 165.77 18.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.976 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.6 166.41 11.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.5 152.13 45.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.703 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 83.62 -10.15 0.98 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.571 -178.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.422 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 35.6 m -152.08 15.39 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.237 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -70.48 78.91 0.56 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.576 0.703 . . . . 0.0 110.752 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.51 3.35 5.63 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.0 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -112.29 -44.04 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.754 0.311 . . . . 0.0 111.016 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 5.9 m-30 -78.79 140.2 38.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.786 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 28.9 m -105.45 151.06 24.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 111.164 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.911 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -145.54 136.8 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.634 -179.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.911 ' N ' HD13 ' A' ' 70' ' ' ILE . 19.3 p -162.41 141.59 9.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.091 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -73.25 165.42 25.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.958 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.415 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 37.1 t0 -97.19 -33.5 11.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.826 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 60.34 58.36 2.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.17 -46.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -140.38 29.29 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.72 55.48 2.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.62 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.494 ' CG2' ' CE1' ' A' ' 80' ' ' TYR . 6.4 m -123.3 158.94 29.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.109 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.19 143.66 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.715 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 21' ' ' SER . 15.2 m-85 -124.5 135.11 52.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.506 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -127.19 121.04 30.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.084 0.469 . . . . 0.0 110.812 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -99.23 101.15 12.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.838 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.577 ' HE1' HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -87.75 95.22 10.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.181 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.92 175.36 8.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.833 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 34.4 48.33 0.27 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.794 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.665 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -54.34 164.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.004 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.671 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -128.68 164.46 38.24 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.813 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 87' ' ' LYS . 63.1 Cg_endo -72.82 6.32 2.5 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.533 2.155 . . . . 0.0 113.155 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -111.89 -0.03 15.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.282 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -84.91 -11.73 54.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.576 0.227 . . . . 0.0 111.237 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 90.8 m -56.02 103.5 0.1 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.67 175.65 4.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.381 . . . . 0.0 111.583 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.678 ' O ' HG13 ' A' ' 93' ' ' VAL . 7.7 p -80.84 105.37 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.082 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 111' ' ' THR . 9.8 m-85 -84.42 105.04 14.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.656 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.4 m -110.96 127.38 55.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.9 t -81.17 127.4 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.485 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -128.15 -177.41 14.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.471 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 34' ' ' MET . . . -146.13 147.77 31.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.848 0.356 . . . . 0.0 111.213 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.458 ' N ' ' CE3' ' A' ' 104' ' ' TRP . . . -78.77 -170.07 37.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.374 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.28 100.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.67 18.54 45.71 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.761 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.19 -20.28 11.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -97.62 -179.81 4.59 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 110.426 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.664 ' H ' HG22 ' A' ' 103' ' ' THR . 71.8 m95 -145.55 102.54 3.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.945 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -134.96 15.6 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.298 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.37 133.22 51.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.786 0.326 . . . . 0.0 110.66 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.408 ' CH2' ' HD2' ' A' ' 45' ' ' ARG . 9.4 m95 -136.25 162.15 33.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.28 -137.19 9.13 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.494 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -87.07 -51.02 6.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.334 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.39 151.28 12.88 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.661 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 111' ' ' THR . 13.9 t -158.56 118.57 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -79.44 142.64 35.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.004 0.43 . . . . 0.0 111.176 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.446 ' N ' HE21 ' A' ' 112' ' ' GLN . 52.6 t -116.31 136.48 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.159 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.794 ' CB ' HD23 ' A' ' 11' ' ' LEU . 99.6 m -109.31 130.0 55.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.011 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.671 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -126.18 -158.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.55 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.469 ' H ' HG12 ' A' ' 115' ' ' VAL . 1.3 t . . . . . 0 C--N 1.332 -0.156 0 CA-C-O 120.869 0.366 . . . . 0.0 110.87 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.609 ' C ' HD12 ' A' ' 4' ' ' LEU . 5.0 pt20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.818 0.342 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 3' ' ' GLN . 4.0 mp -160.61 99.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.02 174.01 8.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.012 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.37 163.97 22.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.733 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -169.62 135.94 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.08 -18.36 26.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.729 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.403 ' HA2' ' CD2' ' A' ' 20' ' ' LEU . . . -54.07 -173.83 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.831 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.12 164.36 10.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.509 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.789 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.5 mp -69.28 146.51 52.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.85 0.357 . . . . 0.0 111.376 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 12' ' ' VAL . 8.5 p -165.53 119.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.174 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -54.76 154.5 5.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.24 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -49.64 138.3 14.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.358 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.99 -21.79 44.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.487 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.52 122.98 6.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.305 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 11.4 p -70.0 130.53 42.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 111.131 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.779 ' CD2' HD21 ' A' ' 20' ' ' LEU . 12.7 tp -109.74 133.74 52.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.494 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -107.29 119.2 38.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 0.0 111.422 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.779 HD21 ' CD2' ' A' ' 18' ' ' LEU . 13.9 mt -114.53 136.32 53.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.534 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.5 p -122.34 111.05 16.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.122 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.4 t -107.29 134.52 50.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.514 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.29 152.4 26.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.253 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.055 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.614 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.98 0.419 . . . . 0.0 110.854 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -120.26 -171.45 2.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.715 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -139.67 160.32 40.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.923 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . 179.56 141.62 4.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.0 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.526 ' CD2' HD22 ' A' ' 81' ' ' LEU . 81.4 m95 -82.72 154.7 24.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.15 0.5 . . . . 0.0 111.285 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.5 m-85 -137.89 -178.27 5.18 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.296 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.523 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -148.85 161.04 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.494 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.725 ' O ' HG12 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -162.7 137.51 6.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.005 0.431 . . . . 0.0 111.387 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.709 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -121.15 166.77 14.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.49 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.709 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 38.0 Cg_endo -66.21 135.77 41.42 Favored 'Trans proline' 0 CA--C 1.517 -0.355 0 C-N-CA 122.169 1.913 . . . . 0.0 112.248 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.43 6.35 33.92 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.458 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.51 -177.23 3.18 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.832 0.348 . . . . 0.0 111.022 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -109.7 -171.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.775 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -86.12 134.43 33.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.078 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -131.74 116.45 17.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.412 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 1.5 t -68.09 169.22 10.56 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.599 0.714 . . . . 0.0 111.328 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.523 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.3 t -132.63 -68.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.372 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -140.94 145.99 36.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.71 0.29 . . . . 0.0 111.307 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.544 ' O ' HG22 ' A' ' 58' ' ' THR . . . -140.85 142.18 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.466 ' HB ' HG23 ' A' ' 58' ' ' THR . 2.4 tt -125.23 145.75 32.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.249 -179.877 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.958 0.408 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.725 HG21 ' CG2' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -118.42 -178.02 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.978 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 52.9 t80 -139.19 96.2 3.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.892 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.37 158.16 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.842 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . -98.13 157.16 16.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 63' ' ' SER . 17.3 p -69.38 151.57 45.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.572 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 86.47 -12.3 0.59 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.556 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.673 HG12 ' HD2' ' A' ' 67' ' ' ARG . 14.8 m -141.97 7.67 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.497 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 80.23 0.55 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.561 0.696 . . . . 0.0 110.781 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 139.49 1.77 1.86 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.619 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.673 ' HD2' HG12 ' A' ' 64' ' ' VAL . 13.4 ptp180 -117.96 -40.03 3.03 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.779 0.289 . . . . 0.0 111.303 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 83' ' ' MET . 14.4 m-30 -90.23 159.0 16.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.115 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.8 m -125.23 157.19 37.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.867 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -156.32 134.47 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.997 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.867 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -160.13 140.25 11.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.842 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -78.24 173.3 12.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.95 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.413 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 33.3 t0 -98.99 -33.59 10.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.034 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.22 28.7 17.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.54 -59.82 1.51 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.953 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -128.06 28.47 5.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.5 60.02 0.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.149 0.5 . . . . 0.0 110.729 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -122.84 147.93 45.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.047 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.6 m -119.78 139.37 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 41.1 m-85 -124.45 115.88 21.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 0.0 111.197 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.691 HD23 ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -112.24 111.77 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.139 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.42 97.29 9.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.769 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.496 ' HE1' ' CZ ' ' A' ' 94' ' ' TYR . 5.3 mtp -77.18 87.66 3.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.258 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -82.02 176.37 9.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.702 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 37.4 48.55 0.86 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.753 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.514 HD23 ' CG2' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -65.98 157.77 29.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.978 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.69 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -129.33 173.83 5.25 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.773 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.38 9.16 3.53 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.613 2.208 . . . . 0.0 113.034 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -113.04 -4.95 13.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.1 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.29 -12.25 58.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.239 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 76.2 m -48.94 104.06 0.06 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.46 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.4 166.62 8.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.365 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 39' ' ' GLN . 9.8 p -76.33 105.26 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.038 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.496 ' CZ ' ' HE1' ' A' ' 83' ' ' MET . 5.0 m-85 -82.54 100.26 10.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.4 m -109.11 134.48 51.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 26.7 p -96.49 146.14 25.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.033 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.16 -178.35 16.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.555 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -131.65 170.18 15.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -118.26 172.56 14.49 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.802 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -159.09 118.08 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.504 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.11 16.03 51.98 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.696 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.31 -12.78 36.73 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.673 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.668 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -98.13 180.0 4.57 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.744 0.307 . . . . 0.0 110.672 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.668 ' H ' HG22 ' A' ' 103' ' ' THR . 83.6 m95 -138.45 101.61 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.815 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -123.21 -8.49 8.19 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.474 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.506 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -91.42 140.4 29.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.827 0.346 . . . . 0.0 111.112 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -141.88 165.47 27.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.795 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.27 -149.25 13.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.524 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.03 -55.63 3.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.686 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.91 150.98 9.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.763 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 111' ' ' THR . 12.4 t -146.84 112.21 5.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.375 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -61.95 140.52 58.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.222 0.534 . . . . 0.0 111.012 -179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.9 t -119.13 97.64 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.037 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.789 ' CB ' HD23 ' A' ' 11' ' ' LEU . 60.5 m -86.13 135.69 33.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 111.285 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 87' ' ' LYS . 2.0 t -130.87 168.0 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.184 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.674 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.99 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.828 0.347 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mp -145.6 162.87 36.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.42 141.96 27.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -94.52 167.79 11.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -168.85 115.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.869 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.23 -34.77 4.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.555 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.83 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -51.42 138.94 27.33 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.817 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.42 -162.88 31.11 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.44 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.597 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.3 mp -69.45 152.23 45.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.846 0.355 . . . . 0.0 111.404 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 12' ' ' VAL . 9.7 p -170.12 109.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -57.56 152.29 15.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.338 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -52.45 153.65 2.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.376 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.08 5.18 75.16 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.722 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.71 119.78 4.37 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.395 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.2 136.82 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 111.032 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.682 HD23 HD21 ' A' ' 20' ' ' LEU . 6.7 tp -127.34 131.3 50.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.403 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.611 ' C ' HD23 ' A' ' 20' ' ' LEU . 4.0 ttt-85 -107.42 133.0 52.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.901 0.381 . . . . 0.0 111.418 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.83 HD22 ' HA2' ' A' ' 9' ' ' GLY . 1.1 mt -120.15 150.78 40.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.072 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.3 p -123.23 140.31 53.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.204 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 48.4 t -134.1 135.15 43.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.697 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.3 157.09 20.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.051 179.912 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 5.4 t80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.962 0.41 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.92 172.39 13.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.55 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.465 ' O ' HG22 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -137.92 117.56 13.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.847 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -145.85 149.65 21.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.849 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.469 ' CE2' HD22 ' A' ' 81' ' ' LEU . 67.4 m95 -88.32 153.62 21.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.13 0.49 . . . . 0.0 111.175 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.3 m-85 -132.32 -178.88 5.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.588 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.676 ' CD ' HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -151.97 157.21 41.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.157 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -157.69 141.4 15.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 111.416 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -127.53 161.63 53.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.535 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 41.0 Cg_endo -67.36 137.09 42.21 Favored 'Trans proline' 0 CA--C 1.518 -0.315 0 C-N-CA 122.287 1.991 . . . . 0.0 112.384 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.37 3.74 40.8 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.671 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -112.51 -176.06 2.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.872 0.368 . . . . 0.0 111.056 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -111.53 157.27 20.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.483 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 15.8 ptt-85 -74.47 133.15 42.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.12 0.486 . . . . 0.0 111.732 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 16.4 pt-20 -134.54 165.11 25.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.903 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 12.1 t -101.03 172.64 6.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.194 0.521 . . . . 0.0 111.164 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.676 HG22 ' CD ' ' A' ' 38' ' ' ARG . 2.8 t -128.95 -67.51 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.367 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.02 135.42 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.0 111.367 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.704 ' O ' HG22 ' A' ' 58' ' ' THR . . . -131.65 144.75 51.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.627 HD12 HG23 ' A' ' 58' ' ' THR . 0.7 OUTLIER -128.11 143.69 40.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.251 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.1 p30 . . . . . 0 N--CA 1.448 -0.561 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.189 -179.82 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.891 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -115.86 -177.79 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 77.1 t80 -139.41 92.27 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.805 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.401 ' CB ' ' HG2' ' A' ' 65' ' ' ARG . 74.9 m-85 -78.7 159.55 27.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.89 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.82 161.51 15.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 0.0 111.304 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' SER . 32.8 t -69.28 152.21 45.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.477 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.8 t 88.83 -14.4 0.36 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.515 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.405 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 34.9 m -150.49 16.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.432 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.401 ' HG2' ' CB ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -78.72 81.3 5.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.523 0.678 . . . . 0.0 111.151 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.89 -11.2 2.36 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.185 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' CG ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -109.46 -51.37 2.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.777 0.323 . . . . 0.0 111.247 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CE2' ' HG2' ' A' ' 83' ' ' MET . 3.1 m-85 -69.93 140.15 53.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.905 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 7.5 m -110.82 146.08 37.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.778 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.891 HG21 HG21 ' A' ' 58' ' ' THR . 1.1 tp -136.42 140.94 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.88 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.451 ' N ' HG13 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -151.13 -174.44 4.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.81 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.523 ' HG3' HG12 ' A' ' 79' ' ' VAL . 6.6 ttm180 -130.83 168.06 17.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.005 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.4 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 34.3 t0 -97.32 -37.56 10.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.844 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.41 35.92 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.81 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.32 -67.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.098 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 29.82 7.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.36 44.99 14.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.68 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 46.6 m -112.64 151.5 30.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.173 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.523 HG12 ' HG3' ' A' ' 72' ' ' ARG . 33.5 m -121.22 158.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.381 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 33.9 m-85 -141.71 129.88 22.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.026 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.469 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -125.21 122.15 36.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.094 0.473 . . . . 0.0 110.898 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -95.57 95.96 8.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.522 ' SD ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -77.08 88.43 3.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.855 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.4 176.26 7.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 36.41 40.76 0.13 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.588 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.614 HD23 ' CG2' ' A' ' 115' ' ' VAL . 0.1 OUTLIER -51.14 158.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.182 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 6.2 mptt -127.64 162.91 46.24 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.78 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 74.2 Cg_endo -74.91 5.71 3.78 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.457 2.105 . . . . 0.0 112.927 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -109.73 -6.82 15.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.134 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.34 -19.4 46.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 89.7 m -50.42 106.83 0.13 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.864 0.364 . . . . 0.0 111.25 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.34 -176.2 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.977 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -87.51 103.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.854 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.537 ' O ' HG22 ' A' ' 111' ' ' THR . 4.1 m-85 -82.75 108.75 16.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.468 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.2 m -107.5 130.68 54.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.316 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 50.6 t -92.35 138.73 31.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.623 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -146.98 176.36 25.89 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.826 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.621 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -126.7 172.94 9.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 0.0 111.011 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -124.84 178.21 16.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.185 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -171.38 122.48 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.379 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.66 15.7 54.39 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.642 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.83 -9.4 47.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.826 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.653 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.3 m -100.16 178.67 4.71 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 110.775 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.653 ' H ' HG22 ' A' ' 103' ' ' THR . 80.0 m95 -140.89 90.95 2.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -110.26 -6.62 14.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.372 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.621 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -90.85 131.26 36.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.706 0.288 . . . . 0.0 110.782 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -141.3 164.09 31.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.001 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.34 -136.66 8.43 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.46 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -102.96 -35.65 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.928 0.394 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.6 151.1 12.59 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.68 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.7 t -144.26 104.77 4.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.852 0.358 . . . . 0.0 110.457 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.77 141.12 58.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 111.113 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 91' ' ' THR . 46.4 t -119.79 130.34 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.304 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.597 ' CB ' HD23 ' A' ' 11' ' ' LEU . 69.1 m -115.72 133.28 56.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.115 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.614 ' CG2' HD23 ' A' ' 86' ' ' LEU . 2.1 t -133.44 168.01 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.306 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.756 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 8.2 t . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.968 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.733 0.301 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 106' ' ' SER . 1.7 mp -156.44 119.26 4.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.133 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -122.9 165.7 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.576 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.44 163.32 15.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.774 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.45 131.23 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.11 -28.36 11.22 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.663 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.401 ' HA2' ' CD2' ' A' ' 20' ' ' LEU . . . -53.23 164.23 2.14 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.869 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.64 171.29 25.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.41 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.839 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.9 mp -69.07 137.2 53.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.928 0.394 . . . . 0.0 111.398 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.23 128.57 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.991 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -64.2 149.35 48.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -49.35 144.32 5.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.382 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.98 -14.95 63.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.635 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.29 129.67 9.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.37 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.08 135.54 49.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 111.03 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.886 HD21 HD21 ' A' ' 20' ' ' LEU . 7.1 tp -119.51 132.12 55.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.292 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -114.04 116.53 29.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.828 0.347 . . . . 0.0 111.369 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.886 HD21 HD21 ' A' ' 18' ' ' LEU . 14.5 mt -107.6 138.31 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.403 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 90.9 p -124.96 120.08 30.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.962 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.439 ' HB3' ' CG1' ' A' ' 79' ' ' VAL . 26.8 t -117.89 131.35 56.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.022 0.439 . . . . 0.0 110.595 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.91 149.14 31.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.287 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.022 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.586 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.44 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 23.4 m-20 -129.15 -169.13 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.471 ' O ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -148.16 120.73 8.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.098 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -144.95 168.87 26.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.861 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.515 ' CD2' HD22 ' A' ' 81' ' ' LEU . 74.8 m95 -107.14 159.5 16.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 111.19 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 11.0 m-85 -137.74 178.3 7.21 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.726 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 10.6 ptm180 -156.34 154.04 29.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.398 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.505 ' O ' HG12 ' A' ' 93' ' ' VAL . 5.0 tp60 -157.02 119.32 3.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.953 0.406 . . . . 0.0 111.449 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -102.91 169.79 7.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.575 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.782 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 58.4 Cg_endo -71.73 138.96 32.86 Favored 'Trans proline' 0 CA--C 1.517 -0.328 0 C-N-CA 122.241 1.961 . . . . 0.0 112.447 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.92 3.44 35.84 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.712 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -118.1 158.41 25.08 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.947 0.403 . . . . 0.0 110.984 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.47 157.23 19.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.215 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.441 ' NE ' ' CZ3' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -69.92 144.36 52.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.165 0.507 . . . . 0.0 111.13 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' ' HG3' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -149.29 146.91 27.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.407 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 2.6 t -77.01 173.11 12.17 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.456 0.646 . . . . 0.0 111.421 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.423 ' N ' ' OG ' ' A' ' 47' ' ' SER . 15.9 t -127.21 -60.63 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.235 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.523 ' CB ' HD13 ' A' ' 70' ' ' ILE . . . -151.99 123.23 7.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.957 0.408 . . . . 0.0 111.197 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.612 ' O ' HG22 ' A' ' 58' ' ' THR . . . -120.34 147.47 44.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.231 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.713 ' CD1' HG23 ' A' ' 58' ' ' THR . 3.1 tp -132.03 141.54 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.027 0.441 . . . . 0.0 111.459 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.422 ' N ' HG13 ' A' ' 51' ' ' ILE . 10.3 m120 . . . . . 0 N--CA 1.448 -0.563 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.815 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.713 HG23 ' CD1' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -105.92 -179.3 3.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.777 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 9.5 t80 -138.6 85.93 2.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.666 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.485 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 58.5 m-85 -72.39 161.74 30.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.06 162.76 15.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 63' ' ' SER . 7.1 m -69.46 151.53 45.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.556 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.3 t 86.33 -12.23 0.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.584 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.464 HG11 ' CE2' ' A' ' 68' ' ' PHE . 34.2 m -145.33 10.27 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.484 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.413 ' HG2' ' CB ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -80.2 81.08 6.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.514 0.673 . . . . 0.0 110.971 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 139.51 -3.62 2.68 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.364 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.86 -51.9 1.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.637 0.256 . . . . 0.0 111.297 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CE2' HG11 ' A' ' 64' ' ' VAL . 5.4 m-30 -69.93 159.16 34.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.554 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 28.9 m -124.17 148.35 47.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.375 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.628 ' CG2' HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -138.99 136.31 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.678 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.472 ' O ' HG23 ' A' ' 79' ' ' VAL . 16.8 p -153.44 -173.76 4.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 111.076 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.45 160.39 39.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.982 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.41 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 13.6 t0 -90.55 -44.77 9.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 69.72 11.69 7.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.71 -34.96 6.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.891 0.377 . . . . 0.0 110.776 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -142.5 26.89 1.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.633 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.65 52.44 5.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.68 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.9 m -116.06 152.2 34.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.095 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 71' ' ' SER . 8.6 p -117.05 143.47 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.453 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 42.5 m-85 -126.64 110.06 12.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.852 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.66 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -112.82 112.29 23.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.46 . . . . 0.0 110.191 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.74 100.29 12.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.269 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.506 ' HE2' HD11 ' A' ' 86' ' ' LEU . 4.7 mtp -81.66 90.48 6.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.829 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 177.09 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 37.46 47.1 0.71 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.671 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.506 HD11 ' HE2' ' A' ' 83' ' ' MET . 0.1 OUTLIER -57.63 165.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.067 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 18.6 mmtt -144.99 164.89 24.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.764 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 55.3 Cg_endo -69.47 2.23 3.56 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.418 2.079 . . . . 0.0 113.222 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -104.34 -0.4 28.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.246 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -89.95 -9.95 46.89 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.41 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 87.1 m -50.35 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.724 0.297 . . . . 0.0 111.156 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.22 169.5 7.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.528 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 93' ' ' VAL . 5.4 p -82.59 107.22 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.291 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.465 ' O ' HG22 ' A' ' 111' ' ' THR . 13.7 m-85 -85.77 105.74 16.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.602 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 37' ' ' PHE . 21.6 m -109.31 138.62 45.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.156 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.4 p -97.64 142.34 29.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.826 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.17 177.16 21.71 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.294 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.663 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -130.29 167.45 18.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.942 0.401 . . . . 0.0 111.098 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.83 175.11 19.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.831 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.86 113.56 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.371 . . . . 0.0 110.735 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.88 16.06 50.83 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.784 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.35 -14.83 33.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.487 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.657 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.1 m -97.92 -179.84 4.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.676 0.274 . . . . 0.0 110.426 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.657 ' H ' HG22 ' A' ' 103' ' ' THR . 77.0 m95 -140.83 98.99 3.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -133.54 10.6 4.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.501 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.663 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -102.38 62.19 0.85 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.308 0.575 . . . . 0.0 110.736 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.441 ' CZ3' ' NE ' ' A' ' 45' ' ' ARG . 29.8 m95 -68.7 165.18 20.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.136 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.77 -121.42 4.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.515 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 -67.79 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 134.41 151.87 6.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.668 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.6 t -151.84 108.35 3.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.551 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -59.23 141.06 55.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.199 0.524 . . . . 0.0 111.13 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 113' ' ' VAL . 37.6 t -121.92 82.85 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.839 ' CB ' HD23 ' A' ' 11' ' ' LEU . 92.7 m -73.25 141.26 47.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 116' ' ' SER . 0.6 OUTLIER -138.71 177.15 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.321 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.658 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 10.5 p . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.788 0.328 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.92 141.16 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.43 164.35 15.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.794 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.85 163.26 17.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.0 t -163.98 119.1 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.63 -22.81 8.11 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.666 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.478 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -47.29 140.62 7.7 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.882 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.39 169.03 37.34 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.375 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.775 HD23 HG21 ' A' ' 114' ' ' THR . 1.8 mp -69.21 145.37 53.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.807 0.337 . . . . 0.0 111.399 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.743 ' CG1' HD22 ' A' ' 86' ' ' LEU . 9.3 p -141.02 132.78 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.38 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.07 139.98 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.452 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.764 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -45.76 130.36 9.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.588 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.65 -20.84 48.87 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.602 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.24 179.66 53.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.571 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 t -120.5 139.0 53.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.992 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.746 HD23 ' CE ' ' A' ' 83' ' ' MET . 9.7 tp -125.6 132.75 52.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.457 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.463 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -114.37 131.17 56.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.0 111.629 -179.315 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.588 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.3 mt -121.24 141.29 51.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.311 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 80' ' ' TYR . 95.4 p -124.03 113.53 18.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' HG23 ' A' ' 78' ' ' THR . 32.6 t -108.18 134.56 50.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.636 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.9 145.46 39.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.155 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' HB3' ' HG3' ' A' ' 100' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 120.831 0.348 . . . . 0.0 111.053 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -59.61 174.86 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.031 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.576 ' HB3' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -143.87 126.59 16.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.17 156.15 26.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.823 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.592 ' CE2' HD22 ' A' ' 81' ' ' LEU . 69.9 m95 -87.31 153.74 21.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.144 0.497 . . . . 0.0 111.315 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.7 m-85 -131.63 178.25 6.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.422 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.608 ' NE ' HG22 ' A' ' 48' ' ' VAL . 7.6 ptt180 -152.34 155.24 37.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.815 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -167.03 148.85 6.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.945 0.402 . . . . 0.0 111.273 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.727 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -126.29 167.19 17.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.606 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.727 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 37.6 Cg_endo -66.15 137.52 48.3 Favored 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 122.228 1.952 . . . . 0.0 112.216 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.92 3.98 45.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.603 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -110.75 -179.61 3.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.819 0.342 . . . . 0.0 110.837 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.01 167.63 9.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.045 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.42 135.19 34.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.098 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HG3' ' CG ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -138.88 166.21 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.657 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 11.4 t -104.47 173.43 6.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.091 0.472 . . . . 0.0 111.078 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.608 HG22 ' NE ' ' A' ' 38' ' ' ARG . 2.4 t -131.52 -66.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.258 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.62 132.04 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.277 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 58' ' ' THR . . . -132.29 145.3 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.276 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.698 ' HB ' HG23 ' A' ' 58' ' ' THR . 19.1 tt -122.78 142.32 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.459 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.645 179.562 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.426 ' HB3' ' H ' ' A' ' 58' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 120.726 0.298 . . . . 0.0 111.178 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.977 HG21 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -97.48 -177.27 3.75 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.967 0.413 . . . . 0.0 110.975 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 63.2 t80 -139.41 93.03 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.725 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CE1' HG22 ' A' ' 70' ' ' ILE . 89.7 m-85 -80.14 158.0 26.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.39 176.13 5.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.282 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.34 152.03 45.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.578 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 62' ' ' SER . 4.0 t 85.82 -11.64 0.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.522 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.9 m -154.32 17.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.442 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 79.32 0.96 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.557 0.694 . . . . 0.0 110.799 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.46 3.47 9.43 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -111.67 -43.65 3.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.0 m-30 -83.36 151.95 25.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.958 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 7.3 m -112.25 149.22 32.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.647 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.977 HG23 HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -163.33 136.84 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.876 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.903 ' N ' HD13 ' A' ' 70' ' ' ILE . 8.0 p -168.35 154.02 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -77.68 139.62 39.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.597 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.506 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 0.4 OUTLIER -79.75 -34.06 40.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.106 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t30 68.21 28.01 6.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.189 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.2 -41.66 4.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.891 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.04 37.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.619 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.5 mttt 61.48 53.12 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.699 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.616 HG22 ' CE1' ' A' ' 80' ' ' TYR . 74.6 m -122.96 147.93 46.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.053 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.7 m -111.57 138.68 39.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.413 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.616 ' CE1' HG22 ' A' ' 78' ' ' THR . 7.3 m-85 -126.21 125.62 42.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.653 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.592 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -122.29 121.68 37.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.181 0.515 . . . . 0.0 110.926 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -100.47 96.79 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.732 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.746 ' CE ' HD23 ' A' ' 18' ' ' LEU . 31.1 mtm -82.21 91.85 6.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.984 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -82.32 176.39 9.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 84' ' ' ASN . 67.1 p 28.99 59.99 0.14 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.754 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.841 HD23 HG22 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -64.54 162.2 15.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.17 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.592 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -126.62 164.42 34.64 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.545 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 74.3 Cg_endo -75.49 6.05 3.84 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.38 2.053 . . . . 0.0 112.956 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -108.51 -6.15 16.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.847 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.31 -16.05 50.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.287 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.5 m -52.76 106.96 0.18 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.771 0.32 . . . . 0.0 111.19 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.5 -170.72 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.436 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 85.6 t -94.33 106.74 18.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.425 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -86.88 103.38 15.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.199 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.3 m -108.49 127.2 53.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 31.9 p -89.78 146.32 24.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.825 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.92 -173.09 20.61 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.463 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -138.17 149.6 46.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 111.107 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . -105.15 148.9 16.65 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.608 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -137.28 122.71 19.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.826 0.346 . . . . 0.0 110.955 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.59 18.38 51.51 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.79 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.75 -10.69 45.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.695 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.667 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.3 m -100.16 -179.96 4.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.667 ' H ' HG22 ' A' ' 103' ' ' THR . 77.2 m95 -145.34 93.92 2.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.884 0.373 . . . . 0.0 110.814 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.4 ' O ' ' CD1' ' A' ' 107' ' ' TRP . 3.8 t70 -112.9 -12.08 13.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.369 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.82 128.76 34.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.768 0.318 . . . . 0.0 110.66 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 105' ' ' ASP . 21.5 m95 -137.87 164.22 29.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.959 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.57 -160.92 19.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -74.23 -38.17 63.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.817 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.52 152.68 26.39 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.647 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.2 t -154.28 122.71 6.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -78.17 143.07 37.54 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.966 0.413 . . . . 0.0 111.131 -179.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 91' ' ' THR . 55.4 t -114.8 132.25 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.159 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.775 HG21 HD23 ' A' ' 11' ' ' LEU . 92.3 m -108.48 132.69 53.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.841 HG22 HD23 ' A' ' 86' ' ' LEU . 2.1 t -130.9 168.23 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.344 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.764 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 2.7 p . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.817 0.342 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp -148.4 152.17 36.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -164.22 163.42 22.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.801 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.23 162.52 15.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.4 t -158.08 123.04 4.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.81 -30.17 10.51 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.583 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.835 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.92 139.86 23.26 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.008 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.82 -159.64 24.22 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.379 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.495 HD23 HG21 ' A' ' 114' ' ' THR . 2.0 mp -69.25 151.1 46.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.473 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.845 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.3 p -159.22 109.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.872 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.41 152.2 46.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.118 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.89 129.98 21.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.386 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.35 22.65 50.75 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.57 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.17 116.04 2.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.377 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 92.9 p -69.94 123.67 22.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 111.047 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.751 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.3 tp -126.96 130.78 50.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.525 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -107.61 131.78 54.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.835 HD22 ' HA2' ' A' ' 9' ' ' GLY . 2.9 mt -116.97 148.28 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.098 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB3' ' CD2' ' A' ' 80' ' ' TYR . 82.7 p -127.85 126.69 42.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.567 ' O ' HG22 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -121.38 109.1 14.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.596 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.66 164.46 22.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.381 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.04 179.908 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.505 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 9.3 t80 . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.949 0.404 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.422 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 7.5 m-20 -111.89 -176.87 3.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.673 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.75 ' O ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -143.09 113.97 7.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.978 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -139.97 158.74 25.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.905 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.448 ' CE2' HD22 ' A' ' 81' ' ' LEU . 63.8 m95 -92.36 154.86 18.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.282 0.563 . . . . 0.0 111.329 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.7 m-85 -135.67 -178.32 5.07 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.455 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.456 ' HG2' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -148.44 156.13 42.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.89 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.439 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 2.0 mm-40 -153.41 171.07 19.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.9 149.23 14.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.617 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.99 134.72 51.17 Favored 'Trans proline' 0 CA--C 1.517 -0.342 0 C-N-CA 122.273 1.982 . . . . 0.0 112.184 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.53 3.91 35.75 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.479 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.08 178.78 4.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.873 0.368 . . . . 0.0 110.897 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 pm0 -96.22 -176.82 3.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.781 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.82 140.77 39.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.829 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' ' HD3' ' A' ' 38' ' ' ARG . 12.0 pt-20 -140.46 164.28 30.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.628 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.565 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.9 t -107.25 171.66 7.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.141 0.496 . . . . 0.0 111.085 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.456 ' CG2' ' HG2' ' A' ' 38' ' ' ARG . 2.8 t -129.51 -69.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.677 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.82 ' HB1' HG21 ' A' ' 70' ' ' ILE . . . -141.05 147.6 38.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 0.0 111.579 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.577 ' O ' HG22 ' A' ' 58' ' ' THR . . . -136.89 141.34 42.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.193 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 34' ' ' MET . 1.6 tt -117.66 141.59 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.047 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.125 -179.857 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.6 mpp_? . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 120.407 0.146 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -116.11 -177.58 3.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.948 0.404 . . . . 0.0 111.096 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 50.9 t80 -135.99 91.33 2.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.853 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.802 ' CE2' HG22 ' A' ' 70' ' ' ILE . 56.0 m-85 -80.39 152.19 28.99 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.98 163.53 14.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.366 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.81 33.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.017 0.437 . . . . 0.0 111.674 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.9 t -118.54 -20.15 8.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.116 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.0 m -152.41 21.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.969 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.91 80.7 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.72 0.771 . . . . 0.0 110.9 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 131.42 3.55 4.22 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.162 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -111.11 -45.91 3.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.744 0.306 . . . . 0.0 111.056 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 83' ' ' MET . 9.7 m-30 -97.21 161.14 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.128 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 97.6 m -129.72 94.98 3.86 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.578 0.704 . . . . 0.0 111.371 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.82 HG21 ' HB1' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -91.18 137.37 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.614 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.434 ' N ' HG13 ' A' ' 70' ' ' ILE . 1.7 m -162.96 170.81 17.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 110.959 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -116.75 139.87 50.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.764 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 45.5 t0 -72.71 -31.23 64.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.946 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 58.9 23.34 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.051 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.457 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -115.72 -39.77 3.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.97 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -135.81 25.89 3.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.927 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.67 49.15 10.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.01 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.415 HG22 ' CE1' ' A' ' 80' ' ' TYR . 89.0 m -125.09 145.99 49.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.3 m -109.74 146.5 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.661 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CD2' ' HB3' ' A' ' 21' ' ' SER . 4.2 m-85 -137.61 134.94 36.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.92 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -128.59 119.16 24.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.068 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -92.51 108.21 19.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.468 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 30.8 mtm -94.39 90.21 6.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.334 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -85.49 175.13 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.67 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 33.16 39.43 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.934 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.605 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -47.51 158.76 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 111.204 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.48 164.25 16.95 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.816 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.74 8.13 4.45 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.66 2.24 . . . . 0.0 112.721 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 10.9 tt0 -119.21 -0.4 11.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.41 -11.04 59.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.658 0.266 . . . . 0.0 111.085 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 113' ' ' VAL . 98.9 m -52.14 108.93 0.33 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 111.345 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.71 174.18 5.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.005 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 93' ' ' VAL . 9.0 p -78.89 104.2 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 111.061 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.504 ' O ' HG22 ' A' ' 111' ' ' THR . 6.0 m-85 -81.22 98.35 8.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.46 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 5.0 m -107.33 129.98 54.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.013 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 28.7 p -99.77 142.57 31.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.682 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -143.05 177.36 22.02 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.318 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.529 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -126.25 164.91 19.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.003 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.18 176.97 22.94 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.724 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.8 117.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.332 . . . . 0.0 110.635 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.34 15.0 50.75 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.759 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.42 -11.67 43.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.644 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.65 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.0 m -102.29 179.45 4.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.551 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.65 ' H ' HG22 ' A' ' 103' ' ' THR . 81.2 m95 -136.75 83.58 2.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.06 -9.58 23.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.496 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.529 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -89.66 134.64 34.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.773 0.32 . . . . 0.0 110.81 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -146.0 165.15 29.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.745 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.05 -170.34 21.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.434 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -70.67 -32.12 69.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.95 0.405 . . . . 0.0 110.696 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.72 151.95 25.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.5 t -144.39 102.15 3.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 110.407 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -63.26 138.56 58.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 0.0 111.264 -179.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.489 HG21 ' CD1' ' A' ' 94' ' ' TYR . 52.4 t -112.47 118.25 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.981 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.495 HG21 HD23 ' A' ' 11' ' ' LEU . 70.4 m -97.65 122.29 40.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.346 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.845 HG13 ' O ' ' A' ' 12' ' ' VAL . 1.4 t -150.99 163.79 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.327 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.845 179.996 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.783 0.325 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mp -156.35 134.99 11.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.969 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 1.5 tt0 -145.39 129.46 17.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.146 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.21 165.09 15.3 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 p -169.66 112.67 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.006 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.67 -26.02 4.93 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.659 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.657 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -52.78 141.09 29.06 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.931 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.18 -178.37 46.82 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.376 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.677 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.3 mp -69.27 140.19 54.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.897 0.38 . . . . 0.0 111.409 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.9 p -149.44 122.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.078 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -58.86 140.31 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.312 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 115' ' ' VAL . . . -53.61 150.64 6.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.309 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.04 -2.15 82.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.837 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.06 -154.77 26.83 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.439 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -140.94 138.0 33.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.944 0.402 . . . . 0.0 111.214 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.593 ' CD2' HD21 ' A' ' 20' ' ' LEU . 15.2 tp -131.87 148.6 52.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.326 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -124.42 125.72 44.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.377 . . . . 0.0 111.55 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.657 HD22 ' HA2' ' A' ' 9' ' ' GLY . 4.0 mt -116.3 138.84 50.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.234 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 24.0 p -123.25 132.57 54.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.034 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.632 ' O ' HG22 ' A' ' 79' ' ' VAL . 31.6 t -131.53 130.96 42.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.747 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.79 165.9 13.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.197 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.48 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 62.0 t80 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.976 0.417 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.486 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 75.0 m-20 -75.43 178.96 5.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.369 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.402 ' HE2' HG11 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -147.77 130.54 16.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 111.366 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -153.11 155.52 26.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.621 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.473 ' CE2' HD22 ' A' ' 81' ' ' LEU . 75.5 m95 -86.97 156.22 19.87 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.359 0.599 . . . . 0.0 111.307 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 6.5 m-85 -140.16 -178.35 5.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.575 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HD2' HG22 ' A' ' 48' ' ' VAL . 1.6 mtp180 -145.81 158.42 43.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.017 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.42 ' HG2' ' CB ' ' A' ' 45' ' ' ARG . 1.8 tm0? -161.33 160.56 29.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.952 0.406 . . . . 0.0 111.303 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.6 155.01 22.14 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.606 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.14 137.42 44.01 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.273 1.982 . . . . 0.0 112.297 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.04 1.07 38.48 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.635 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.83 -177.33 3.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.879 0.371 . . . . 0.0 111.155 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -109.54 159.03 17.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.384 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.42 ' CB ' ' HG2' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -81.14 143.28 32.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 111.123 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.86 140.95 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.431 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.4 t -81.32 172.13 13.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.183 0.516 . . . . 0.0 110.919 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.441 HG22 ' HD2' ' A' ' 38' ' ' ARG . 3.1 t -129.99 -68.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.55 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -146.01 126.67 14.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 0.0 111.368 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.657 ' O ' HG22 ' A' ' 58' ' ' THR . . . -126.2 144.73 50.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.422 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.547 ' HB ' HG23 ' A' ' 58' ' ' THR . 8.0 tt -125.33 148.47 29.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.022 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.89 179.716 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.422 ' O ' HG13 ' A' ' 51' ' ' ILE . 4.4 mmm180 . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.741 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -137.41 -175.09 3.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.072 0.463 . . . . 0.0 111.028 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.478 ' N ' ' O ' ' A' ' 50' ' ' ALA . 75.1 t80 -139.82 92.48 2.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.542 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -75.0 160.97 29.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.999 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.94 158.69 17.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 63' ' ' SER . 36.5 t -69.35 150.46 47.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.711 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 87.36 -12.94 0.49 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.671 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 m -151.67 14.21 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.566 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.13 81.0 4.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.61 0.719 . . . . 0.0 110.464 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.9 -4.97 2.2 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.427 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.17 -36.67 3.72 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 111.201 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.2 m-30 -82.83 135.87 34.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.83 0.348 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 3.7 m -99.65 145.43 27.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.195 0.521 . . . . 0.0 111.32 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.896 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -133.53 135.94 55.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.251 -179.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.896 ' N ' HD13 ' A' ' 70' ' ' ILE . 28.7 t -166.29 146.74 6.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.968 0.413 . . . . 0.0 111.302 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.693 ' NE ' HG12 ' A' ' 79' ' ' VAL . 9.2 mpt_? -114.79 144.5 43.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.658 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -64.93 -30.15 71.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.899 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 57.36 24.9 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.977 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.79 -46.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.916 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.99 19.47 16.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp 56.31 46.94 20.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.905 0.383 . . . . 0.0 110.806 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.409 ' CG2' ' CZ ' ' A' ' 80' ' ' TYR . 42.1 m -120.53 143.32 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.315 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.693 HG12 ' NE ' ' A' ' 72' ' ' ARG . 28.9 m -101.99 150.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.481 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 21' ' ' SER . 28.9 m-85 -145.55 124.25 12.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.279 . . . . 0.0 110.866 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.486 HD21 HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -124.99 121.37 34.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.074 0.464 . . . . 0.0 110.584 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -99.74 94.96 6.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.792 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.573 ' HE1' HD23 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -79.72 95.29 5.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 -179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -88.96 176.89 6.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.619 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 t 36.23 41.94 0.16 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.549 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.81 166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.385 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 3.5 mmtp -126.18 162.26 47.08 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.706 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 64.7 Cg_endo -73.94 8.04 2.19 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.411 2.074 . . . . 0.0 113.104 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -119.42 8.94 11.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.258 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.3 -19.08 30.38 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.592 0.234 . . . . 0.0 111.229 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 63.6 m -49.91 103.66 0.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 111.463 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.02 -174.86 1.87 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.9 t -90.01 105.05 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.654 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.55 ' O ' HG22 ' A' ' 111' ' ' THR . 4.1 m-85 -87.03 107.75 18.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.086 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.413 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 4.7 m -106.86 167.21 10.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.4 ' N ' HG22 ' A' ' 95' ' ' THR . 4.3 p -129.91 133.64 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.421 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.01 -177.12 15.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.695 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 33' ' ' ASP . . . -136.36 167.2 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 111.077 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -108.58 -175.22 21.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.565 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.69 115.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.818 0.342 . . . . 0.0 110.594 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.1 15.66 50.91 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.701 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.83 -12.44 38.32 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.749 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.663 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.5 m -100.46 178.93 4.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.694 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.663 ' H ' HG22 ' A' ' 103' ' ' THR . 73.9 m95 -140.67 96.62 3.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.684 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -117.9 -5.87 11.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.483 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.63 130.82 37.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.851 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -142.28 164.94 28.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.983 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -101.37 -135.63 8.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.425 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -26.69 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 98.06 148.86 24.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.669 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 94' ' ' TYR . 3.7 t -148.15 119.24 7.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.884 0.373 . . . . 0.0 110.38 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 139.63 57.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.319 0.58 . . . . 0.0 111.351 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 91' ' ' THR . 37.9 t -123.92 86.52 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.677 ' HB ' HD23 ' A' ' 11' ' ' LEU . 74.1 m -77.71 148.48 34.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.994 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 116' ' ' SER . 2.2 t -126.08 168.58 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.883 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 115' ' ' VAL . 29.2 t . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.179 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.809 0.338 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp -151.63 107.39 3.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 71.7 mt-30 -93.65 168.2 11.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.823 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -120.93 163.35 18.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.822 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.36 124.88 4.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.994 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.23 -29.28 10.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.609 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.645 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.92 138.61 25.64 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.847 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.54 -159.62 29.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.352 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.662 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.2 mp -69.38 149.08 48.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.814 0.34 . . . . 0.0 111.375 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.704 HG11 HD22 ' A' ' 86' ' ' LEU . 7.1 p -142.88 126.48 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -70.09 127.05 31.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.012 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.45 125.14 13.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.464 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.03 -1.64 33.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.939 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.84 -153.02 10.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.531 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -139.37 142.51 37.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.886 ' CD2' HD21 ' A' ' 20' ' ' LEU . 3.7 tp -124.87 130.12 51.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.283 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.85 128.16 54.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.397 . . . . 0.0 111.562 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.886 HD21 ' CD2' ' A' ' 18' ' ' LEU . 5.5 mt -116.09 136.67 52.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.244 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.431 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 90.5 p -119.31 115.34 23.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.022 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.458 ' O ' HG22 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -113.95 116.45 29.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.11 148.69 21.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.56 ' HB2' ' SD ' ' A' ' 34' ' ' MET . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.875 0.369 . . . . 0.0 110.973 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.429 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 1.0 OUTLIER -86.67 178.31 7.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.032 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.788 ' HB3' HG11 ' A' ' 79' ' ' VAL . 3.9 mtm -146.65 132.32 18.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.031 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.34 151.19 23.36 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.658 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.704 ' CE2' HD22 ' A' ' 81' ' ' LEU . 74.3 m95 -88.29 155.94 19.46 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.206 0.527 . . . . 0.0 111.346 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -138.99 -179.27 5.74 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.703 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.552 ' CG ' HG22 ' A' ' 48' ' ' VAL . 9.9 mtm-85 -143.19 162.09 36.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.922 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -148.45 124.06 10.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.198 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -118.79 157.61 49.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.733 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 48.6 Cg_endo -68.85 137.26 37.73 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.295 1.997 . . . . 0.0 112.383 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 2.26 36.74 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.642 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.97 -175.09 2.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.859 0.361 . . . . 0.0 111.032 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -111.63 -171.73 1.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.636 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -78.2 125.45 29.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -121.53 119.2 31.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.458 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.3 t -71.43 170.69 12.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.269 0.557 . . . . 0.0 110.784 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.1 t -130.94 -69.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.442 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -145.21 128.91 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.035 0.445 . . . . 0.0 111.213 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.682 ' O ' HG22 ' A' ' 58' ' ' THR . . . -123.55 144.78 49.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.127 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 57' ' ' ARG . 8.7 tp -128.96 145.75 35.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.373 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.1 t30 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.717 179.794 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.67 ' O ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.917 0.389 . . . . 0.0 111.168 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.688 HG21 ' CG2' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -119.67 -177.9 3.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.902 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' ALA . 8.2 t80 -137.35 89.67 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.739 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -76.82 156.3 32.36 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.05 167.74 9.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.246 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 63' ' ' SER . 18.7 p -69.33 152.69 44.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.551 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 86.09 -11.99 0.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.486 -178.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.417 HG11 ' CE2' ' A' ' 68' ' ' PHE . 35.4 m -151.05 15.75 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.385 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.02 79.11 0.66 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.514 0.673 . . . . 0.0 110.724 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.47 3.88 8.45 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.896 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -114.3 -40.98 3.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 111.08 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 5.8 m-30 -93.5 117.38 30.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 11.8 m -79.57 152.57 30.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.907 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -148.38 136.42 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.012 -178.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.907 ' N ' HD13 ' A' ' 70' ' ' ILE . 4.8 m -161.49 -164.65 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.775 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -139.74 169.65 17.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.968 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.405 ' HB2' ' HE1' ' A' ' 80' ' ' TYR . 0.9 OUTLIER -77.75 -12.85 60.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.286 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 44.76 40.24 4.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 111.268 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.9 -49.36 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.064 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 mtmm -115.52 -72.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 167.14 44.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.599 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.2 m -110.33 145.13 38.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.187 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.788 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.6 m -108.66 142.0 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.748 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 1.3 m-85 -134.33 128.93 34.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.913 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.704 HD22 ' CE2' ' A' ' 36' ' ' TRP . 1.3 pt? -127.07 125.82 41.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.064 0.459 . . . . 0.0 110.747 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.81 96.72 8.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.617 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -78.56 88.03 4.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.212 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.62 176.89 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 38.35 48.34 1.17 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.494 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.704 HD22 HG11 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -70.61 165.72 22.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.327 -179.499 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -133.59 178.0 1.98 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.218 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 92.5 Cg_endo -81.31 9.68 3.76 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.316 2.011 . . . . 0.0 112.734 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 7.5 tp10 -109.17 -12.45 14.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.706 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.23 -21.34 58.7 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 110.986 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.532 HG23 ' HA ' ' A' ' 114' ' ' THR . 98.6 m -50.6 107.73 0.19 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.45 -172.34 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.308 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.5 t -90.28 105.15 15.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.542 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.473 ' O ' HG22 ' A' ' 111' ' ' THR . 13.0 m-85 -88.77 107.66 19.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 83.2 m -113.44 136.54 52.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 11.8 p -100.36 160.4 14.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.818 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -159.2 -170.92 24.34 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.999 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 33' ' ' ASP . . . -143.17 172.49 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.745 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -142.27 -175.69 15.8 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.906 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.463 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 31.1 tt0 -162.33 129.02 3.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.59 15.23 46.22 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.852 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.63 -14.36 32.42 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.68 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.6 HG22 ' H ' ' A' ' 104' ' ' TRP . 3.7 m -92.02 176.73 6.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.578 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.6 ' H ' HG22 ' A' ' 103' ' ' THR . 72.2 m95 -147.76 100.21 3.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.768 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -120.71 -3.26 9.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.568 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.89 137.87 34.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.841 0.353 . . . . 0.0 110.86 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -142.89 167.2 22.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.87 -155.8 18.97 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.575 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -87.34 -36.5 17.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 110.853 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.71 153.39 17.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.576 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.6 t -146.9 107.97 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.653 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.68 141.57 55.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.133 0.492 . . . . 0.0 110.941 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.1 t -121.75 126.6 74.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.387 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.662 ' HB ' HD23 ' A' ' 11' ' ' LEU . 88.5 m -102.25 133.33 47.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.043 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.431 HG21 HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -149.84 163.03 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.424 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.909 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.469 ' C ' HD12 ' A' ' 4' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.028 0.442 . . . . 0.0 110.48 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.485 HD11 ' OH ' ' A' ' 32' ' ' TYR . 5.7 mp -142.63 104.27 4.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.83 167.74 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.36 164.98 13.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -162.3 114.3 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.84 -36.3 3.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.656 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.516 ' CA ' HD22 ' A' ' 20' ' ' LEU . . . -50.03 139.12 19.59 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.913 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.39 -170.69 40.05 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.332 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.619 HD23 HG21 ' A' ' 114' ' ' THR . 1.9 mp -69.44 155.24 40.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.903 0.382 . . . . 0.0 111.593 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.53 ' CG1' HD22 ' A' ' 86' ' ' LEU . 8.1 p -169.41 120.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.888 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.66 144.32 27.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.69 124.78 11.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.452 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.99 17.76 31.45 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.68 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.72 -166.68 22.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.543 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -129.28 136.63 50.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.956 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.806 ' CD2' HD21 ' A' ' 20' ' ' LEU . 3.5 tp -142.66 131.03 22.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.585 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.479 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -112.23 132.91 54.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.185 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.806 HD21 ' CD2' ' A' ' 18' ' ' LEU . 4.1 mt -117.13 135.4 53.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.7 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -120.0 105.77 11.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.769 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.97 116.07 31.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.72 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.87 155.47 17.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.292 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HB2' ' HG ' ' A' ' 4' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.485 ' OH ' HD11 ' A' ' 4' ' ' LEU . 53.5 t80 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.945 0.402 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 74.6 m-20 -62.75 -175.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.455 ' O ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -146.9 124.59 11.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.764 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -147.45 150.8 23.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.986 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.451 ' CH2' ' CB ' ' A' ' 20' ' ' LEU . 74.1 m95 -91.44 153.46 19.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.225 0.536 . . . . 0.0 111.371 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.0 m-85 -133.39 -177.15 4.4 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.323 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.772 ' HD3' HG22 ' A' ' 48' ' ' VAL . 14.9 ptt180 -156.54 159.93 39.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.743 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -162.37 133.76 5.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.205 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.736 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -110.54 167.63 8.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.613 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.736 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 48.8 Cg_endo -68.89 138.01 39.55 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.265 1.977 . . . . 0.0 112.328 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.18 4.49 36.4 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.641 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -112.62 -177.12 3.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.868 0.366 . . . . 0.0 111.047 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -102.39 -171.54 1.98 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.581 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.9 ptm85 -100.59 128.89 46.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -131.14 147.92 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.304 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.4 t -82.58 175.68 9.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.263 0.554 . . . . 0.0 111.112 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.772 HG22 ' HD3' ' A' ' 38' ' ' ARG . 3.5 t -132.36 -66.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.143 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.35 123.43 10.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.017 0.437 . . . . 0.0 111.184 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 59' ' ' TYR . . . -118.35 148.85 42.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.108 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 34' ' ' MET . 4.0 tt -133.46 146.54 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.894 0.378 . . . . 0.0 111.534 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.922 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.725 0.298 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.995 HG21 HG21 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -102.89 178.06 4.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.753 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.769 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 86.2 t80 -140.45 90.81 2.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.668 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.452 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 4.6 m-85 -78.8 159.09 28.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.06 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.75 166.53 11.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 63' ' ' SER . 3.7 t -69.48 151.69 45.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.759 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 84.65 -11.0 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.617 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -152.75 16.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.314 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.452 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -70.64 79.1 0.59 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.559 0.695 . . . . 0.0 110.88 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.96 2.93 8.46 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.88 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -108.34 -33.47 7.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.76 0.314 . . . . 0.0 111.211 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 9.0 m-30 -96.03 127.77 42.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.151 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 56.9 m -83.54 145.04 29.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.375 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.995 HG21 HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -134.74 136.59 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.216 -179.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.408 ' N ' HG13 ' A' ' 70' ' ' ILE . 76.9 p -154.92 -175.88 5.65 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.973 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -138.27 165.9 25.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.084 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.718 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 33.8 t70 -86.6 -31.57 21.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t30 60.74 29.5 19.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.718 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -151.9 -57.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.08 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -102.73 11.32 37.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.277 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.49 52.25 4.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.647 ' OG1' ' CZ ' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -115.54 154.93 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.935 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 21' ' ' SER . 6.1 p -119.81 132.11 70.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.84 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.647 ' CZ ' ' OG1' ' A' ' 78' ' ' THR . 17.6 m-85 -118.11 107.96 14.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.132 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 69' ' ' THR . 0.2 OUTLIER -107.74 114.38 28.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.958 179.44 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.31 95.23 8.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.304 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.49 ' HB2' HD11 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -80.96 89.85 5.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.981 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -76.95 174.16 10.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.856 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 84' ' ' ASN . 0.6 OUTLIER 22.09 53.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.075 179.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.53 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.3 OUTLIER -44.56 162.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.537 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.503 ' O ' HG11 ' A' ' 115' ' ' VAL . 22.3 mmtt -110.75 161.0 26.65 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.787 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 72.1 Cg_endo -76.84 8.15 3.25 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.441 2.094 . . . . 0.0 112.908 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -121.68 2.91 10.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.236 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.66 -12.42 55.96 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.624 0.25 . . . . 0.0 111.23 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 88.9 m -55.89 104.82 0.15 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 111.17 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.54 -174.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.268 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.9 t -87.63 103.26 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.725 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.502 ' CD1' HG21 ' A' ' 113' ' ' VAL . 8.3 m-85 -82.7 105.79 14.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.914 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 88.5 m -111.64 133.18 54.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 28.0 p -100.45 150.09 23.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.014 0.435 . . . . 0.0 111.155 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -143.22 -175.36 16.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.246 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.517 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -135.39 164.4 27.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 111.028 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -96.06 -171.67 35.47 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 179.42 111.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.713 0.292 . . . . 0.0 110.743 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.74 16.14 50.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.693 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 -13.99 36.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.522 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.0 m -100.01 179.17 4.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.605 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.655 ' H ' HG22 ' A' ' 103' ' ' THR . 82.2 m95 -135.5 93.82 3.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.736 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -118.0 -4.27 11.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.341 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.517 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -90.22 135.69 33.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.756 0.313 . . . . 0.0 110.786 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -141.58 165.45 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.094 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.2 -148.22 11.86 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.486 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.02 -48.63 6.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 116.1 151.28 9.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.763 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 t -142.49 110.33 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.333 . . . . 0.0 110.454 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 141.11 58.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.21 0.528 . . . . 0.0 111.036 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 94' ' ' TYR . 47.0 t -119.12 125.64 74.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.297 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.619 HG21 HD23 ' A' ' 11' ' ' LEU . 75.3 m -101.41 117.94 35.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 111.03 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -133.49 -158.96 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.524 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.412 ' H ' HG12 ' A' ' 115' ' ' VAL . 6.1 t . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.916 0.389 . . . . 0.0 111.077 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.918 0.39 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 mp -146.78 159.01 44.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.793 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -152.7 175.23 13.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.288 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -128.7 173.22 10.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.988 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.1 t -170.16 143.59 2.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.064 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.67 -33.07 5.95 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.725 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.499 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -49.66 140.1 15.85 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.003 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.99 -170.58 43.33 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.396 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.561 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.6 mp -69.49 156.01 39.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.782 0.325 . . . . 0.0 111.414 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.9 p -170.01 115.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.92 158.82 1.92 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.381 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -48.95 145.44 3.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.435 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.09 15.87 65.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.603 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.42 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -105.79 112.18 3.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.348 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.93 131.0 43.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.825 HD23 HD21 ' A' ' 20' ' ' LEU . 6.0 tp -124.21 131.91 53.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.656 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -101.61 128.23 47.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.903 0.382 . . . . 0.0 111.461 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.825 HD21 HD23 ' A' ' 18' ' ' LEU . 8.5 mt -116.06 145.41 43.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.341 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.5 p -125.76 128.51 47.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.899 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 43.9 t -124.76 136.0 53.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -113.09 144.57 42.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.893 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.486 ' HB3' ' CD ' ' A' ' 77' ' ' LYS . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.321 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 121.089 0.471 . . . . 0.0 111.752 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -157.46 -173.9 4.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.031 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.12 158.47 43.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.691 0.281 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . 172.35 145.25 4.87 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.045 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.404 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 60.4 m95 -88.55 155.32 19.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.974 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.2 m-85 -132.31 -179.63 5.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.954 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.754 ' HD3' HG22 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -151.68 161.9 41.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.755 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.438 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 2.1 tm0? -149.06 147.24 28.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.183 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.442 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -132.59 158.13 76.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.655 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.442 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 56.0 Cg_endo -70.25 136.19 31.1 Favored 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 122.341 2.027 . . . . 0.0 112.415 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.77 -1.01 25.19 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.602 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -121.02 150.87 40.48 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 120.871 0.367 . . . . 0.0 110.958 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -69.88 -177.23 1.25 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.458 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -94.14 144.59 25.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 7.3 pt-20 -136.11 167.1 21.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.325 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 7.9 t -102.68 172.84 6.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.157 0.503 . . . . 0.0 110.989 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.754 HG22 ' HD3' ' A' ' 38' ' ' ARG . 3.1 t -128.69 -68.78 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.203 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -137.08 144.51 43.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.103 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 58' ' ' THR . . . -144.36 142.43 30.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.414 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.572 ' HB ' HG23 ' A' ' 58' ' ' THR . 2.1 tt -121.47 143.68 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.983 -179.781 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.004 0.43 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 1.04 HG21 HG21 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -127.49 -175.96 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.024 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.525 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 86.8 t80 -139.61 125.47 19.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.456 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.432 ' OH ' HG22 ' A' ' 70' ' ' ILE . 7.2 m-30 -113.68 162.52 16.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.31 160.43 14.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.231 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 p -80.78 36.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.864 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 t -118.22 -20.93 8.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.153 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 66' ' ' GLY . 29.7 m -157.05 21.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.045 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.94 80.07 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.651 0.739 . . . . 0.0 111.045 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 135.93 1.16 3.02 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.316 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.65 -35.72 3.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 111.24 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 4.6 m-30 -93.3 159.85 15.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 62.0 m -129.14 155.07 46.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.04 HG21 HG21 ' A' ' 58' ' ' THR . 5.6 tp -140.53 144.66 26.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.955 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.16 170.87 21.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.971 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -133.91 141.9 47.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.19 -18.49 42.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.214 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.2 p30 44.48 30.26 0.47 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.415 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.13 -74.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.64 23.41 14.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.486 ' CD ' ' HB3' ' A' ' 24' ' ' ALA . 0.1 OUTLIER 70.05 62.54 0.24 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.599 HG22 ' CE1' ' A' ' 80' ' ' TYR . 91.6 m -131.25 143.67 50.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 111.231 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.3 147.87 19.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.341 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.599 ' CE1' HG22 ' A' ' 78' ' ' THR . 3.8 m-85 -135.17 128.07 31.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.852 0.358 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.619 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -121.93 118.05 27.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.357 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.51 103.51 15.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.063 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.559 ' HE1' HG21 ' A' ' 113' ' ' VAL . 22.1 mtm -81.53 88.22 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.92 176.45 7.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 36.07 44.9 0.28 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.791 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.669 HD23 HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -58.72 156.53 10.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -123.74 171.76 6.54 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.085 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 86.1 Cg_endo -81.77 11.12 3.21 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.433 2.089 . . . . 0.0 112.884 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -118.53 -6.31 10.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.355 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.586 ' OD2' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -86.32 -13.19 47.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.499 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.763 ' OG1' HG23 ' A' ' 115' ' ' VAL . 99.4 m -54.53 112.52 1.02 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 111.456 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.2 -170.72 1.01 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.172 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.2 t -94.31 105.36 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.586 ' CE2' HG21 ' A' ' 48' ' ' VAL . 11.0 m-85 -86.87 110.67 20.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.051 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.6 t -109.28 127.34 54.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.981 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 46.9 t -77.42 145.62 37.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.08 166.67 30.53 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.693 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.732 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -131.08 150.12 52.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.328 . . . . 0.0 110.978 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . -96.36 165.45 23.79 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.805 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -158.27 113.8 2.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.55 16.26 49.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.98 -16.0 28.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.496 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.2 m -97.72 179.75 4.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.659 0.266 . . . . 0.0 110.393 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.67 ' H ' HG22 ' A' ' 103' ' ' THR . 81.9 m95 -142.13 91.14 2.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 107' ' ' TRP . 7.4 t70 -106.27 -18.4 14.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.142 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.732 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 2.9 t -75.16 130.3 38.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.799 0.333 . . . . 0.0 110.786 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.403 ' CD1' ' O ' ' A' ' 105' ' ' ASP . 58.0 m95 -139.19 165.04 28.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.708 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.04 -156.37 15.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.539 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -86.21 -25.44 25.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.95 150.31 24.08 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 94' ' ' TYR . 2.4 t -152.31 114.03 4.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.823 0.344 . . . . 0.0 110.166 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.495 HE21 ' N ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -79.29 137.75 37.48 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 120.941 0.401 . . . . 0.0 111.034 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.559 HG21 ' HE1' ' A' ' 83' ' ' MET . 56.0 t -116.86 110.76 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.734 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.643 ' HA ' HG23 ' A' ' 91' ' ' THR . 86.4 m -97.42 132.63 42.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.863 0.363 . . . . 0.0 111.361 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.763 HG23 ' OG1' ' A' ' 91' ' ' THR . 2.5 t -112.42 169.18 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.8 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.841 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.932 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.409 ' C ' HD12 ' A' ' 4' ' ' LEU . 2.3 mt-30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.811 0.338 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.603 HD13 ' HA2' ' A' ' 97' ' ' GLY . 1.4 mp -160.94 77.27 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -69.85 151.8 45.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.773 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -110.57 165.46 11.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.871 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.9 t -166.05 121.65 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.72 -40.76 2.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.703 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.664 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.04 139.72 18.6 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.923 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.93 -161.47 27.8 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.431 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.734 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.5 mp -69.43 145.84 52.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.869 0.366 . . . . 0.0 111.514 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.9 p -170.16 111.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.998 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.23 151.97 45.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.72 146.95 3.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.332 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.21 -13.67 65.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.55 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.88 114.11 3.95 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.371 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -69.95 136.22 50.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 111.128 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.41 HD23 HD21 ' A' ' 20' ' ' LEU . 2.3 tp -136.04 129.95 32.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.178 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.515 ' C ' HD23 ' A' ' 20' ' ' LEU . 5.0 ttp180 -102.43 145.55 29.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.117 0.484 . . . . 0.0 111.651 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.682 ' HG ' HD23 ' A' ' 81' ' ' LEU . 6.4 mt -117.64 147.99 42.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.808 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 90.7 p -125.73 114.21 18.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.274 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.513 ' HB3' HG22 ' A' ' 79' ' ' VAL . 3.8 t -117.16 128.8 55.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.597 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.84 141.64 49.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.371 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.043 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.603 ' CD1' ' HB1' ' A' ' 98' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 110.952 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -70.67 161.15 31.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.743 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.669 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.6 mtm -132.45 128.39 37.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.479 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 50' ' ' ALA . . . -153.29 159.9 28.85 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.113 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.464 ' CZ2' ' HB2' ' A' ' 20' ' ' LEU . 93.1 m95 -86.73 154.11 21.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.12 0.486 . . . . 0.0 110.93 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.3 m-85 -136.89 -176.53 4.4 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.74 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.52 ' HG2' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -146.99 150.75 35.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.837 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.41 ' HG2' ' HG2' ' A' ' 45' ' ' ARG . 1.6 mm-40 -153.81 176.77 11.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.024 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -174.21 152.92 1.89 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.522 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.7 137.15 62.03 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.29 1.993 . . . . 0.0 112.142 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.09 7.36 37.08 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.512 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.81 -169.58 1.48 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 111.02 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -114.91 176.68 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.771 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HG2' ' HG2' ' A' ' 39' ' ' GLN . 2.1 mtm-85 -97.65 134.91 40.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 0.0 111.175 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -138.96 163.65 31.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.439 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.544 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.5 t -110.61 171.15 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.246 0.546 . . . . 0.0 111.236 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.52 ' CG2' ' HG2' ' A' ' 38' ' ' ARG . 6.0 t -129.51 -69.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.306 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 70' ' ' ILE . . . -136.2 133.87 37.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.385 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.722 ' O ' HG22 ' A' ' 58' ' ' THR . . . -128.43 145.2 51.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.017 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 34' ' ' MET . 3.5 tt -128.01 147.85 32.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.358 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.76 179.941 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 120.767 0.318 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.8 HG21 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -122.46 -178.45 3.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.473 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 23.3 t80 -138.67 90.31 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.39 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.458 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 8.2 m-85 -80.51 154.9 27.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.18 159.69 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.194 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 63' ' ' SER . 17.9 p -69.09 153.83 43.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.32 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 62' ' ' SER . 2.3 p 87.12 -12.59 0.52 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.462 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -149.11 15.47 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.335 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 6.5 tpt180 -77.69 83.5 4.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.779 0.8 . . . . 0.0 110.305 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.61 -7.12 3.31 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.587 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.466 ' HD2' ' CE1' ' A' ' 68' ' ' PHE . 1.3 ptp180 -116.52 -38.13 3.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.708 0.29 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.466 ' CE1' ' HD2' ' A' ' 67' ' ' ARG . 3.3 m-30 -90.42 93.82 9.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.49 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 95.5 m -76.53 116.53 17.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.146 0.498 . . . . 0.0 111.313 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -109.69 131.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.772 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.36 172.44 18.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.019 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 72' ' ' ARG . 13.5 ttp-105 -105.92 153.92 21.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.407 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 39.7 t0 -91.36 -29.64 16.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.4 26.19 14.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.023 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -114.34 -33.47 5.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.073 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.5 42.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.722 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.11 40.86 14.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.701 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.1 m -97.55 148.56 23.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.062 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 22' ' ' CYS . 30.7 m -122.82 132.08 72.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.428 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 25.1 m-85 -113.1 116.07 29.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.988 0.423 . . . . 0.0 110.801 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.682 HD23 ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -113.35 103.29 11.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.445 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -85.9 98.97 11.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.994 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.586 ' HB3' HD11 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -83.53 88.24 7.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.936 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 176.16 6.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.777 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 34.78 48.19 0.3 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.698 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' A' ' 83' ' ' MET . 0.5 OUTLIER -62.09 165.84 5.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.459 . . . . 0.0 111.197 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 33.1 mmtt -135.47 163.54 50.04 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.419 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 63.2 Cg_endo -73.23 9.08 1.54 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.365 2.043 . . . . 0.0 113.091 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.92 9.06 13.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.189 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.66 -7.54 37.25 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.533 0.206 . . . . 0.0 111.401 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.7 m -56.33 113.1 1.43 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.767 0.317 . . . . 0.0 111.271 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 112' ' ' GLN . . . -170.56 -172.53 1.24 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.313 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 84.0 t -96.16 102.63 13.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.183 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.504 ' O ' HG22 ' A' ' 111' ' ' THR . 24.7 m-85 -84.91 99.52 11.0 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.764 0.316 . . . . 0.0 111.117 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 62.0 m -106.2 129.97 54.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -99.79 147.77 25.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.456 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.603 ' HA2' HD13 ' A' ' 4' ' ' LEU . . . -159.65 -169.44 22.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.145 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.603 ' HB1' ' CD1' ' A' ' 32' ' ' TYR . . . -134.51 172.68 12.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.875 0.369 . . . . 0.0 110.968 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -147.05 173.35 27.25 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.778 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -160.01 144.92 14.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.58 16.22 49.77 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.58 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.23 -4.92 58.84 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.671 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.656 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -107.35 179.17 4.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.796 0.331 . . . . 0.0 110.579 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.656 ' H ' HG22 ' A' ' 103' ' ' THR . 77.5 m95 -139.06 105.33 5.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.514 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -12.32 11.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.49 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -93.31 133.43 36.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -144.86 165.0 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.0 -165.55 22.26 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.578 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -75.02 -29.11 60.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.16 152.51 28.73 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.603 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.9 t -148.16 114.31 5.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.455 HE21 ' N ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -80.22 142.46 34.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.018 0.437 . . . . 0.0 111.228 -179.168 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.455 ' N ' HE21 ' A' ' 112' ' ' GLN . 54.9 t -114.51 131.83 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.961 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.734 ' CB ' HD23 ' A' ' 11' ' ' LEU . 97.6 m -110.38 132.48 54.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.867 0.365 . . . . 0.0 111.182 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 116' ' ' SER . 2.0 t -141.27 168.01 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.156 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.49 ' H ' HG12 ' A' ' 115' ' ' VAL . 55.2 p . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.178 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.771 0.32 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.3 mp -148.05 136.8 21.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.1 169.54 17.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -124.96 164.45 20.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 m -166.24 125.79 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 114.01 -30.6 7.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.602 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -49.86 140.32 16.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.896 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.57 175.84 42.44 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.366 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.795 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.8 mp -69.15 144.83 53.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.88 0.371 . . . . 0.0 111.468 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.83 126.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -58.97 155.97 12.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.252 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.46 131.7 20.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.388 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.75 3.18 83.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.743 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.63 118.77 6.01 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.471 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.53 140.64 49.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 0.0 111.231 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.807 ' CD2' HD21 ' A' ' 20' ' ' LEU . 3.7 tp -136.0 129.1 31.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.703 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.46 119.26 39.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.807 HD21 ' CD2' ' A' ' 18' ' ' LEU . 12.7 mt -100.74 138.72 37.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.005 0.431 . . . . 0.0 110.427 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.442 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 7.1 m -117.31 111.11 18.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.213 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' HG23 ' A' ' 78' ' ' THR . 42.9 t -106.09 133.58 50.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.533 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.26 160.65 21.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.51 ' HB3' ' HD3' ' A' ' 77' ' ' LYS . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.719 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.95 0.405 . . . . 0.0 110.827 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.459 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -130.11 179.8 5.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.638 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.65 ' HB3' HG11 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -136.72 124.71 22.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.754 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.9 160.85 28.34 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.906 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 77.2 m95 -95.61 157.15 16.03 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.069 0.461 . . . . 0.0 111.303 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 11.7 m-85 -135.38 179.65 6.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.342 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.18 151.08 34.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.719 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.678 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -143.59 148.57 36.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.997 0.427 . . . . 0.0 111.222 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -143.0 158.6 58.66 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.624 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 39.7 Cg_endo -67.11 137.4 44.04 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.318 2.012 . . . . 0.0 112.281 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.64 0.44 48.63 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.649 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.25 -173.77 2.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.874 0.369 . . . . 0.0 111.074 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -118.7 -174.97 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.535 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.46 135.7 40.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 111.113 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.27 119.3 15.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.266 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 1.4 t -68.55 170.03 9.91 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.426 HG21 ' HE1' ' A' ' 94' ' ' TYR . 21.2 t -130.06 -57.6 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.958 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -152.6 163.24 40.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.949 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.568 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -161.08 147.58 14.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.665 HD13 ' N ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -140.09 143.47 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 111.597 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.665 ' N ' HD13 ' A' ' 51' ' ' ILE . 7.9 t-20 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.267 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.901 0.381 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.733 HG21 HG23 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -115.8 178.92 4.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.239 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.1 t80 -141.55 135.33 30.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.524 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.499 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 28.7 m-85 -123.23 163.1 21.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 110.895 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -106.5 155.92 19.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.987 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.18 34.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 111.762 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 64' ' ' VAL . 41.0 t -121.65 -15.13 8.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.236 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.562 HG12 ' HD2' ' A' ' 67' ' ' ARG . 15.7 m -156.76 19.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.232 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -65.98 80.15 0.08 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.563 0.697 . . . . 0.0 110.846 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.98 -2.38 1.16 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.809 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HD2' HG12 ' A' ' 64' ' ' VAL . 2.6 ptp180 -126.58 -36.16 2.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.833 0.316 . . . . 0.0 111.654 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CE2' HG11 ' A' ' 64' ' ' VAL . 7.8 m-30 -94.2 146.98 23.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.196 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 82' ' ' GLN . 5.5 m -112.89 154.42 26.39 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.406 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.895 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -146.02 134.23 16.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.915 -179.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.895 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -162.49 -172.51 3.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.806 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.557 ' CD ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -134.53 155.65 50.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.573 ' OD1' ' HB2' ' A' ' 75' ' ' ALA . 7.4 t0 -69.05 -27.84 66.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.042 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 66.71 23.34 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.022 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HB2' ' OD1' ' A' ' 73' ' ' ASP . . . -102.87 -57.78 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.923 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 4.4 ptpp? -130.21 -54.59 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.713 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 1.8 ttmp? 169.6 74.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.647 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.605 HG22 ' CE1' ' A' ' 80' ' ' TYR . 33.4 m -137.7 140.62 40.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.085 0.469 . . . . 0.0 111.243 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 34' ' ' MET . 35.3 m -116.03 135.91 54.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.827 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.605 ' CE1' HG22 ' A' ' 78' ' ' THR . 1.5 m-85 -124.79 129.54 50.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.758 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.733 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -118.09 118.95 33.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 110.404 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.554 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -93.36 102.83 15.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.031 -179.109 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.544 ' HE3' HD11 ' A' ' 81' ' ' LEU . 1.6 mtt -91.59 88.73 6.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.444 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.16 175.89 8.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.666 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 35.35 50.4 0.54 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.881 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.475 HD23 HG22 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -61.09 161.06 9.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.809 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.63 ' O ' HG11 ' A' ' 115' ' ' VAL . 4.2 mttp -134.07 172.82 6.65 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.919 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 87' ' ' LYS . 72.0 Cg_endo -76.28 5.0 4.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.546 2.164 . . . . 0.0 113.076 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.2 tp10 -103.25 -16.95 15.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.739 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -78.48 -17.0 56.91 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.097 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 99.4 m -51.74 102.78 0.05 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.076 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.48 -171.57 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.923 0.392 . . . . 0.0 111.56 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.483 HG22 ' HG3' ' A' ' 112' ' ' GLN . 91.2 t -93.16 109.87 22.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.82 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.51 ' CE1' ' HE1' ' A' ' 83' ' ' MET . 13.2 m-85 -91.89 109.07 20.4 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.651 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 m -108.72 139.2 43.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.0 111.372 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.7 t -94.86 146.04 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.645 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 107' ' ' TRP . . . -148.0 -178.82 23.49 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.74 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.719 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -142.46 165.44 27.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.024 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.58 168.87 14.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.812 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -167.74 120.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.728 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.6 14.76 51.54 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.817 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.46 -12.95 43.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.434 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.658 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.3 m -101.89 -179.96 4.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.687 0.28 . . . . 0.0 110.538 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.658 ' H ' HG22 ' A' ' 103' ' ' THR . 73.3 m95 -137.41 81.84 1.89 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.767 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.27 13.7 24.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.463 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.684 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -105.54 130.02 53.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.813 0.339 . . . . 0.0 110.853 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.406 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 31.5 m95 -137.62 164.5 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.045 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.89 -118.29 4.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.6 -44.48 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 110.984 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.97 152.03 13.66 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.762 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 111' ' ' THR . 15.3 t -154.28 117.23 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.263 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.483 ' HG3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -80.17 143.29 33.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.0 0.429 . . . . 0.0 111.007 -179.334 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.469 ' N ' HE21 ' A' ' 112' ' ' GLN . 48.4 t -116.13 128.46 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.21 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.795 ' CB ' HD23 ' A' ' 11' ' ' LEU . 95.0 m -104.53 122.19 45.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.155 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.63 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -119.67 -151.58 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.393 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 115' ' ' VAL . 75.2 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.769 0.319 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.443 HD11 ' OH ' ' A' ' 32' ' ' TYR . 3.4 mp -143.56 122.59 12.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.868 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -138.51 163.93 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.09 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.71 163.63 14.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.71 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.06 117.32 3.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.914 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.02 -31.41 6.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.498 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -49.51 140.58 14.2 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.878 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.75 -159.2 30.55 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.395 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.404 HD23 HG21 ' A' ' 114' ' ' THR . 1.7 mp -69.45 150.13 47.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.845 0.355 . . . . 0.0 111.427 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.1 p -165.53 106.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.975 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -56.26 150.03 15.23 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.308 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.77 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -51.22 141.5 14.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.318 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.16 -4.66 85.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.753 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.4 119.82 6.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.299 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 p -69.87 133.68 47.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 111.229 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.869 ' CD2' HD21 ' A' ' 20' ' ' LEU . 6.5 tp -118.81 132.09 56.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.425 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.34 121.08 43.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 0.0 111.472 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.869 HD21 ' CD2' ' A' ' 18' ' ' LEU . 15.7 mt -109.32 137.88 46.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.409 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -119.99 113.18 20.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.172 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 17.4 t -111.04 133.91 53.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.361 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.2 147.16 32.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.199 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.51 ' HB3' ' HE3' ' A' ' 34' ' ' MET . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.075 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.0 t80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.0 0.429 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.473 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 5.3 m-20 -58.85 178.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.597 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.688 ' HB3' HG11 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -141.87 118.36 10.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 111.025 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -154.54 150.47 22.05 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.811 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.479 ' CD2' HD22 ' A' ' 81' ' ' LEU . 76.2 m95 -88.82 152.69 21.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.224 0.535 . . . . 0.0 111.176 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.543 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -131.98 -177.31 4.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.727 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HD2' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -151.23 161.48 42.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.723 179.535 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.614 ' O ' HG12 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -163.59 158.72 20.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.995 0.426 . . . . 0.0 111.284 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -148.27 161.33 34.46 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.681 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.549 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 37.1 Cg_endo -65.73 137.13 48.53 Favored 'Trans proline' 0 CA--C 1.518 -0.322 0 C-N-CA 122.256 1.971 . . . . 0.0 112.343 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.05 3.05 42.71 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.33 -174.73 2.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.78 0.324 . . . . 0.0 111.035 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -111.17 -171.16 1.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -90.62 131.66 36.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.062 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -133.0 129.62 38.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.599 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.543 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.3 t -85.45 171.28 11.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.285 0.564 . . . . 0.0 110.877 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.565 HG21 ' HE1' ' A' ' 94' ' ' TYR . 5.8 t -127.2 -68.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.403 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -142.67 129.21 20.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.237 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.57 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -132.67 143.16 49.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.377 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.838 ' HB ' HG23 ' A' ' 58' ' ' THR . 2.0 tt -120.51 136.6 57.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.32 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.654 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.378 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.838 HG23 ' HB ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -111.47 -178.46 3.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.809 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 50.8 t80 -137.61 96.24 3.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.935 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -85.9 157.14 20.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 111.033 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.75 162.9 13.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.333 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.0 m -81.76 33.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.015 0.436 . . . . 0.0 111.709 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -118.94 -25.3 6.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.838 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 30.8 m -148.7 18.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.03 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -71.22 81.21 0.72 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.761 0.791 . . . . 0.0 110.451 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 145.52 -6.69 1.47 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 114.431 -1.259 . . . . 0.0 112.495 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.446 ' CZ ' HG12 ' A' ' 64' ' ' VAL . 3.4 ptt180 -123.56 -37.53 2.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.681 0.277 . . . . 0.0 111.305 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.526 ' CZ ' HG11 ' A' ' 64' ' ' VAL . 4.8 m-30 -84.15 152.23 24.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.078 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 28.9 m -125.22 154.13 42.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.935 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.781 HG21 HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -144.52 137.91 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.073 -179.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.413 ' N ' HG13 ' A' ' 70' ' ' ILE . 90.0 p -163.06 135.76 5.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.628 ' HE ' HD13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -88.4 166.94 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.023 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.423 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 11.2 t0 -94.05 -31.0 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.985 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.78 28.62 16.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.33 -52.03 2.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.07 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -132.67 31.6 3.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt 61.74 50.55 4.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 59.3 m -114.0 150.19 34.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.821 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.688 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.7 m -122.53 145.24 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.835 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 27.2 m-85 -130.64 118.79 21.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.972 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.629 HD23 ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -114.86 113.98 24.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 110.324 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -92.96 99.26 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.158 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.516 ' HE2' ' CZ ' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -79.88 86.79 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.88 176.35 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 36.6 47.36 0.52 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.805 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.462 HD23 ' OD2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -59.04 161.84 4.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.788 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -122.9 172.24 5.64 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.139 0.495 . . . . 0.0 111.678 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.69 13.44 2.11 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.567 2.178 . . . . 0.0 112.961 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -131.02 13.73 5.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.504 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.563 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -89.08 -7.14 56.4 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.529 0.204 . . . . 0.0 111.192 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.0 m -55.81 107.75 0.38 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.664 0.269 . . . . 0.0 111.373 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.42 170.23 7.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.551 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 93' ' ' VAL . 5.3 p -82.09 107.07 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.565 ' HE1' HG21 ' A' ' 48' ' ' VAL . 10.4 m-85 -87.7 103.72 15.86 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.832 0.349 . . . . 0.0 111.256 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.493 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 5.6 t -104.99 130.46 53.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.426 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.7 t -84.96 142.56 29.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.281 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.52 162.46 29.31 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.755 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.41 165.49 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.836 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -96.82 179.34 34.11 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.682 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 177.9 118.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 0.0 110.698 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.7 14.48 50.97 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.811 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.66 -11.99 46.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.577 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.5 m -106.08 -179.26 3.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.642 0.258 . . . . 0.0 110.521 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.684 ' H ' HG22 ' A' ' 103' ' ' THR . 57.0 m95 -137.22 87.1 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.663 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -118.12 10.23 12.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.608 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.01 61.44 1.51 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.191 0.52 . . . . 0.0 110.768 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -69.97 165.46 21.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.104 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.74 -141.74 8.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.567 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -89.68 -48.25 7.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.331 . . . . 0.0 111.0 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 111.12 151.58 12.24 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.766 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 111' ' ' THR . 12.0 t -153.77 113.27 3.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -74.6 142.05 44.66 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.091 0.472 . . . . 0.0 111.272 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 91' ' ' THR . 55.8 t -114.65 117.79 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.037 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.404 HG21 HD23 ' A' ' 11' ' ' LEU . 88.8 m -96.69 119.35 35.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.094 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.788 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -110.68 -167.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.4 179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 54.4 p . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 120.813 0.34 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.492 ' C ' HD12 ' A' ' 4' ' ' LEU . 50.6 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.782 0.325 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 3' ' ' GLN . 4.7 mp -153.89 148.94 26.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.32 166.76 29.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.957 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.28 162.79 23.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.782 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.6 p -170.0 118.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.8 -27.67 4.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.596 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -53.69 179.83 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.716 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.12 177.9 25.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.317 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.805 HD23 HG21 ' A' ' 114' ' ' THR . 1.4 mp -69.03 126.05 28.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.074 0.464 . . . . 0.0 111.33 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.966 HG11 ' HB2' ' A' ' 18' ' ' LEU . 29.5 m -126.75 140.33 49.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.606 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -70.13 138.58 52.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.922 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -53.17 126.09 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.405 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.94 19.38 36.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.681 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -113.31 -156.43 12.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.405 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 t -138.64 137.89 37.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.933 0.397 . . . . 0.0 111.116 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.966 ' HB2' HG11 ' A' ' 12' ' ' VAL . 12.9 tp -135.18 133.29 38.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.589 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -110.68 126.74 54.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.338 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.587 HD21 ' CD2' ' A' ' 18' ' ' LEU . 5.7 mt -113.81 139.34 49.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.242 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.8 p -115.98 114.82 25.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.994 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.7 t -106.54 134.69 49.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.617 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -122.89 142.03 51.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.127 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.984 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.546 ' CD2' ' HB1' ' A' ' 98' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.433 -1.298 0 CA-C-O 120.977 0.418 . . . . 0.0 111.622 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -83.95 -176.64 6.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.084 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.1 mtp -144.02 126.61 16.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.33 154.45 25.87 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.928 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.544 ' CE2' HD22 ' A' ' 81' ' ' LEU . 73.9 m95 -86.93 153.84 21.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 111.438 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.4 m-85 -135.89 -178.81 5.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.768 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.494 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.9 OUTLIER -147.66 155.05 41.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.976 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.641 ' O ' HG12 ' A' ' 93' ' ' VAL . 2.1 tm0? -154.34 135.77 14.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.93 147.68 57.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.744 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.65 136.84 51.66 Favored 'Trans proline' 0 CA--C 1.517 -0.351 0 C-N-CA 122.247 1.965 . . . . 0.0 112.273 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.9 3.02 41.43 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.6 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.41 -162.92 0.82 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.692 0.282 . . . . 0.0 110.953 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -118.01 158.2 25.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.789 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.416 ' CG ' ' HG2' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -76.76 149.37 36.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.072 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.29 165.42 34.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.711 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.549 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.8 t -107.04 172.19 6.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.151 0.501 . . . . 0.0 110.865 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.494 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.6 t -128.58 -69.36 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.652 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -147.4 133.5 19.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 0.0 111.356 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.534 ' O ' HG22 ' A' ' 58' ' ' THR . . . -130.96 143.39 50.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.222 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.652 ' HB ' HG23 ' A' ' 58' ' ' THR . 7.3 tp -124.57 141.14 45.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.182 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.57 179.703 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 1.036 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -96.75 -178.44 4.24 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.022 0.439 . . . . 0.0 110.974 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' N ' ' O ' ' A' ' 50' ' ' ALA . 7.0 t80 -140.18 93.06 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.719 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -76.98 159.42 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.844 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.87 165.97 12.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.133 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 63' ' ' SER . 2.5 p -69.48 150.94 46.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.666 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 86.7 -12.38 0.56 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.618 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' A' ' 68' ' ' PHE . 16.9 m -149.15 12.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.525 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -81.39 81.85 7.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.634 0.73 . . . . 0.0 110.513 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.87 -6.81 2.38 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.309 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -119.08 -46.71 2.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.669 0.271 . . . . 0.0 111.257 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CE2' HG11 ' A' ' 64' ' ' VAL . 6.7 m-30 -69.94 139.85 52.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.702 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 6.9 m -111.55 153.45 26.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.887 0.375 . . . . 0.0 111.02 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.036 HG21 HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -139.45 140.34 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.834 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.439 ' N ' HG13 ' A' ' 70' ' ' ILE . 9.9 t -154.69 123.65 6.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 162.08 29.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.961 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 42.6 t0 -91.89 -38.26 12.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 59.7 47.78 10.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.743 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.3 -60.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -126.82 33.1 5.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.21 54.17 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 110.598 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.407 ' HB ' ' CB ' ' A' ' 73' ' ' ASP . 92.7 m -119.17 148.83 42.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.073 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.44 144.09 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.673 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 28.5 m-85 -127.45 120.14 27.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.821 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.587 HD21 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -115.28 116.66 28.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.103 0.478 . . . . 0.0 110.644 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -95.9 96.09 8.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.962 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.574 ' HE1' HD11 ' A' ' 20' ' ' LEU . 15.6 mtm -80.41 95.42 6.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.95 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.35 176.71 6.62 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.734 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 t 35.9 40.59 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.739 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -55.34 163.72 1.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.211 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.74 160.96 48.94 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.802 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.1 3.73 5.92 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.49 2.127 . . . . 0.0 112.848 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 12.7 tp10 -107.01 -10.38 15.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.782 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.66 -10.53 59.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.932 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 73.3 m -48.31 106.07 0.09 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.403 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.51 177.92 3.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.328 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 39' ' ' GLN . 5.0 p -83.95 107.35 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.454 ' CD1' HG21 ' A' ' 113' ' ' VAL . 6.1 m-85 -83.99 99.36 10.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.975 0.417 . . . . 0.0 110.679 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 m -103.04 132.05 49.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.282 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.7 t -90.42 135.62 33.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.657 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -136.16 176.0 20.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.402 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.546 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -131.57 148.01 52.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . -107.82 151.1 16.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.606 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -143.8 126.61 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.31 15.8 52.53 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.784 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.19 -9.77 46.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.791 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.7 m -102.22 179.98 4.16 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.598 0.237 . . . . 0.0 110.419 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.67 ' H ' HG22 ' A' ' 103' ' ' THR . 76.6 m95 -145.28 92.29 2.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -115.34 -2.76 12.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.406 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -94.41 132.39 39.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -136.55 164.67 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.28 -141.65 10.12 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.48 -45.49 8.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 113.11 153.82 11.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.532 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 1.8 t -152.58 106.93 3.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 110.526 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -60.21 141.66 55.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.136 0.493 . . . . 0.0 110.996 -179.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.4 t -119.91 88.01 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.181 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.805 HG21 HD23 ' A' ' 11' ' ' LEU . 59.1 m -76.67 132.87 39.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.218 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.541 HG21 HD23 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -144.79 156.51 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.396 179.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 1.1 m . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.798 0.332 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mp -114.83 138.87 50.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 11.2 mt-30 -144.89 134.28 23.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.667 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.13 163.52 13.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.859 0.361 . . . . 0.0 110.897 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.9 t -163.79 118.93 1.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.16 -37.57 3.04 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.715 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.712 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -49.12 139.16 14.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.095 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.43 -165.7 34.0 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.413 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.566 HD23 HG21 ' A' ' 114' ' ' THR . 1.8 mp -69.35 148.64 49.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.882 0.372 . . . . 0.0 111.595 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.673 HG13 HD22 ' A' ' 86' ' ' LEU . 7.2 p -170.12 106.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -56.68 159.59 3.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.347 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -51.2 153.71 1.9 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.304 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.48 9.2 68.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.647 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.74 113.62 2.92 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.383 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 m -69.95 135.96 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.737 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.8 tp -133.4 131.64 40.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.66 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -108.07 129.58 55.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.162 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.737 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.7 mt -113.68 144.87 42.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.131 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.474 ' HG ' ' HD2' ' A' ' 80' ' ' TYR . 1.9 m -126.97 118.98 25.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.498 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.511 ' SG ' HG23 ' A' ' 79' ' ' VAL . 19.3 p -125.07 121.34 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.999 0.428 . . . . 0.0 110.354 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.26 171.66 9.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.349 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.847 179.958 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.0 t80 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.427 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 12.8 m-20 -48.58 164.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.846 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.425 ' CE ' HG13 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -145.5 126.28 14.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.821 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.423 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -155.82 155.13 26.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.818 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.866 ' CE2' HD22 ' A' ' 81' ' ' LEU . 78.4 m95 -84.34 153.36 23.53 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.066 0.46 . . . . 0.0 111.022 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 8.9 m-85 -133.2 -176.38 4.11 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.389 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.532 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -146.81 156.67 43.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.668 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -153.94 111.39 3.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.125 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -97.96 160.74 27.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.685 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 53.8 Cg_endo -69.53 136.99 35.04 Favored 'Trans proline' 0 CA--C 1.518 -0.315 0 C-N-CA 122.294 1.996 . . . . 0.0 112.322 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.33 1.89 30.6 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.665 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.56 -174.8 2.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 110.974 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -103.18 -172.76 2.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.598 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -99.26 124.99 44.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -123.18 137.91 54.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.711 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.5 t -75.43 172.19 12.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.517 0.675 . . . . 0.0 111.526 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.532 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.7 t -131.02 -67.7 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.107 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -142.8 128.16 18.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.119 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -136.29 145.99 46.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.743 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.826 ' HB ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -123.12 140.82 45.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.239 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 . . . . . 0 N--CA 1.448 -0.57 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.029 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.849 0.357 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.826 HG23 ' HB ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -96.87 179.74 4.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.745 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 57.4 t80 -140.42 95.59 2.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.574 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 68' ' ' PHE . 78.3 m-85 -78.99 169.84 17.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.45 170.73 7.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.67 150.86 46.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.715 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.0 t 81.96 -8.04 1.33 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.752 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -151.29 11.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.434 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 79.23 0.86 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.534 0.683 . . . . 0.0 110.681 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.9 1.71 5.8 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.07 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.39 -52.92 2.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 4.4 m-30 -74.86 133.65 41.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.668 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 25.0 m -95.68 153.33 17.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.03 0.443 . . . . 0.0 110.975 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.898 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -152.78 136.12 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.596 -179.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.898 ' N ' HD13 ' A' ' 70' ' ' ILE . 10.3 t -156.14 153.39 29.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.958 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.413 ' HG3' HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -101.65 141.42 34.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.822 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.596 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 26.5 t0 -74.67 -30.37 61.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.916 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 m120 59.59 27.38 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.596 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -119.94 -54.63 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.018 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -122.76 27.33 7.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp 59.49 51.09 6.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.852 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.61 HG22 ' CE1' ' A' ' 80' ' ' TYR . 69.3 m -122.16 148.67 44.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.125 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.511 HG23 ' SG ' ' A' ' 22' ' ' CYS . 17.3 m -119.0 142.35 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.699 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.61 ' CE1' HG22 ' A' ' 78' ' ' THR . 1.2 m-85 -128.36 138.15 52.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.866 HD22 ' CE2' ' A' ' 36' ' ' TRP . 1.1 pt? -131.35 124.26 30.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.095 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -96.78 99.74 11.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.165 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -84.69 89.69 7.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.64 174.28 11.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 0.0 111.184 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 32.4 47.08 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.951 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.673 HD22 HG13 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -48.56 158.95 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 111.125 -179.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -126.42 174.34 4.23 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.632 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 86.3 Cg_endo -81.18 8.22 4.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.436 2.091 . . . . 0.0 112.855 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -109.69 -8.66 14.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.8 -20.01 43.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.234 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 114' ' ' THR . 95.5 m -54.22 101.99 0.05 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 111.305 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.54 -175.61 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.8 t -87.37 102.89 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.623 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -83.65 104.38 13.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.454 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 19.0 m -105.3 132.35 51.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.328 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.0 t -96.16 135.73 37.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.601 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.3 177.3 20.79 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.706 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -131.59 167.56 19.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.357 . . . . 0.0 111.012 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -119.45 -165.63 13.1 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.825 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.62 113.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.798 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.99 52.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.62 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.83 -12.41 34.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.752 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.634 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.2 m -96.15 177.52 5.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.891 0.377 . . . . 0.0 110.8 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.634 ' H ' HG22 ' A' ' 103' ' ' THR . 76.8 m95 -145.42 107.26 4.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.741 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -133.35 10.67 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.396 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 1.4 t -112.19 134.67 53.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.817 0.341 . . . . 0.0 110.896 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -141.6 165.05 28.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.05 -152.62 16.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -85.54 -31.86 22.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 95.72 156.44 31.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.65 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 111' ' ' THR . 14.8 t -147.99 112.7 5.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.341 . . . . 0.0 110.527 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.02 141.37 56.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 110.992 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.4 t -120.02 136.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.445 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.566 HG21 HD23 ' A' ' 11' ' ' LEU . 48.1 m -121.18 137.43 54.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.857 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.659 ' CG2' HD23 ' A' ' 86' ' ' LEU . 2.1 t -135.69 168.37 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.248 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.059 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.811 0.338 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 24' ' ' ALA . 5.0 mp -145.72 130.61 18.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -118.06 157.03 27.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.777 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.26 168.3 9.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.072 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.15 131.82 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.969 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.21 -18.59 57.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.749 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.588 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -52.07 138.27 31.29 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.874 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.85 -169.63 39.74 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.435 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.83 HD23 HG21 ' A' ' 114' ' ' THR . 1.7 mp -69.51 154.33 42.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.902 0.382 . . . . 0.0 111.58 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.654 ' HB ' HD13 ' A' ' 18' ' ' LEU . 7.2 p -154.39 113.92 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.927 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.0 144.18 7.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.384 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.577 ' HA ' HG12 ' A' ' 115' ' ' VAL . . . -49.81 121.35 5.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.314 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.8 15.32 58.22 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.599 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.415 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -109.72 133.36 11.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.371 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER -71.12 126.2 28.95 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.099 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.918 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.2 tp -120.52 131.34 54.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.523 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -110.23 122.44 47.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 111.607 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.918 HD21 ' CD2' ' A' ' 18' ' ' LEU . 6.8 mt -113.21 138.06 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.193 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.465 ' HB2' ' CD2' ' A' ' 80' ' ' TYR . 12.6 t -121.47 118.62 29.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.967 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 5.9 p -126.66 133.56 50.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.984 0.421 . . . . 0.0 111.174 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -113.87 172.85 6.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.234 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.41 ' HB2' ' HG ' ' A' ' 4' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.738 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 1.5 t80 . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.905 0.383 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 46.7 m-20 -110.1 178.76 4.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.775 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.516 ' HB3' HG11 ' A' ' 79' ' ' VAL . 1.8 ttm -150.11 129.6 13.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.123 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -150.15 154.47 25.69 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.839 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.665 ' CE2' HD22 ' A' ' 81' ' ' LEU . 84.8 m95 -83.57 155.61 23.19 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.1 0.476 . . . . 0.0 111.312 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.4 m-85 -137.82 -178.28 5.18 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.473 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.556 ' CG ' HG22 ' A' ' 48' ' ' VAL . 2.0 mtm180 -148.41 159.33 44.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.993 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -153.63 109.12 3.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.107 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.66 154.06 38.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.714 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.2 140.43 44.75 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.369 2.046 . . . . 0.0 112.426 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.0 -8.17 39.2 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.728 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -117.87 -179.1 3.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.842 0.353 . . . . 0.0 110.914 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.26 170.63 8.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.552 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.88 130.66 35.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.802 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.14 144.34 51.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.608 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.526 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.0 t -80.76 174.82 11.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.211 0.529 . . . . 0.0 111.054 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.556 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.1 t -131.45 -70.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.358 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -141.26 133.78 28.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 58' ' ' THR . . . -130.33 143.39 50.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.417 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.664 ' HB ' HG23 ' A' ' 58' ' ' THR . 6.5 tp -123.4 142.42 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.045 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.951 179.864 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.634 0.255 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.729 HG21 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -99.16 -179.94 4.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.991 0.424 . . . . 0.0 110.95 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 45.2 t80 -137.92 97.8 3.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.783 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -78.65 155.5 29.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.826 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.13 176.1 5.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.225 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -69.57 151.68 45.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.655 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.7 m 81.99 -9.0 1.25 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.571 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.53 HG21 ' CG1' ' A' ' 48' ' ' VAL . 35.4 m -151.56 13.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.352 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.74 80.11 1.12 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.707 0.765 . . . . 0.0 110.387 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.16 6.91 17.78 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.812 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -110.96 -45.31 3.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.814 0.34 . . . . 0.0 111.192 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CE2' HG11 ' A' ' 64' ' ' VAL . 7.8 m-30 -93.02 149.59 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.018 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 14.2 m -107.33 155.5 19.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.909 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -158.13 136.45 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.116 -179.018 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.909 ' N ' HD13 ' A' ' 70' ' ' ILE . 1.9 p -154.74 170.69 21.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.415 ' HB3' ' NH1' ' A' ' 72' ' ' ARG . 16.9 mtp-105 -113.62 146.19 40.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.926 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 22.5 t0 -89.9 -11.02 43.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.339 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 43.65 30.97 0.4 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.767 0.317 . . . . 0.0 111.558 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.7 -64.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.32 39.0 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.79 52.18 2.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.828 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.562 HG22 ' CE1' ' A' ' 80' ' ' TYR . 79.9 m -115.92 143.92 44.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.116 0.484 . . . . 0.0 111.358 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 34' ' ' MET . 32.7 m -121.98 132.3 71.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.033 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.562 ' CE1' HG22 ' A' ' 78' ' ' THR . 2.5 m-85 -115.32 119.43 36.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.665 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -115.17 115.47 26.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 0.0 110.48 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.01 92.48 6.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.785 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.435 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -73.09 92.1 1.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.009 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -86.74 176.02 7.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 35.96 47.22 0.4 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.723 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.404 ' CD1' ' CB ' ' A' ' 83' ' ' MET . 0.2 OUTLIER -64.94 158.49 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.844 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.503 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -112.12 166.52 10.76 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.686 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.92 11.99 2.38 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.616 2.21 . . . . 0.0 112.959 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -131.76 11.42 4.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.495 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -87.08 -5.18 59.12 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.634 0.254 . . . . 0.0 111.195 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 89.5 m -55.39 118.01 4.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 111.028 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.52 -172.26 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.499 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 93.0 t -92.99 106.26 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.496 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -88.57 103.06 15.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.874 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.421 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 6.1 t -105.75 142.22 35.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.226 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.57 144.36 25.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.92 175.89 20.07 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.313 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.738 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -143.59 167.65 21.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.902 0.382 . . . . 0.0 111.312 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -121.26 178.39 16.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.848 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -164.52 117.89 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.751 0.31 . . . . 0.0 110.416 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.8 16.41 51.54 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.729 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.66 -12.63 35.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.83 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.635 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.2 m -97.19 178.71 5.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.762 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.635 ' H ' HG22 ' A' ' 103' ' ' THR . 78.5 m95 -141.56 103.96 4.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -136.66 21.26 3.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.114 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.655 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -115.03 138.16 51.18 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.801 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -137.34 166.87 22.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.003 0.43 . . . . 0.0 111.117 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -111.03 -155.97 14.02 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.443 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -82.32 -41.1 20.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.948 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 104.86 151.37 21.0 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.799 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 111' ' ' THR . 11.0 t -152.62 121.06 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.423 HE21 ' N ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -77.7 144.38 37.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.957 0.408 . . . . 0.0 111.045 -179.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.423 ' N ' HE21 ' A' ' 112' ' ' GLN . 54.1 t -115.03 128.11 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.321 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.83 HG21 HD23 ' A' ' 11' ' ' LEU . 93.7 m -100.93 130.48 46.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.992 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -136.2 -162.0 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.611 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.501 ' H ' HG12 ' A' ' 115' ' ' VAL . 6.0 t . . . . . 0 C--N 1.333 -0.128 0 CA-C-O 120.857 0.36 . . . . 0.0 110.825 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.752 0.31 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.76 154.39 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.788 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -148.77 174.14 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.994 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.46 122.06 9.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -115.95 158.67 22.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -123.17 170.42 10.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -160.74 133.9 6.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.031 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.31 -32.16 6.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.567 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.29 138.77 27.03 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.948 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.41 -161.8 35.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.289 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.693 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.3 mp -69.39 143.85 53.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.889 0.376 . . . . 0.0 111.485 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.6 p -162.29 113.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.077 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.01 148.04 36.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.84 145.9 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.391 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.38 -7.34 79.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.678 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.21 118.64 5.91 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.318 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -70.01 135.58 49.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 111.126 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.663 ' CD2' HD21 ' A' ' 20' ' ' LEU . 14.2 tp -116.81 134.01 55.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.379 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.442 ' NE ' ' HB3' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -107.42 119.66 40.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.505 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.673 ' HB2' HD23 ' A' ' 81' ' ' LEU . 14.4 mt -111.28 139.14 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.36 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.8 p -126.28 98.79 5.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.968 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 41.4 t -95.19 135.23 37.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.711 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.77 145.66 43.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.273 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.75 133.24 45.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.97 132.31 15.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.99 -92.73 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.528 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.99 107.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 110.93 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 28' ' ' THR . 12.8 t -170.1 120.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.853 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.76 36.58 0.84 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.98 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.1 t -110.16 -81.51 0.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.759 0.314 . . . . 0.0 110.823 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.526 HG23 ' H ' ' A' ' 101' ' ' GLY . 5.2 t -139.68 29.63 2.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.108 0.48 . . . . 0.0 110.496 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.601 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -69.71 166.91 18.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.094 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 52' ' ' ASN . 0.4 OUTLIER -153.39 178.49 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.552 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.523 ' HB3' HG11 ' A' ' 79' ' ' VAL . 1.6 mtm -140.98 123.05 15.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.287 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -150.55 150.52 22.54 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.247 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.475 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 79.1 m95 -84.51 152.79 23.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.141 0.496 . . . . 0.0 110.939 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.6 m-85 -132.14 -178.77 5.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.396 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HD3' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -154.91 161.08 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.976 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.538 ' O ' HG12 ' A' ' 93' ' ' VAL . 8.1 tt0 -161.6 147.49 13.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -127.69 163.46 42.83 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.656 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.59 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 55.6 Cg_endo -70.19 138.28 36.11 Favored 'Trans proline' 0 CA--C 1.518 -0.318 0 C-N-CA 122.275 1.983 . . . . 0.0 112.372 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.41 -0.73 39.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.752 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.89 -177.45 3.13 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -100.13 -172.14 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HD2' ' CH2' ' A' ' 107' ' ' TRP . 10.2 ptt-85 -102.79 136.06 43.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.365 . . . . 0.0 111.046 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 1.7 pt-20 -131.6 163.65 27.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.331 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.532 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.1 t -104.26 171.08 7.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.267 0.556 . . . . 0.0 111.089 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.615 HG22 ' HD3' ' A' ' 38' ' ' ARG . 6.0 t -126.9 -67.09 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.491 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.6 136.82 26.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.325 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -141.88 146.33 35.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.94 HG23 HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -114.87 143.29 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.846 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 26.1 t-20 -86.88 167.82 13.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.177 0.513 . . . . 0.0 110.444 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -117.04 84.04 2.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.131 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.48 -79.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.691 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 169.88 64.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.36 -75.98 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.927 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.39 -164.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.94 HG23 HG23 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -98.72 -177.42 3.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.484 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.2 t80 -138.73 92.32 2.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.787 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 49' ' ' ALA . 12.8 m-85 -93.53 166.27 12.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.013 0.435 . . . . 0.0 111.071 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.24 159.45 19.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.366 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.48 37.19 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 0.0 111.838 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.4 t -116.35 -24.99 7.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.96 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.487 ' HA ' ' NH1' ' A' ' 67' ' ' ARG . 26.9 m -156.82 21.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.046 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.424 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 16.2 ttp85 -75.26 86.32 2.47 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.884 0.849 . . . . 0.0 110.689 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.84 -17.93 0.85 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.314 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.487 ' NH1' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -115.26 -33.16 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.642 0.258 . . . . 0.0 111.304 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.477 ' CE2' ' HG2' ' A' ' 83' ' ' MET . 2.6 m-85 -88.88 137.02 32.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.128 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 10.1 m -106.82 153.63 22.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.907 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -141.35 136.14 32.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.942 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.907 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -152.66 178.72 9.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.671 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.83 167.59 18.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.019 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.606 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 16.8 t0 -79.4 -37.01 38.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.788 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 m120 62.97 35.5 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.819 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.606 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -134.46 -47.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.18 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.4 tttp -130.07 -64.36 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt 167.66 70.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 64.9 m -135.65 144.78 46.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.006 0.432 . . . . 0.0 111.063 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.523 HG11 ' HB3' ' A' ' 34' ' ' MET . 33.8 m -116.54 147.6 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.696 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 2.2 m-85 -136.72 128.65 29.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.906 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -124.7 121.7 35.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.167 0.508 . . . . 0.0 110.808 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -94.59 99.21 11.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.583 ' O ' HD13 ' A' ' 86' ' ' LEU . 1.5 mtp -80.51 87.82 5.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.003 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.65 176.06 7.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.738 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 34.96 48.96 0.37 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.594 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 83' ' ' MET . 1.2 mp -58.2 165.88 1.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.313 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.435 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -145.3 167.89 13.35 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.817 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 54.8 Cg_endo -69.71 1.59 4.26 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.553 2.169 . . . . 0.0 113.148 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -98.76 -20.3 16.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.874 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.15 -21.18 46.86 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.083 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 114' ' ' THR . 99.9 m -51.79 101.55 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.782 0.325 . . . . 0.0 111.198 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.41 177.66 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.345 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.709 ' O ' HG13 ' A' ' 93' ' ' VAL . 9.4 p -80.88 101.57 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.197 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.441 ' O ' HG22 ' A' ' 111' ' ' THR . 3.9 m-85 -81.65 101.71 10.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.026 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.493 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 6.3 t -103.23 125.42 49.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.466 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.9 t -81.93 136.5 35.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.171 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.47 176.69 22.14 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.118 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.601 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -139.37 167.81 21.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.355 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -126.52 170.42 18.33 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.239 -0.982 . . . . 0.0 113.172 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -156.82 132.52 9.45 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.526 ' H ' HG23 ' A' ' 31' ' ' THR . . . 62.98 13.48 48.26 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.73 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.52 -9.47 45.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.886 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.662 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -101.82 179.56 4.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.849 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.662 ' H ' HG22 ' A' ' 103' ' ' THR . 84.3 m95 -136.72 86.23 2.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.576 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -113.56 19.04 17.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.96 132.42 56.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.426 ' CH2' ' HD2' ' A' ' 45' ' ' ARG . 19.5 m95 -139.24 164.02 30.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.025 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.87 -142.84 10.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.574 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.63 -35.32 15.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.382 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 99.8 150.69 25.38 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.863 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 111' ' ' THR . 7.9 t -145.27 114.67 7.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.481 HE21 ' N ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -76.63 132.36 39.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.971 0.415 . . . . 0.0 111.272 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.481 ' N ' HE21 ' A' ' 112' ' ' GLN . 60.7 t -110.14 124.08 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.901 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.693 ' HB ' HD23 ' A' ' 11' ' ' LEU . 89.7 m -112.49 117.26 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.585 HG12 ' H ' ' A' ' 116' ' ' SER . 0.4 OUTLIER -121.62 -168.84 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.083 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.585 ' H ' HG12 ' A' ' 115' ' ' VAL . 77.5 p -165.34 -87.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.605 0.241 . . . . 0.0 111.262 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.862 -179.929 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.779 0.324 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -106.42 158.87 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -122.79 164.13 18.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.04 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.464 HD23 ' HB2' ' A' ' 24' ' ' ALA . 1.7 mp -142.48 -179.57 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -169.13 169.07 9.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.96 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.04 163.31 18.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 p -167.74 126.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.62 -31.83 6.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.664 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' HD22 ' A' ' 20' ' ' LEU . . . -55.39 179.11 0.34 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.766 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.12 -157.79 27.49 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.076 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.755 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.2 mp -69.45 145.36 52.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.812 0.339 . . . . 0.0 111.262 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.594 HG11 HD22 ' A' ' 86' ' ' LEU . 7.7 p -146.54 132.97 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.171 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.96 129.48 41.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.187 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' HA ' HG12 ' A' ' 115' ' ' VAL . . . -51.61 128.2 22.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.401 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.25 -3.04 82.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.942 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.8 -144.56 14.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.444 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.58 140.97 33.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.934 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.807 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.8 tp -129.84 141.46 50.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.446 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.563 ' C ' HD23 ' A' ' 20' ' ' LEU . 31.5 ttt85 -122.09 131.38 53.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.489 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.807 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.9 mt -121.53 145.1 48.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.291 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.471 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 98.5 p -126.11 108.84 11.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.278 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 50.0 t -101.22 135.88 41.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.507 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -122.0 147.85 45.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.939 0.399 . . . . 0.0 111.424 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB3' ' HE1' ' A' ' 34' ' ' MET . . . -121.41 163.93 17.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.822 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.768 ' O ' HG12 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -138.07 114.82 10.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.066 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.82 145.39 5.67 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.571 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -79.8 149.66 30.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.0 p -152.94 155.03 36.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.195 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.56 32.23 0.43 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.191 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.93 53.19 1.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.6 23.33 13.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.66 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' CE2' HG21 ' A' ' 2' ' ' VAL . 43.8 t80 -69.42 90.35 0.52 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.521 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.45 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 71.6 m-20 -84.47 -176.88 6.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.258 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.576 ' HB3' HG11 ' A' ' 79' ' ' VAL . 2.9 mtt -141.21 117.78 10.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.33 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -141.22 168.16 25.49 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.039 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.45 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 77.7 m95 -103.0 158.76 16.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 111.163 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 13.8 m-85 -134.72 178.49 6.97 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' HG2' HG22 ' A' ' 48' ' ' VAL . 10.0 ptm180 -148.58 155.22 40.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.929 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.422 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.8 OUTLIER -145.85 110.69 5.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.5 153.24 48.09 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.37 136.46 40.07 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.325 2.016 . . . . 0.0 112.454 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.09 -1.36 33.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.657 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.74 -179.34 3.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.909 0.385 . . . . 0.0 111.048 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.45 -171.58 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.449 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -96.7 154.57 17.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.37 0.605 . . . . 0.0 111.329 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' CG ' ' HG3' ' A' ' 38' ' ' ARG . 7.8 pt-20 -157.46 139.24 14.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.241 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 1.6 t -67.99 171.98 6.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.478 0.656 . . . . 0.0 111.446 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.497 HG21 ' CE1' ' A' ' 94' ' ' TYR . 2.8 t -130.0 -67.8 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.221 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.14 124.42 13.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -120.62 147.3 45.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.337 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 34' ' ' MET . 0.6 OUTLIER -127.31 141.34 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.924 0.392 . . . . 0.0 111.286 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.403 ' N ' HG13 ' A' ' 51' ' ' ILE . 1.6 t-20 -89.32 -164.02 1.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.785 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.454 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -105.86 -167.33 1.3 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.509 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 t0 44.19 26.27 0.15 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.923 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.5 t 41.88 78.5 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 111.452 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.61 -72.87 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.305 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -162.21 167.66 23.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 1.012 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -107.63 -179.03 3.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.002 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 50' ' ' ALA . 12.8 t80 -139.04 86.58 2.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.713 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.448 ' CE2' HG22 ' A' ' 70' ' ' ILE . 9.3 m-85 -86.79 143.57 27.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.38 165.14 24.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.442 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.4 p -82.33 33.66 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 0.0 111.701 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.4 p -118.99 -21.56 7.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.126 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.536 HG11 ' CE1' ' A' ' 68' ' ' PHE . 17.4 m -148.46 19.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.019 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.5 ttt85 -62.49 79.25 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.63 0.729 . . . . 0.0 110.832 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 134.09 3.16 3.24 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.175 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -119.1 -52.87 2.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.816 0.341 . . . . 0.0 111.069 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CE1' HG11 ' A' ' 64' ' ' VAL . 5.2 m-30 -75.5 150.85 38.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.1 m -113.32 157.87 21.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.007 0.432 . . . . 0.0 110.98 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.012 HG21 HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -151.58 135.18 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.96 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.892 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -164.8 152.04 11.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.716 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 164.31 11.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.07 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.457 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 54.2 t0 -76.93 -30.33 56.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.989 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.35 25.61 13.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.087 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.25 -52.59 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.892 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 2.6 pttt -134.16 -57.53 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 173.42 70.96 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.779 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.469 HG22 ' CE1' ' A' ' 80' ' ' TYR . 25.8 m -134.92 139.42 44.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.114 0.483 . . . . 0.0 111.336 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 34' ' ' MET . 35.6 m -115.92 146.16 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.336 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 1.9 m-85 -135.1 155.16 51.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.72 0.295 . . . . 0.0 111.035 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.526 HD21 HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -146.31 125.62 13.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.952 0.406 . . . . 0.0 110.941 179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.61 96.5 7.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.536 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.502 ' SD ' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -79.38 91.25 5.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.271 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.44 178.53 6.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 t 38.99 40.75 0.48 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.441 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.594 HD22 HG11 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -60.38 159.49 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.145 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.556 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 16.5 mmmt -128.62 163.67 43.36 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.411 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 57.8 Cg_endo -70.99 6.96 1.49 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.37 2.047 . . . . 0.0 113.271 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -109.2 -8.1 15.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.009 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.27 -11.15 58.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.652 0.263 . . . . 0.0 111.308 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.434 ' OG1' HG23 ' A' ' 115' ' ' VAL . 97.6 m -53.18 107.7 0.26 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.057 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.61 -177.65 2.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.525 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 93.5 t -89.75 105.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.792 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.51 ' O ' HG22 ' A' ' 111' ' ' THR . 11.3 m-85 -87.91 110.2 20.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 7.2 m -111.15 136.08 50.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.718 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.423 ' HB3' ' CE3' ' A' ' 36' ' ' TRP . 15.7 p -98.91 138.66 35.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 111.175 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.73 -169.3 11.69 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.361 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -136.92 167.41 21.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 111.193 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -104.01 -175.8 25.57 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.629 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -173.75 108.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.73 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.09 16.69 49.32 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.764 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.0 -16.51 25.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.558 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.667 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -96.49 179.81 4.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.769 0.319 . . . . 0.0 110.475 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.667 ' H ' HG22 ' A' ' 103' ' ' THR . 79.9 m95 -141.88 92.51 2.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.766 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -117.43 -2.18 11.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.586 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.676 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 1.2 t -93.28 132.49 37.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -137.28 162.63 33.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.38 -92.49 2.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.403 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -140.36 -69.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 110.845 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 141.54 151.08 5.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.738 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.6 t -147.25 106.46 3.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.899 0.38 . . . . 0.0 110.45 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -66.17 142.22 57.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.203 0.525 . . . . 0.0 111.04 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 91' ' ' THR . 41.1 t -117.62 116.43 51.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.182 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.755 ' CB ' HD23 ' A' ' 11' ' ' LEU . 90.1 m -100.58 108.55 20.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.075 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 116' ' ' SER . 0.3 OUTLIER -108.31 -158.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.396 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.495 ' H ' HG12 ' A' ' 115' ' ' VAL . 0.4 OUTLIER 78.92 -58.4 0.42 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.873 0.368 . . . . 0.0 111.031 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.934 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.829 0.347 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.2 155.37 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -143.41 150.14 38.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 mp -147.82 151.54 36.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -154.32 173.11 16.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.06 164.31 14.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.792 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.92 101.3 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.28 87.17 1.97 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.423 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.62 152.87 16.22 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.447 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.71 -155.25 26.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.41 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.74 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.7 mp -69.03 134.67 49.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.908 0.385 . . . . 0.0 111.247 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG1' HD22 ' A' ' 86' ' ' LEU . 8.0 p -142.33 128.96 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.282 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 132.56 46.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.309 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.658 ' HB3' ' HA ' ' A' ' 117' ' ' SER . . . -46.54 154.26 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.582 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.18 -9.14 73.93 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.792 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.78 -163.14 25.98 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.608 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.48 141.37 41.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.856 ' CD2' HD21 ' A' ' 20' ' ' LEU . 7.1 tp -128.77 132.27 47.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.612 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -111.57 116.9 31.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.381 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.856 HD21 ' CD2' ' A' ' 18' ' ' LEU . 9.9 mt -104.69 133.74 49.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.626 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 p -112.25 134.94 53.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.659 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -134.29 126.12 29.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.92 0.39 . . . . 0.0 111.135 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.19 152.75 21.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.971 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' HB3' ' HE2' ' A' ' 34' ' ' MET . . . -134.39 112.96 11.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -103.39 157.35 17.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.12 146.21 10.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.515 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -70.15 137.75 51.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.742 0.306 . . . . 0.0 110.856 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.7 t -159.9 127.63 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.023 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.89 35.83 1.56 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.147 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 t -116.09 46.34 1.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 110.972 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.86 32.38 21.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.01 0.433 . . . . 0.0 110.441 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.619 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.8 138.46 54.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.026 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.442 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 39.1 m-20 -123.45 -176.38 3.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.703 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.406 ' HE2' ' HB3' ' A' ' 24' ' ' ALA . 3.9 ttm -145.63 126.43 14.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.192 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.86 162.71 28.97 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.733 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.435 ' CH2' ' CB ' ' A' ' 20' ' ' LEU . 79.7 m95 -91.63 155.12 18.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 111.487 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -137.69 -177.94 5.02 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.785 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.533 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -151.49 163.14 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.559 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.723 ' O ' HG12 ' A' ' 93' ' ' VAL . 4.5 tp60 -165.91 128.37 2.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.03 0.443 . . . . 0.0 111.621 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -113.45 167.94 8.57 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.496 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.725 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 59.6 Cg_endo -72.3 137.56 28.64 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.233 1.955 . . . . 0.0 112.476 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.33 2.0 24.22 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.703 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -119.48 152.0 37.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -77.21 156.1 31.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.387 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.9 143.0 52.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.951 0.405 . . . . 0.0 111.245 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.43 143.25 48.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.211 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.533 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.6 t -83.57 172.79 12.0 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 111.183 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.533 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.0 t -129.19 -66.64 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.976 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.09 161.67 40.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -160.24 144.4 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.995 0.426 . . . . 0.0 111.511 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.661 HD13 ' HD2' ' A' ' 72' ' ' ARG . 1.4 tt -123.24 143.67 35.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -81.47 177.9 8.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.016 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -118.84 -37.38 3.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.087 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.27 -52.68 13.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.365 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 26.3 t -87.2 -102.34 0.07 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.066 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 55' ' ' SER . . . 177.25 -35.05 0.01 OUTLIER 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.735 0.302 . . . . 0.0 111.339 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.13 148.64 0.41 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.515 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.71 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -108.99 -179.36 3.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.022 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -140.6 142.18 35.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.382 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.466 ' HH ' ' HA ' ' A' ' 69' ' ' THR . 3.7 m-85 -128.86 168.32 16.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.84 0.353 . . . . 0.0 111.026 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.0 168.07 13.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 63' ' ' SER . 56.3 m -69.24 153.07 44.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.498 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 t 84.38 -10.23 0.89 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.522 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.435 HG21 ' CG1' ' A' ' 48' ' ' VAL . 28.6 m -154.2 16.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.462 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 8.9 tpt180 -82.08 83.15 7.41 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.665 0.745 . . . . 0.0 109.962 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.09 -0.65 7.71 Favored Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.158 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -110.81 -52.63 2.77 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.837 0.351 . . . . 0.0 110.794 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.3 m-30 -76.86 149.34 36.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.466 ' HA ' ' HH ' ' A' ' 60' ' ' TYR . 6.8 m -111.05 152.37 26.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.71 HG21 HG21 ' A' ' 58' ' ' THR . 6.2 tp -137.49 146.19 28.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.761 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.08 172.33 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 111.032 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.661 ' HD2' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -130.85 143.61 50.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.913 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.409 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 7.2 t0 -83.57 -38.07 22.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.09 26.75 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.43 -42.71 2.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.963 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.25 29.09 2.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.876 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt 61.93 53.97 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.9 m -118.36 148.72 42.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.026 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.75 141.02 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.843 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 24.9 m-85 -125.96 126.69 44.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.977 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -120.63 116.81 26.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.978 0.418 . . . . 0.0 110.51 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -94.76 94.59 8.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.156 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.575 ' CE ' HD23 ' A' ' 18' ' ' LEU . 25.9 mtm -78.02 92.91 4.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.798 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.83 176.44 6.63 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 37.21 43.32 0.34 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.695 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.403 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -55.98 156.65 5.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.02 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.508 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.24 170.77 8.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.855 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 89.8 Cg_endo -77.96 8.15 3.62 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.515 2.143 . . . . 0.0 112.954 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -116.92 7.52 13.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.257 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -92.4 -10.06 39.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.304 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 97.9 m -53.97 107.79 0.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.256 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.29 177.0 4.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 39' ' ' GLN . 4.2 p -85.69 106.33 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.027 0.441 . . . . 0.0 110.846 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.96 101.8 13.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.137 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 9.1 m -113.13 136.03 53.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.609 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 25.6 p -100.65 147.12 26.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.029 0.442 . . . . 0.0 111.365 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.83 -171.28 12.45 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.214 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.619 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -138.19 166.73 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 111.269 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -111.61 176.26 18.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.665 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -162.49 113.69 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 110.575 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.66 16.97 52.86 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.695 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.87 -14.17 31.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -96.32 179.31 5.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.548 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.66 ' H ' HG22 ' A' ' 103' ' ' THR . 78.0 m95 -143.76 102.64 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.795 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.11 11.02 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.439 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.87 137.91 42.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.642 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -140.73 164.11 31.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.964 0.412 . . . . 0.0 111.034 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.18 -130.71 6.3 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.337 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -98.81 -63.23 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 0.0 110.807 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.89 151.07 8.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.665 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 111' ' ' THR . 15.4 t -145.28 109.72 4.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.359 . . . . 0.0 110.428 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.54 141.63 55.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.208 0.528 . . . . 0.0 111.035 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 91' ' ' THR . 41.3 t -119.21 131.82 70.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.254 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.74 ' CB ' HD23 ' A' ' 11' ' ' LEU . 83.9 m -116.85 138.67 51.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.207 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 116' ' ' SER . 2.0 t -139.11 168.17 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.28 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.518 ' H ' HG12 ' A' ' 115' ' ' VAL . 51.5 m -150.76 -54.53 0.15 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.104 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.658 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 6.2 p . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.88 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.77 0.319 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.558 HG23 ' OG ' ' A' ' 106' ' ' SER . 2.9 m -69.96 152.11 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.236 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.606 ' C ' HD12 ' A' ' 4' ' ' LEU . 3.6 pt20 -133.77 165.3 25.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.606 HD12 ' C ' ' A' ' 3' ' ' GLN . 6.5 mp -140.07 135.32 32.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.17 131.41 44.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.75 164.68 17.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.7 p -158.19 111.73 2.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.03 84.51 1.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.355 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.44 143.81 8.96 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.547 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.83 -156.19 21.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.528 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.764 HD23 ' CG2' ' A' ' 114' ' ' THR . 1.7 mp -69.08 143.19 54.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.919 0.39 . . . . 0.0 111.362 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.97 126.88 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.135 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.57 139.95 56.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -52.32 137.06 29.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.323 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.5 -15.73 60.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.703 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.61 -154.65 7.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.42 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.62 139.29 31.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.011 0.434 . . . . 0.0 111.213 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.837 HD21 HD21 ' A' ' 20' ' ' LEU . 10.8 tp -124.45 135.31 53.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.554 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.06 115.31 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 111.557 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.837 HD21 HD21 ' A' ' 18' ' ' LEU . 12.4 mt -112.61 132.48 55.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.577 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -120.67 113.34 20.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.67 123.14 49.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.791 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.71 165.76 11.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.298 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.96 137.82 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.5 m -122.62 162.74 21.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.986 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.5 152.11 10.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.98 125.14 25.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.695 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.444 HG21 ' CD2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -149.05 86.41 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.293 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.31 30.95 7.79 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.911 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 t -109.15 33.66 4.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.752 0.31 . . . . 0.0 110.965 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 m 71.69 32.02 2.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.975 0.417 . . . . 0.0 110.424 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.638 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.64 130.27 42.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.741 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.474 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 46.9 m-20 -115.47 -173.65 2.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.86 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.638 ' HB3' HG11 ' A' ' 79' ' ' VAL . 9.3 mtm -145.87 124.71 12.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.055 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.88 152.93 24.88 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.829 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 96' ' ' CYS . 73.1 m95 -88.46 154.82 20.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.114 0.483 . . . . 0.0 111.427 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.63 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.1 m-85 -133.65 -178.69 5.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.266 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.486 ' CD ' HG22 ' A' ' 48' ' ' VAL . 1.6 ptm180 -152.94 157.86 41.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.752 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.422 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 2.2 tm0? -145.46 145.4 31.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.946 0.403 . . . . 0.0 111.336 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.37 151.77 78.11 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.44 139.6 41.75 Favored 'Trans proline' 0 CA--C 1.517 -0.345 0 C-N-CA 122.362 2.041 . . . . 0.0 112.537 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.76 -7.08 43.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.764 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.45 -166.68 1.21 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.798 0.333 . . . . 0.0 110.9 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.86 -171.71 1.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -98.19 133.77 42.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.935 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HG2' ' HG3' ' A' ' 38' ' ' ARG . 4.1 pt-20 -131.79 152.28 51.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.423 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 6.6 t -83.41 174.66 10.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.382 0.61 . . . . 0.0 111.079 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.547 ' CG1' HG21 ' A' ' 64' ' ' VAL . 3.8 t -130.12 -62.47 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.071 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -151.88 129.83 11.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.509 ' O ' HG22 ' A' ' 58' ' ' THR . . . -127.98 145.26 51.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.386 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 58' ' ' THR . 11.0 tt -126.98 142.29 43.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.32 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -88.05 -163.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.74 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -109.01 -33.64 6.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.702 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -178.83 38.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.65 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 t -93.44 -62.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.062 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.24 -62.87 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.339 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.74 -142.52 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.861 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 1.065 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -97.85 -179.77 4.54 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.987 0.423 . . . . 0.0 111.19 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 50' ' ' ALA . 65.3 t80 -139.7 91.0 2.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.64 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.428 ' OH ' HG22 ' A' ' 70' ' ' ILE . 47.3 m-85 -76.83 158.06 31.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.2 172.01 7.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.167 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -69.57 150.87 46.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.618 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.0 OUTLIER 84.72 -11.19 0.81 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.623 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' A' ' 68' ' ' PHE . 16.4 m -149.21 12.45 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.48 79.2 1.05 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.537 0.684 . . . . 0.0 110.7 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.73 3.11 10.26 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.825 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -108.01 -41.32 4.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.732 0.301 . . . . 0.0 111.09 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.592 ' CE2' HG11 ' A' ' 64' ' ' VAL . 9.5 m-30 -94.27 146.72 23.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.124 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.7 m -105.12 158.03 16.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.812 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.065 HG21 HG21 ' A' ' 58' ' ' THR . 2.7 tp -144.79 139.92 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.106 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 m -154.42 137.35 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.679 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.449 ' HB3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -90.13 152.01 21.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.245 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.467 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 39.4 t0 -84.43 -36.5 22.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.793 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.99 29.98 19.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.95 -46.12 1.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.09 31.76 1.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.482 ' HB3' ' HE1' ' A' ' 34' ' ' MET . 22.5 mtmt 62.77 56.14 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 73' ' ' ASP . 60.6 m -116.04 150.31 37.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.638 HG11 ' HB3' ' A' ' 34' ' ' MET . 31.5 m -128.5 131.95 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.928 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.577 ' CD1' ' HB3' ' A' ' 21' ' ' SER . 25.6 m-85 -113.09 120.58 41.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.195 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.618 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -114.09 112.61 23.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.068 179.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -96.35 96.84 9.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.203 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.674 ' SD ' HD23 ' A' ' 18' ' ' LEU . 1.3 mtp -81.94 88.3 6.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.03 177.66 6.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.57 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 t 37.98 40.85 0.32 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.516 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 162.62 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.628 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -128.99 170.83 9.84 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.779 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 84.5 Cg_endo -77.67 10.82 2.4 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 113.089 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -122.02 10.98 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.342 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -95.94 -15.46 22.35 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.608 0.242 . . . . 0.0 111.36 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.556 ' OG1' HG23 ' A' ' 115' ' ' VAL . 82.9 m -49.27 112.86 0.69 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.435 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.34 173.65 5.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.969 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 93' ' ' VAL . 7.4 p -81.1 105.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.979 0.419 . . . . 0.0 110.925 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -83.95 99.08 10.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.959 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 4.3 m -105.63 128.03 53.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 14.0 p -95.15 143.78 26.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.964 0.411 . . . . 0.0 111.224 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' HA2' HD22 ' A' ' 4' ' ' LEU . . . -139.81 -173.06 13.03 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.158 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.638 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -144.69 166.37 25.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.957 0.408 . . . . 0.0 111.264 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.93 171.68 18.21 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.676 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.01 115.5 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.621 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.89 15.8 50.05 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.782 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.77 -14.67 31.98 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.528 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.5 m -99.1 178.79 4.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.789 0.328 . . . . 0.0 110.608 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.651 ' H ' HG22 ' A' ' 103' ' ' THR . 71.5 m95 -138.2 93.06 2.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.655 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -119.2 2.33 11.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.52 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.558 ' OG ' HG23 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -96.04 132.72 41.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 110.898 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -140.91 164.93 28.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.71 -154.81 18.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -30.75 20.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.333 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.94 151.0 26.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.883 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 111' ' ' THR . 12.4 t -145.34 109.45 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.262 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -67.61 141.55 56.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.158 0.504 . . . . 0.0 111.052 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 91' ' ' THR . 43.5 t -119.87 126.23 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.329 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.764 ' CG2' HD23 ' A' ' 11' ' ' LEU . 94.8 m -109.99 142.62 41.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.955 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 87' ' ' LYS . 2.6 t -127.52 169.54 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.155 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.689 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -149.01 -162.9 1.66 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.813 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.881 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.8 162.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.78 150.23 39.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 mp -149.12 155.1 40.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -150.66 161.11 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.714 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.81 164.72 12.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.83 0.348 . . . . 0.0 110.978 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 m -164.76 95.65 0.72 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.59 -28.43 2.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.638 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.825 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.0 138.43 20.89 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.9 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.0 -172.49 43.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.089 -0.576 . . . . 0.0 112.373 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.794 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.5 mp -69.35 150.03 47.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.863 0.363 . . . . 0.0 111.554 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.665 ' CG1' HD22 ' A' ' 86' ' ' LEU . 7.8 p -153.39 116.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.941 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.74 139.77 25.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.426 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.17 123.3 7.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.82 0.56 60.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.834 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.31 138.55 14.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.449 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 t -79.68 141.54 36.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 110.966 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.646 HD23 HD21 ' A' ' 20' ' ' LEU . 14.9 tp -132.92 150.44 52.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.309 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' C ' HD23 ' A' ' 20' ' ' LEU . 4.9 ttt180 -125.45 126.56 45.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.402 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.825 HD22 ' HA2' ' A' ' 9' ' ' GLY . 2.2 mt -114.49 149.72 35.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.799 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 71.1 m -131.21 118.63 20.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.05 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 19.0 p -125.37 131.34 52.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.58 169.11 9.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.311 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.61 105.29 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.9 p -97.89 103.03 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.52 161.49 13.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -69.94 92.94 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 28' ' ' THR . 12.6 t -154.3 105.35 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.001 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' A' ' 53' ' ' TRP . . . -165.86 34.23 0.24 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.485 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.5 t -121.86 -74.06 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 111.326 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.1 p -114.0 -27.42 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.404 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -69.45 130.84 43.63 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.919 0.39 . . . . 0.0 111.275 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.436 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 44.2 m-20 -101.6 -172.45 2.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.941 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.406 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -143.6 124.1 13.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.733 0.301 . . . . 0.0 111.273 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.52 166.11 29.62 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.939 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.518 ' CE2' HD22 ' A' ' 81' ' ' LEU . 52.6 m95 -91.9 156.2 17.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.133 0.492 . . . . 0.0 111.307 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 8.1 m-85 -136.45 179.18 6.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.938 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 16.7 ptm180 -152.86 160.56 43.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.723 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.645 ' O ' HG12 ' A' ' 93' ' ' VAL . 12.6 tt0 -165.5 159.83 17.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.064 0.459 . . . . 0.0 111.459 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -136.01 162.33 57.32 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.506 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 52.2 Cg_endo -69.59 137.39 35.86 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.387 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.54 3.07 38.67 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.722 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 -172.87 2.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.783 0.325 . . . . 0.0 111.058 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.85 -178.84 3.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.739 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.408 ' HD2' ' CH2' ' A' ' 107' ' ' TRP . 18.2 ptt-85 -103.28 139.65 38.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.173 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HG3' ' CG ' ' A' ' 38' ' ' ARG . 18.1 pt-20 -140.73 146.74 38.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.236 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.7 t -83.85 175.2 9.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.316 0.579 . . . . 0.0 111.363 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.4 -57.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.786 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.29 157.66 43.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.719 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -158.19 140.97 14.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.06 0.457 . . . . 0.0 111.484 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.679 HD13 HG23 ' A' ' 58' ' ' THR . 7.5 tp -121.21 139.82 47.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.835 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -72.83 157.65 37.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.933 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.445 ' CD1' ' HA2' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -88.65 81.61 7.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.533 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.414 ' O ' ' CB ' ' A' ' 55' ' ' SER . 4.8 p-10 173.75 -27.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.974 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER 80.37 86.38 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.759 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.36 -44.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.139 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.428 ' O ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -149.04 149.4 31.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.998 0.428 . . . . 0.0 111.291 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.679 HG23 HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -117.48 -178.13 3.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.599 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.6 t80 -136.93 142.59 42.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.561 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.431 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 5.8 m-85 -126.44 165.77 18.46 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.976 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.6 166.41 11.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.5 152.13 45.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.703 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 83.62 -10.15 0.98 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.571 -178.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.422 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 35.6 m -152.08 15.39 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.237 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -70.48 78.91 0.56 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.576 0.703 . . . . 0.0 110.752 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.51 3.35 5.63 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.0 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -112.29 -44.04 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.754 0.311 . . . . 0.0 111.016 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 5.9 m-30 -78.79 140.2 38.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.786 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 28.9 m -105.45 151.06 24.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.084 0.468 . . . . 0.0 111.164 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.911 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -145.54 136.8 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.634 -179.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.911 ' N ' HD13 ' A' ' 70' ' ' ILE . 19.3 p -162.41 141.59 9.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.091 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -73.25 165.42 25.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.958 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.415 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 37.1 t0 -97.19 -33.5 11.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.826 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 60.34 58.36 2.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.17 -46.05 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -140.38 29.29 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.72 55.48 2.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.62 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.494 ' CG2' ' CE1' ' A' ' 80' ' ' TYR . 6.4 m -123.3 158.94 29.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.109 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.19 143.66 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.715 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 21' ' ' SER . 15.2 m-85 -124.5 135.11 52.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.506 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -127.19 121.04 30.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.084 0.469 . . . . 0.0 110.812 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -99.23 101.15 12.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.838 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.577 ' HE1' HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -87.75 95.22 10.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.181 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.92 175.36 8.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.833 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 34.4 48.33 0.27 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.794 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.665 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -54.34 164.36 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.004 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.671 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -128.68 164.46 38.24 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.813 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 87' ' ' LYS . 63.1 Cg_endo -72.82 6.32 2.5 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.533 2.155 . . . . 0.0 113.155 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -111.89 -0.03 15.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.282 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -84.91 -11.73 54.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.576 0.227 . . . . 0.0 111.237 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 90.8 m -56.02 103.5 0.1 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.67 175.65 4.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.899 0.381 . . . . 0.0 111.583 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.678 ' O ' HG13 ' A' ' 93' ' ' VAL . 7.7 p -80.84 105.37 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.082 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 111' ' ' THR . 9.8 m-85 -84.42 105.04 14.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.656 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.4 m -110.96 127.38 55.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.9 t -81.17 127.4 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.485 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -128.15 -177.41 14.86 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.471 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 34' ' ' MET . . . -146.13 147.77 31.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.848 0.356 . . . . 0.0 111.213 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.458 ' N ' ' CE3' ' A' ' 104' ' ' TRP . . . -78.77 -170.07 37.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.374 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.28 100.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.67 18.54 45.71 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.761 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.19 -20.28 11.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -97.62 -179.81 4.59 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 110.426 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.664 ' H ' HG22 ' A' ' 103' ' ' THR . 71.8 m95 -145.55 102.54 3.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 110.945 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -134.96 15.6 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.298 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.37 133.22 51.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.786 0.326 . . . . 0.0 110.66 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.408 ' CH2' ' HD2' ' A' ' 45' ' ' ARG . 9.4 m95 -136.25 162.15 33.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.976 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.28 -137.19 9.13 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.494 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -87.07 -51.02 6.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.334 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.39 151.28 12.88 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.661 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 111' ' ' THR . 13.9 t -158.56 118.57 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -79.44 142.64 35.72 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.004 0.43 . . . . 0.0 111.176 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.446 ' N ' HE21 ' A' ' 112' ' ' GLN . 52.6 t -116.31 136.48 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.159 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.794 ' CB ' HD23 ' A' ' 11' ' ' LEU . 99.6 m -109.31 130.0 55.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.011 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.671 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -126.18 -158.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.55 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.469 ' H ' HG12 ' A' ' 115' ' ' VAL . 1.3 t 65.66 169.96 0.21 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.869 0.366 . . . . 0.0 110.87 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.945 -179.9 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.448 ' HG2' HG22 ' A' ' 2' ' ' VAL . 7.7 tt0 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.541 0.21 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.869 HG12 ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER -112.33 151.76 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.634 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.609 ' C ' HD12 ' A' ' 4' ' ' LEU . 5.0 pt20 -89.62 155.1 19.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.124 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 3' ' ' GLN . 4.0 mp -160.61 99.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.02 174.01 8.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.012 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.37 163.97 22.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.733 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -169.62 135.94 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.08 -18.36 26.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.729 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.403 ' HA2' ' CD2' ' A' ' 20' ' ' LEU . . . -54.07 -173.83 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.831 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.12 164.36 10.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.509 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.789 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.5 mp -69.28 146.51 52.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.85 0.357 . . . . 0.0 111.376 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 12' ' ' VAL . 8.5 p -165.53 119.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.174 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -54.76 154.5 5.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.24 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -49.64 138.3 14.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.358 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.99 -21.79 44.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.487 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.52 122.98 6.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.305 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 11.4 p -70.0 130.53 42.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 111.131 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.779 ' CD2' HD21 ' A' ' 20' ' ' LEU . 12.7 tp -109.74 133.74 52.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.494 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -107.29 119.2 38.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 0.0 111.422 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.779 HD21 ' CD2' ' A' ' 18' ' ' LEU . 13.9 mt -114.53 136.32 53.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.534 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.5 p -122.34 111.05 16.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.122 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.4 t -107.29 134.52 50.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.514 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.29 152.4 26.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.253 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.32 154.0 38.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.869 ' HB3' HG12 ' A' ' 2' ' ' VAL . 12.2 t -69.93 121.56 17.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.08 56.99 5.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.541 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -125.3 62.14 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.851 HG21 ' CD1' ' A' ' 32' ' ' TYR . 16.5 p -117.9 -161.1 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.706 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.36 -33.84 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.141 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.0 t -69.95 -75.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.4 t -174.36 41.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.851 ' CD1' HG21 ' A' ' 28' ' ' THR . 0.0 OUTLIER -69.6 130.72 43.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.854 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -120.26 -171.45 2.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.715 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -139.67 160.32 40.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.923 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . 179.56 141.62 4.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.0 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.526 ' CD2' HD22 ' A' ' 81' ' ' LEU . 81.4 m95 -82.72 154.7 24.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.15 0.5 . . . . 0.0 111.285 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.5 m-85 -137.89 -178.27 5.18 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.296 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.523 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -148.85 161.04 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.494 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.725 ' O ' HG12 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -162.7 137.51 6.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.005 0.431 . . . . 0.0 111.387 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.709 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -121.15 166.77 14.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.49 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.709 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 38.0 Cg_endo -66.21 135.77 41.42 Favored 'Trans proline' 0 CA--C 1.517 -0.355 0 C-N-CA 122.169 1.913 . . . . 0.0 112.248 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.43 6.35 33.92 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.458 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.51 -177.23 3.18 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.832 0.348 . . . . 0.0 111.022 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -109.7 -171.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.775 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -86.12 134.43 33.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.078 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -131.74 116.45 17.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.412 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 1.5 t -68.09 169.22 10.56 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.599 0.714 . . . . 0.0 111.328 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.523 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.3 t -132.63 -68.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.372 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -140.94 145.99 36.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.71 0.29 . . . . 0.0 111.307 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.544 ' O ' HG22 ' A' ' 58' ' ' THR . . . -140.85 142.18 34.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.466 ' HB ' HG23 ' A' ' 58' ' ' THR . 2.4 tt -125.23 145.75 32.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.56 -167.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.249 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.32 59.49 1.02 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.008 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -177.28 32.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.37 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 m 41.67 33.76 0.34 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.441 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.34 -57.1 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.147 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.81 178.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.06 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.725 HG21 ' CG2' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -118.42 -178.02 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.978 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 52.9 t80 -139.19 96.2 3.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.892 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.37 158.16 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.842 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . -98.13 157.16 16.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 63' ' ' SER . 17.3 p -69.38 151.57 45.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.572 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 86.47 -12.3 0.59 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.556 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.673 HG12 ' HD2' ' A' ' 67' ' ' ARG . 14.8 m -141.97 7.67 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.497 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 80.23 0.55 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.561 0.696 . . . . 0.0 110.781 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 139.49 1.77 1.86 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.619 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.673 ' HD2' HG12 ' A' ' 64' ' ' VAL . 13.4 ptp180 -117.96 -40.03 3.03 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.779 0.289 . . . . 0.0 111.303 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 83' ' ' MET . 14.4 m-30 -90.23 159.0 16.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.115 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.8 m -125.23 157.19 37.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.867 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -156.32 134.47 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.997 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.867 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -160.13 140.25 11.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.842 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -78.24 173.3 12.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.95 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.413 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 33.3 t0 -98.99 -33.59 10.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.034 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.22 28.7 17.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.54 -59.82 1.51 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.953 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -128.06 28.47 5.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.5 60.02 0.75 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.149 0.5 . . . . 0.0 110.729 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -122.84 147.93 45.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.047 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.6 m -119.78 139.37 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.714 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 41.1 m-85 -124.45 115.88 21.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 0.0 111.197 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.691 HD23 ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -112.24 111.77 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.139 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.42 97.29 9.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.769 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.496 ' HE1' ' CZ ' ' A' ' 94' ' ' TYR . 5.3 mtp -77.18 87.66 3.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.258 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -82.02 176.37 9.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.702 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 37.4 48.55 0.86 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.753 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.514 HD23 ' CG2' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -65.98 157.77 29.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.978 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.69 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -129.33 173.83 5.25 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.773 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.38 9.16 3.53 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.613 2.208 . . . . 0.0 113.034 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -113.04 -4.95 13.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.1 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.29 -12.25 58.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.239 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 76.2 m -48.94 104.06 0.06 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.46 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.4 166.62 8.5 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.365 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 39' ' ' GLN . 9.8 p -76.33 105.26 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.038 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.496 ' CZ ' ' HE1' ' A' ' 83' ' ' MET . 5.0 m-85 -82.54 100.26 10.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.4 m -109.11 134.48 51.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 26.7 p -96.49 146.14 25.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.033 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.16 -178.35 16.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.555 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -131.65 170.18 15.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -118.26 172.56 14.49 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.802 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -159.09 118.08 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.504 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.11 16.03 51.98 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.696 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.31 -12.78 36.73 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.673 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.668 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -98.13 180.0 4.57 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.744 0.307 . . . . 0.0 110.672 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.668 ' H ' HG22 ' A' ' 103' ' ' THR . 83.6 m95 -138.45 101.61 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.815 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -123.21 -8.49 8.19 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.474 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.506 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -91.42 140.4 29.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.827 0.346 . . . . 0.0 111.112 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -141.88 165.47 27.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.795 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.27 -149.25 13.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.524 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.03 -55.63 3.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.686 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.91 150.98 9.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.763 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 111' ' ' THR . 12.4 t -146.84 112.21 5.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.375 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -61.95 140.52 58.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.222 0.534 . . . . 0.0 111.012 -179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.9 t -119.13 97.64 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.037 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.789 ' CB ' HD23 ' A' ' 11' ' ' LEU . 60.5 m -86.13 135.69 33.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 111.285 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 87' ' ' LYS . 2.0 t -130.87 168.0 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.184 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -136.46 -167.53 2.08 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.99 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.259 -0.876 . . . . 0.0 110.853 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.814 0.34 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.656 HG12 ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER -113.21 156.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -149.73 173.05 14.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.954 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mp -145.6 162.87 36.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.42 141.96 27.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -94.52 167.79 11.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -168.85 115.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.869 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 119.23 -34.77 4.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.555 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.83 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -51.42 138.94 27.33 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.817 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.42 -162.88 31.11 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.44 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.597 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.3 mp -69.45 152.23 45.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.846 0.355 . . . . 0.0 111.404 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 12' ' ' VAL . 9.7 p -170.12 109.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -57.56 152.29 15.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.338 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -52.45 153.65 2.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.376 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.08 5.18 75.16 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.722 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.71 119.78 4.37 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.395 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.2 136.82 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 111.032 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.682 HD23 HD21 ' A' ' 20' ' ' LEU . 6.7 tp -127.34 131.3 50.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.403 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.611 ' C ' HD23 ' A' ' 20' ' ' LEU . 4.0 ttt-85 -107.42 133.0 52.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.901 0.381 . . . . 0.0 111.418 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.83 HD22 ' HA2' ' A' ' 9' ' ' GLY . 1.1 mt -120.15 150.78 40.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.072 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.3 p -123.23 140.31 53.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.204 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 48.4 t -134.1 135.15 43.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.697 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.3 157.09 20.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.11 -168.81 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.051 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.656 ' HB3' HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -110.21 152.94 25.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.897 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.23 23.3 35.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.667 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -94.14 55.96 2.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.924 0.392 . . . . 0.0 110.836 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.2 t -167.19 -166.46 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.6 42.2 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.763 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.0 t -122.92 -70.31 0.78 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.378 . . . . 0.0 110.821 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.64 28.34 1.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.787 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CZ ' ' CB ' ' A' ' 98' ' ' ALA . 5.4 t80 -69.85 141.06 53.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.056 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.92 172.39 13.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.55 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.465 ' O ' HG22 ' A' ' 51' ' ' ILE . 1.0 OUTLIER -137.92 117.56 13.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.847 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -145.85 149.65 21.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.849 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.469 ' CE2' HD22 ' A' ' 81' ' ' LEU . 67.4 m95 -88.32 153.62 21.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.13 0.49 . . . . 0.0 111.175 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.3 m-85 -132.32 -178.88 5.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.588 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.676 ' CD ' HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -151.97 157.21 41.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.157 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -157.69 141.4 15.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 111.416 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -127.53 161.63 53.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.535 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 41.0 Cg_endo -67.36 137.09 42.21 Favored 'Trans proline' 0 CA--C 1.518 -0.315 0 C-N-CA 122.287 1.991 . . . . 0.0 112.384 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.37 3.74 40.8 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.671 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -112.51 -176.06 2.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.872 0.368 . . . . 0.0 111.056 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -111.53 157.27 20.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.483 ' HA ' ' HG2' ' A' ' 39' ' ' GLN . 15.8 ptt-85 -74.47 133.15 42.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.12 0.486 . . . . 0.0 111.732 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 16.4 pt-20 -134.54 165.11 25.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.903 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 12.1 t -101.03 172.64 6.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.194 0.521 . . . . 0.0 111.164 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.676 HG22 ' CD ' ' A' ' 38' ' ' ARG . 2.8 t -128.95 -67.51 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.367 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.02 135.42 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.0 111.367 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.704 ' O ' HG22 ' A' ' 58' ' ' THR . . . -131.65 144.75 51.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.627 HD12 HG23 ' A' ' 58' ' ' THR . 0.7 OUTLIER -128.11 143.69 40.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.251 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -69.72 -165.24 0.08 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.189 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.19 -58.49 2.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.73 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -54.54 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.187 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 p 173.48 69.12 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.901 0.381 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.84 -72.3 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.77 -170.18 1.0 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.062 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.891 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -115.86 -177.79 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 77.1 t80 -139.41 92.27 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.805 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.401 ' CB ' ' HG2' ' A' ' 65' ' ' ARG . 74.9 m-85 -78.7 159.55 27.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.89 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.82 161.51 15.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 0.0 111.304 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' SER . 32.8 t -69.28 152.21 45.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.477 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.8 t 88.83 -14.4 0.36 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.515 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.405 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 34.9 m -150.49 16.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.432 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.401 ' HG2' ' CB ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -78.72 81.3 5.03 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.523 0.678 . . . . 0.0 111.151 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.89 -11.2 2.36 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.185 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' CG ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -109.46 -51.37 2.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.777 0.323 . . . . 0.0 111.247 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CE2' ' HG2' ' A' ' 83' ' ' MET . 3.1 m-85 -69.93 140.15 53.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.905 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 7.5 m -110.82 146.08 37.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.778 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.891 HG21 HG21 ' A' ' 58' ' ' THR . 1.1 tp -136.42 140.94 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.88 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.451 ' N ' HG13 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -151.13 -174.44 4.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.81 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.523 ' HG3' HG12 ' A' ' 79' ' ' VAL . 6.6 ttm180 -130.83 168.06 17.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.005 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 34.3 t0 -97.32 -37.56 10.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.844 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.41 35.92 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.81 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.32 -67.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.098 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 29.82 7.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.36 44.99 14.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.68 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 46.6 m -112.64 151.5 30.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.173 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.523 HG12 ' HG3' ' A' ' 72' ' ' ARG . 33.5 m -121.22 158.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.381 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 33.9 m-85 -141.71 129.88 22.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.026 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.469 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -125.21 122.15 36.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.094 0.473 . . . . 0.0 110.898 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -95.57 95.96 8.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.522 ' SD ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -77.08 88.43 3.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.855 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.4 176.26 7.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 36.41 40.76 0.13 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.588 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.614 HD23 ' CG2' ' A' ' 115' ' ' VAL . 0.1 OUTLIER -51.14 158.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.182 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 6.2 mptt -127.64 162.91 46.24 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.78 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 74.2 Cg_endo -74.91 5.71 3.78 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.457 2.105 . . . . 0.0 112.927 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -109.73 -6.82 15.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.134 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.34 -19.4 46.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.078 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 89.7 m -50.42 106.83 0.13 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.864 0.364 . . . . 0.0 111.25 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.34 -176.2 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.977 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -87.51 103.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.854 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.537 ' O ' HG22 ' A' ' 111' ' ' THR . 4.1 m-85 -82.75 108.75 16.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.468 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.2 m -107.5 130.68 54.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.316 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 50.6 t -92.35 138.73 31.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.623 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -146.98 176.36 25.89 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.826 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.621 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -126.7 172.94 9.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 0.0 111.011 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -124.84 178.21 16.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.185 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -171.38 122.48 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.379 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.66 15.7 54.39 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.642 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.83 -9.4 47.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.826 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.653 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.3 m -100.16 178.67 4.71 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 110.775 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.653 ' H ' HG22 ' A' ' 103' ' ' THR . 80.0 m95 -140.89 90.95 2.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -110.26 -6.62 14.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.372 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.621 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -90.85 131.26 36.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.706 0.288 . . . . 0.0 110.782 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -141.3 164.09 31.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.001 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.34 -136.66 8.43 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.46 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -102.96 -35.65 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.928 0.394 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.6 151.1 12.59 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.68 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.7 t -144.26 104.77 4.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.852 0.358 . . . . 0.0 110.457 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.77 141.12 58.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 111.113 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 91' ' ' THR . 46.4 t -119.79 130.34 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.304 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.597 ' CB ' HD23 ' A' ' 11' ' ' LEU . 69.1 m -115.72 133.28 56.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.115 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.614 ' CG2' HD23 ' A' ' 86' ' ' LEU . 2.1 t -133.44 168.01 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.306 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.756 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 8.2 t -145.33 -165.37 2.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.968 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.828 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.817 0.342 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 2' ' ' VAL . 3.2 m -69.98 147.85 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.247 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -76.51 170.12 16.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 106' ' ' SER . 1.7 mp -156.44 119.26 4.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.133 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -122.9 165.7 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.576 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.44 163.32 15.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.774 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.45 131.23 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.11 -28.36 11.22 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.663 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.401 ' HA2' ' CD2' ' A' ' 20' ' ' LEU . . . -53.23 164.23 2.14 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.869 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.64 171.29 25.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.41 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.839 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.9 mp -69.07 137.2 53.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.928 0.394 . . . . 0.0 111.398 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.23 128.57 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.991 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -64.2 149.35 48.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -49.35 144.32 5.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.382 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.98 -14.95 63.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.635 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.29 129.67 9.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.37 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.08 135.54 49.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 111.03 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.886 HD21 HD21 ' A' ' 20' ' ' LEU . 7.1 tp -119.51 132.12 55.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.292 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -114.04 116.53 29.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.828 0.347 . . . . 0.0 111.369 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.886 HD21 HD21 ' A' ' 18' ' ' LEU . 14.5 mt -107.6 138.31 44.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.403 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 90.9 p -124.96 120.08 30.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.962 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.439 ' HB3' ' CG1' ' A' ' 79' ' ' VAL . 26.8 t -117.89 131.35 56.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.022 0.439 . . . . 0.0 110.595 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.91 149.14 31.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.287 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.97 -168.97 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.022 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -100.34 147.38 25.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.841 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.55 69.73 3.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.553 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -169.8 76.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 0.0 110.843 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 t -156.89 -168.75 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.29 38.36 0.23 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.615 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.75 54.1 1.63 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.97 0.414 . . . . 0.0 110.745 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.5 m 72.74 13.79 5.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.586 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -69.44 147.28 51.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.928 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.44 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 23.4 m-20 -129.15 -169.13 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.677 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.471 ' O ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -148.16 120.73 8.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.098 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -144.95 168.87 26.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.861 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.515 ' CD2' HD22 ' A' ' 81' ' ' LEU . 74.8 m95 -107.14 159.5 16.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 111.19 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 11.0 m-85 -137.74 178.3 7.21 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.726 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HG3' ' HG3' ' A' ' 46' ' ' GLU . 10.6 ptm180 -156.34 154.04 29.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.398 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.505 ' O ' HG12 ' A' ' 93' ' ' VAL . 5.0 tp60 -157.02 119.32 3.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.953 0.406 . . . . 0.0 111.449 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -102.91 169.79 7.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.575 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.782 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 58.4 Cg_endo -71.73 138.96 32.86 Favored 'Trans proline' 0 CA--C 1.517 -0.328 0 C-N-CA 122.241 1.961 . . . . 0.0 112.447 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.92 3.44 35.84 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.712 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -118.1 158.41 25.08 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.947 0.403 . . . . 0.0 110.984 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.47 157.23 19.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.215 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.441 ' NE ' ' CZ3' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -69.92 144.36 52.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.165 0.507 . . . . 0.0 111.13 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' ' HG3' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -149.29 146.91 27.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.407 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 2.6 t -77.01 173.11 12.17 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.456 0.646 . . . . 0.0 111.421 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.423 ' N ' ' OG ' ' A' ' 47' ' ' SER . 15.9 t -127.21 -60.63 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.235 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.523 ' CB ' HD13 ' A' ' 70' ' ' ILE . . . -151.99 123.23 7.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.957 0.408 . . . . 0.0 111.197 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.612 ' O ' HG22 ' A' ' 58' ' ' THR . . . -120.34 147.47 44.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.231 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.713 ' CD1' HG23 ' A' ' 58' ' ' THR . 3.1 tp -132.03 141.54 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.027 0.441 . . . . 0.0 111.459 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' N ' HG13 ' A' ' 51' ' ' ILE . 10.3 m120 -71.21 170.1 13.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.815 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -100.19 30.02 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.871 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -140.3 15.92 2.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.183 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.7 p 50.08 43.12 25.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.876 0.369 . . . . 0.0 111.092 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.65 -65.68 0.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.344 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -153.56 160.77 42.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.998 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.713 HG23 ' CD1' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -105.92 -179.3 3.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.777 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 9.5 t80 -138.6 85.93 2.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.666 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.485 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 58.5 m-85 -72.39 161.74 30.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.06 162.76 15.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 63' ' ' SER . 7.1 m -69.46 151.53 45.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.556 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.3 t 86.33 -12.23 0.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.584 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.464 HG11 ' CE2' ' A' ' 68' ' ' PHE . 34.2 m -145.33 10.27 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.484 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.413 ' HG2' ' CB ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -80.2 81.08 6.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.514 0.673 . . . . 0.0 110.971 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 139.51 -3.62 2.68 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.364 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.86 -51.9 1.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.637 0.256 . . . . 0.0 111.297 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CE2' HG11 ' A' ' 64' ' ' VAL . 5.4 m-30 -69.93 159.16 34.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.554 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 28.9 m -124.17 148.35 47.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.375 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.628 ' CG2' HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -138.99 136.31 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.678 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.472 ' O ' HG23 ' A' ' 79' ' ' VAL . 16.8 p -153.44 -173.76 4.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 111.076 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.45 160.39 39.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.982 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.41 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 13.6 t0 -90.55 -44.77 9.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 69.72 11.69 7.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.71 -34.96 6.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.891 0.377 . . . . 0.0 110.776 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -142.5 26.89 1.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.633 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.65 52.44 5.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.68 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.9 m -116.06 152.2 34.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.095 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 71' ' ' SER . 8.6 p -117.05 143.47 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.453 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 42.5 m-85 -126.64 110.06 12.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.852 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.66 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -112.82 112.29 23.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.46 . . . . 0.0 110.191 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.74 100.29 12.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.269 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.506 ' HE2' HD11 ' A' ' 86' ' ' LEU . 4.7 mtp -81.66 90.48 6.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.829 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 177.09 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 37.46 47.1 0.71 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.671 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.506 HD11 ' HE2' ' A' ' 83' ' ' MET . 0.1 OUTLIER -57.63 165.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.067 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 18.6 mmtt -144.99 164.89 24.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.764 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 55.3 Cg_endo -69.47 2.23 3.56 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.418 2.079 . . . . 0.0 113.222 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -104.34 -0.4 28.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.246 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -89.95 -9.95 46.89 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.41 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 87.1 m -50.35 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.724 0.297 . . . . 0.0 111.156 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.22 169.5 7.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.528 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 93' ' ' VAL . 5.4 p -82.59 107.22 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.291 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.465 ' O ' HG22 ' A' ' 111' ' ' THR . 13.7 m-85 -85.77 105.74 16.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.602 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 37' ' ' PHE . 21.6 m -109.31 138.62 45.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.156 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.4 p -97.64 142.34 29.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.826 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.17 177.16 21.71 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.294 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.663 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -130.29 167.45 18.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.942 0.401 . . . . 0.0 111.098 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.83 175.11 19.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.831 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.86 113.56 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.371 . . . . 0.0 110.735 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.88 16.06 50.83 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.784 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.35 -14.83 33.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.487 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.657 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.1 m -97.92 -179.84 4.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.676 0.274 . . . . 0.0 110.426 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.657 ' H ' HG22 ' A' ' 103' ' ' THR . 77.0 m95 -140.83 98.99 3.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -133.54 10.6 4.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.501 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.663 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.6 OUTLIER -102.38 62.19 0.85 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.308 0.575 . . . . 0.0 110.736 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.441 ' CZ3' ' NE ' ' A' ' 45' ' ' ARG . 29.8 m95 -68.7 165.18 20.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.136 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.77 -121.42 4.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.515 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 -67.79 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 134.41 151.87 6.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.668 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.6 t -151.84 108.35 3.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.551 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -59.23 141.06 55.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.199 0.524 . . . . 0.0 111.13 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 113' ' ' VAL . 37.6 t -121.92 82.85 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.839 ' CB ' HD23 ' A' ' 11' ' ' LEU . 92.7 m -73.25 141.26 47.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 116' ' ' SER . 0.6 OUTLIER -138.71 177.15 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.321 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.658 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 10.5 p -147.65 -171.37 3.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.832 0.349 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.91 155.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.202 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.93 160.31 16.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.92 141.16 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.43 164.35 15.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.794 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.85 163.26 17.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.0 t -163.98 119.1 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.63 -22.81 8.11 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.666 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.478 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -47.29 140.62 7.7 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.882 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.39 169.03 37.34 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.375 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.775 HD23 HG21 ' A' ' 114' ' ' THR . 1.8 mp -69.21 145.37 53.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.807 0.337 . . . . 0.0 111.399 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.743 ' CG1' HD22 ' A' ' 86' ' ' LEU . 9.3 p -141.02 132.78 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.38 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.07 139.98 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.452 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.764 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -45.76 130.36 9.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.588 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.65 -20.84 48.87 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.602 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.24 179.66 53.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.571 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 t -120.5 139.0 53.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.992 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.746 HD23 ' CE ' ' A' ' 83' ' ' MET . 9.7 tp -125.6 132.75 52.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.457 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.463 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -114.37 131.17 56.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.0 111.629 -179.315 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.588 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.3 mt -121.24 141.29 51.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.311 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 80' ' ' TYR . 95.4 p -124.03 113.53 18.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' HG23 ' A' ' 78' ' ' THR . 32.6 t -108.18 134.56 50.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.636 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.9 145.46 39.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.155 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.42 113.76 26.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.52 89.05 6.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 153.32 154.52 6.78 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.568 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -76.36 130.71 38.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.078 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 32' ' ' TYR . 44.9 p -85.92 90.28 8.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.26 -34.51 26.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.51 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.86 4.66 47.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.62 0.248 . . . . 0.0 111.392 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.8 p 54.88 50.13 16.29 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.834 0.349 . . . . 0.0 111.065 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -69.7 132.94 46.92 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -59.61 174.86 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.031 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.576 ' HB3' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -143.87 126.59 16.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.17 156.15 26.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.823 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.592 ' CE2' HD22 ' A' ' 81' ' ' LEU . 69.9 m95 -87.31 153.74 21.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.144 0.497 . . . . 0.0 111.315 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.7 m-85 -131.63 178.25 6.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.422 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.608 ' NE ' HG22 ' A' ' 48' ' ' VAL . 7.6 ptt180 -152.34 155.24 37.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.815 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -167.03 148.85 6.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.945 0.402 . . . . 0.0 111.273 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.727 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -126.29 167.19 17.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.606 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.727 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 37.6 Cg_endo -66.15 137.52 48.3 Favored 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 122.228 1.952 . . . . 0.0 112.216 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.92 3.98 45.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.603 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -110.75 -179.61 3.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.819 0.342 . . . . 0.0 110.837 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.01 167.63 9.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.045 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.42 135.19 34.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.098 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HG3' ' CG ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -138.88 166.21 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.657 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 11.4 t -104.47 173.43 6.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.091 0.472 . . . . 0.0 111.078 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.608 HG22 ' NE ' ' A' ' 38' ' ' ARG . 2.4 t -131.52 -66.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.258 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -144.62 132.04 20.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.277 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 58' ' ' THR . . . -132.29 145.3 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.276 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.698 ' HB ' HG23 ' A' ' 58' ' ' THR . 19.1 tt -122.78 142.32 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.459 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -81.06 -176.51 5.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.645 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -97.05 68.67 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.966 0.412 . . . . 0.0 110.575 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.83 30.4 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.453 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -85.08 -61.77 1.69 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.084 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.98 -74.52 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.436 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.426 ' HB3' ' H ' ' A' ' 58' ' ' THR . 0.3 OUTLIER -156.05 -159.03 0.86 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.178 -179.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.977 HG21 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -97.48 -177.27 3.75 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.967 0.413 . . . . 0.0 110.975 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 63.2 t80 -139.41 93.03 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.725 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CE1' HG22 ' A' ' 70' ' ' ILE . 89.7 m-85 -80.14 158.0 26.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.39 176.13 5.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.282 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.34 152.03 45.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.578 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 62' ' ' SER . 4.0 t 85.82 -11.64 0.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.522 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.9 m -154.32 17.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.442 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 79.32 0.96 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.557 0.694 . . . . 0.0 110.799 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.46 3.47 9.43 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -111.67 -43.65 3.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.0 m-30 -83.36 151.95 25.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.958 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 7.3 m -112.25 149.22 32.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.647 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.977 HG23 HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -163.33 136.84 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.876 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.903 ' N ' HD13 ' A' ' 70' ' ' ILE . 8.0 p -168.35 154.02 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -77.68 139.62 39.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.597 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.506 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 0.4 OUTLIER -79.75 -34.06 40.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.106 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t30 68.21 28.01 6.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.189 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.2 -41.66 4.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.891 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.04 37.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.619 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.5 mttt 61.48 53.12 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.699 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.616 HG22 ' CE1' ' A' ' 80' ' ' TYR . 74.6 m -122.96 147.93 46.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.053 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.7 m -111.57 138.68 39.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.413 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.616 ' CE1' HG22 ' A' ' 78' ' ' THR . 7.3 m-85 -126.21 125.62 42.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.653 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.592 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -122.29 121.68 37.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.181 0.515 . . . . 0.0 110.926 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -100.47 96.79 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.732 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.746 ' CE ' HD23 ' A' ' 18' ' ' LEU . 31.1 mtm -82.21 91.85 6.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.984 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -82.32 176.39 9.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 84' ' ' ASN . 67.1 p 28.99 59.99 0.14 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.754 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.841 HD23 HG22 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -64.54 162.2 15.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.17 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.592 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -126.62 164.42 34.64 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.545 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 74.3 Cg_endo -75.49 6.05 3.84 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.38 2.053 . . . . 0.0 112.956 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -108.51 -6.15 16.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.847 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.31 -16.05 50.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.287 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.5 m -52.76 106.96 0.18 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.771 0.32 . . . . 0.0 111.19 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.5 -170.72 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.436 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 85.6 t -94.33 106.74 18.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.425 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -86.88 103.38 15.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.199 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.3 m -108.49 127.2 53.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 31.9 p -89.78 146.32 24.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.825 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.92 -173.09 20.61 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.463 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -138.17 149.6 46.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 111.107 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . -105.15 148.9 16.65 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.608 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -137.28 122.71 19.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.826 0.346 . . . . 0.0 110.955 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.59 18.38 51.51 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.79 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.75 -10.69 45.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.695 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.667 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.3 m -100.16 -179.96 4.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.667 ' H ' HG22 ' A' ' 103' ' ' THR . 77.2 m95 -145.34 93.92 2.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.884 0.373 . . . . 0.0 110.814 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.4 ' O ' ' CD1' ' A' ' 107' ' ' TRP . 3.8 t70 -112.9 -12.08 13.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.369 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.82 128.76 34.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.768 0.318 . . . . 0.0 110.66 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 105' ' ' ASP . 21.5 m95 -137.87 164.22 29.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.959 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.57 -160.92 19.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -74.23 -38.17 63.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.799 0.333 . . . . 0.0 110.817 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.52 152.68 26.39 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.647 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.2 t -154.28 122.71 6.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -78.17 143.07 37.54 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 120.966 0.413 . . . . 0.0 111.131 -179.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 91' ' ' THR . 55.4 t -114.8 132.25 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.159 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.775 HG21 HD23 ' A' ' 11' ' ' LEU . 92.3 m -108.48 132.69 53.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.841 HG22 HD23 ' A' ' 86' ' ' LEU . 2.1 t -130.9 168.23 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.344 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.764 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 2.7 p -135.39 -177.13 4.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.785 0.326 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.601 HG12 ' CB ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -133.27 165.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.988 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -101.01 149.77 23.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp -148.4 152.17 36.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -164.22 163.42 22.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.801 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.23 162.52 15.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.4 t -158.08 123.04 4.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.81 -30.17 10.51 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.583 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.835 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.92 139.86 23.26 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.008 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.82 -159.64 24.22 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.379 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.495 HD23 HG21 ' A' ' 114' ' ' THR . 2.0 mp -69.25 151.1 46.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.473 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.845 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.3 p -159.22 109.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.872 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.41 152.2 46.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.118 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.89 129.98 21.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.386 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.35 22.65 50.75 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.57 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.17 116.04 2.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.377 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 92.9 p -69.94 123.67 22.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 111.047 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.751 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.3 tp -126.96 130.78 50.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.525 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -107.61 131.78 54.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.835 HD22 ' HA2' ' A' ' 9' ' ' GLY . 2.9 mt -116.97 148.28 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.098 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB3' ' CD2' ' A' ' 80' ' ' TYR . 82.7 p -127.85 126.69 42.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.14 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.567 ' O ' HG22 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -121.38 109.1 14.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.596 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.66 164.46 22.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.381 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -146.42 -168.21 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.04 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.601 ' CB ' HG12 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -114.08 147.35 38.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.97 83.21 0.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.395 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -152.83 106.52 3.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.957 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.557 HG22 ' CD1' ' A' ' 32' ' ' TYR . 18.0 p -141.62 -176.49 4.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.765 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.78 -22.74 5.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.438 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.697 ' O ' HG22 ' A' ' 31' ' ' THR . 2.3 t -114.28 51.36 0.88 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.049 0.452 . . . . 0.0 110.207 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 30' ' ' SER . 7.1 t 52.9 32.5 12.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.864 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.557 ' CD1' HG22 ' A' ' 28' ' ' THR . 9.3 t80 -69.69 112.27 6.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.701 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.422 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 7.5 m-20 -111.89 -176.87 3.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.673 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.75 ' O ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -143.09 113.97 7.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.978 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -139.97 158.74 25.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.905 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.448 ' CE2' HD22 ' A' ' 81' ' ' LEU . 63.8 m95 -92.36 154.86 18.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.282 0.563 . . . . 0.0 111.329 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.7 m-85 -135.67 -178.32 5.07 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.455 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.456 ' HG2' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -148.44 156.13 42.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.89 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.439 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 2.0 mm-40 -153.41 171.07 19.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.9 149.23 14.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.617 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.99 134.72 51.17 Favored 'Trans proline' 0 CA--C 1.517 -0.342 0 C-N-CA 122.273 1.982 . . . . 0.0 112.184 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.53 3.91 35.75 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.479 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.08 178.78 4.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.873 0.368 . . . . 0.0 110.897 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 pm0 -96.22 -176.82 3.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.781 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.82 140.77 39.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.829 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' ' HD3' ' A' ' 38' ' ' ARG . 12.0 pt-20 -140.46 164.28 30.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.628 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.565 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.9 t -107.25 171.66 7.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.141 0.496 . . . . 0.0 111.085 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.456 ' CG2' ' HG2' ' A' ' 38' ' ' ARG . 2.8 t -129.51 -69.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.677 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.82 ' HB1' HG21 ' A' ' 70' ' ' ILE . . . -141.05 147.6 38.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 0.0 111.579 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.577 ' O ' HG22 ' A' ' 58' ' ' THR . . . -136.89 141.34 42.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.193 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 34' ' ' MET . 1.6 tt -117.66 141.59 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.047 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -87.91 -176.5 5.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.125 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -109.17 -32.49 7.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.846 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -161.58 30.2 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 t -86.37 -78.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.778 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.25 -72.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.017 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.6 mpp_? -141.93 -126.9 0.1 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -116.11 -177.58 3.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.948 0.404 . . . . 0.0 111.096 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 50.9 t80 -135.99 91.33 2.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.853 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.802 ' CE2' HG22 ' A' ' 70' ' ' ILE . 56.0 m-85 -80.39 152.19 28.99 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.98 163.53 14.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.366 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.81 33.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.017 0.437 . . . . 0.0 111.674 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.9 t -118.54 -20.15 8.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.116 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.0 m -152.41 21.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.969 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.91 80.7 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.72 0.771 . . . . 0.0 110.9 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 131.42 3.55 4.22 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.162 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -111.11 -45.91 3.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.744 0.306 . . . . 0.0 111.056 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 83' ' ' MET . 9.7 m-30 -97.21 161.14 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.128 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 97.6 m -129.72 94.98 3.86 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.578 0.704 . . . . 0.0 111.371 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.82 HG21 ' HB1' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -91.18 137.37 21.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.614 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.434 ' N ' HG13 ' A' ' 70' ' ' ILE . 1.7 m -162.96 170.81 17.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 110.959 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -116.75 139.87 50.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.764 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 45.5 t0 -72.71 -31.23 64.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.946 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 58.9 23.34 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.051 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.457 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -115.72 -39.77 3.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.97 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -135.81 25.89 3.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.927 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.67 49.15 10.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.01 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.415 HG22 ' CE1' ' A' ' 80' ' ' TYR . 89.0 m -125.09 145.99 49.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.3 m -109.74 146.5 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.661 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CD2' ' HB3' ' A' ' 21' ' ' SER . 4.2 m-85 -137.61 134.94 36.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.92 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -128.59 119.16 24.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.068 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -92.51 108.21 19.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.468 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 30.8 mtm -94.39 90.21 6.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.334 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -85.49 175.13 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.67 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 33.16 39.43 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.934 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.605 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -47.51 158.76 0.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 111.204 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.48 164.25 16.95 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.816 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.74 8.13 4.45 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.66 2.24 . . . . 0.0 112.721 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 10.9 tt0 -119.21 -0.4 11.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.41 -11.04 59.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.658 0.266 . . . . 0.0 111.085 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 113' ' ' VAL . 98.9 m -52.14 108.93 0.33 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 111.345 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.71 174.18 5.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.005 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 93' ' ' VAL . 9.0 p -78.89 104.2 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 111.061 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.504 ' O ' HG22 ' A' ' 111' ' ' THR . 6.0 m-85 -81.22 98.35 8.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.46 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 5.0 m -107.33 129.98 54.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.013 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 28.7 p -99.77 142.57 31.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.682 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -143.05 177.36 22.02 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.318 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.529 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -126.25 164.91 19.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.003 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.18 176.97 22.94 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.724 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.8 117.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.332 . . . . 0.0 110.635 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.58 ' H ' HG22 ' A' ' 31' ' ' THR . . . 62.34 15.0 50.75 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.759 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.42 -11.67 43.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.644 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.65 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.0 m -102.29 179.45 4.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.551 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.65 ' H ' HG22 ' A' ' 103' ' ' THR . 81.2 m95 -136.75 83.58 2.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.589 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.06 -9.58 23.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.496 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.529 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -89.66 134.64 34.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.773 0.32 . . . . 0.0 110.81 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -146.0 165.15 29.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.745 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.05 -170.34 21.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.434 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -70.67 -32.12 69.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.95 0.405 . . . . 0.0 110.696 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.72 151.95 25.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.5 t -144.39 102.15 3.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 110.407 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -63.26 138.56 58.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.387 0.613 . . . . 0.0 111.264 -179.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.489 HG21 ' CD1' ' A' ' 94' ' ' TYR . 52.4 t -112.47 118.25 57.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.981 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.495 HG21 HD23 ' A' ' 11' ' ' LEU . 70.4 m -97.65 122.29 40.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.346 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.845 HG13 ' O ' ' A' ' 12' ' ' VAL . 1.4 t -150.99 163.79 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.327 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t 168.79 -57.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.803 0.335 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER -112.24 156.11 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.975 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -153.04 174.19 14.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mp -156.35 134.99 11.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.969 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 1.5 tt0 -145.39 129.46 17.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.146 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.21 165.09 15.3 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 p -169.66 112.67 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.006 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.67 -26.02 4.93 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.659 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.657 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -52.78 141.09 29.06 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.931 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.18 -178.37 46.82 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.376 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.677 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.3 mp -69.27 140.19 54.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.897 0.38 . . . . 0.0 111.409 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.9 p -149.44 122.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.078 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -58.86 140.31 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.312 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 115' ' ' VAL . . . -53.61 150.64 6.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.309 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.04 -2.15 82.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.837 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.06 -154.77 26.83 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.439 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -140.94 138.0 33.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.944 0.402 . . . . 0.0 111.214 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.593 ' CD2' HD21 ' A' ' 20' ' ' LEU . 15.2 tp -131.87 148.6 52.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.326 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -124.42 125.72 44.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.377 . . . . 0.0 111.55 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.657 HD22 ' HA2' ' A' ' 9' ' ' GLY . 4.0 mt -116.3 138.84 50.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.234 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 24.0 p -123.25 132.57 54.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.034 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.632 ' O ' HG22 ' A' ' 79' ' ' VAL . 31.6 t -131.53 130.96 42.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.747 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.79 165.9 13.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.197 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.82 -169.25 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.509 ' HB3' HG12 ' A' ' 2' ' ' VAL . 17.5 p -83.76 157.68 22.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.28 -48.41 1.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.52 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.6 mtp85 -70.5 82.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.485 HG21 ' CG ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -134.03 137.5 44.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.04 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.45 30.49 1.72 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.322 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.4 t -126.8 45.67 2.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.779 0.323 . . . . 0.0 110.863 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.451 ' HG1' ' H ' ' A' ' 101' ' ' GLY . 6.5 p 56.11 33.96 22.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.41 . . . . 0.0 110.541 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CG ' HG21 ' A' ' 28' ' ' THR . 62.0 t80 -69.24 79.77 0.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.025 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.486 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 75.0 m-20 -75.43 178.96 5.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.369 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.402 ' HE2' HG11 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -147.77 130.54 16.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 111.366 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -153.11 155.52 26.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.621 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.473 ' CE2' HD22 ' A' ' 81' ' ' LEU . 75.5 m95 -86.97 156.22 19.87 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.359 0.599 . . . . 0.0 111.307 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 6.5 m-85 -140.16 -178.35 5.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.575 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HD2' HG22 ' A' ' 48' ' ' VAL . 1.6 mtp180 -145.81 158.42 43.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.017 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.42 ' HG2' ' CB ' ' A' ' 45' ' ' ARG . 1.8 tm0? -161.33 160.56 29.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.952 0.406 . . . . 0.0 111.303 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.6 155.01 22.14 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.606 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.14 137.42 44.01 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.273 1.982 . . . . 0.0 112.297 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.04 1.07 38.48 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.635 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.83 -177.33 3.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.879 0.371 . . . . 0.0 111.155 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -109.54 159.03 17.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.384 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.42 ' CB ' ' HG2' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -81.14 143.28 32.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 111.123 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.86 140.95 33.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.431 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.4 t -81.32 172.13 13.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.183 0.516 . . . . 0.0 110.919 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.441 HG22 ' HD2' ' A' ' 38' ' ' ARG . 3.1 t -129.99 -68.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.55 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -146.01 126.67 14.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 0.0 111.368 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.657 ' O ' HG22 ' A' ' 58' ' ' THR . . . -126.2 144.73 50.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.422 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.547 ' HB ' HG23 ' A' ' 58' ' ' THR . 8.0 tt -125.33 148.47 29.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.022 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.438 ' ND2' ' CB ' ' A' ' 55' ' ' SER . 5.3 t30 -99.42 167.73 10.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.89 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.436 ' N ' ' ND2' ' A' ' 52' ' ' ASN . 3.5 t-105 -91.41 78.57 5.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.731 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.66 92.83 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.166 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.438 ' CB ' ' ND2' ' A' ' 52' ' ' ASN . 40.1 t -163.91 -74.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.714 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -116.82 -76.43 0.57 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.432 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 4.4 mmm180 -171.18 -103.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.538 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.741 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -137.41 -175.09 3.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.072 0.463 . . . . 0.0 111.028 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.478 ' N ' ' O ' ' A' ' 50' ' ' ALA . 75.1 t80 -139.82 92.48 2.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.542 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -75.0 160.97 29.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.999 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.94 158.69 17.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 63' ' ' SER . 36.5 t -69.35 150.46 47.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.711 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 87.36 -12.94 0.49 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.671 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 m -151.67 14.21 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.566 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.13 81.0 4.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.61 0.719 . . . . 0.0 110.464 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.9 -4.97 2.2 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.427 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.17 -36.67 3.72 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 111.201 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 6.2 m-30 -82.83 135.87 34.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.83 0.348 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 3.7 m -99.65 145.43 27.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.195 0.521 . . . . 0.0 111.32 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.896 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -133.53 135.94 55.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.251 -179.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.896 ' N ' HD13 ' A' ' 70' ' ' ILE . 28.7 t -166.29 146.74 6.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.968 0.413 . . . . 0.0 111.302 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.693 ' NE ' HG12 ' A' ' 79' ' ' VAL . 9.2 mpt_? -114.79 144.5 43.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.658 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -64.93 -30.15 71.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.899 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 57.36 24.9 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.977 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.79 -46.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.916 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.99 19.47 16.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp 56.31 46.94 20.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.905 0.383 . . . . 0.0 110.806 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.409 ' CG2' ' CZ ' ' A' ' 80' ' ' TYR . 42.1 m -120.53 143.32 48.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.315 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.693 HG12 ' NE ' ' A' ' 72' ' ' ARG . 28.9 m -101.99 150.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.481 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 21' ' ' SER . 28.9 m-85 -145.55 124.25 12.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.279 . . . . 0.0 110.866 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.486 HD21 HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -124.99 121.37 34.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.074 0.464 . . . . 0.0 110.584 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -99.74 94.96 6.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.792 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.573 ' HE1' HD23 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -79.72 95.29 5.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 -179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -88.96 176.89 6.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.619 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 t 36.23 41.94 0.16 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.549 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.81 166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.385 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 3.5 mmtp -126.18 162.26 47.08 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.706 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 64.7 Cg_endo -73.94 8.04 2.19 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.411 2.074 . . . . 0.0 113.104 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -119.42 8.94 11.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.258 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.3 -19.08 30.38 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.592 0.234 . . . . 0.0 111.229 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 63.6 m -49.91 103.66 0.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 111.463 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.02 -174.86 1.87 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.9 t -90.01 105.05 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.654 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.55 ' O ' HG22 ' A' ' 111' ' ' THR . 4.1 m-85 -87.03 107.75 18.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.086 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.413 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 4.7 m -106.86 167.21 10.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.4 ' N ' HG22 ' A' ' 95' ' ' THR . 4.3 p -129.91 133.64 46.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.421 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.01 -177.12 15.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.695 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 33' ' ' ASP . . . -136.36 167.2 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 111.077 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -108.58 -175.22 21.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.565 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.69 115.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.818 0.342 . . . . 0.0 110.594 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.451 ' H ' ' HG1' ' A' ' 31' ' ' THR . . . 62.1 15.66 50.91 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.701 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.83 -12.44 38.32 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.749 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.663 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.5 m -100.46 178.93 4.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.694 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.663 ' H ' HG22 ' A' ' 103' ' ' THR . 73.9 m95 -140.67 96.62 3.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.684 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -117.9 -5.87 11.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.483 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.63 130.82 37.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.851 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -142.28 164.94 28.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.983 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -101.37 -135.63 8.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.425 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -26.69 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 98.06 148.86 24.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.669 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 94' ' ' TYR . 3.7 t -148.15 119.24 7.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.884 0.373 . . . . 0.0 110.38 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 139.63 57.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.319 0.58 . . . . 0.0 111.351 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 91' ' ' THR . 37.9 t -123.92 86.52 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.677 ' HB ' HD23 ' A' ' 11' ' ' LEU . 74.1 m -77.71 148.48 34.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.994 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 116' ' ' SER . 2.2 t -126.08 168.58 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.883 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 115' ' ' VAL . 29.2 t -77.42 -72.93 0.33 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.179 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.903 -179.82 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.78 0.324 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -110.69 155.78 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -139.89 177.8 7.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp -151.63 107.39 3.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 71.7 mt-30 -93.65 168.2 11.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.823 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -120.93 163.35 18.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.822 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.36 124.88 4.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.994 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.23 -29.28 10.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.609 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.645 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.92 138.61 25.64 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.847 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.54 -159.62 29.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.352 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.662 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.2 mp -69.38 149.08 48.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.814 0.34 . . . . 0.0 111.375 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.704 HG11 HD22 ' A' ' 86' ' ' LEU . 7.1 p -142.88 126.48 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -70.09 127.05 31.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.012 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 117' ' ' SER . . . -51.45 125.14 13.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.464 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.03 -1.64 33.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.939 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.84 -153.02 10.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.531 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -139.37 142.51 37.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.886 ' CD2' HD21 ' A' ' 20' ' ' LEU . 3.7 tp -124.87 130.12 51.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.283 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.85 128.16 54.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.397 . . . . 0.0 111.562 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.886 HD21 ' CD2' ' A' ' 18' ' ' LEU . 5.5 mt -116.09 136.67 52.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.244 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.431 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 90.5 p -119.31 115.34 23.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.022 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.458 ' O ' HG22 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -113.95 116.45 29.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.11 148.69 21.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.56 ' HB2' ' SD ' ' A' ' 34' ' ' MET . . . -105.64 95.82 6.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.602 ' O ' HG12 ' A' ' 2' ' ' VAL . 77.3 p -69.94 149.37 47.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.55 -139.23 15.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.461 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.41 123.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 0.0 110.827 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 t -157.18 115.63 3.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.37 30.57 7.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.982 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 t -97.04 37.05 1.34 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.827 0.346 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.6 m 65.25 34.15 8.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.406 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -69.25 111.64 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.973 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.429 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 1.0 OUTLIER -86.67 178.31 7.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.032 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.788 ' HB3' HG11 ' A' ' 79' ' ' VAL . 3.9 mtm -146.65 132.32 18.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.031 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -149.34 151.19 23.36 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.658 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.704 ' CE2' HD22 ' A' ' 81' ' ' LEU . 74.3 m95 -88.29 155.94 19.46 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.206 0.527 . . . . 0.0 111.346 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -138.99 -179.27 5.74 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.703 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.552 ' CG ' HG22 ' A' ' 48' ' ' VAL . 9.9 mtm-85 -143.19 162.09 36.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.922 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -148.45 124.06 10.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.198 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -118.79 157.61 49.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.733 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 48.6 Cg_endo -68.85 137.26 37.73 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.295 1.997 . . . . 0.0 112.383 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.85 2.26 36.74 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.642 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.97 -175.09 2.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.859 0.361 . . . . 0.0 111.032 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -111.63 -171.73 1.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.636 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -78.2 125.45 29.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -121.53 119.2 31.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.458 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.3 t -71.43 170.69 12.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.269 0.557 . . . . 0.0 110.784 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.1 t -130.94 -69.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.442 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -145.21 128.91 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.035 0.445 . . . . 0.0 111.213 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.682 ' O ' HG22 ' A' ' 58' ' ' THR . . . -123.55 144.78 49.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.127 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 57' ' ' ARG . 8.7 tp -128.96 145.75 35.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.373 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -88.1 -162.11 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.717 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -106.59 -30.22 9.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.339 . . . . 0.0 110.846 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' A' ' 55' ' ' SER . 73.2 m-20 -125.99 156.21 40.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.818 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.657 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 1.0 OUTLIER 86.09 -29.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.537 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 55' ' ' SER . . . 82.72 -12.61 0.89 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.858 0.361 . . . . 0.0 111.67 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.67 ' O ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -54.34 139.76 35.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.688 HG21 ' CG2' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -119.67 -177.9 3.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.902 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' ALA . 8.2 t80 -137.35 89.67 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.739 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -76.82 156.3 32.36 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.05 167.74 9.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.246 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 63' ' ' SER . 18.7 p -69.33 152.69 44.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.551 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 86.09 -11.99 0.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.486 -178.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.417 HG11 ' CE2' ' A' ' 68' ' ' PHE . 35.4 m -151.05 15.75 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.385 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.02 79.11 0.66 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.514 0.673 . . . . 0.0 110.724 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.47 3.88 8.45 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.896 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -114.3 -40.98 3.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 111.08 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 5.8 m-30 -93.5 117.38 30.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 11.8 m -79.57 152.57 30.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.907 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -148.38 136.42 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.012 -178.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.907 ' N ' HD13 ' A' ' 70' ' ' ILE . 4.8 m -161.49 -164.65 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.775 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -139.74 169.65 17.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.968 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.405 ' HB2' ' HE1' ' A' ' 80' ' ' TYR . 0.9 OUTLIER -77.75 -12.85 60.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.286 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 44.76 40.24 4.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 111.268 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.9 -49.36 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.064 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 mtmm -115.52 -72.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 167.14 44.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.599 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.2 m -110.33 145.13 38.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.187 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.788 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.6 m -108.66 142.0 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.748 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 80' ' ' TYR . 1.3 m-85 -134.33 128.93 34.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.913 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.704 HD22 ' CE2' ' A' ' 36' ' ' TRP . 1.3 pt? -127.07 125.82 41.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.064 0.459 . . . . 0.0 110.747 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.81 96.72 8.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.617 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -78.56 88.03 4.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.212 -179.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.62 176.89 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 38.35 48.34 1.17 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.494 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.704 HD22 HG11 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -70.61 165.72 22.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.327 -179.499 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -133.59 178.0 1.98 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.218 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 92.5 Cg_endo -81.31 9.68 3.76 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.316 2.011 . . . . 0.0 112.734 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 7.5 tp10 -109.17 -12.45 14.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.706 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.23 -21.34 58.7 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 110.986 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.532 HG23 ' HA ' ' A' ' 114' ' ' THR . 98.6 m -50.6 107.73 0.19 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.45 -172.34 1.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.308 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.5 t -90.28 105.15 15.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.542 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.473 ' O ' HG22 ' A' ' 111' ' ' THR . 13.0 m-85 -88.77 107.66 19.08 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 83.2 m -113.44 136.54 52.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 11.8 p -100.36 160.4 14.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.818 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -159.2 -170.92 24.34 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.999 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 33' ' ' ASP . . . -143.17 172.49 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.745 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -142.27 -175.69 15.8 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.906 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.463 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 31.1 tt0 -162.33 129.02 3.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.59 15.23 46.22 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.852 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.63 -14.36 32.42 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.68 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.6 HG22 ' H ' ' A' ' 104' ' ' TRP . 3.7 m -92.02 176.73 6.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.578 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.6 ' H ' HG22 ' A' ' 103' ' ' THR . 72.2 m95 -147.76 100.21 3.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.768 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -120.71 -3.26 9.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.568 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.89 137.87 34.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.841 0.353 . . . . 0.0 110.86 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -142.89 167.2 22.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.87 -155.8 18.97 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.575 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -87.34 -36.5 17.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 110.853 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.71 153.39 17.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.576 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.6 t -146.9 107.97 4.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.653 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.68 141.57 55.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.133 0.492 . . . . 0.0 110.941 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.1 t -121.75 126.6 74.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.387 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.662 ' HB ' HD23 ' A' ' 11' ' ' LEU . 88.5 m -102.25 133.33 47.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.043 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.431 HG21 HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -149.84 163.03 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.424 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.6 t 177.83 -78.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.555 ' HA ' ' HB3' ' A' ' 14' ' ' ALA . 9.8 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.929 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.873 0.368 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.21 155.95 14.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.469 ' C ' HD12 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -146.57 160.63 41.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.48 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.485 HD11 ' OH ' ' A' ' 32' ' ' TYR . 5.7 mp -142.63 104.27 4.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.83 167.74 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.36 164.98 13.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -162.3 114.3 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.955 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.84 -36.3 3.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.656 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.516 ' CA ' HD22 ' A' ' 20' ' ' LEU . . . -50.03 139.12 19.59 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.913 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.39 -170.69 40.05 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.332 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.619 HD23 HG21 ' A' ' 114' ' ' THR . 1.9 mp -69.44 155.24 40.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.903 0.382 . . . . 0.0 111.593 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.53 ' CG1' HD22 ' A' ' 86' ' ' LEU . 8.1 p -169.41 120.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.888 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.66 144.32 27.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.69 124.78 11.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.452 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.99 17.76 31.45 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.68 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.72 -166.68 22.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.543 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t -129.28 136.63 50.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.956 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.806 ' CD2' HD21 ' A' ' 20' ' ' LEU . 3.5 tp -142.66 131.03 22.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.585 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.479 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -112.23 132.91 54.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.185 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.806 HD21 ' CD2' ' A' ' 18' ' ' LEU . 4.1 mt -117.13 135.4 53.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.7 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -120.0 105.77 11.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.769 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.97 116.07 31.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.72 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.87 155.47 17.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.292 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HB2' ' HG ' ' A' ' 4' ' ' LEU . . . -169.74 86.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.951 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -105.36 162.77 13.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.028 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 153.8 -113.2 0.56 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -121.04 93.67 4.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 0.0 110.752 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.918 HG21 ' CZ2' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -102.94 -175.71 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.192 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.23 13.35 8.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.903 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.72 50.73 2.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.911 0.386 . . . . 0.0 110.592 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.75 26.73 15.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.62 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.645 ' HB3' HG22 ' A' ' 28' ' ' THR . 53.5 t80 -69.73 65.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.057 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 74.6 m-20 -62.75 -175.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.455 ' O ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -146.9 124.59 11.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.764 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . -147.45 150.8 23.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.986 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.451 ' CH2' ' CB ' ' A' ' 20' ' ' LEU . 74.1 m95 -91.44 153.46 19.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.225 0.536 . . . . 0.0 111.371 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 9.0 m-85 -133.39 -177.15 4.4 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.323 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.772 ' HD3' HG22 ' A' ' 48' ' ' VAL . 14.9 ptt180 -156.54 159.93 39.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.743 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -162.37 133.76 5.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.205 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.736 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -110.54 167.63 8.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.613 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.736 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 48.8 Cg_endo -68.89 138.01 39.55 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.265 1.977 . . . . 0.0 112.328 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.18 4.49 36.4 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.641 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -112.62 -177.12 3.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.868 0.366 . . . . 0.0 111.047 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -102.39 -171.54 1.98 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.581 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.9 ptm85 -100.59 128.89 46.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -131.14 147.92 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.304 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.4 t -82.58 175.68 9.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.263 0.554 . . . . 0.0 111.112 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.772 HG22 ' HD3' ' A' ' 38' ' ' ARG . 3.5 t -132.36 -66.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.143 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.35 123.43 10.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.017 0.437 . . . . 0.0 111.184 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 59' ' ' TYR . . . -118.35 148.85 42.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.108 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 34' ' ' MET . 4.0 tt -133.46 146.54 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.894 0.378 . . . . 0.0 111.534 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -69.93 -173.53 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.922 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.918 ' CZ2' HG21 ' A' ' 28' ' ' THR . 8.2 t-105 -95.69 22.54 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.324 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -164.54 28.76 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.197 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.3 p 47.58 28.69 1.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.313 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.9 -47.99 41.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.07 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -154.37 137.04 15.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.731 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.995 HG21 HG21 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -102.89 178.06 4.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.753 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.769 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 86.2 t80 -140.45 90.81 2.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.668 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.452 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 4.6 m-85 -78.8 159.09 28.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.06 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.75 166.53 11.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 63' ' ' SER . 3.7 t -69.48 151.69 45.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.759 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.5 m 84.65 -11.0 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.617 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -152.75 16.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.314 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.452 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -70.64 79.1 0.59 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.559 0.695 . . . . 0.0 110.88 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.96 2.93 8.46 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.88 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -108.34 -33.47 7.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.76 0.314 . . . . 0.0 111.211 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CD2' ' HG2' ' A' ' 83' ' ' MET . 9.0 m-30 -96.03 127.77 42.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.151 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 56.9 m -83.54 145.04 29.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.375 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.995 HG21 HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -134.74 136.59 52.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.216 -179.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.408 ' N ' HG13 ' A' ' 70' ' ' ILE . 76.9 p -154.92 -175.88 5.65 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.973 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -138.27 165.9 25.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.084 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.718 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 33.8 t70 -86.6 -31.57 21.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t30 60.74 29.5 19.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.718 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -151.9 -57.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.08 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -102.73 11.32 37.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.277 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.49 52.25 4.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.647 ' OG1' ' CZ ' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -115.54 154.93 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.935 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 21' ' ' SER . 6.1 p -119.81 132.11 70.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.84 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.647 ' CZ ' ' OG1' ' A' ' 78' ' ' THR . 17.6 m-85 -118.11 107.96 14.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.132 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 69' ' ' THR . 0.2 OUTLIER -107.74 114.38 28.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.958 179.44 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.31 95.23 8.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.304 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.49 ' HB2' HD11 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -80.96 89.85 5.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.981 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -76.95 174.16 10.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.856 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 84' ' ' ASN . 0.6 OUTLIER 22.09 53.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.075 179.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.53 HD22 ' CG1' ' A' ' 12' ' ' VAL . 0.3 OUTLIER -44.56 162.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.537 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.503 ' O ' HG11 ' A' ' 115' ' ' VAL . 22.3 mmtt -110.75 161.0 26.65 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.787 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 72.1 Cg_endo -76.84 8.15 3.25 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.441 2.094 . . . . 0.0 112.908 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -121.68 2.91 10.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.236 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.66 -12.42 55.96 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.624 0.25 . . . . 0.0 111.23 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 88.9 m -55.89 104.82 0.15 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 111.17 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.54 -174.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.268 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.9 t -87.63 103.26 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.725 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.502 ' CD1' HG21 ' A' ' 113' ' ' VAL . 8.3 m-85 -82.7 105.79 14.02 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.914 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 88.5 m -111.64 133.18 54.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . 28.0 p -100.45 150.09 23.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.014 0.435 . . . . 0.0 111.155 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -143.22 -175.36 16.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.246 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.517 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -135.39 164.4 27.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 0.0 111.028 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -96.06 -171.67 35.47 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 179.42 111.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.713 0.292 . . . . 0.0 110.743 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.74 16.14 50.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.693 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 -13.99 36.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.522 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.0 m -100.01 179.17 4.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.605 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.655 ' H ' HG22 ' A' ' 103' ' ' THR . 82.2 m95 -135.5 93.82 3.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.736 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -118.0 -4.27 11.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.341 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.517 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -90.22 135.69 33.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.756 0.313 . . . . 0.0 110.786 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -141.58 165.45 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.094 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.2 -148.22 11.86 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.486 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.02 -48.63 6.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 116.1 151.28 9.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.763 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.3 t -142.49 110.33 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.333 . . . . 0.0 110.454 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 141.11 58.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.21 0.528 . . . . 0.0 111.036 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 94' ' ' TYR . 47.0 t -119.12 125.64 74.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.297 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.619 HG21 HD23 ' A' ' 11' ' ' LEU . 75.3 m -101.41 117.94 35.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 111.03 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -133.49 -158.96 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.524 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.412 ' H ' HG12 ' A' ' 115' ' ' VAL . 6.1 t 77.01 169.76 0.24 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.916 0.389 . . . . 0.0 111.077 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.933 -179.878 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.763 0.316 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.695 HG12 ' HA3' ' A' ' 26' ' ' GLY . 4.2 m -69.97 149.11 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.19 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -100.79 154.0 19.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.99 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 mp -146.78 159.01 44.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.793 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -152.7 175.23 13.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.288 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -128.7 173.22 10.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.988 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.1 t -170.16 143.59 2.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.064 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.67 -33.07 5.95 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.725 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.499 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -49.66 140.1 15.85 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.003 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.99 -170.58 43.33 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.396 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.561 HD23 ' HB ' ' A' ' 114' ' ' THR . 1.6 mp -69.49 156.01 39.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.782 0.325 . . . . 0.0 111.414 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.9 p -170.01 115.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.92 158.82 1.92 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.381 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -48.95 145.44 3.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.435 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.09 15.87 65.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.603 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.42 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -105.79 112.18 3.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.348 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.93 131.0 43.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.825 HD23 HD21 ' A' ' 20' ' ' LEU . 6.0 tp -124.21 131.91 53.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.656 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -101.61 128.23 47.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.903 0.382 . . . . 0.0 111.461 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.825 HD21 HD23 ' A' ' 18' ' ' LEU . 8.5 mt -116.06 145.41 43.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.341 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.5 p -125.76 128.51 47.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.899 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 43.9 t -124.76 136.0 53.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -113.09 144.57 42.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.893 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.486 ' HB3' ' CD ' ' A' ' 77' ' ' LYS . . . -121.95 100.31 6.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.321 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.4 p -77.6 109.81 11.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.715 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.695 ' HA3' HG12 ' A' ' 2' ' ' VAL . . . 124.25 167.49 12.71 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.226 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -169.9 99.78 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.348 . . . . 0.0 111.213 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.78 HG22 ' HD2' ' A' ' 32' ' ' TYR . 9.7 t -70.04 -156.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.683 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.87 53.98 0.55 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.287 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 31' ' ' THR . 34.6 t -124.73 -72.93 0.65 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.072 0.463 . . . . 0.0 111.169 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 30' ' ' SER . 0.2 OUTLIER 175.35 54.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.834 -179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.78 ' HD2' HG22 ' A' ' 28' ' ' THR . 0.1 OUTLIER -69.05 173.24 5.68 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.752 -179.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -157.46 -173.9 4.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.031 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.12 158.47 43.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.691 0.281 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 50' ' ' ALA . . . 172.35 145.25 4.87 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.045 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.404 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 60.4 m95 -88.55 155.32 19.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.974 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 7.2 m-85 -132.31 -179.63 5.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.954 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.754 ' HD3' HG22 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -151.68 161.9 41.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.755 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.438 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 2.1 tm0? -149.06 147.24 28.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.183 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.442 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -132.59 158.13 76.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.655 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.442 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 56.0 Cg_endo -70.25 136.19 31.1 Favored 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 122.341 2.027 . . . . 0.0 112.415 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.77 -1.01 25.19 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.602 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -121.02 150.87 40.48 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 120.871 0.367 . . . . 0.0 110.958 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -69.88 -177.23 1.25 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.458 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -94.14 144.59 25.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 7.3 pt-20 -136.11 167.1 21.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.325 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 7.9 t -102.68 172.84 6.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.157 0.503 . . . . 0.0 110.989 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.754 HG22 ' HD3' ' A' ' 38' ' ' ARG . 3.1 t -128.69 -68.78 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.203 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -137.08 144.51 43.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.103 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 58' ' ' THR . . . -144.36 142.43 30.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.414 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.572 ' HB ' HG23 ' A' ' 58' ' ' THR . 2.1 tt -121.47 143.68 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -75.13 157.48 34.6 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.983 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.72 43.95 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.529 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -176.95 36.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.098 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 25.5 t -169.97 -99.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.803 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 55' ' ' SER . . . 176.56 -37.86 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.088 0 CA-C-O 120.841 0.353 . . . . 0.0 111.313 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -54.18 160.18 1.66 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.557 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 1.04 HG21 HG21 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -127.49 -175.96 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.024 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.525 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 86.8 t80 -139.61 125.47 19.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.456 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.432 ' OH ' HG22 ' A' ' 70' ' ' ILE . 7.2 m-30 -113.68 162.52 16.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.31 160.43 14.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.231 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 p -80.78 36.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.864 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 t -118.22 -20.93 8.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.153 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 66' ' ' GLY . 29.7 m -157.05 21.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.045 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.94 80.07 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.651 0.739 . . . . 0.0 111.045 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . 135.93 1.16 3.02 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.316 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.65 -35.72 3.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 111.24 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 4.6 m-30 -93.3 159.85 15.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 62.0 m -129.14 155.07 46.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.04 HG21 HG21 ' A' ' 58' ' ' THR . 5.6 tp -140.53 144.66 26.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.955 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.16 170.87 21.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.971 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -133.91 141.9 47.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.19 -18.49 42.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.214 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.2 p30 44.48 30.26 0.47 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.415 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.13 -74.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.64 23.41 14.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.486 ' CD ' ' HB3' ' A' ' 24' ' ' ALA . 0.1 OUTLIER 70.05 62.54 0.24 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.94 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.599 HG22 ' CE1' ' A' ' 80' ' ' TYR . 91.6 m -131.25 143.67 50.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 111.231 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.3 147.87 19.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.341 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.599 ' CE1' HG22 ' A' ' 78' ' ' THR . 3.8 m-85 -135.17 128.07 31.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.852 0.358 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.619 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -121.93 118.05 27.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.357 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.51 103.51 15.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.063 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.559 ' HE1' HG21 ' A' ' 113' ' ' VAL . 22.1 mtm -81.53 88.22 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.92 176.45 7.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 36.07 44.9 0.28 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.791 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.669 HD23 HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -58.72 156.53 10.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.973 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -123.74 171.76 6.54 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.085 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 86.1 Cg_endo -81.77 11.12 3.21 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.433 2.089 . . . . 0.0 112.884 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -118.53 -6.31 10.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.355 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.586 ' OD2' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -86.32 -13.19 47.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.499 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.763 ' OG1' HG23 ' A' ' 115' ' ' VAL . 99.4 m -54.53 112.52 1.02 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 111.456 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.2 -170.72 1.01 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.172 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.2 t -94.31 105.36 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.586 ' CE2' HG21 ' A' ' 48' ' ' VAL . 11.0 m-85 -86.87 110.67 20.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.051 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.6 t -109.28 127.34 54.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.981 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 46.9 t -77.42 145.62 37.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.08 166.67 30.53 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.693 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.732 ' HB3' ' CB ' ' A' ' 106' ' ' SER . . . -131.08 150.12 52.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.328 . . . . 0.0 110.978 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . -96.36 165.45 23.79 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.805 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -158.27 113.8 2.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.55 16.26 49.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.98 -16.0 28.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.496 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 104' ' ' TRP . 5.2 m -97.72 179.75 4.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.659 0.266 . . . . 0.0 110.393 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.67 ' H ' HG22 ' A' ' 103' ' ' THR . 81.9 m95 -142.13 91.14 2.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 107' ' ' TRP . 7.4 t70 -106.27 -18.4 14.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.142 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.732 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 2.9 t -75.16 130.3 38.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.799 0.333 . . . . 0.0 110.786 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.403 ' CD1' ' O ' ' A' ' 105' ' ' ASP . 58.0 m95 -139.19 165.04 28.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.708 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.04 -156.37 15.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.539 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -86.21 -25.44 25.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.95 150.31 24.08 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 94' ' ' TYR . 2.4 t -152.31 114.03 4.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.823 0.344 . . . . 0.0 110.166 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.495 HE21 ' N ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -79.29 137.75 37.48 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 120.941 0.401 . . . . 0.0 111.034 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.559 HG21 ' HE1' ' A' ' 83' ' ' MET . 56.0 t -116.86 110.76 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.734 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.643 ' HA ' HG23 ' A' ' 91' ' ' THR . 86.4 m -97.42 132.63 42.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.863 0.363 . . . . 0.0 111.361 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.763 HG23 ' OG1' ' A' ' 91' ' ' THR . 2.5 t -112.42 169.18 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.8 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.841 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -144.85 -165.45 2.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.932 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.864 0.364 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.73 156.42 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.409 ' C ' HD12 ' A' ' 4' ' ' LEU . 2.3 mt-30 -153.51 -178.84 7.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.603 HD13 ' HA2' ' A' ' 97' ' ' GLY . 1.4 mp -160.94 77.27 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -69.85 151.8 45.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.773 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -110.57 165.46 11.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.871 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.9 t -166.05 121.65 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.72 -40.76 2.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.703 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.664 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -50.04 139.72 18.6 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.923 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.93 -161.47 27.8 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.431 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.734 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.5 mp -69.43 145.84 52.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.869 0.366 . . . . 0.0 111.514 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.9 p -170.16 111.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.998 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.23 151.97 45.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 117' ' ' SER . . . -49.72 146.95 3.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.332 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.21 -13.67 65.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.55 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.88 114.11 3.95 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.371 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -69.95 136.22 50.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.864 0.364 . . . . 0.0 111.128 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD23 HD21 ' A' ' 20' ' ' LEU . 2.3 tp -136.04 129.95 32.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.178 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.515 ' C ' HD23 ' A' ' 20' ' ' LEU . 5.0 ttp180 -102.43 145.55 29.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.117 0.484 . . . . 0.0 111.651 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.682 ' HG ' HD23 ' A' ' 81' ' ' LEU . 6.4 mt -117.64 147.99 42.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.808 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 90.7 p -125.73 114.21 18.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.274 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.513 ' HB3' HG22 ' A' ' 79' ' ' VAL . 3.8 t -117.16 128.8 55.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.597 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.84 141.64 49.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.371 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.27 131.45 55.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.043 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.0 p -80.99 154.99 26.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.31 137.26 3.02 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.541 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.53 113.14 12.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.28 -169.11 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.01 31.83 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.757 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.8 t -129.3 52.19 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 110.498 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.49 ' O ' HG22 ' A' ' 31' ' ' THR . 17.0 m 65.52 21.28 11.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.729 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.603 ' CD1' ' HB1' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -77.76 86.49 4.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.952 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -70.67 161.15 31.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.743 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.669 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.6 mtm -132.45 128.39 37.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.479 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 50' ' ' ALA . . . -153.29 159.9 28.85 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.113 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.464 ' CZ2' ' HB2' ' A' ' 20' ' ' LEU . 93.1 m95 -86.73 154.11 21.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.12 0.486 . . . . 0.0 110.93 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.3 m-85 -136.89 -176.53 4.4 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.74 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.52 ' HG2' ' CG2' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -146.99 150.75 35.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.837 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.41 ' HG2' ' HG2' ' A' ' 45' ' ' ARG . 1.6 mm-40 -153.81 176.77 11.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.024 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -174.21 152.92 1.89 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.522 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.7 137.15 62.03 Favored 'Trans proline' 0 CA--C 1.518 -0.309 0 C-N-CA 122.29 1.993 . . . . 0.0 112.142 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.09 7.36 37.08 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.512 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.81 -169.58 1.48 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 111.02 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -114.91 176.68 4.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.771 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HG2' ' HG2' ' A' ' 39' ' ' GLN . 2.1 mtm-85 -97.65 134.91 40.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 0.0 111.175 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -138.96 163.65 31.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.439 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.544 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.5 t -110.61 171.15 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.246 0.546 . . . . 0.0 111.236 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.52 ' CG2' ' HG2' ' A' ' 38' ' ' ARG . 6.0 t -129.51 -69.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.306 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 70' ' ' ILE . . . -136.2 133.87 37.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.385 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.722 ' O ' HG22 ' A' ' 58' ' ' THR . . . -128.43 145.2 51.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.017 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 34' ' ' MET . 3.5 tt -128.01 147.85 32.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.358 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -97.97 169.12 9.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.76 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.459 ' CZ3' ' HD2' ' A' ' 72' ' ' ARG . 21.8 t-105 -107.0 -31.18 8.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.14 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.17 -75.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.406 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.423 ' CB ' ' HD2' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -92.92 -87.66 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.298 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -178.71 -29.1 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' HD2' ' CB ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -38.44 151.95 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.767 0.318 . . . . 0.0 111.389 -179.48 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.8 HG21 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -122.46 -178.45 3.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.473 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 23.3 t80 -138.67 90.31 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.39 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.458 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 8.2 m-85 -80.51 154.9 27.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.18 159.69 15.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.194 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 63' ' ' SER . 17.9 p -69.09 153.83 43.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.32 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 62' ' ' SER . 2.3 p 87.12 -12.59 0.52 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.462 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -149.11 15.47 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.335 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 6.5 tpt180 -77.69 83.5 4.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.779 0.8 . . . . 0.0 110.305 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.61 -7.12 3.31 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.587 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.466 ' HD2' ' CE1' ' A' ' 68' ' ' PHE . 1.3 ptp180 -116.52 -38.13 3.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.708 0.29 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.466 ' CE1' ' HD2' ' A' ' 67' ' ' ARG . 3.3 m-30 -90.42 93.82 9.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.49 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 95.5 m -76.53 116.53 17.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.146 0.498 . . . . 0.0 111.313 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -109.69 131.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.772 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.36 172.44 18.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.019 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HD2' ' CZ3' ' A' ' 53' ' ' TRP . 13.5 ttp-105 -105.92 153.92 21.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 39.7 t0 -91.36 -29.64 16.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.4 26.19 14.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.023 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -114.34 -33.47 5.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.073 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.5 42.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.722 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.11 40.86 14.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.701 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.1 m -97.55 148.56 23.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.062 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 22' ' ' CYS . 30.7 m -122.82 132.08 72.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.428 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 25.1 m-85 -113.1 116.07 29.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.988 0.423 . . . . 0.0 110.801 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.682 HD23 ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -113.35 103.29 11.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.445 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -85.9 98.97 11.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.994 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.586 ' HB3' HD11 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -83.53 88.24 7.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.936 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 176.16 6.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.777 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 34.78 48.19 0.3 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.698 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' A' ' 83' ' ' MET . 0.5 OUTLIER -62.09 165.84 5.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.459 . . . . 0.0 111.197 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 33.1 mmtt -135.47 163.54 50.04 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.419 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 63.2 Cg_endo -73.23 9.08 1.54 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.365 2.043 . . . . 0.0 113.091 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.92 9.06 13.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.189 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.66 -7.54 37.25 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.533 0.206 . . . . 0.0 111.401 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.7 m -56.33 113.1 1.43 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.767 0.317 . . . . 0.0 111.271 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 112' ' ' GLN . . . -170.56 -172.53 1.24 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.313 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 84.0 t -96.16 102.63 13.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.183 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.504 ' O ' HG22 ' A' ' 111' ' ' THR . 24.7 m-85 -84.91 99.52 11.0 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.764 0.316 . . . . 0.0 111.117 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 37' ' ' PHE . 62.0 m -106.2 129.97 54.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -99.79 147.77 25.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.456 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.603 ' HA2' HD13 ' A' ' 4' ' ' LEU . . . -159.65 -169.44 22.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.145 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.603 ' HB1' ' CD1' ' A' ' 32' ' ' TYR . . . -134.51 172.68 12.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.875 0.369 . . . . 0.0 110.968 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -147.05 173.35 27.25 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.778 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -160.01 144.92 14.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.58 16.22 49.77 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.58 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.23 -4.92 58.84 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.671 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.656 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.4 m -107.35 179.17 4.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.796 0.331 . . . . 0.0 110.579 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.656 ' H ' HG22 ' A' ' 103' ' ' THR . 77.5 m95 -139.06 105.33 5.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.514 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -12.32 11.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.49 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -93.31 133.43 36.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -144.86 165.0 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.0 -165.55 22.26 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.578 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -75.02 -29.11 60.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.16 152.51 28.73 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.603 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 94' ' ' TYR . 1.9 t -148.16 114.31 5.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.455 HE21 ' N ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -80.22 142.46 34.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.018 0.437 . . . . 0.0 111.228 -179.168 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.455 ' N ' HE21 ' A' ' 112' ' ' GLN . 54.9 t -114.51 131.83 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.961 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.734 ' CB ' HD23 ' A' ' 11' ' ' LEU . 97.6 m -110.38 132.48 54.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.867 0.365 . . . . 0.0 111.182 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 116' ' ' SER . 2.0 t -141.27 168.01 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.156 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.49 ' H ' HG12 ' A' ' 115' ' ' VAL . 55.2 p -167.02 -53.95 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.178 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 2.7 t . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.832 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.786 0.327 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -109.29 154.79 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -104.46 161.39 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.3 mp -148.05 136.8 21.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.1 169.54 17.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -124.96 164.45 20.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 m -166.24 125.79 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 114.01 -30.6 7.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.602 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -49.86 140.32 16.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.896 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.57 175.84 42.44 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.366 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.795 HD23 ' CB ' ' A' ' 114' ' ' THR . 1.8 mp -69.15 144.83 53.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.88 0.371 . . . . 0.0 111.468 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.83 126.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -58.97 155.97 12.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.252 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.46 131.7 20.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.388 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.75 3.18 83.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.743 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.63 118.77 6.01 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.471 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.53 140.64 49.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 0.0 111.231 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.807 ' CD2' HD21 ' A' ' 20' ' ' LEU . 3.7 tp -136.0 129.1 31.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.703 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.46 119.26 39.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.807 HD21 ' CD2' ' A' ' 18' ' ' LEU . 12.7 mt -100.74 138.72 37.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.005 0.431 . . . . 0.0 110.427 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.442 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 7.1 m -117.31 111.11 18.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.213 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' HG23 ' A' ' 78' ' ' THR . 42.9 t -106.09 133.58 50.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.533 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.26 160.65 21.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.51 ' HB3' ' HD3' ' A' ' 77' ' ' LYS . . . -152.25 139.56 19.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.956 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.698 ' O ' HG12 ' A' ' 2' ' ' VAL . 4.7 m -114.79 126.6 55.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.05 100.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 122.24 23.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.936 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.0 p -110.9 177.15 4.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.92 33.85 1.81 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.584 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.18 47.27 1.79 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.822 0.344 . . . . 0.0 111.03 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.1 p 55.38 32.98 19.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.719 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -69.63 139.1 53.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.827 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.459 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -130.11 179.8 5.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.638 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.65 ' HB3' HG11 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -136.72 124.71 22.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.754 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.9 160.85 28.34 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.906 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 22' ' ' CYS . 77.2 m95 -95.61 157.15 16.03 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.069 0.461 . . . . 0.0 111.303 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 11.7 m-85 -135.38 179.65 6.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.342 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.18 151.08 34.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.719 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.678 ' O ' ' HB1' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -143.59 148.57 36.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.997 0.427 . . . . 0.0 111.222 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -143.0 158.6 58.66 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.624 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 39.7 Cg_endo -67.11 137.4 44.04 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.318 2.012 . . . . 0.0 112.281 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.64 0.44 48.63 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.649 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.25 -173.77 2.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.874 0.369 . . . . 0.0 111.074 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -118.7 -174.97 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.535 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.46 135.7 40.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 111.113 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.27 119.3 15.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.266 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 1.4 t -68.55 170.03 9.91 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.426 HG21 ' HE1' ' A' ' 94' ' ' TYR . 21.2 t -130.06 -57.6 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.958 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -152.6 163.24 40.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.949 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.568 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -161.08 147.58 14.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.665 HD13 ' N ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -140.09 143.47 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 111.597 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.665 ' N ' HD13 ' A' ' 51' ' ' ILE . 7.9 t-20 -72.33 -155.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.267 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -57.25 3.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.745 0.307 . . . . 0.0 110.409 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -175.04 141.37 0.57 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 0.0 111.313 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.1 t 72.66 41.37 0.56 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.688 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 57' ' ' ARG . . . -137.19 -78.73 0.39 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.775 0.322 . . . . 0.0 110.674 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 162.11 -176.19 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.042 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.733 HG21 HG23 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -115.8 178.92 4.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.239 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.1 t80 -141.55 135.33 30.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.524 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.499 ' CZ ' HG22 ' A' ' 70' ' ' ILE . 28.7 m-85 -123.23 163.1 21.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 110.895 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -106.5 155.92 19.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.987 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.18 34.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 111.762 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 64' ' ' VAL . 41.0 t -121.65 -15.13 8.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.236 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.562 HG12 ' HD2' ' A' ' 67' ' ' ARG . 15.7 m -156.76 19.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.232 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -65.98 80.15 0.08 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.563 0.697 . . . . 0.0 110.846 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.98 -2.38 1.16 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.809 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HD2' HG12 ' A' ' 64' ' ' VAL . 2.6 ptp180 -126.58 -36.16 2.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.833 0.316 . . . . 0.0 111.654 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CE2' HG11 ' A' ' 64' ' ' VAL . 7.8 m-30 -94.2 146.98 23.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.196 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 82' ' ' GLN . 5.5 m -112.89 154.42 26.39 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.406 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.895 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -146.02 134.23 16.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.915 -179.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.895 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -162.49 -172.51 3.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.806 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.557 ' CD ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -134.53 155.65 50.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.573 ' OD1' ' HB2' ' A' ' 75' ' ' ALA . 7.4 t0 -69.05 -27.84 66.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.042 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 66.71 23.34 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.022 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HB2' ' OD1' ' A' ' 73' ' ' ASP . . . -102.87 -57.78 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.923 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 4.4 ptpp? -130.21 -54.59 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.713 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 1.8 ttmp? 169.6 74.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.647 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.605 HG22 ' CE1' ' A' ' 80' ' ' TYR . 33.4 m -137.7 140.62 40.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.085 0.469 . . . . 0.0 111.243 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 34' ' ' MET . 35.3 m -116.03 135.91 54.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.827 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.605 ' CE1' HG22 ' A' ' 78' ' ' THR . 1.5 m-85 -124.79 129.54 50.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.758 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.733 HD21 HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -118.09 118.95 33.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 110.404 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.554 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -93.36 102.83 15.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.031 -179.109 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.544 ' HE3' HD11 ' A' ' 81' ' ' LEU . 1.6 mtt -91.59 88.73 6.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.444 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.16 175.89 8.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.666 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 35.35 50.4 0.54 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.881 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.475 HD23 HG22 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -61.09 161.06 9.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.809 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.63 ' O ' HG11 ' A' ' 115' ' ' VAL . 4.2 mttp -134.07 172.82 6.65 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.919 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 87' ' ' LYS . 72.0 Cg_endo -76.28 5.0 4.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.546 2.164 . . . . 0.0 113.076 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.2 tp10 -103.25 -16.95 15.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.739 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -78.48 -17.0 56.91 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.097 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 99.4 m -51.74 102.78 0.05 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.076 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.48 -171.57 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.923 0.392 . . . . 0.0 111.56 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.483 HG22 ' HG3' ' A' ' 112' ' ' GLN . 91.2 t -93.16 109.87 22.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.82 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.51 ' CE1' ' HE1' ' A' ' 83' ' ' MET . 13.2 m-85 -91.89 109.07 20.4 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.651 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 m -108.72 139.2 43.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.0 111.372 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.7 t -94.86 146.04 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.645 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 107' ' ' TRP . . . -148.0 -178.82 23.49 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.74 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.719 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -142.46 165.44 27.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.024 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.58 168.87 14.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.812 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -167.74 120.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.728 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.6 14.76 51.54 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.817 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.46 -12.95 43.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.434 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.658 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.3 m -101.89 -179.96 4.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.687 0.28 . . . . 0.0 110.538 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.658 ' H ' HG22 ' A' ' 103' ' ' THR . 73.3 m95 -137.41 81.84 1.89 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.767 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.27 13.7 24.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.463 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.684 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -105.54 130.02 53.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.813 0.339 . . . . 0.0 110.853 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.406 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 31.5 m95 -137.62 164.5 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.045 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.89 -118.29 4.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.6 -44.48 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 110.984 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.97 152.03 13.66 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.762 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 111' ' ' THR . 15.3 t -154.28 117.23 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 0.0 110.263 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.483 ' HG3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -80.17 143.29 33.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.0 0.429 . . . . 0.0 111.007 -179.334 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.469 ' N ' HE21 ' A' ' 112' ' ' GLN . 48.4 t -116.13 128.46 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.21 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.795 ' CB ' HD23 ' A' ' 11' ' ' LEU . 95.0 m -104.53 122.19 45.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.155 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.63 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -119.67 -151.58 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.393 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 115' ' ' VAL . 75.2 m 65.76 156.22 0.09 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.889 0.376 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.99 156.87 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.976 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.72 153.59 45.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.841 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.443 HD11 ' OH ' ' A' ' 32' ' ' TYR . 3.4 mp -143.56 122.59 12.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.868 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -138.51 163.93 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.09 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.71 163.63 14.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.71 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.06 117.32 3.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.914 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.02 -31.41 6.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.498 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -49.51 140.58 14.2 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.878 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.75 -159.2 30.55 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.395 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.404 HD23 HG21 ' A' ' 114' ' ' THR . 1.7 mp -69.45 150.13 47.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.845 0.355 . . . . 0.0 111.427 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.1 p -165.53 106.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.975 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -56.26 150.03 15.23 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.308 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.77 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -51.22 141.5 14.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.318 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.16 -4.66 85.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.753 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.4 119.82 6.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.299 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 p -69.87 133.68 47.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 111.229 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.869 ' CD2' HD21 ' A' ' 20' ' ' LEU . 6.5 tp -118.81 132.09 56.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.425 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.34 121.08 43.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 0.0 111.472 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.869 HD21 ' CD2' ' A' ' 18' ' ' LEU . 15.7 mt -109.32 137.88 46.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.409 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -119.99 113.18 20.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.172 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 17.4 t -111.04 133.91 53.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.361 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.2 147.16 32.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.199 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.51 ' HB3' ' HE3' ' A' ' 34' ' ' MET . . . -150.18 78.78 1.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.075 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -98.38 163.44 12.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.5 -149.08 20.18 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.513 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.59 105.33 13.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.868 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 p -152.07 123.22 7.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.01 35.76 1.35 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.611 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.4 -72.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.986 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.5 p -156.88 36.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.659 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.0 t80 -69.51 65.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.078 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.473 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 5.3 m-20 -58.85 178.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.597 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.688 ' HB3' HG11 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -141.87 118.36 10.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 111.025 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -154.54 150.47 22.05 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.811 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.479 ' CD2' HD22 ' A' ' 81' ' ' LEU . 76.2 m95 -88.82 152.69 21.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.224 0.535 . . . . 0.0 111.176 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.543 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.0 m-85 -131.98 -177.31 4.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.727 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HD2' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -151.23 161.48 42.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.723 179.535 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.614 ' O ' HG12 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -163.59 158.72 20.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.995 0.426 . . . . 0.0 111.284 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.549 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -148.27 161.33 34.46 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.681 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.549 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 37.1 Cg_endo -65.73 137.13 48.53 Favored 'Trans proline' 0 CA--C 1.518 -0.322 0 C-N-CA 122.256 1.971 . . . . 0.0 112.343 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.05 3.05 42.71 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.33 -174.73 2.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.78 0.324 . . . . 0.0 111.035 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -111.17 -171.16 1.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -90.62 131.66 36.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.062 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -133.0 129.62 38.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.599 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.543 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.3 t -85.45 171.28 11.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.285 0.564 . . . . 0.0 110.877 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.565 HG21 ' HE1' ' A' ' 94' ' ' TYR . 5.8 t -127.2 -68.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.403 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -142.67 129.21 20.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.237 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.57 ' HB1' ' CH2' ' A' ' 104' ' ' TRP . . . -132.67 143.16 49.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.377 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.838 ' HB ' HG23 ' A' ' 58' ' ' THR . 2.0 tt -120.51 136.6 57.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.32 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.13 171.03 14.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.378 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.7 33.24 5.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.608 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.95 21.78 5.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.9 t 57.9 91.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.01 -71.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.194 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -179.15 -166.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.19 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.838 HG23 ' HB ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -111.47 -178.46 3.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.809 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 50.8 t80 -137.61 96.24 3.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.935 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -85.9 157.14 20.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 111.033 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.75 162.9 13.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.333 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.0 m -81.76 33.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.015 0.436 . . . . 0.0 111.709 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -118.94 -25.3 6.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.838 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 30.8 m -148.7 18.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.03 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -71.22 81.21 0.72 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.761 0.791 . . . . 0.0 110.451 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 145.52 -6.69 1.47 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 114.431 -1.259 . . . . 0.0 112.495 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.446 ' CZ ' HG12 ' A' ' 64' ' ' VAL . 3.4 ptt180 -123.56 -37.53 2.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.681 0.277 . . . . 0.0 111.305 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.526 ' CZ ' HG11 ' A' ' 64' ' ' VAL . 4.8 m-30 -84.15 152.23 24.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.078 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 28.9 m -125.22 154.13 42.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.935 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.781 HG21 HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -144.52 137.91 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.073 -179.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.413 ' N ' HG13 ' A' ' 70' ' ' ILE . 90.0 p -163.06 135.76 5.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.628 ' HE ' HD13 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -88.4 166.94 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.023 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.423 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 11.2 t0 -94.05 -31.0 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.985 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.78 28.62 16.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.928 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.33 -52.03 2.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.07 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -132.67 31.6 3.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt 61.74 50.55 4.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 59.3 m -114.0 150.19 34.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.821 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.688 HG11 ' HB3' ' A' ' 34' ' ' MET . 34.7 m -122.53 145.24 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.835 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 27.2 m-85 -130.64 118.79 21.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.972 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.629 HD23 ' HB2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -114.86 113.98 24.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 110.324 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -92.96 99.26 11.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.158 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.516 ' HE2' ' CZ ' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -79.88 86.79 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.88 176.35 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 36.6 47.36 0.52 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.805 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.462 HD23 ' OD2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -59.04 161.84 4.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.788 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -122.9 172.24 5.64 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.139 0.495 . . . . 0.0 111.678 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.69 13.44 2.11 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.567 2.178 . . . . 0.0 112.961 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -131.02 13.73 5.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.504 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.563 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -89.08 -7.14 56.4 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.529 0.204 . . . . 0.0 111.192 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.0 m -55.81 107.75 0.38 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.664 0.269 . . . . 0.0 111.373 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.42 170.23 7.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.551 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 93' ' ' VAL . 5.3 p -82.09 107.07 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.565 ' HE1' HG21 ' A' ' 48' ' ' VAL . 10.4 m-85 -87.7 103.72 15.86 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.832 0.349 . . . . 0.0 111.256 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.493 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 5.6 t -104.99 130.46 53.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.426 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.7 t -84.96 142.56 29.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.281 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.52 162.46 29.31 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.755 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.41 165.49 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.836 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 32' ' ' TYR . . . -96.82 179.34 34.11 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.682 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 177.9 118.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 0.0 110.698 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.7 14.48 50.97 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.811 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.66 -11.99 46.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.577 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.5 m -106.08 -179.26 3.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.642 0.258 . . . . 0.0 110.521 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.684 ' H ' HG22 ' A' ' 103' ' ' THR . 57.0 m95 -137.22 87.1 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.663 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -118.12 10.23 12.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.608 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.01 61.44 1.51 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.191 0.52 . . . . 0.0 110.768 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -69.97 165.46 21.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.104 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -110.74 -141.74 8.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.567 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -89.68 -48.25 7.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.331 . . . . 0.0 111.0 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 111.12 151.58 12.24 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.766 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 111' ' ' THR . 12.0 t -153.77 113.27 3.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -74.6 142.05 44.66 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.091 0.472 . . . . 0.0 111.272 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 91' ' ' THR . 55.8 t -114.65 117.79 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.037 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.404 HG21 HD23 ' A' ' 11' ' ' LEU . 88.8 m -96.69 119.35 35.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.094 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.788 HG11 ' O ' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -110.68 -167.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.4 179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 54.4 p -176.38 -166.99 0.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.813 0.34 . . . . 0.0 110.883 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.924 0.392 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -112.08 155.17 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.492 ' C ' HD12 ' A' ' 4' ' ' LEU . 50.6 mm-40 -158.22 172.57 18.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 3' ' ' GLN . 4.7 mp -153.89 148.94 26.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.32 166.76 29.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.957 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.28 162.79 23.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.782 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.6 p -170.0 118.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.8 -27.67 4.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.596 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -53.69 179.83 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.716 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.12 177.9 25.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.317 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.805 HD23 HG21 ' A' ' 114' ' ' THR . 1.4 mp -69.03 126.05 28.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.074 0.464 . . . . 0.0 111.33 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.966 HG11 ' HB2' ' A' ' 18' ' ' LEU . 29.5 m -126.75 140.33 49.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.606 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -70.13 138.58 52.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.922 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -53.17 126.09 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.405 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.94 19.38 36.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.681 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -113.31 -156.43 12.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.405 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 t -138.64 137.89 37.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.933 0.397 . . . . 0.0 111.116 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.966 ' HB2' HG11 ' A' ' 12' ' ' VAL . 12.9 tp -135.18 133.29 38.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.589 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -110.68 126.74 54.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.338 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.587 HD21 ' CD2' ' A' ' 18' ' ' LEU . 5.7 mt -113.81 139.34 49.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.242 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.8 p -115.98 114.82 25.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.994 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.7 t -106.54 134.69 49.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.617 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -122.89 142.03 51.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.127 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -116.6 -178.41 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.512 ' O ' HG12 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -156.45 156.55 33.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.78 111.35 1.78 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.65 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -71.16 113.42 8.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 110.665 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.7 172.03 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 110.927 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.32 -29.91 2.2 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.625 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -69.87 -9.79 56.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.578 0.228 . . . . 0.0 111.548 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.3 m 71.07 60.2 0.18 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.976 0.417 . . . . 0.0 110.834 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.546 ' CD2' ' HB1' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -69.14 132.33 46.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.622 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -83.95 -176.64 6.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.084 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.1 mtp -144.02 126.61 16.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -148.33 154.45 25.87 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.928 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.544 ' CE2' HD22 ' A' ' 81' ' ' LEU . 73.9 m95 -86.93 153.84 21.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 111.438 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.4 m-85 -135.89 -178.81 5.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.768 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.494 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.9 OUTLIER -147.66 155.05 41.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.976 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.641 ' O ' HG12 ' A' ' 93' ' ' VAL . 2.1 tm0? -154.34 135.77 14.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.93 147.68 57.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.744 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.65 136.84 51.66 Favored 'Trans proline' 0 CA--C 1.517 -0.351 0 C-N-CA 122.247 1.965 . . . . 0.0 112.273 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.9 3.02 41.43 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.6 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.41 -162.92 0.82 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.692 0.282 . . . . 0.0 110.953 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -118.01 158.2 25.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.789 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.416 ' CG ' ' HG2' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -76.76 149.37 36.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.072 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.29 165.42 34.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.711 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.549 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.8 t -107.04 172.19 6.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.151 0.501 . . . . 0.0 110.865 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.494 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.6 t -128.58 -69.36 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.652 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -147.4 133.5 19.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 0.0 111.356 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.534 ' O ' HG22 ' A' ' 58' ' ' THR . . . -130.96 143.39 50.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.222 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.652 ' HB ' HG23 ' A' ' 58' ' ' THR . 7.3 tp -124.57 141.14 45.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.182 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -81.67 -163.15 0.6 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.57 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.35 59.03 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.994 0.426 . . . . 0.0 110.467 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 60.19 29.91 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.5 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.3 p -89.66 -53.09 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.235 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.67 -73.19 0.51 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.809 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.18 -161.06 0.35 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 111.19 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 1.036 HG21 HG21 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -96.75 -178.44 4.24 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.022 0.439 . . . . 0.0 110.974 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' N ' ' O ' ' A' ' 50' ' ' ALA . 7.0 t80 -140.18 93.06 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.719 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -76.98 159.42 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.844 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.87 165.97 12.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.133 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 63' ' ' SER . 2.5 p -69.48 150.94 46.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.666 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 62' ' ' SER . 0.3 OUTLIER 86.7 -12.38 0.56 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.618 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' A' ' 68' ' ' PHE . 16.9 m -149.15 12.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.525 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -81.39 81.85 7.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.634 0.73 . . . . 0.0 110.513 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.87 -6.81 2.38 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.309 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -119.08 -46.71 2.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.669 0.271 . . . . 0.0 111.257 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CE2' HG11 ' A' ' 64' ' ' VAL . 6.7 m-30 -69.94 139.85 52.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.702 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 6.9 m -111.55 153.45 26.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.887 0.375 . . . . 0.0 111.02 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.036 HG21 HG21 ' A' ' 58' ' ' THR . 0.5 OUTLIER -139.45 140.34 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.834 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.439 ' N ' HG13 ' A' ' 70' ' ' ILE . 9.9 t -154.69 123.65 6.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 162.08 29.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.961 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . 42.6 t0 -91.89 -38.26 12.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 59.7 47.78 10.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.743 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.3 -60.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -126.82 33.1 5.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.21 54.17 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 110.598 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.407 ' HB ' ' CB ' ' A' ' 73' ' ' ASP . 92.7 m -119.17 148.83 42.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.073 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.44 144.09 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.673 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 73' ' ' ASP . 28.5 m-85 -127.45 120.14 27.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.821 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.587 HD21 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -115.28 116.66 28.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.103 0.478 . . . . 0.0 110.644 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -95.9 96.09 8.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.962 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.574 ' HE1' HD11 ' A' ' 20' ' ' LEU . 15.6 mtm -80.41 95.42 6.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.95 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.35 176.71 6.62 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.734 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 t 35.9 40.59 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.739 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -55.34 163.72 1.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.211 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.74 160.96 48.94 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.802 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.1 3.73 5.92 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.49 2.127 . . . . 0.0 112.848 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 12.7 tp10 -107.01 -10.38 15.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.782 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.66 -10.53 59.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.932 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 73.3 m -48.31 106.07 0.09 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.403 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.51 177.92 3.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.328 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 39' ' ' GLN . 5.0 p -83.95 107.35 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.454 ' CD1' HG21 ' A' ' 113' ' ' VAL . 6.1 m-85 -83.99 99.36 10.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.975 0.417 . . . . 0.0 110.679 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 m -103.04 132.05 49.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.282 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.7 t -90.42 135.62 33.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.657 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -136.16 176.0 20.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.402 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.546 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -131.57 148.01 52.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . -107.82 151.1 16.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.606 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -143.8 126.61 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.674 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.31 15.8 52.53 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.784 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.19 -9.77 46.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.791 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.7 m -102.22 179.98 4.16 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.598 0.237 . . . . 0.0 110.419 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.67 ' H ' HG22 ' A' ' 103' ' ' THR . 76.6 m95 -145.28 92.29 2.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -115.34 -2.76 12.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.406 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -94.41 132.39 39.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -136.55 164.67 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.28 -141.65 10.12 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.48 -45.49 8.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 113.11 153.82 11.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.532 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 1.8 t -152.58 106.93 3.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 110.526 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -60.21 141.66 55.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.136 0.493 . . . . 0.0 110.996 -179.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.4 t -119.91 88.01 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.181 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.805 HG21 HD23 ' A' ' 11' ' ' LEU . 59.1 m -76.67 132.87 39.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.218 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.541 HG21 HD23 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -144.79 156.51 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.396 179.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 1.1 m 172.31 169.78 0.11 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.917 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.967 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.884 0.373 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.524 HG13 ' HA3' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -113.53 156.79 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.966 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.33 139.67 21.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mp -114.83 138.87 50.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 11.2 mt-30 -144.89 134.28 23.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.667 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.13 163.52 13.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.859 0.361 . . . . 0.0 110.897 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.9 t -163.79 118.93 1.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.16 -37.57 3.04 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.715 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.712 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -49.12 139.16 14.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.095 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.43 -165.7 34.0 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.413 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.566 HD23 HG21 ' A' ' 114' ' ' THR . 1.8 mp -69.35 148.64 49.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.882 0.372 . . . . 0.0 111.595 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.673 HG13 HD22 ' A' ' 86' ' ' LEU . 7.2 p -170.12 106.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -56.68 159.59 3.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.347 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 116' ' ' SER . . . -51.2 153.71 1.9 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.304 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.48 9.2 68.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.647 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.74 113.62 2.92 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.383 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 m -69.95 135.96 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.154 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.737 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.8 tp -133.4 131.64 40.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.66 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -108.07 129.58 55.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.162 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.737 HD21 ' CD2' ' A' ' 18' ' ' LEU . 3.7 mt -113.68 144.87 42.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.131 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.474 ' HG ' ' HD2' ' A' ' 80' ' ' TYR . 1.9 m -126.97 118.98 25.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.498 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.511 ' SG ' HG23 ' A' ' 79' ' ' VAL . 19.3 p -125.07 121.34 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.999 0.428 . . . . 0.0 110.354 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.26 171.66 9.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.349 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.98 55.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.0 p -70.08 154.38 42.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.524 ' HA3' HG13 ' A' ' 2' ' ' VAL . . . 167.23 -110.02 0.38 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.488 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.52 65.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -127.73 -167.55 1.77 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' H ' HG22 ' A' ' 28' ' ' THR . . . 147.69 39.32 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.797 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.6 t -124.44 -70.77 0.74 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.803 0.335 . . . . 0.0 110.73 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.63 27.45 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 2.0 t80 -69.76 65.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.065 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.427 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 12.8 m-20 -48.58 164.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.846 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.425 ' CE ' HG13 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -145.5 126.28 14.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.821 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.423 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -155.82 155.13 26.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.818 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.866 ' CE2' HD22 ' A' ' 81' ' ' LEU . 78.4 m95 -84.34 153.36 23.53 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.066 0.46 . . . . 0.0 111.022 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 8.9 m-85 -133.2 -176.38 4.11 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.389 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.532 ' CG ' HG22 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -146.81 156.67 43.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.668 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -153.94 111.39 3.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.125 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -97.96 160.74 27.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.685 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 53.8 Cg_endo -69.53 136.99 35.04 Favored 'Trans proline' 0 CA--C 1.518 -0.315 0 C-N-CA 122.294 1.996 . . . . 0.0 112.322 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.33 1.89 30.6 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.665 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.56 -174.8 2.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 110.974 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -103.18 -172.76 2.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.598 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -99.26 124.99 44.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -123.18 137.91 54.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.711 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.5 t -75.43 172.19 12.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.517 0.675 . . . . 0.0 111.526 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.532 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.7 t -131.02 -67.7 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.107 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -142.8 128.16 18.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.119 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 59' ' ' TYR . . . -136.29 145.99 46.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.743 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.826 ' HB ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -123.12 140.82 45.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.239 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -78.5 158.64 28.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.029 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.82 46.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.599 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.443 ' OD2' ' HB2' ' A' ' 56' ' ' ALA . 2.3 p-10 -144.45 21.73 1.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.58 56.41 7.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.03 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.443 ' HB2' ' OD2' ' A' ' 54' ' ' ASP . . . -113.34 -72.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.242 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -175.57 172.95 2.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.986 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.826 HG23 ' HB ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -96.87 179.74 4.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.745 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 57.4 t80 -140.42 95.59 2.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.574 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 68' ' ' PHE . 78.3 m-85 -78.99 169.84 17.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.45 170.73 7.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.3 OUTLIER -69.67 150.86 46.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.715 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 62' ' ' SER . 3.0 t 81.96 -8.04 1.33 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.752 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -151.29 11.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.434 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 79.23 0.86 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.534 0.683 . . . . 0.0 110.681 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.9 1.71 5.8 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.07 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.39 -52.92 2.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 4.4 m-30 -74.86 133.65 41.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.668 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 25.0 m -95.68 153.33 17.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.03 0.443 . . . . 0.0 110.975 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.898 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -152.78 136.12 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.596 -179.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.898 ' N ' HD13 ' A' ' 70' ' ' ILE . 10.3 t -156.14 153.39 29.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.958 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.413 ' HG3' HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -101.65 141.42 34.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.822 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.596 ' OD2' ' HB3' ' A' ' 75' ' ' ALA . 26.5 t0 -74.67 -30.37 61.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.916 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 m120 59.59 27.38 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.596 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -119.94 -54.63 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.018 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -122.76 27.33 7.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp 59.49 51.09 6.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.852 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.61 HG22 ' CE1' ' A' ' 80' ' ' TYR . 69.3 m -122.16 148.67 44.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.125 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.511 HG23 ' SG ' ' A' ' 22' ' ' CYS . 17.3 m -119.0 142.35 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.699 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.61 ' CE1' HG22 ' A' ' 78' ' ' THR . 1.2 m-85 -128.36 138.15 52.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.866 HD22 ' CE2' ' A' ' 36' ' ' TRP . 1.1 pt? -131.35 124.26 30.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.095 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -96.78 99.74 11.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.165 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -84.69 89.69 7.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.64 174.28 11.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 0.0 111.184 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 32.4 47.08 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.951 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.673 HD22 HG13 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -48.56 158.95 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 111.125 -179.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -126.42 174.34 4.23 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.632 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 87' ' ' LYS . 86.3 Cg_endo -81.18 8.22 4.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.436 2.091 . . . . 0.0 112.855 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -109.69 -8.66 14.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.8 -20.01 43.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.234 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 114' ' ' THR . 95.5 m -54.22 101.99 0.05 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 111.305 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.54 -175.61 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.8 t -87.37 102.89 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.623 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -83.65 104.38 13.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.454 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 19.0 m -105.3 132.35 51.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.328 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.0 t -96.16 135.73 37.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.601 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.3 177.3 20.79 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.706 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -131.59 167.56 19.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.357 . . . . 0.0 111.012 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -119.45 -165.63 13.1 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.825 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.62 113.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.798 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.99 52.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.62 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.83 -12.41 34.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.752 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.634 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.2 m -96.15 177.52 5.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.891 0.377 . . . . 0.0 110.8 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.634 ' H ' HG22 ' A' ' 103' ' ' THR . 76.8 m95 -145.42 107.26 4.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.741 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -133.35 10.67 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.396 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 1.4 t -112.19 134.67 53.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.817 0.341 . . . . 0.0 110.896 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -141.6 165.05 28.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -108.05 -152.62 16.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -85.54 -31.86 22.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 95.72 156.44 31.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.65 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 111' ' ' THR . 14.8 t -147.99 112.7 5.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.341 . . . . 0.0 110.527 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.02 141.37 56.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 110.992 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 91' ' ' THR . 42.4 t -120.02 136.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.445 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.566 HG21 HD23 ' A' ' 11' ' ' LEU . 48.1 m -121.18 137.43 54.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.857 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.659 ' CG2' HD23 ' A' ' 86' ' ' LEU . 2.1 t -135.69 168.37 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.248 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -136.36 -167.17 2.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.059 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.897 -179.969 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.852 0.358 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.96 155.06 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.224 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -91.85 162.35 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 24' ' ' ALA . 5.0 mp -145.72 130.61 18.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -118.06 157.03 27.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.777 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.26 168.3 9.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.072 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.15 131.82 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.969 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.21 -18.59 57.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.749 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.588 ' HA2' HD22 ' A' ' 20' ' ' LEU . . . -52.07 138.27 31.29 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.874 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.85 -169.63 39.74 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.435 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.83 HD23 HG21 ' A' ' 114' ' ' THR . 1.7 mp -69.51 154.33 42.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.902 0.382 . . . . 0.0 111.58 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.654 ' HB ' HD13 ' A' ' 18' ' ' LEU . 7.2 p -154.39 113.92 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.927 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.0 144.18 7.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.384 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.577 ' HA ' HG12 ' A' ' 115' ' ' VAL . . . -49.81 121.35 5.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.314 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.8 15.32 58.22 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.599 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.415 ' O ' HG21 ' A' ' 12' ' ' VAL . . . -109.72 133.36 11.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.371 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER -71.12 126.2 28.95 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.099 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.918 ' CD2' HD21 ' A' ' 20' ' ' LEU . 5.2 tp -120.52 131.34 54.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.523 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -110.23 122.44 47.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 111.607 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.918 HD21 ' CD2' ' A' ' 18' ' ' LEU . 6.8 mt -113.21 138.06 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.193 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.465 ' HB2' ' CD2' ' A' ' 80' ' ' TYR . 12.6 t -121.47 118.62 29.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.967 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 5.9 p -126.66 133.56 50.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.984 0.421 . . . . 0.0 111.174 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -113.87 172.85 6.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.234 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.41 ' HB2' ' HG ' ' A' ' 4' ' ' LEU . . . -138.34 120.63 15.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.6 t -82.55 110.35 17.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 164.46 -176.5 40.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.446 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ttm-85 -107.1 137.41 45.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.811 0.339 . . . . 0.0 110.937 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.544 HG21 ' CH2' ' A' ' 53' ' ' TRP . 16.8 p -102.4 -178.07 3.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.776 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.37 -26.0 2.97 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.806 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 t -94.52 36.33 1.17 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.602 0.239 . . . . 0.0 111.225 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.91 33.47 7.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.952 0.406 . . . . 0.0 110.567 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.738 ' CE2' ' HB1' ' A' ' 98' ' ' ALA . 1.5 t80 -69.45 122.87 19.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.722 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 104' ' ' TRP . 46.7 m-20 -110.1 178.76 4.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.775 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.516 ' HB3' HG11 ' A' ' 79' ' ' VAL . 1.8 ttm -150.11 129.6 13.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.123 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 50' ' ' ALA . . . -150.15 154.47 25.69 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.839 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.665 ' CE2' HD22 ' A' ' 81' ' ' LEU . 84.8 m95 -83.57 155.61 23.19 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.1 0.476 . . . . 0.0 111.312 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 47' ' ' SER . 7.4 m-85 -137.82 -178.28 5.18 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.473 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.556 ' CG ' HG22 ' A' ' 48' ' ' VAL . 2.0 mtm180 -148.41 159.33 44.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.993 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -153.63 109.12 3.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.107 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.66 154.06 38.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.714 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.2 140.43 44.75 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.369 2.046 . . . . 0.0 112.426 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.0 -8.17 39.2 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.728 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -117.87 -179.1 3.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.842 0.353 . . . . 0.0 110.914 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.26 170.63 8.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.552 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.88 130.66 35.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.802 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.14 144.34 51.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.608 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.526 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.0 t -80.76 174.82 11.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.211 0.529 . . . . 0.0 111.054 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.556 HG22 ' CG ' ' A' ' 38' ' ' ARG . 2.1 t -131.45 -70.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.358 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 59' ' ' TYR . . . -141.26 133.78 28.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 58' ' ' THR . . . -130.33 143.39 50.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.417 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.664 ' HB ' HG23 ' A' ' 58' ' ' THR . 6.5 tp -123.4 142.42 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.045 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -80.05 -164.42 0.67 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.951 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.544 ' CH2' HG21 ' A' ' 28' ' ' THR . 10.6 t-105 -109.97 64.91 0.61 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.714 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 61.82 56.85 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.65 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 m -123.34 -71.38 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -115.41 -72.57 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.498 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -172.71 -153.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.901 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.729 HG21 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -99.16 -179.94 4.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.991 0.424 . . . . 0.0 110.95 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 49' ' ' ALA . 45.2 t80 -137.92 97.8 3.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.783 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -78.65 155.5 29.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.826 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.13 176.1 5.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.225 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -69.57 151.68 45.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.655 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 62' ' ' SER . 1.7 m 81.99 -9.0 1.25 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.571 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.53 HG21 ' CG1' ' A' ' 48' ' ' VAL . 35.4 m -151.56 13.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.352 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.74 80.11 1.12 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.707 0.765 . . . . 0.0 110.387 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.16 6.91 17.78 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.812 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -110.96 -45.31 3.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.814 0.34 . . . . 0.0 111.192 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CE2' HG11 ' A' ' 64' ' ' VAL . 7.8 m-30 -93.02 149.59 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.018 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 14.2 m -107.33 155.5 19.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.909 HD13 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -158.13 136.45 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.116 -179.018 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.909 ' N ' HD13 ' A' ' 70' ' ' ILE . 1.9 p -154.74 170.69 21.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.415 ' HB3' ' NH1' ' A' ' 72' ' ' ARG . 16.9 mtp-105 -113.62 146.19 40.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.926 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 22.5 t0 -89.9 -11.02 43.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.339 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 43.65 30.97 0.4 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.767 0.317 . . . . 0.0 111.558 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.7 -64.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.32 39.0 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.79 52.18 2.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.828 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.562 HG22 ' CE1' ' A' ' 80' ' ' TYR . 79.9 m -115.92 143.92 44.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.116 0.484 . . . . 0.0 111.358 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 34' ' ' MET . 32.7 m -121.98 132.3 71.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.033 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.562 ' CE1' HG22 ' A' ' 78' ' ' THR . 2.5 m-85 -115.32 119.43 36.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.665 HD22 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -115.17 115.47 26.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.058 0.456 . . . . 0.0 110.48 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.01 92.48 6.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.785 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.435 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -73.09 92.1 1.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.009 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -86.74 176.02 7.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 35.96 47.22 0.4 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.723 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.404 ' CD1' ' CB ' ' A' ' 83' ' ' MET . 0.2 OUTLIER -64.94 158.49 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.844 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.503 ' O ' HG11 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -112.12 166.52 10.76 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.686 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.92 11.99 2.38 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.616 2.21 . . . . 0.0 112.959 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -131.76 11.42 4.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.495 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -87.08 -5.18 59.12 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.634 0.254 . . . . 0.0 111.195 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 89.5 m -55.39 118.01 4.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.715 0.293 . . . . 0.0 111.028 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -170.52 -172.26 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.499 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 93.0 t -92.99 106.26 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.496 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -88.57 103.06 15.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.874 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.421 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 6.1 t -105.75 142.22 35.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.226 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.57 144.36 25.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.92 175.89 20.07 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.313 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.738 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -143.59 167.65 21.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.902 0.382 . . . . 0.0 111.312 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 104' ' ' TRP . . . -121.26 178.39 16.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.848 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -164.52 117.89 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.751 0.31 . . . . 0.0 110.416 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.8 16.41 51.54 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.729 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.66 -12.63 35.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.83 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.635 HG22 ' H ' ' A' ' 104' ' ' TRP . 4.2 m -97.19 178.71 5.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.762 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.635 ' H ' HG22 ' A' ' 103' ' ' THR . 78.5 m95 -141.56 103.96 4.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -136.66 21.26 3.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.114 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.655 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -115.03 138.16 51.18 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.801 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -137.34 166.87 22.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.003 0.43 . . . . 0.0 111.117 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -111.03 -155.97 14.02 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.443 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -82.32 -41.1 20.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.948 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 95' ' ' THR . . . 104.86 151.37 21.0 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.799 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 111' ' ' THR . 11.0 t -152.62 121.06 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.423 HE21 ' N ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -77.7 144.38 37.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.957 0.408 . . . . 0.0 111.045 -179.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.423 ' N ' HE21 ' A' ' 112' ' ' GLN . 54.1 t -115.03 128.11 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.321 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.83 HG21 HD23 ' A' ' 11' ' ' LEU . 93.7 m -100.93 130.48 46.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.992 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -136.2 -162.0 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.611 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.501 ' H ' HG12 ' A' ' 115' ' ' VAL . 6.0 t 76.0 171.38 0.25 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.857 0.36 . . . . 0.0 110.825 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.959 -179.835 . . . . . . . . 0 0 . 1 stop_ save_